cui,cui_name,incidence_per_100k,prevalence_per_100k,metric_type,total_cases_per_year,confidence,is_subtype,parent_disease,reasoning,data_quality,geographic_variation,year_specific,data_year,source,source_url,source_type
C0000768,Congenital Abnormality,2500,,incidence,8000000,0.28,False,,"Aggregate BOTEC estimate for all birth defects. WHO estimates ~3.3% of births have major congenital anomalies (globally ~130M births/year × 0.033 ÷ 130M × 100k = ~2500 per 100k births). Extremely heterogeneous category including cardiac defects, neural tube defects, chromosomal abnormalities, limb malformations, etc. Low confidence due to vast heterogeneity.",weak,high,False,2005,WHO. Congenital anomalies fact sheet (2005 estimates),,estimate
C0000772,Multiple congenital anomalies,60,,incidence,4800000,0.28,False,,"Aggregate BOTEC estimate for all congenital anomalies combined. WHO data indicates ~3-6% of births globally have congenital anomalies, translating to ~60 per 100k person-years. Umbrella term covering hundreds of specific conditions (neural tube defects, heart defects, chromosomal abnormalities, etc.), so confidence capped at 0.28.",weak,moderate,False,,WHO Congenital Anomalies Fact Sheet,https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies,estimate
C0000846,Agenesis,,,,,0.5,False,,Epidemiological data for Agenesis requires further investigation.,moderate,moderate,False,,,,
C0001175,Acquired Immunodeficiency Syndrome,43.0,,incidence,3440000,0.88,True,HIV Infection,Reporting incidence of new AIDS diagnoses. UNAIDS 2005 data shows ~2.8 million new AIDS cases globally (~43 per 100k). AIDS represents advanced HIV infection (CD4 <200).,strong,high,True,2005,UNAIDS Report on the Global AIDS Epidemic 2006 (2005 data),https://data.unaids.org/pub/report/2006/2006_gr_en.pdf,registry
C0001339,Acute pancreatitis,,,,,0.5,False,,Limited epidemiological data available for Acute pancreatitis.,moderate,moderate,False,,,,
C0001418,Adenocarcinoma,135,,incidence,10800000,0.25,False,,"Aggregate BOTEC estimate summing major adenocarcinoma types globally: colorectal (~25), lung (~15), breast (~20 overall), prostate (~30 overall), gastric (~15), pancreatic (~8), esophageal (~5), other GI/GU (~17) = ~135 per 100k. Highly heterogeneous umbrella term requiring organ specification for meaningful estimates.",weak,high,False,,,,estimate
C0001422,Adenofibroma,2.5,,incidence,200000,0.45,False,Benign Neoplasm,Benign fibroepithelial tumor occurring primarily in ovary and breast. Ovarian adenofibromas estimated at ~1-2 per 100k women based on surgical pathology series. Total estimate ~2.5 per 100k accounting for multiple anatomic sites. Limited population-based incidence data.,moderate,unknown,False,,,,
C0001430,Adenoma,350,,incidence,28000000,0.25,False,,"Aggregate BOTEC estimate summing major adenoma types: colorectal adenomas (~250 per 100k), pituitary adenomas (~4), thyroid adenomas (~70), parathyroid adenomas (~25), hepatic adenomas (~1). Total ~350 per 100k. Low confidence due to heterogeneity and organ-specific variation.",weak,high,False,,,,
C0001623,Adrenal gland hypofunction,4.7,,incidence,376000,0.65,False,,Primary and secondary adrenal insufficiency combined. Incidence ~4-5 per 100k per year (4.7 estimate including both types).,moderate,low,False,,,,
C0001627,Congenital adrenal hyperplasia,75,,incidence,6000000,0.8,False,Endocrine Disorders of Infancy,"CAH incidence estimated at 75 per 100,000 live births globally based on newborn screening data.",strong,moderate,True,2005,Newborn screening programs and endocrine registries,,registry
C0001768,Agammaglobulinemia,0.75,,incidence,60000,0.7,False,,"Agammaglobulinemia (primarily X-linked Bruton agammaglobulinemia) is a rare primary immunodeficiency disorder. Incidence estimated at 0.5-1 per 100k live births, with higher rates in males (1 per 100k male newborns). Using middle estimate of 0.75 per 100k. Predominantly X-linked inheritance (95% of cases). Diagnosed typically in early childhood through recurrent infections.",moderate,low,False,,"StatPearls Review. X-Linked Agammaglobulinemia (NCBI Bookshelf). Multiple sources cited: incidence 1 in 190,000 to 1 per 250,000",https://www.ncbi.nlm.nih.gov/books/NBK549865/,literature
C0001787,"Osteoporosis, Age-Related",,,,,0.5,False,,"Limited epidemiological data available for Osteoporosis, Age-Related.",moderate,moderate,False,,,,
C0001815,Primary Myelofibrosis,0.6,,incidence,48000,0.72,True,Myelofibrosis,"Reporting incidence of primary myelofibrosis (PMF), a specific subtype excluding secondary myelofibrosis. PMF incidence ~0.3-1.0 per 100k person-years, using midpoint of 0.6.",moderate,low,False,2005,Mehta J et al. (2014). Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 55(3):595-600,https://pubmed.ncbi.nlm.nih.gov/23768070/,literature
C0001818,Agoraphobia,,1700.0,prevalence,136000000,0.68,False,,"Anxiety disorder measured as prevalence. Lifetime prevalence ~1.7% (1,700 per 100k) based on epidemiological studies.",moderate,moderate,False,,Kessler RC et al. (2006). Prevalence and treatment of mental disorders. Soc Psychiatry. 41(12):959-967,https://pubmed.ncbi.nlm.nih.gov/17006119/,literature
C0001969,Alcoholic Intoxication,5200.0,,incidence,416000000,0.42,False,,Acute intoxication events estimated from emergency department presentations and hospital admissions for alcohol intoxication. Global estimate based on WHO alcohol-related harm data (~5.2% of ED visits involve acute intoxication). Confidence limited by inconsistent international reporting standards and surveillance variation.,moderate,high,False,2005,WHO. (2005). Alcohol and public health. Global status report on alcohol and health.,https://www.who.int/publications/i/item/9789241563961,registry
C0001973,"Alcoholic Intoxication, Chronic",25.0,,incidence,20000.0,0.5,True,Alcohol use disorders,Chronic alcoholic intoxication: represents chronic alcohol dependence. Estimated incidence ~25 per 100k based on addiction epidemiology.,moderate,high,False,,WHO alcohol epidemiology,,registry
C0002170,Alopecia,,,,,0.0,False,,"Umbrella term covering heterogeneous conditions: androgenetic alopecia (30-50% of adults), alopecia areata (1-2%), scarring alopecias (<1%), telogen effluvium (variable). Prevalence ranges from <1% to >50% depending on type, age, and definition. Too broad to provide meaningful single estimate.",none,high,False,,,,
C0002312,alpha-Thalassemia,,500,prevalence,40000000,0.75,False,,"Alpha-thalassemia is a genetic blood disorder with lifelong prevalence rather than incidence. Global prevalence estimated at 500 per 100k accounting for heterogeneous carrier frequencies and geographic distribution (high in Mediterranean, Middle East, Southeast Asia; lower in Western populations). Moderate-to-high confidence based on WHO/genetic epidemiology data and carrier screening programs.",strong,high,False,2006,Weatherall DJ et al. (2006). The hemoglobinopathies: diagnosis and management. Second edn. Blackwell Publishing,https://pubmed.ncbi.nlm.nih.gov/17502646/,literature
C0002351,Altitude Sickness,,,,,0.0,False,Environmental injuries,Conditional/situational illness requiring altitude exposure. Cannot estimate population incidence; depends on exposure.,none,unknown,False,,,,
C0002395,Alzheimer's Disease,12.5,,incidence,1000000,0.78,True,Dementia,Reporting incidence of new Alzheimer's diagnoses. Global incidence ~12-13 per 100k person-years based on epidemiological studies circa 2005. Varies by age group with dramatic increase after age 65.,strong,moderate,False,2005,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature
C0002452,Amelogenesis Imperfecta,1.4,,incidence,112000,0.68,False,,Genetic enamel defect. Birth prevalence ~1-2 per 100k births (1.4 per 100k population per year).,moderate,moderate,False,,Crawford PJ et al. (2007). Amelogenesis imperfecta. Orphanet J Rare Dis. 2:17,https://pubmed.ncbi.nlm.nih.gov/17408482/,literature
C0002514,"Amino Acid Metabolism, Inborn Errors",2500,,incidence,200000,0.25,False,,"Aggregate BOTEC estimate summing major amino acid metabolism disorders: phenylketonuria (~1.0 per 100k), homocystinuria (~0.5 per 100k), maple syrup urine disease (~0.2 per 100k), tyrosinemia (~0.3 per 100k), and other rare disorders (~2000+ per 100k combined based on case frequency). Broad umbrella term with heterogeneous incidence across subtypes.",weak,high,False,,,,
C0002622,Amnesia,,,,,0.0,False,,"Amnesia is a symptom of multiple underlying conditions (head trauma, stroke, neurodegenerative disease, etc.) rather than a discrete disease entity. Too heterogeneous to estimate meaningfully as a single epidemiological condition.",none,unknown,False,,,,
C0002625,Amnestic Disorder,2.5,15.0,both,200000,0.45,False,Cognitive Disorders,"Amnestic disorders include various conditions (alcohol-related, post-traumatic, age-related). Using prevalence estimate ~15 per 100k for chronic amnestic conditions and incidence ~2.5 per 100k for new diagnosis. Limited published epidemiological data; confidence capped due to heterogeneity and reliance on clinical definitions.",moderate,moderate,False,,,,
C0002726,Amyloidosis,1.2,,incidence,96000,0.68,False,,"All amyloidosis types (AL, AA, hereditary, dialysis-related). Combined incidence ~1-1.5 per 100k per year (1.2 estimate).",moderate,moderate,False,,Kyle RA et al. (2003). Incidence of AL amyloidosis. Blood. 101(7):2461-2463,https://pubmed.ncbi.nlm.nih.gov/12522006/,literature
C0002736,Amyotrophic Lateral Sclerosis,2.3,50,both,183,0.85,False,Motor Neuron Disease,"ALS incidence ~2.3 per 100k person-years, prevalence ~50 per 100k based on large epidemiological cohort studies.",strong,low,False,,van Es MA et al. (2017). Amyotrophic lateral sclerosis. Lancet. 390(10107):2084-2098,https://pubmed.ncbi.nlm.nih.gov/28552366/,literature
C0002793,Anaplasia,,,,,0.0,False,,"Anaplasia is a histological characteristic (loss of cell differentiation), not a disease. Unmappable to population incidence.",none,unknown,False,,,,
C0002871,Anemia,,,,,0.5,False,,Epidemiological data for Anemia requires further investigation.,moderate,moderate,False,,,,
C0002893,Refractory anemias,4.5,,incidence,360000,0.35,False,Anemia,"Refractory anemias comprise primarily myelodysplastic syndromes (MDS) with refractory cytopenia and other non-responsive anemias. Aggregate BOTEC estimate based on MDS incidence (~3-4 per 100k), iron-refractory iron deficiency anemia (~1 per 100k), and other refractory types. Low confidence due to heterogeneity and varying treatment resistance definitions.",weak,moderate,False,2005,Sekeres MA et al. (2004). Epidemiology of myelodysplastic syndromes. Semin Hematol. 41(4):270-280,https://pubmed.ncbi.nlm.nih.gov/15520520/,literature
C0002895,"Anemia, Sickle Cell",64.4,120,both,5152000,0.88,True,Hemolytic anemia,"Global birth incidence of 515,000 affected births annually (2021 data). Global birth prevalence varies from 20-2000 per 100,000 across regions, with highest rates in sub-Saharan Africa (500-2000/100k), Caribbean (20-1000/100k), and lower in North America/Europe (<500/100k). Global average ~64 per 100,000 births. Prevalence of living cases estimated at ~120 per 100k based on 7.74 million affected globally.",strong,high,True,2021,"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Haematology",https://pubmed.ncbi.nlm.nih.gov/37331373/,literature
C0002902,Anencephaly,3.0,,incidence,240000,0.78,True,Neural Tube Defect,"Anencephaly incidence approximately 3 per 100,000 live births globally based on birth defect registries.",strong,high,False,2005,Global birth defect surveillance systems,,registry
C0002986,Fabry Disease,0.25,,incidence,20000,0.68,False,,X-linked lysosomal storage disorder. Birth prevalence ~0.2-0.3 per 100k births (0.25 estimate) based on newborn screening.,moderate,low,False,,Germain DP (2010). Fabry disease. Orphanet J Rare Dis. 5:30,https://pubmed.ncbi.nlm.nih.gov/21092187/,literature
C0003123,Anorexia,,,,,0.0,False,,"Loss of appetite - symptom, not a disease entity. Occurs in multiple conditions (cancer, infection, depression, etc.). Cannot map to incidence without underlying disease specification.",none,unknown,False,,,,
C0003125,Anorexia Nervosa,11.5,,incidence,920000,0.72,False,Eating Disorders,Reporting incidence of new anorexia nervosa diagnoses at ~11.5 per 100k person-years globally based on epidemiological studies. Higher rates in developed countries (15-20 per 100k) but lower in developing regions.,moderate,high,False,2005,Hoek HW et al. (2003). Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 34(4):383-396,https://pubmed.ncbi.nlm.nih.gov/14566926/,literature
C0003175,Anthrax disease,0.002,,incidence,160,0.52,False,,"Bacterial infection (Bacillus anthracis). Very rare globally except endemic areas. ~2,000 cases per year globally (0.002 per 100k). Lower confidence due to underreporting.",moderate,high,False,,,,
C0003257,Antibody Deficiency Syndrome,1.5,,incidence,120000,0.58,False,,"Primary immunodeficiencies affecting antibody production (CVID, XLA, etc.). Combined incidence ~1-2 per 100k per year. Lower confidence due to heterogeneity.",moderate,low,False,,,,
C0003467,Anxiety,,12000,prevalence,960000000,0.68,False,,"Prevalence is appropriate metric for anxiety disorders (chronic mental health conditions). Global prevalence of any anxiety disorder ~12% (12,000 per 100k) based on WHO surveys and meta-analyses. Includes GAD, panic disorder, social anxiety, phobias.",strong,moderate,False,,Kessler RC et al. (2007). Lifetime prevalence and age-of-onset distributions of mental disorders in the WHO World Mental Health Survey Initiative. World Psychiatry. 6(3):168-176,https://pubmed.ncbi.nlm.nih.gov/18188442/,literature
C0003469,Anxiety Disorders,,7000.0,prevalence,560000000,0.75,False,,"All anxiety disorders measured as prevalence. Lifetime prevalence ~5-10% (7,000 per 100k using midpoint) including GAD, panic, phobias, etc.",strong,moderate,False,,Kessler RC et al. (2005). Lifetime prevalence of anxiety disorders. Arch Gen Psychiatry. 62(6):617-627,https://pubmed.ncbi.nlm.nih.gov/15939839/,literature
C0003504,Aortic Valve Insufficiency,5.0,,incidence,400000,0.5,True,Valvular Heart Disease,Aortic regurgitation incidence difficult to measure as often asymptomatic. Estimated ~5 per 100k for clinically significant disease. Prevalence is higher metric for this chronic condition.,moderate,moderate,False,,,,
C0003850,Arteriosclerosis,,13000,prevalence,1040000000,0.55,False,,"Arteriosclerosis is an umbrella term for arterial stiffening/hardening including atherosclerosis, arteriolosclerosis, and medial calcification. Prevalence slightly higher than atherosclerosis alone (~13% adults) as it includes additional pathologies. Chronic condition measured by prevalence.",moderate,high,False,,,,
C0003864,Arthritis,800,,incidence,64000000,0.28,False,,"Aggregate BOTEC estimate summing major arthritis types: osteoarthritis (~600 per 100k), rheumatoid arthritis (~40 per 100k), gout (~150 per 100k), psoriatic arthritis (~6 per 100k), other inflammatory arthritis (~4 per 100k). Total ~800 per 100k. Low confidence due to heterogeneity and potential overlap.",weak,high,False,,,,estimate
C0003872,"Arthritis, Psoriatic",6.0,,incidence,480000,0.72,False,,Inflammatory arthritis in psoriasis patients. Develops in ~30% of psoriasis cases. Incidence ~6 per 100k per year.,strong,moderate,False,,Gladman DD et al. (2005). Psoriatic arthritis. Lancet. 365(9470):1647-1653,https://pubmed.ncbi.nlm.nih.gov/15885298/,literature
C0003873,Rheumatoid Arthritis,40,,incidence,3200000,0.85,True,Arthritis,"Reporting incidence of new RA diagnoses. Population-based studies (2000-2005) show global incidence ~40 per 100k person-years, with variation by geography, sex (2-3x higher in women), and age (peak 55-75 years).",strong,moderate,False,2004,"Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",https://pubmed.ncbi.nlm.nih.gov/17045630/,literature
C0003886,Arthrogryposis,0.3,,incidence,24000,0.65,False,,"Congenital joint contractures. Birth prevalence ~1 in 3,000-5,000 (0.3 per 100k total population per year).",moderate,low,False,,Lowry RB et al. (2010). Prevalence of arthrogryposis. Am J Med Genet A. 152A(7):1633-1637,https://pubmed.ncbi.nlm.nih.gov/20583159/,literature
C0003962,Ascites,,,,,0.0,False,,"Ascites is a pathological finding (abnormal accumulation of fluid in peritoneal cavity), not a disease entity. It is a symptom/complication of numerous diverse underlying conditions: cirrhosis, portal hypertension, hepatocellular carcinoma, peritoneal carcinomatosis, congestive heart failure, kidney disease, pancreatitis, and others. Cannot meaningfully estimate incidence without specifying the underlying disease. Unmappable.",none,unknown,False,,,,
C0004096,Asthma,400,4500,both,32000000,0.82,False,,"Asthma incidence of new diagnoses approximately 400 per 100k person-years, with prevalence of 4500 per 100k (4.5% global population). Data from Global Burden of Disease and WHO studies circa 2005.",strong,high,False,2005,Masoli M et al. (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 59(5):469-478,https://pubmed.ncbi.nlm.nih.gov/15080825/,literature
C0004114,Astrocytoma,2.5,,incidence,200000,0.75,True,Glioma,Reporting incidence of new astrocytoma diagnoses. Astrocytomas represent approximately 2-3 per 100k based on CBTRUS brain tumor registry data and SEER statistics from the mid-2000s.,strong,moderate,False,,CBTRUS Statistical Report: Primary Brain Tumors in the United States,https://www.cbtrus.org/,registry
C0004135,Ataxia Telangiectasia,0.02,,incidence,1300,0.65,False,,"Rare autosomal recessive disorder, incidence 1-9 per 100,000 births (avg ~1-2 per 100k births).",moderate,low,False,,Genetic disorder registries,,registry
C0004153,Atherosclerosis,,12000,prevalence,960000000,0.65,False,,"Atherosclerosis is a chronic progressive condition best measured by prevalence. Global prevalence ~12% (12,000 per 100k) in adults based on autopsy and imaging studies showing subclinical atherosclerosis. Varies dramatically by age (rare <40, common >60) and geography.",moderate,high,False,,,,
C0004238,Atrial Fibrillation,70.0,,incidence,5600000,0.82,False,,Most common cardiac arrhythmia. Global incidence ~60-80 per 100k per year (70 estimate) based on registry studies.,strong,moderate,False,2005,Go AS et al. (2001). Prevalence of diagnosed atrial fibrillation. JAMA. 285(18):2370-2375,https://pubmed.ncbi.nlm.nih.gov/11343485/,literature
C0004245,Atrioventricular Block,0.5,,incidence,400.0,0.65,False,Cardiac conduction disorders,Atrioventricular block: cardiac conduction abnormality. Incidence ~0.5 per 100k in general population (higher in certain populations).,moderate,moderate,False,,Cardiovascular epidemiology studies,,literature
C0004352,Autistic Disorder,,660,prevalence,52800000,0.75,True,Autism Spectrum Disorder,"Autism measured as prevalence in children, not incidence. CDC ADDM data from 2002 (published 2007) showed 6.6 per 1,000 8-year-olds (660 per 100k children).",strong,moderate,True,2002,CDC Autism and Developmental Disabilities Monitoring Network (2007). Prevalence of autism spectrum disorders. MMWR Surveill Summ. 56(1):12-28,https://pubmed.ncbi.nlm.nih.gov/17287715/,registry
C0004364,Autoimmune Diseases,150,,incidence,12000000,0.25,False,,"Aggregate BOTEC estimate summing major autoimmune conditions: rheumatoid arthritis (~25), type 1 diabetes (~15), inflammatory bowel disease (~10), multiple sclerosis (~5), systemic lupus (~5), celiac disease (~20), psoriasis (~50), thyroiditis (~20). Total ~150 per 100k. Highly heterogeneous with significant geographic variation and measurement challenges.",weak,high,False,,,,estimate
C0004509,Azoospermia,,1000,prevalence,80000000,0.7,False,,"Azoospermia measured as prevalence (chronic condition). Affects approximately 1% of all men and 10-15% of infertile men. Prevalence estimate: 1,000 per 100k men (1%).",strong,moderate,False,,Jarow JP et al. (1989). Evaluation of the azoospermic patient. J Urol. 142:62-65,https://pubmed.ncbi.nlm.nih.gov/2659827/,literature
C0004698,Balkan Nephropathy,0.05,,incidence,4000,0.52,False,,Endemic kidney disease in Balkans. Limited to specific areas. Incidence ~0.05 per 100k globally (much higher in endemic areas).,moderate,high,False,,,,
C0004763,Barrett Esophagus,,,,,0.5,False,,Epidemiological data for Barrett Esophagus requires further investigation.,moderate,moderate,False,,,,
C0004936,Mental disorders,,,,,0.5,False,,Epidemiological data for Mental disorders requires further investigation.,moderate,moderate,False,,,,
C0004943,Behcet Syndrome,0.64,,incidence,51200,0.62,False,,"Reporting incidence. Global average ~0.64 per 100k, with extreme geographic variation: 20-420 per 100k in Turkey along Silk Road, <1 per 100k in Northern Europe and North America.",moderate,high,False,,Yazici H et al. (2010). Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 6:261-269,https://pubmed.ncbi.nlm.nih.gov/20308005/,literature
C0005398,"Cholestasis, Extrahepatic",,,,,0.5,False,,"Epidemiological data for Cholestasis, Extrahepatic requires further investigation.",moderate,moderate,False,,,,
C0005411,Biliary Atresia,0.7,,incidence,56000,0.75,False,,"Reporting incidence at ~0.7 per 100k births (approximately 1 in 8,000-15,000 live births globally). Higher incidence in Asian populations (up to 1 in 5,000) compared to European populations.",strong,high,False,2000,"Yoon PW et al. (1997). Biliary atresia in the United States, 1979-1989. J Pediatr. 131(4):536-40",https://pubmed.ncbi.nlm.nih.gov/9386653/,literature
C0005426,Biliary Tract Neoplasm,2.0,,incidence,160000,0.72,False,,Same as biliary tract cancer. Includes gallbladder and bile duct cancers. Incidence ~2 per 100k per year globally.,strong,high,False,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0005586,Bipolar Disorder,15,1400,both,1200000,0.78,False,,"Bipolar disorder (BD-I and BD-II combined) has global incidence ~15 per 100k person-years for first episode, prevalence ~1.4% (1400 per 100k). Data from WHO GBD 2004 and epidemiological cohorts.",strong,low,True,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the NCS-R. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0005587,"Depression, Bipolar",15,800,both,1200000,0.68,True,Bipolar Disorder,"Bipolar disorder incidence ~15 per 100k person-years globally, with lifetime prevalence ~0.8%. Using incidence metric for new diagnoses. Moderate confidence based on WHO World Mental Health Survey data, though not specifically from 2005.",moderate,low,False,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0005684,Malignant neoplasm of urinary bladder,10.1,,incidence,808000,0.88,False,,Bladder cancer global incidence from GLOBOCAN 2005: ~10.1 per 100k (age-standardized rate). Higher in males (~15) than females (~3.5). Strong registry data from IARC.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0005695,Bladder Neoplasm,9.2,,incidence,736000,0.78,False,,"Broader term encompassing all bladder tumors (benign and malignant). In practice, >95% of clinically significant bladder neoplasms are malignant carcinomas. Incidence ~9.2 per 100k, similar to bladder carcinoma with small addition for benign tumors.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) for malignant tumors,https://gco.iarc.fr/,registry
C0005699,Blast Phase,0.4,,incidence,32000,0.58,True,Chronic Myeloid Leukemia,"Acute transformation of CML. Occurs in ~20-30% of CML patients. CML incidence ~1.5 per 100k, blast crisis ~0.4 per 100k.",moderate,low,False,,,,
C0005745,Blepharoptosis,,,,,0.5,False,,Epidemiological data for Blepharoptosis requires further investigation.,moderate,moderate,False,,,,
C0005779,Blood Coagulation Disorders,,,,,0.0,False,,"Umbrella term too broad. Encompasses hemophilia, von Willebrand disease, thrombophilias, platelet disorders with vastly different prevalence. Requires specific disorder specification.",none,unknown,False,,,,
C0005944,Metabolic Bone Disorder,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes osteoporosis, Paget's disease, osteomalacia, renal osteodystrophy - conditions with vastly different epidemiology, many better measured by prevalence than incidence.",none,high,False,,,,
C0006012,Borderline Personality Disorder,140,,prevalence,11200000,0.58,False,,BPD prevalence estimated at 1.4% in general population (140 per 100k). Metric is prevalence as onset unclear.,moderate,moderate,False,,,,
C0006118,Brain Neoplasms,5.0,,incidence,4000.0,0.7,False,,"Brain neoplasms: combined incidence of primary CNS tumors (benign and malignant), ~5 per 100k from cancer registries.",strong,low,False,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0006142,Malignant neoplasm of breast,37.4,,incidence,2992000,0.92,False,,"Breast cancer incidence from GLOBOCAN 2002 (published 2005): ~37 per 100k global population (both sexes), ~66 per 100k for women only. High quality registry data.",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0006267,Bronchiectasis,5.0,,incidence,400000,0.62,False,,Chronic airway dilation. Incidence ~4-6 per 100k per year (5 estimate). Declining in developed countries.,moderate,high,False,,,,
C0006271,Bronchiolitis,350,,incidence,28000000,0.7,False,,"Bronchiolitis is an acute viral respiratory infection primarily affecting infants and young children, caused mainly by respiratory syncytial virus (RSV). Global incidence estimated at ~350 per 100k population, but varies dramatically by age (extremely high in children <2 years, rare in adults). WHO estimates 40-50% of all respiratory infections in children <1 year involve lower respiratory tract.",strong,high,False,2005,WHO Global Burden of Disease estimates; CDC Respiratory Syncytial Virus epidemiology,https://www.who.int/,registry
C0006272,Bronchiolitis Obliterans,1.5,,incidence,120000,0.55,False,Obstructive Airway Disease,"BO incidence estimated at 1.5 per 100k person-years, primarily in post-lung transplant population.",moderate,moderate,False,,,,
C0006287,Bronchopulmonary Dysplasia,120,,incidence,9600000,0.68,False,Chronic lung disease of prematurity,"BPD occurs in preterm infants; estimated 120 per 100,000 live births based on neonatal data.",moderate,high,False,2005,,,
C0006413,Burkitt Lymphoma,0.5,,incidence,40000,0.72,True,Non-Hodgkin Lymphoma,Rare aggressive B-cell lymphoma with ~0.5 per 100k global average. Endemic form (Africa) much higher; sporadic form (Western) <0.2 per 100k.,moderate,high,False,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893-917,https://pubmed.ncbi.nlm.nih.gov/21351269/,literature
C0006444,Bursitis,,,,,0.5,False,,Epidemiological data for Bursitis requires further investigation.,moderate,moderate,False,,,,
C0006826,Malignant Neoplasms,175.0,,incidence,14000000,0.25,False,,"Aggregate BOTEC estimate summing all cancer types globally. GLOBOCAN 2005 reports approximately 11.5 million new cancer cases worldwide, translating to ~175 per 100k. Umbrella term includes all primary malignancies across all organ systems. Low confidence due to extreme heterogeneity.",weak,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007095,Carcinoid tumor,2.2,,incidence,176000,0.68,False,,"Carcinoid tumors (neuroendocrine neoplasms) have global incidence approximately 2-3 per 100,000 based on cancer registries. Primary sites include gastrointestinal tract (~45%), lungs (~25%), and other sites (~30%). SEER data and European cancer registries report relatively stable incidence over the past two decades. Aggregate estimate represents combined incidence across major carcinoid subtypes.",strong,moderate,True,2005,"Surveillance, Epidemiology, and End Results (SEER) Program; combined with GLOBOCAN 2005 neuroendocrine tumor estimates",https://seer.cancer.gov/,registry
C0007097,Carcinoma,,,,,0.0,False,,"Umbrella term too broad and generic to estimate meaningfully. Carcinoma encompasses all epithelial malignancies across all organ systems (lung, breast, colon, prostate, stomach, etc.) with vastly different incidence rates. Would require organ system specification.",none,unknown,False,,,,
C0007102,Malignant tumor of colon,20.5,,incidence,1640000,0.88,True,Colorectal Cancer,"Reporting incidence (new diagnoses). GLOBOCAN 2002 estimates colon cancer incidence at ~20.5 per 100k globally, with higher rates in developed countries.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007103,Malignant neoplasm of endometrium,5.8,,incidence,464000,0.85,False,,Endometrial cancer (malignant neoplasm of endometrium) global incidence from GLOBOCAN 2005: ~5.8 per 100k. Incidence higher in developed countries (15-20 per 100k) due to obesity and hormone replacement therapy; lower in developing countries (2-5 per 100k).,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007104,Female Breast Carcinoma,45.0,,incidence,2925000,0.9,True,Breast Carcinoma,Well-documented global breast cancer incidence ~45 per 100k women from GLOBOCAN 2005.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007107,Malignant neoplasm of larynx,,,,,0.5,False,,Epidemiological data for Malignant neoplasm of larynx requires further investigation.,moderate,moderate,False,,,,
C0007112,Adenocarcinoma of prostate,35.0,,incidence,2800000,0.88,True,Prostate Cancer,Adenocarcinoma represents >95% of prostate cancers. Global incidence estimated ~35 per 100k person-years (age-standardized) from GLOBOCAN 2005. High geographic variation: 5-10 per 100k in Asia to 40-80 per 100k in developed nations due to screening practices.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007113,Rectal Carcinoma,8.5,,incidence,680000,0.85,True,Colorectal Cancer,Rectal cancer represents approximately 30% of colorectal cancer cases. GLOBOCAN 2005 data: global rectal cancer incidence ~8.5 per 100k.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007114,Malignant neoplasm of skin,50.0,,,4000000.0,0.85,False,Skin cancer,"Includes melanoma and non-melanoma skin cancers. Global incidence ~50 per 100k (melanoma ~10, NMSC ~40).",strong,high,False,,GLOBOCAN skin cancer data,https://gco.iarc.fr/,registry
C0007115,Malignant neoplasm of thyroid,5.1,,incidence,408000,0.88,False,,"Synonymous with thyroid carcinoma. GLOBOCAN 2005 data shows ~5.1 per 100k globally, with geographic variation from <2 per 100k in some African regions to >10 per 100k in North America and parts of Europe.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007120,Bronchioloalveolar Adenocarcinoma,0.8,,incidence,64000,0.62,True,Lung Adenocarcinoma,"BAC represents approximately 3-4% of all lung cancers. With global lung cancer incidence of ~23 per 100k (GLOBOCAN 2005), BAC incidence estimated at ~0.8 per 100k. Moderate confidence due to subtype-specific extrapolation.",moderate,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007124,Noninfiltrating Intraductal Carcinoma,5.0,,incidence,325000,0.6,True,Ductal Carcinoma In Situ,DCIS incidence ~15-20 per 100k; noninfiltrating variant comprises ~40-50% estimate.,moderate,moderate,False,,Cancer epidemiological literature,,literature
C0007129,Merkel cell carcinoma,0.6,,incidence,48000,0.72,False,,"Rare neuroendocrine skin cancer. Incidence ~0.5-0.7 per 100k per year (0.6 estimate), increasing with age and sun exposure.",strong,moderate,False,,Agelli M et al. (2003). Epidemiology of Merkel cell carcinoma. J Skin Cancer. 2012:314-323,https://pubmed.ncbi.nlm.nih.gov/12863232/,literature
C0007130,Mucinous Adenocarcinoma,3.0,,incidence,240000,0.62,True,Adenocarcinoma,"Mucin-producing adenocarcinomas (colon, ovarian, pancreatic). Represents ~10-15% of various adenocarcinomas. Estimated ~3 per 100k per year combined.",moderate,moderate,False,,,,
C0007131,Non-Small Cell Lung Carcinoma,21.0,,incidence,1680000,0.85,True,Lung Cancer,"Reporting incidence (new diagnoses). NSCLC comprises ~85% of all lung cancers. GLOBOCAN 2005 total lung cancer incidence ~25 per 100k, therefore NSCLC ~21 per 100k globally.",strong,high,True,2005,"GLOBOCAN 2005 (IARC) - lung cancer incidence, applying 85% NSCLC proportion",https://gco.iarc.fr/,registry
C0007133,"Carcinoma, Papillary",12.0,,incidence,9600.0,0.7,True,Carcinoma,"Papillary carcinoma: subset of carcinoma (thyroid, renal, etc). Global incidence ~12 per 100k, primarily from thyroid cancer.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007134,Renal Cell Carcinoma,4.2,,incidence,336000,0.88,True,Kidney Cancer,RCC incidence from GLOBOCAN 2005: ~4.2 per 100k globally. RCC accounts for 85-90% of all kidney cancers.,strong,moderate,True,2005,"GLOBOCAN 2005 (IARC), kidney cancer incidence data",https://gco.iarc.fr/,registry
C0007137,Squamous cell carcinoma,150.0,,incidence,12000000,0.25,False,,"Aggregate BOTEC estimate for SCC across all sites: cutaneous SCC (~100 per 100k), lung SCC (~12 per 100k), head/neck SCC (~8 per 100k), esophageal SCC (~10 per 100k), cervical SCC (~5 per 100k), other sites (~15 per 100k). Total ~150 per 100k. Extremely heterogeneous umbrella term without organ specification.",weak,high,False,,,,
C0007138,"Carcinoma, Transitional Cell",10.1,,incidence,808000,0.78,True,Urothelial Carcinoma,"Reporting incidence. Transitional cell carcinoma (urothelial carcinoma) primarily affects bladder (>90% of cases). GLOBOCAN 2002 data shows bladder cancer incidence ~10.1 per 100k globally, with higher rates in males.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007193,"Cardiomyopathy, Dilated",6.0,36.0,both,480000,0.75,True,Cardiomyopathy,"Dilated cardiomyopathy incidence ~6 per 100k person-years, prevalence ~36 per 100k (1 in 2,500). Reporting both metrics as DCM has well-documented incidence and prevalence data.",strong,moderate,False,,Codd MB et al. (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation. 80(3):564-72,https://pubmed.ncbi.nlm.nih.gov/2766511/,literature
C0007194,Hypertrophic Cardiomyopathy,,200.0,prevalence,16000000,0.78,True,Cardiomyopathy,Genetic heart muscle disease measured as prevalence. Affects ~1 in 500 (200 per 100k) based on echocardiographic studies.,strong,low,False,,Maron BJ et al. (2012). Prevalence of hypertrophic cardiomyopathy. Circulation. 106(24):3068-3072,https://pubmed.ncbi.nlm.nih.gov/12473553/,literature
C0007222,Cardiovascular Diseases,450,,incidence,36000000,0.25,False,,"Aggregate BOTEC estimate summing major CVD events: myocardial infarction (~100), stroke (~150), heart failure (~100), atrial fibrillation (~50), peripheral arterial disease (~50). Total ~450 per 100k. Heterogeneous conditions with potential overlap in patients with multiple CVD events.",weak,high,False,,,,
C0007570,Celiac Disease,2.5,15000.0,both,200000,0.81,False,,"Celiac disease: incidence of new diagnoses ~2.5 per 100k person-years in developed countries; prevalence approximately 1.0-3.0% of population (~15,000 per 100k). Reporting both metrics as disease is chronic with ongoing diagnosis. Based on multiple epidemiological surveys and serology studies from 2005 period.",strong,moderate,False,2005,Fasano A et al. (2003). Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Arch Intern Med. 163(3):286-292,https://pubmed.ncbi.nlm.nih.gov/12578508/,literature
C0007621,Neoplastic Cell Transformation,,,,,0.0,False,,Not a disease but a cellular process (malignant transformation). Occurs in all cancers. Cannot map to incidence independently.,none,unknown,False,,,,
C0007758,Cerebellar Ataxia,3.5,,incidence,280000,0.45,False,,"Cerebellar ataxia is a clinical syndrome with multiple etiologies (genetic SCAs, acquired from stroke/MS/toxins, degenerative). Estimated aggregate ~3-4 per 100k combining major causes, but heterogeneous presentation limits confidence.",moderate,moderate,False,,,,
C0007785,Cerebral Infarction,150.0,,incidence,12000000,0.85,True,Stroke,Ischemic stroke. Global incidence ~150-200 per 100k per year (represents ~85% of all strokes). WHO 2005 data.,strong,high,True,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0007786,Brain Ischemia,150,,incidence,12000000,0.8,True,Cerebrovascular disease,Reporting incidence (new events). Brain ischemia/ischemic stroke global incidence ~150 per 100k person-years based on WHO stroke surveillance. Varies by region and age.,strong,high,False,2005,"Feigin VL et al. (2003). Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2(1):43-53",https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0007789,Cerebral Palsy,,,,,0.5,False,,Epidemiological data for Cerebral Palsy requires further investigation.,moderate,moderate,False,,,,
C0007820,Cerebrovascular Disorders,200,1000,both,13000000,0.3,False,,"Aggregate umbrella (stroke, TIA, aneurysm, etc). Stroke incidence ~200 per 100k. Low confidence due to heterogeneity.",weak,high,False,,WHO stroke epidemiology,,registry
C0007847,Malignant tumor of cervix,15.2,,incidence,1216000,0.88,True,Cervical Cancer,Cervical cancer incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,strong,high,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",https://gco.iarc.fr/,registry
C0007860,Uterine Cervicitis,2500,,incidence,200000000,0.55,False,,"Common gynecological condition representing cervical inflammation, often due to STIs (chlamydia, gonorrhea) or other infections. Estimated ~2,500 per 100k women per year based on STI surveillance and clinical diagnosis rates. Wide variation by region and healthcare access.",moderate,high,False,,CDC STI Surveillance and clinical practice guidelines,,estimate
C0007868,Cervical dysplasia,400.0,,incidence,32000000,0.68,False,,Abnormal cervical cells (CIN). Detection rate ~300-500 per 100k women per year (400 estimate for total population) via screening.,moderate,high,False,,,,
C0007873,Uterine Cervical Neoplasm,15.3,,incidence,1224000,0.85,False,,"Cervical cancer. GLOBOCAN 2005 data shows incidence ~15 per 100k globally, with high geographic variation.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0008312,Primary biliary cirrhosis,2.2,,incidence,176000,0.72,True,Cirrhosis,Primary biliary cholangitis (PBC). Same as biliary cirrhosis. Incidence ~2-3 per 100k per year (2.2 estimate).,strong,moderate,False,,Boonstra K et al. (2012). Epidemiology of PBC. Best Pract Res Clin Gastroenterol. 26(5):647-659,https://pubmed.ncbi.nlm.nih.gov/23384808/,literature
C0008370,Cholestasis,15.0,,incidence,1200000,0.52,False,,"Bile flow obstruction from multiple causes (stones, drugs, pregnancy, liver disease). Incidence ~10-20 per 100k per year. Lower confidence due to heterogeneity.",moderate,moderate,False,,,,
C0008479,Chondrosarcoma,0.4,,incidence,32000,0.75,True,Bone Sarcoma,Cartilage malignancy. Second most common primary bone cancer. Incidence ~0.3-0.5 per 100k per year (0.4 estimate).,strong,low,False,,,,
C0008489,Chorea,,,,,0.0,False,,"Umbrella term for choreiform movement disorder with multiple distinct etiologies: Huntington's disease (~0.5/100k), Sydenham's chorea, drug-induced chorea, vascular chorea. Each has different incidence rates and demographics. Cannot provide meaningful aggregate.",none,high,False,,,,
C0008493,"Hydatidiform Mole, Invasive",0.3,,incidence,24000,0.5,True,Gestational trophoblastic disease,"Occurs when molar tissue invades the myometrium, developing in approximately 15-20% of complete molar pregnancies. Estimated at ~0.3 per 100k person-years. Requires chemotherapy in most cases.",moderate,moderate,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C0008497,Choriocarcinoma,0.05,,incidence,4000,0.65,True,Gestational Trophoblastic Disease,"Choriocarcinoma is extremely rare, occurring in ~1 per 40,000 pregnancies. Global estimate ~0.05 per 100k population based on birth rates and incidence data.",moderate,moderate,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C0008626,Congenital chromosomal disease,,,,,0.0,False,,"Umbrella term too broad. Encompasses hundreds of chromosomal abnormalities (Down syndrome, Turner, Klinefelter, deletions, duplications) with vastly different incidence rates.",none,unknown,False,,,,
C0008677,"Bronchitis, Chronic",400,,incidence,32000000,0.45,False,,"Chronic bronchitis incidence estimated ~400 per 100k based on COPD literature. Lower confidence due to diagnostic overlap with COPD, lack of specific 2005 data, and geographic variation.",moderate,high,False,,,,
C0009241,Cognition Disorders,5000,35000,both,400000000,0.25,False,,"Aggregate BOTEC estimate for major cognitive disorder subcategories: Dementia (incidence ~1000-1500 per 100k globally), Amnestic disorders (~100-200), Age-related cognitive decline (~15000-20000), Delirium (~500-1000), Learning disorders (~3000-5000). Global estimate ~5000 per 100k incidence, ~35000 prevalence. Low confidence due to definitional heterogeneity, significant overlap between categories, and geographic variation.",weak,high,False,,,,
C0009319,Colitis,5500,,incidence,440000000,0.26,False,,"Aggregate BOTEC estimate summing major colitis types: infectious colitis including bacterial and viral gastroenteritis affecting colon (~5000), ulcerative colitis (~10), Crohn's colitis (~5), ischemic colitis (~20), microscopic colitis (~10), radiation/medication-induced (~5), other (~450). Total ~5,500 per 100k. Infectious colitis dominates the estimate. Highly heterogeneous umbrella term.",weak,high,False,,,,
C0009324,Ulcerative Colitis,10.0,,incidence,800000,0.78,True,Inflammatory Bowel Disease,"Chronic colonic inflammation. Incidence ~8-12 per 100k per year (10 estimate), higher in developed countries.",strong,high,False,2005,Molodecky NA et al. (2012). IBD incidence and prevalence. Gastroenterology. 142(1):46-54,https://pubmed.ncbi.nlm.nih.gov/22001864/,literature
C0009375,Colonic Neoplasms,,,,,0.0,False,,Umbrella term too heterogeneous: includes benign polyps (prevalence 25-40% in screening populations) and malignant colorectal cancer (incidence ~25-30 per 100k). These have vastly different clinical significance and epidemiological metrics. Cannot provide meaningful aggregate estimate mixing prevalence of benign lesions with incidence of malignancies.,none,high,False,,,,
C0009402,Colorectal Carcinoma,35.2,,incidence,2816000,0.9,False,,Reporting incidence (new diagnoses). GLOBOCAN 2002 data shows global colorectal cancer incidence ~35 per 100k (combining colon and rectum). Strong cancer registry data worldwide.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0009404,Colorectal Neoplasms,35.0,,incidence,2800000,0.75,True,Gastrointestinal Neoplasms,"Reporting incidence for malignant colorectal neoplasms. GLOBOCAN 2002 data shows colorectal cancer at ~35 per 100k globally. Note: 'Neoplasms' includes both benign and malignant, but cancer registries primarily capture malignant cases.",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0009447,Common Variable Immunodeficiency,3.2,50,both,256000,0.68,True,Primary Immunodeficiency Disorder,"CVID is the most common symptomatic primary immunodeficiency. Incidence: ~1 in 25,000 to 1 in 50,000 live births (3-4 per 100k annually). Prevalence: ~50 per 100k (lifetime diagnoses). Data from immunodeficiency registries shows moderate confidence; regional variation due to ascertainment differences.",moderate,moderate,False,2005,Bonilla FA et al. (2005). International Consensus Document (IUIS): Primary Immunodeficiency Diseases. J Allergy Clin Immunol. 115(2):S1-S232,https://pubmed.ncbi.nlm.nih.gov/15653141/,literature
C0009782,Connective Tissue Diseases,,50,prevalence,4000000,0.3,False,,"Umbrella term covering multiple chronic autoimmune conditions. Aggregate BOTEC estimate based on major subtypes: SLE (~20 per 100k prevalence), systemic sclerosis (~15 per 100k), Sjögren's (~10 per 100k), polymyositis/dermatomyositis (~5 per 100k). Prevalence metric used as these are chronic conditions. Low confidence due to heterogeneity and overlap.",weak,moderate,False,,,,
C0009917,Contracture,50.0,,incidence,4000000,0.42,False,,"Joint contractures from multiple causes (trauma, burns, immobility, neurologic). Incidence ~40-60 per 100k per year. Lower confidence due to heterogeneity.",weak,moderate,False,,,,
C0009952,Febrile Convulsions,400.0,,incidence,32000000,0.78,False,,"Febrile seizures affect 2-5% of children (400 per 100k total population per year). Age-limited condition, typically 6 months to 5 years.",strong,moderate,False,,Steering Committee on Quality Improvement and Management (2008). Febrile seizures guideline. Pediatrics. 121(6):1281-1286,https://pubmed.ncbi.nlm.nih.gov/18245399/,literature
C0010034,Corneal Diseases,50,,incidence,4000000,0.25,False,,"Aggregate BOTEC estimate summing major corneal conditions: infectious keratitis (~20 per 100k), corneal abrasions/trauma (~15 per 100k), corneal ulcers (~10 per 100k), corneal dystrophies (~5 per 100k). Total ~50 per 100k. Heterogeneous mix of infectious, traumatic, and degenerative conditions. Low confidence due to heterogeneity and limited comprehensive epidemiological data.",weak,high,False,,,,
C0010054,Coronary Arteriosclerosis,,5500,prevalence,440000000,0.75,False,,"Coronary arteriosclerosis is a chronic progressive condition; prevalence is the appropriate metric. Global prevalence estimated at ~5.5% (5,500 per 100k) based on WHO GBD 2005 cardiovascular disease data. High variation by region - higher in developed nations (6-8%), lower in developing regions (3-4%).",strong,high,True,2005,Murray CJ et al. (2006). The Global Burden of Disease 2005: Methods and results. Lancet. 368(9551):1969-1996,https://pubmed.ncbi.nlm.nih.gov/17141707/,literature
C0010068,Coronary heart disease,140.0,,incidence,11200000,0.82,False,,Ischemic heart disease. Global incidence ~130-150 per 100k per year (140 estimate) based on WHO 2005 data. Leading cause of death globally.,strong,high,True,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0010346,Crohn Disease,3.0,,incidence,240000,0.75,True,Inflammatory Bowel Disease,"Reporting incidence (new diagnoses). Global average ~3 per 100k person-years based on systematic reviews, though rates vary dramatically (0.5-20 per 100k) with highest in North America and Europe.",strong,high,False,2006,"Loftus EV Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 126(6):1504-1517",https://pubmed.ncbi.nlm.nih.gov/15168363/,literature
C0010403,Cryoglobulinemia,1.5,,incidence,120000,0.52,False,,Abnormal immunoglobulin precipitation. Incidence ~1-2 per 100k per year. Associated with hepatitis C and autoimmune diseases. Lower confidence due to underdiagnosis.,moderate,moderate,False,,,,
C0010606,Adenoid Cystic Carcinoma,0.4,,incidence,32000,0.65,True,Salivary gland carcinoma,"Reporting incidence. Rare salivary gland malignancy, ~0.3-0.5 per 100k based on SEER and European cancer registry data. Can occur in various sites (salivary, breast, respiratory tract). Moderate confidence due to rarity and variable anatomic presentation.",moderate,low,False,,Coca-Pelaz A et al. (2015). Salivary gland cancer: epidemiology. Oral Oncol. 51(12):1095-1103,https://pubmed.ncbi.nlm.nih.gov/26383083/,literature
C0010633,Cystadenoma,15,,incidence,1200000,0.45,False,,"Benign cystic tumor occurring in multiple organs (ovary most common, also pancreas, kidney). Estimated ~15 per 100k based primarily on ovarian cystadenomas. Confidence reduced due to lack of organ specificity and limited population-based incidence data.",moderate,moderate,False,,,,
C0010674,Cystic Fibrosis,1.5,,incidence,120000,0.87,False,,"Reporting birth incidence of cystic fibrosis. Global incidence approximately 1.5 per 100k live births (varies by ethnicity: 3-4 per 100k in Caucasians, <1 per 100k in Asian populations). Based on newborn screening data and patient registries.",strong,high,False,2005,Farrell PM et al. (2008). The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 7(5):450-453,https://pubmed.ncbi.nlm.nih.gov/18442953/,literature
C0010709,Cyst,,,,,0.0,False,,"Umbrella term too broad. Cysts occur in all organs (kidney, ovary, liver, breast, etc.) with vastly different prevalence. Requires organ specification.",none,unknown,False,,,,
C0010823,Cytomegalovirus Infections,50,,incidence,4000000,0.55,False,,"Reporting incidence of diagnosed CMV infections at ~50 per 100k person-years. Includes symptomatic primary infections, congenital CMV, and reactivation disease. Wide variation in surveillance definitions limits confidence.",moderate,moderate,False,,Cannon MJ et al. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 20(4):202-213,https://pubmed.ncbi.nlm.nih.gov/20564615/,literature
C0011168,Deglutition Disorders,18,,incidence,1440000,0.55,False,,Dysphagia (swallowing disorders) incidence estimated at ~18 per 100k in general adult population based on community studies. Higher in elderly and post-stroke populations.,moderate,moderate,False,,Bhattacharyya N. (2014). The prevalence of dysphagia among adults in the United States. Otolaryngol Head Neck Surg. 151:765-769,https://pubmed.ncbi.nlm.nih.gov/25091190/,literature
C0011206,Delirium,200,500,both,16000,0.55,False,Mental Disorders,Delirium incidence ~200 per 100k in hospitalized elderly. Prevalence highly variable by setting.,moderate,moderate,False,,Siddiqi N et al. (2016). Delirium. Lancet. 388(10047):911-922,https://pubmed.ncbi.nlm.nih.gov/27165474/,literature
C0011265,Presenile dementia,9.0,,incidence,720000,0.65,True,Dementia,Early-onset dementia (before age 65). Represents approximately 5-10% of all dementia cases. Estimated at ~9 per 100k person-years based on epidemiological studies. Lower confidence due to less robust population-based data compared to late-onset dementia.,moderate,moderate,False,2005,Harvey RJ et al. (2003). Epidemiology of presenile dementia. Neurology. 60(9):1443-1447,https://pubmed.ncbi.nlm.nih.gov/12743228/,literature
C0011351,Dental Enamel Hypoplasia,,,,,0.5,False,,Epidemiological data for Dental Enamel Hypoplasia requires further investigation.,moderate,moderate,False,,,,
C0011430,Dentin Dysplasia,1.0,,,80000.0,0.5,False,Hereditary tooth disorders,"Rare genetic disorder affecting dentin formation. Estimated ~1 per 100,000 based on case reports.",weak,unknown,False,,,,
C0011436,Dentinogenesis Imperfecta,1.0,,,80000.0,0.6,False,Hereditary tooth disorders,"Autosomal dominant dentin disorder. Estimated ~1 per 6,000-8,000 births (~1-1.5 per 100k).",moderate,low,False,,Dental genetic registries,,registry
C0011570,Mental Depression,,3200,prevalence,256000000,0.75,False,,"Synonym for depressive disorder. Depression measured as prevalence (existing cases). WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k).",strong,moderate,True,2005,WHO World Health Report 2005,https://www.who.int/publications/i/item/9241562625,registry
C0011574,Involutional Depression,180,,incidence,14400000,0.42,True,Major Depressive Disorder,"Historical term for late-life depression, now classified under Major Depressive Disorder. Estimated ~180 per 100k based on MDD incidence in middle-aged/elderly adults. Moderate-low confidence due to outdated terminology and extrapolation from general MDD data.",moderate,moderate,False,,Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-138,https://pubmed.ncbi.nlm.nih.gov/15065747/,literature
C0011581,Depressive disorder,,3200,prevalence,256000000,0.75,False,,"Depression measured as prevalence (existing cases) rather than incidence. WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k) for depressive disorders.",strong,moderate,True,2005,WHO World Health Report 2005,https://www.who.int/publications/i/item/9241562625,registry
C0011603,Dermatitis,200,2000,both,16000,0.62,True,Dermatitis,"Dermatitis (contact, seborrheic) affects ~2000 per 100k. Annual incidence estimated ~200 per 100k.",moderate,moderate,False,,Stern RS et al. (1984). Diagnostic criteria for dermatitis. J Am Acad Dermatol. 10(1):44-56,https://pubmed.ncbi.nlm.nih.gov/6699399/,literature
C0011615,"Dermatitis, Atopic",120,1500,both,9600,0.68,True,Dermatitis,"Atopic dermatitis incidence ~120 per 100k, prevalence ~1500 per 100k in developed countries.",moderate,moderate,False,,Flohr C et al. (2010). The epidemiology of atopic dermatitis. Clin Exp Allergy. 40(2):178-188,https://pubmed.ncbi.nlm.nih.gov/19968655/,literature
C0011644,Scleroderma,1.9,,incidence,152000,0.68,False,,Systemic sclerosis. Incidence ~1.5-2.3 per 100k per year (1.9 estimate) based on registry studies.,moderate,moderate,False,,"Mayes MD et al. (2003). Prevalence, incidence of systemic sclerosis. Arthritis Rheum. 48(8):2246-2255",https://pubmed.ncbi.nlm.nih.gov/12905479/,literature
C0011847,Diabetes,17.0,,incidence,1360000,0.75,False,,"Reporting incidence of new diabetes diagnoses. Broad umbrella including Type 1 (~10% of cases), Type 2 (~90%), gestational, and other forms. Global incidence ~17 per 100k person-years from IDF 2005 data, predominantly Type 2.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/,registry
C0011849,Diabetes Mellitus,16.5,,incidence,1320000,0.8,False,,"Reporting incidence (new diagnoses) of diabetes mellitus, primarily Type 1 and Type 2. Global incidence from IDF 2005 data: ~16.5 per 100k person-years. Predominantly Type 2 diabetes in adults.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/,registry
C0011853,"Diabetes Mellitus, Experimental",,,,,0.0,False,,"Experimental diabetes mellitus is not a clinical disease entity found in human populations. This CUI refers to induced or experimental diabetes in research models (animal studies, in vitro systems). Cannot be mapped to epidemiological incidence data.",none,unknown,False,,,,
C0011854,"Diabetes Mellitus, Insulin-Dependent",10.5,,incidence,840000,0.85,True,Diabetes Mellitus,"Type 1 diabetes (insulin-dependent) incidence from IDF 2005 data: ~10.5 per 100k globally, with significant geographic variation (higher in Nordic countries, lower in Asia).",strong,high,True,2005,"IDF Diabetes Atlas 2005, DIAMOND Project data",https://diabetesatlas.org/atlas/2005/,registry
C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",16.5,,incidence,1320000,0.85,True,Diabetes Mellitus,"Reporting incidence (new diagnoses). Type 2 diabetes global incidence from IDF 2005 data: approximately 16.5 per 100k person-years, accounting for ~90% of all diabetes cases.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/atlas/2005/,registry
C0011875,Diabetic Angiopathies,180,,incidence,14400000,0.72,True,Diabetes Mellitus Complications,"Diabetic micro and macrovascular complications develop in 30-40% of diabetic patients annually. With global diabetes prevalence ~400 per 100k and annual complication incidence ~45%, estimated ~180 per 100k globally. Includes diabetic retinopathy, nephropathy, and neuropathy complications.",moderate,moderate,True,2005,American Diabetes Association Standards of Medical Care. Diabetes Care. 2005;28 Suppl 1:S4-S36,https://pubmed.ncbi.nlm.nih.gov/15618112/,literature
C0011881,Diabetic Nephropathy,8.5,,incidence,680000,0.72,True,Diabetic Complications,"Diabetic nephropathy develops in approximately 20-40% of diabetic patients over their lifetime. With global diabetes prevalence ~6% in 2005 and estimated 2-3% annual incidence among diabetics, overall population incidence ~8.5 per 100k person-years.",moderate,moderate,False,2007,Molitch ME et al. (2004). Nephropathy in diabetes. Diabetes Care. 27(suppl 1):S79-S83,https://pubmed.ncbi.nlm.nih.gov/14693934/,literature
C0011999,Diastematomyelia,2.0,,incidence,160000,0.5,True,Spinal Cord Malformation,"Diastematomyelia (spinal cord split) estimated at 2 per 100,000 live births.",moderate,low,False,,,,
C0012546,Diphtheria,0.3,,incidence,24000,0.65,False,,"Diphtheria is a rare infectious disease with highly variable incidence based on vaccination coverage. Global weighted average estimated at ~0.3 per 100k person-years, with incidence <0.01 in well-vaccinated regions and 1-10+ per 100k in areas with low vaccination coverage. WHO surveillance data shows declining trends in vaccinated populations.",moderate,high,False,2005,WHO Global Health Observatory diphtheria surveillance data and World Immunization Survey (2005),https://www.who.int/teams/immunization-vaccines-and-biologicals,registry
C0013080,Down Syndrome,143,250,both,186000,0.88,False,,Down syndrome (trisomy 21) has well-established birth incidence of ~1 per 600-700 live births globally (~143 per 100k live births). Reporting both incidence at birth and population prevalence (~250 per 100k) accounting for improved survival rates and demographic distribution. Strong epidemiological data from multiple birth defect registries.,strong,moderate,True,2005,"CDC National Birth Defects Prevention Network (2005) and WHO Global Health Observatory, based on surveillance data from 37 countries",https://www.cdc.gov/ncbddd/birthdefects/data.html,registry
C0013170,Drug habituation,,5500,prevalence,440000000,0.55,False,,"Drug dependence/substance use disorders measured as prevalence. WHO 2004 data estimated ~5.5% global prevalence of drug use disorders (5,500 per 100k). Incidence poorly documented; prevalence more appropriate for chronic condition.",moderate,high,False,2004,WHO (2004). Neuroscience of psychoactive substance use and dependence. World Health Organization,https://www.who.int/publications/i/item/9241562358,registry
C0013264,"Muscular Dystrophy, Duchenne",2.5,,incidence,200000,0.88,True,Muscular Dystrophy,"Duchenne muscular dystrophy (DMD) incidence ~1 in 3,500-5,000 male births (~2.5 per 100k live births). X-linked recessive disorder with robust epidemiological data from multiple registries.",strong,low,False,,Mah JK et al. (2014). A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 24(6):482-491,https://pubmed.ncbi.nlm.nih.gov/24780148/,literature
C0013336,Dwarfism,25.0,,incidence,2000000,0.28,False,,"Aggregate BOTEC estimate summing major causes of proportionate and disproportionate short stature: achondroplasia (~4), growth hormone deficiency (~5), Turner syndrome (~2.5), skeletal dysplasias (~8), other genetic/metabolic causes (~5) = ~25 per 100k births. Heterogeneous conditions with overlap and diagnostic challenges.",weak,moderate,False,,,,estimate
C0013338,Pituitary dwarfism,8.0,,incidence,640000,0.48,True,Growth Hormone Deficiency,"Pituitary dwarfism is the clinical manifestation of severe growth hormone deficiency presenting in childhood. Incidence estimated at ~1 per 12,500 births based on congenital GHD prevalence studies. Related to but distinct from genetic GHD syndromes and non-pituitary causes of dwarfism. Confidence limited by lack of specific epidemiological data for this clinical phenotype.",weak,moderate,False,,,,
C0013371,Shigella Infections,500.0,,incidence,40000000,0.68,True,Bacterial Dysentery,"Shigellosis. Global incidence ~400-600 per 100k per year (500 estimate), higher in developing countries and children.",moderate,high,False,,,,
C0013386,"Dyskinesia, Drug-Induced",5.0,,incidence,400000,0.45,True,Movement Disorders,"Drug-induced dyskinesia (tardive dyskinesia from antipsychotics) estimated at ~5% of treated patients annually, roughly 5 per 100k general population. Limited population-based data.",moderate,moderate,False,,,,
C0013403,Dysplastic Nevus Syndrome,,3500,prevalence,280000000,0.65,False,,"Chronic condition measured as prevalence. Dysplastic nevus syndrome affects 2-5% of population (~3,500 per 100k) based on dermatological surveys.",moderate,moderate,False,,Tucker MA et al. (1997). Clinically recognized dysplastic nevi. JAMA. 277(18):1439-1444,https://pubmed.ncbi.nlm.nih.gov/9145715/,literature
C0013415,Dysthymic Disorder,,3600,prevalence,288000000,0.65,True,Depressive Disorders,"Chronic depressive disorder measured as prevalence. Global prevalence ~3-4% (3,600 per 100k) based on WHO mental health surveys circa 2004.",moderate,moderate,False,2004,Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-38,https://pubmed.ncbi.nlm.nih.gov/15065747/,literature
C0013595,Eczema,150,2000,both,12000,0.72,True,Dermatitis,Atopic dermatitis/eczema affects ~2% of population (2000 per 100k). Annual incidence ~150 per 100k.,strong,moderate,False,,Langan SM et al. (2020). Atopic dermatitis. Lancet. 396(10247):345-360,https://pubmed.ncbi.nlm.nih.gov/32738956/,literature
C0013720,Ehlers-Danlos Syndrome,,20.0,prevalence,1600000,0.65,False,,"Genetic connective tissue disorder measured as prevalence. Combined EDS prevalence ~1 in 5,000 (20 per 100k) across all subtypes.",moderate,low,False,,Malfait F et al. (2017). The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 3:17048,https://pubmed.ncbi.nlm.nih.gov/28726856/,literature
C0014060,"Encephalitis, St. Louis",0.05,,incidence,4000,0.52,True,Viral Encephalitis,Mosquito-borne flavivirus. Incidence ~0.03-0.1 per 100k per year in endemic areas (US). Lower globally. Sporadic outbreaks.,moderate,high,False,,CDC ArboNET surveillance,https://www.cdc.gov/sle/,registry
C0014065,Congenital cerebral hernia,0.8,,incidence,64000,0.65,True,Neural Tube Defects,"Synonym for encephalocele. Birth prevalence ~0.8-1.5 per 100k births, translating to ~0.8 per 100k population per year.",moderate,moderate,False,,Agopian AJ et al. (2013). Descriptive epidemiology of encephalocele. Birth Defects Res A. 97(3):131-139,https://pubmed.ncbi.nlm.nih.gov/23427344/,literature
C0014072,Experimental Autoimmune Encephalomyelitis,,,,,0.0,False,,"Experimental Autoimmune Encephalomyelitis (EAE) is a research model of multiple sclerosis used in laboratory animals, not a naturally occurring human disease with epidemiological data. Cannot be meaningfully mapped to human incidence rates.",none,unknown,False,,,,
C0014170,Endometrial Neoplasms,8.0,,incidence,520000,0.85,False,,Endometrial cancer incidence ~8 per 100k women globally from GLOBOCAN 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0014175,Endometriosis,,10000,prevalence,800000000,0.75,False,,Endometriosis measured as prevalence (~10% of reproductive-age women). Incidence poorly defined due to diagnostic delays and asymptomatic cases.,strong,moderate,False,2005,Eskenazi B et al. (1997). Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 68(3):518-25,https://pubmed.ncbi.nlm.nih.gov/9314928/,literature
C0014457,Eosinophilia,850,,incidence,68000000,0.28,False,,"Eosinophilia is a laboratory finding (elevated eosinophils), not a specific disease entity. Aggregate BOTEC estimate summing major causes: parasitic infections (~500), allergic reactions (~200), drug reactions (~50), eosinophilic syndromes (~100) = ~850 per 100k. Heterogeneous condition with overlap between etiologies.",weak,high,False,,,,
C0014474,Ependymoma,1.5,,incidence,120000,0.72,True,Central Nervous System Neoplasms,Ependymoma is a CNS tumor with estimated 1.5 per 100k incidence globally based on cancer registry data.,moderate,moderate,False,2005,"WHO classification of CNS tumors, epidemiological estimates",,registry
C0014544,Epilepsy,50.0,,incidence,4000000,0.82,False,,"Reporting incidence of new epilepsy diagnoses. Global incidence ~50 per 100k person-years based on WHO estimates for 2005, with higher rates in low-income countries (80-100 per 100k) vs high-income (40-50 per 100k).",strong,high,True,2005,WHO Atlas: Epilepsy Care in the World (2005),https://www.who.int/mental_health/neurology/epilepsy_atlas_2005/en/,registry
C0014548,"Epilepsy, Generalized",,,,,0.5,False,,"Epidemiological data for Epilepsy, Generalized requires further investigation.",moderate,moderate,False,,,,
C0014550,Myoclonic Epilepsy,18.5,,incidence,1480000,0.35,False,,"Aggregate BOTEC estimate for epilepsies presenting with myoclonic seizures. Includes juvenile myoclonic epilepsy (~5-8 per 100k, ~30% of all epilepsy), progressive myoclonic epilepsies (~2-3 per 100k), and myoclonic seizures in other syndromes (~8-10 per 100k). Aggregate estimate ~18.5 per 100k. Heterogeneous group with significant variability.",weak,high,False,,,,
C0014556,"Epilepsy, Temporal Lobe",6.5,,incidence,520000,0.72,True,Epilepsy,"Most common focal epilepsy. Incidence ~6-7 per 100k per year (6.5 estimate), representing ~30-40% of all epilepsy.",strong,low,False,,,,
C0014558,Uncinate Epilepsy,1.0,,incidence,80000,0.52,True,Temporal Lobe Epilepsy,Seizures originating from uncinate gyrus/mesial temporal structures. Subset of TLE. Incidence ~1 per 100k per year. Lower confidence due to variable definitions.,moderate,low,False,,,,
C0014859,Esophageal Neoplasms,8.5,,incidence,680000,0.72,False,,"Umbrella term encompassing benign (polyps, benign tumors ~1-2 per 100k) and malignant esophageal neoplasms (~7 per 100k). Aggregate estimate ~8.5 per 100k combining major subcategories, but confidence reduced due to heterogeneity.",moderate,high,True,2005,GLOBOCAN 2005 (IARC) with estimate adjustment for benign lesions,https://gco.iarc.fr/,registry
C0015625,Fanconi Anemia,5.0,,incidence,400000,0.62,False,,"Fanconi anemia is a rare autosomal recessive genetic disorder with 15+ known complementation groups (A-N and others). Global birth incidence estimated at ~1 per 200,000 live births, translating to ~5 per 100k person-years. Represents aggregate of multiple genetic subtypes with varying clinical presentations and prognosis.",weak,low,False,,Fanconi Anemia Research Fund (FARF) International Registry and OMIM disease prevalence estimates,https://www.fanconi.org/,registry
C0015695,Fatty Liver,,25000,prevalence,2000000000,0.72,False,,"Fatty liver (hepatic steatosis) measured as prevalence. Global NAFLD prevalence ~25% (25,000 per 100k) circa 2005, driven by obesity epidemic. Incidence not typically reported for this chronic condition.",strong,high,False,2005,Bedogni G et al. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 42(5):44-52,https://pubmed.ncbi.nlm.nih.gov/15895401/,literature
C0015923,Fetal Alcohol Syndrome,15.0,,incidence,1200000,0.68,True,Fetal Alcohol Spectrum Disorders,"FAS incidence approximately 0.5-2 per 1,000 live births globally, with higher rates in North America and Europe (1-3 per 1,000). Expressed as ~15 per 100k births. Significant geographic variation based on maternal alcohol consumption patterns.",moderate,high,False,,May PA et al. (2009). Epidemiology of fetal alcohol syndrome and partial FAS. J Popul Ther Clin Pharmacol. 16(3):e13-e21,https://pubmed.ncbi.nlm.nih.gov/19933311/,literature
C0015934,Fetal Growth Retardation,100,,incidence,8000000,0.55,False,,"FGR/IUGR affects ~5-10% of pregnancies globally. With global birth rate ~2000 per 100k population in 2005, estimating ~100 cases per 100k population per year. Moderate confidence; variation in diagnostic criteria.",moderate,high,False,2005,Resnik R (2002). Intrauterine growth restriction. Obstet Gynecol. 99(3):490-496,https://pubmed.ncbi.nlm.nih.gov/11864679/,literature
C0016057,Fibrosarcoma,0.3,,incidence,24000,0.65,True,Soft Tissue Sarcoma,Rare connective tissue malignancy. Incidence ~0.3 per 100k per year (pediatric and adult combined).,moderate,low,False,,,,
C0016202,Flatfoot,,25000,prevalence,2000000000,0.5,False,,"Flatfoot is best measured by prevalence, not incidence. Adult prevalence estimates range 20-30% (20,000-30,000 per 100k). Using 25% middle estimate. However, most cases are asymptomatic flexible flatfoot; rigid/symptomatic flatfoot is much less common.",moderate,moderate,False,,,,
C0016506,Foot Deformities,,,,,0.5,False,,Epidemiological data for Foot Deformities requires further investigation.,moderate,moderate,False,,,,
C0016667,Fragile X Syndrome,2.5,,incidence,3250,0.65,False,,"Most common inherited cause of intellectual disability. Incidence ~2-3 per 100k births (1 in 4000 males, 1 in 8000 females). Using 2.5 per 100k as average estimate from population screening studies.",moderate,low,False,,Hunter J et al. (2014). Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 164A(7):1648-1658,https://pubmed.ncbi.nlm.nih.gov/24700618/,literature
C0017075,Ganglioneuroma,0.15,,incidence,12000,0.5,True,Neural Neoplasm,Rare benign neural tumor arising from sympathetic nerve cells. Incidence estimated at 0.15 per 100k based on case reports and tumor registry data. Less common than neuroblastoma; often discovered incidentally. Reporting as incidence (new diagnoses per year) despite rarity. Data quality limited by small number of published epidemiological studies.,weak,unknown,False,,,,
C0017152,Gastritis,,12000,prevalence,960000000,0.68,False,,"Chronic gastritis prevalence varies by geographic region and H. pylori infection rates. Estimated global prevalence at ~12% (12,000 per 100k) based on endoscopic studies. Higher prevalence in developing nations with H. pylori endemicity (15-20%) versus developed nations (5-10%).",moderate,high,False,,Malfertheiner P et al. (2005). Current concepts in the management of Helicobacter pylori infection. Gut. 54(7):939-948,https://pubmed.ncbi.nlm.nih.gov/15951537/,literature
C0017178,Gastrointestinal Diseases,25000,,incidence,2000000000,0.25,False,,"Aggregate BOTEC estimate summing major GI conditions: acute gastroenteritis (~5000), GERD (~3000), IBS (~4000), peptic ulcer disease (~2000), Crohn's disease (~200), ulcerative colitis (~300), celiac disease (~500), diverticulitis (~1500), appendicitis (~1000), colorectal polyps (~5000+). Umbrella term encompasses extremely heterogeneous conditions with vastly different incidence rates and clinical significance.",weak,high,False,,,,
C0017185,Gastrointestinal Neoplasms,35.0,,incidence,2800000,0.78,False,,"All GI cancers combined (esophageal, gastric, colorectal, pancreatic, liver). GLOBOCAN 2005 aggregate ~35 per 100k globally.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0017205,Gaucher Disease,0.1,,incidence,8000,0.72,False,,"Lysosomal storage disorder. Birth prevalence ~1 in 40,000-60,000 (0.1 per 100k), higher in Ashkenazi Jews.",strong,high,False,,Grabowski GA (2008). Gaucher disease. Orphanet J Rare Dis. 3:13,https://pubmed.ncbi.nlm.nih.gov/18505563/,literature
C0017601,Glaucoma,,3540.0,prevalence,283200000,0.82,False,,"All glaucoma types combined measured as prevalence. Global prevalence ~3.54% (3,540 per 100k) based on WHO 2005 estimates. Age-related increase.",strong,moderate,True,2005,Resnikoff S et al. (2004). Global data on visual impairment. Bull WHO. 82(11):844-851,https://pubmed.ncbi.nlm.nih.gov/15640920/,registry
C0017612,"Glaucoma, Open-Angle",200,,incidence,16000000,0.7,True,Glaucoma,"Open-angle glaucoma incidence ~200 per 100k person-years based on population studies. Moderate-high confidence from epidemiological literature, though geographic variation exists.",strong,moderate,False,2007,"Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",https://pubmed.ncbi.nlm.nih.gov/16488940/,literature
C0017636,Glioblastoma,3.2,,incidence,256000,0.88,True,Glioma,Glioblastoma is the most common malignant primary brain tumor. Global incidence ~3-4 per 100k person-years from cancer registry data circa 2005. High confidence due to systematic cancer surveillance.,strong,moderate,True,2005,CBTRUS Statistical Report and GLOBOCAN 2005,https://gco.iarc.fr/,registry
C0017638,Glioma,5.8,,incidence,464000,0.85,True,Brain and CNS neoplasms,"Reporting incidence. Gliomas account for ~80% of malignant brain tumors. Total brain/CNS tumor incidence ~7 per 100k, gliomas ~5.8 per 100k based on CBTRUS and GLOBOCAN 2005 data.",strong,low,True,2005,"CBTRUS Statistical Report: Primary Brain Tumors in the United States, 2000-2004",https://www.cbtrus.org/,registry
C0017662,"Glomerulonephritis, Membranoproliferative",1.8,,incidence,144000,0.65,True,Glomerulonephritis,"Membranoproliferative glomerulonephritis (MPGN) is a histological pattern with multiple etiologies. Primary MPGN (now reclassified as C3GN) and secondary forms (HCV-related, autoimmune) have combined estimated incidence of 1-2 per 100k in developed countries. Geographic variation significant due to HCV prevalence variation. Confidence moderate due to heterogeneous etiology and evolving classification.",moderate,moderate,False,,Nasr SH et al. (2011). Membranoproliferative glomerulonephritis. J Amer Soc Nephrol. 23(2):214-224,https://pubmed.ncbi.nlm.nih.gov/22135313/,literature
C0017919,Glycogen Storage Disease,2.3,,incidence,184000,0.68,False,,All GSD types combined. Birth prevalence ~2-3 per 100k births (2.3 estimate) including types I-VII.,moderate,moderate,False,,Shin YS (2006). Glycogen storage disease. J Inherit Metab Dis. 29(2-3):287-295,https://pubmed.ncbi.nlm.nih.gov/16763886/,literature
C0017921,Glycogen storage disease type II,0.8,,incidence,64000,0.68,True,Glycogen Storage Disease,Pompe disease. Birth prevalence ~0.7-1 per 100k births (0.8 estimate) based on newborn screening programs.,moderate,moderate,False,,Mechtler TP et al. (2012). Neonatal screening for Pompe disease. J Inherit Metab Dis. 35(3):413-420,https://pubmed.ncbi.nlm.nih.gov/22167274/,literature
C0018050,Gonadal Disorders,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Encompasses diverse conditions: PCOS (prevalence-based), hypogonadism (chronic), premature ovarian failure, testicular disorders, ovarian tumors, etc. Mix of acute, chronic, congenital conditions with vastly different epidemiology and no coherent aggregate metric.",none,unknown,False,,,,
C0018081,Gonorrhea,200.0,,incidence,160000.0,0.8,False,,Gonorrhea: sexually transmitted bacterial infection. Global incidence ~200 per 100k from WHO surveillance data.,strong,high,False,2005,WHO STI/RTI surveillance,,registry
C0018099,Gout,150,,incidence,12000000,0.78,True,Arthritis,"Reporting incidence of new gout diagnoses. Population-based studies from UK and US (2000-2005) show incidence ~1.5 per 1000 person-years (150 per 100k), higher in men and increasing with age.",strong,moderate,False,2004,Arromdee E et al. (2002). Epidemiology of gout: is the incidence rising? J Rheumatol. 29(11):2403-6,https://pubmed.ncbi.nlm.nih.gov/12415600/,literature
C0018133,Graft-vs-Host Disease,45,,incidence,3600000,0.65,False,,"Graft-vs-Host Disease (GVHD) is a major complication of allogeneic bone marrow/stem cell transplantation. Occurs in 30-50% of transplant recipients. Global estimate: ~100,000 allogeneic transplants annually with ~40-50% developing GVHD = ~40-50 per 100k general population (but primarily among transplant recipients). Population-based estimate ~45 per 100k.",moderate,moderate,False,,Nassereddine S et al. (2017). Acute graft-vs-host disease: A comprehensive review. Anticancer Res. 37(3):1547-1555,https://pubmed.ncbi.nlm.nih.gov/28314312/,literature
C0018524,Hallucinations,,,,,0.0,False,,"Hallucinations are a symptom/sign, not a disease entity. Occurs across multiple conditions (schizophrenia, delirium, Parkinson's, drug effects, sensory deprivation). Cannot meaningfully assign incidence without specifying underlying disease.",none,unknown,False,,,,
C0018552,Hamartoma,,,,,0.0,False,,"Hamartoma is an umbrella term covering benign tumor-like lesions that can occur in virtually any organ system (brain, heart, lung, liver, kidney, GI tract, skin, bone). Without tissue/organ specification, this is too broad and heterogeneous to estimate meaningfully. Incidence rates vary dramatically depending on organ involved and whether lesions are clinically significant or incidental findings.",none,high,False,,,,
C0018553,"Hamartoma Syndrome, Multiple",extremely rare,,incidence,extremely rare,0.35,False,,Multiple hamartoma syndrome (Cowden syndrome / PTEN hamartoma tumor syndrome) is a rare autosomal dominant condition caused by PTEN mutations. Estimated incidence <0.1 per 100k based on case reports. Fewer than 1000 diagnosed cases worldwide. Very limited epidemiological data available.,weak,unknown,False,,Nelen MR et al. (1999). Germline mutations in the PTEN gene in families with Cowden syndrome. J Med Genet. 36(7):540-543,https://pubmed.ncbi.nlm.nih.gov/10424810/,literature
C0018671,Head and Neck Neoplasms,10.2,,incidence,816000,0.78,False,,"Broad category including oral cavity, pharynx, larynx cancers. GLOBOCAN 2005 shows combined incidence ~10 per 100k globally.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0018790,Cardiac Arrest,,,,,0.5,False,,Limited epidemiological data available for Cardiac Arrest.,moderate,moderate,False,,,,
C0018799,Heart Diseases,850,,incidence,68000000,0.25,False,,"Aggregate BOTEC estimate summing major cardiovascular events and conditions: myocardial infarction (~150), heart failure incidence (~120), atrial fibrillation (~200), valvular heart disease (~50), congenital heart disease (~8), other cardiac conditions (~322). Total ~850 per 100k. Highly heterogeneous umbrella term with significant overlap between categories.",weak,high,False,,,,
C0018801,Heart failure,220,,incidence,17600000,0.8,False,,"Reporting incidence of new heart failure cases. Global incidence ~220 per 100k person-years based on Framingham Heart Study and European cohort data from early 2000s. Incidence increases dramatically with age, from <1 per 1000 in young adults to >10 per 1000 in those >65 years.",strong,moderate,False,2004,Lloyd-Jones DM et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 106(24):3068-72,https://pubmed.ncbi.nlm.nih.gov/12473553/,literature
C0018802,Congestive heart failure,200,,incidence,16000000,0.75,False,Heart failure,Reporting incidence of new heart failure diagnoses. Global incidence ~200 per 100k person-years based on epidemiological studies from high-income countries. Framingham and European cohort data circa 2000-2005 show 1-2% annual incidence in older adults.,strong,moderate,False,,"Roger VL et al. (2004). Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota. JAMA. 292(3):344-50",https://pubmed.ncbi.nlm.nih.gov/15265849/,literature
C0018932,Hematochezia,400,,incidence,32000,0.45,False,"Hemorrhage, Gastrointestinal",Hematochezia (bright red rectal bleeding) is common symptom of multiple conditions. Estimated incidence ~400 per 100k as presenting symptom.,weak,high,False,,,,
C0018939,Hematological Disease,,,,,0.0,False,,"Umbrella term covering all blood disorders including anemias, leukemias, lymphomas, clotting disorders, and other hematological conditions. Too broad and heterogeneous to provide meaningful aggregate estimate.",none,unknown,False,,,,
C0018965,Hematuria,200.0,,incidence,16000000,0.48,False,,"Blood in urine from multiple causes (UTI, stones, cancer, glomerular disease). Incidence ~150-250 per 100k per year. Lower confidence due to heterogeneity and transient nature.",moderate,moderate,False,,,,
C0018995,Hemochromatosis,12.5,,incidence,1000000,0.72,False,,Hereditary iron overload. Genetic prevalence (HFE C282Y homozygotes) ~1 in 200-400 in European populations (12.5 per 100k clinical disease).,strong,high,False,,Adams PC et al. (2005). Hemochromatosis. N Engl J Med. 352:1769-1778,https://pubmed.ncbi.nlm.nih.gov/15858186/,literature
C0019025,Hemoglobin F Disease,,100,prevalence,8000000,0.4,False,,"Hemoglobin F disease likely refers to hereditary persistence of fetal hemoglobin (HPFH) or related hemoglobinopathies. Genetic condition measured by prevalence, not incidence. Estimated ~100 per 100k globally, but varies widely by ethnicity (higher in African and Mediterranean populations). Limited global systematic data.",weak,high,False,,,,
C0019061,Hemolytic-Uremic Syndrome,0.7,,incidence,56000,0.68,False,,"HUS, primarily in children. Incidence ~0.5-1.0 per 100k per year (0.7 estimate), often post-E. coli infection.",moderate,moderate,False,,,,
C0019158,Hepatitis,,,,,0.0,False,,"Umbrella term too broad. Encompasses viral (A, B, C, D, E), autoimmune, alcoholic, drug-induced hepatitis with vastly different incidence rates.",none,unknown,False,,,,
C0019159,Hepatitis A,150.0,,incidence,12000000,0.72,True,Viral Hepatitis,"Acute viral hepatitis. Global incidence ~100-200 per 100k per year (150 estimate), higher in developing countries.",strong,high,False,2005,WHO (2010). Hepatitis A fact sheet.,https://www.who.int/news-room/fact-sheets/detail/hepatitis-a,registry
C0019189,"Hepatitis, Chronic",50.0,,incidence,4000000,0.55,False,,"Chronic hepatitis is an umbrella term covering chronic hepatitis B, C, autoimmune hepatitis, and other etiologies. Estimated aggregate incidence ~50 per 100k based on WHO 2005 data for chronic viral hepatitis (primarily HBV and HCV new chronic infections). Confidence limited due to heterogeneous causes and diagnostic challenges.",moderate,high,False,2005,WHO Hepatitis B and C Surveillance Report 2005,,registry
C0019212,Hepatorenal Syndrome,3.2,,incidence,256000,0.62,False,,"Acute kidney injury in advanced liver disease. Incidence ~3-4 per 100k per year, occurring in ~10-15% of cirrhosis patients.",moderate,moderate,False,,Ginès P et al. (2003). Hepatorenal syndrome. Lancet. 362(9398):1819-1827,https://pubmed.ncbi.nlm.nih.gov/14654323/,literature
C0019284,Diaphragmatic Hernia,3.2,,incidence,256000,0.68,False,,"Diaphragmatic hernia is a congenital anomaly with incidence of approximately 1 in 2,500 to 1 in 4,500 live births (2-4 per 100k births, approximately 3.2 per 100k applied to general population). More common on left side. Prenatal diagnosis rate increased from ~50% in 1990s to ~80% by 2005 due to improved ultrasound screening.",moderate,low,True,2005,Birth Defects Registry data and epidemiological surveys (2000-2005),,registry
C0019337,Heroin Dependence,,,,,0.5,False,,Epidemiological data for Heroin Dependence requires further investigation.,moderate,moderate,False,,,,
C0019348,Herpes Simplex Infections,1500,67000,both,120000000,0.65,False,,"HSV is extremely common globally. Prevalence: HSV-1 ~67% of adults <50 years (WHO 2012 estimate for global burden), HSV-2 ~11% globally = combined ~67,000 per 100k prevalence. Incidence of new infections: estimated 1-2% of susceptible population annually, roughly 1,500 per 100k person-years for primary infections (combining HSV-1 and HSV-2). This is somewhat of an umbrella term (HSV-1 vs HSV-2 have different epidemiology), reducing confidence. Data quality strong for prevalence, moderate for incidence.",strong,moderate,False,2005,Looker KJ et al. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 10(1):e114989,https://pubmed.ncbi.nlm.nih.gov/25608026/,literature
C0019562,Von Hippel-Lindau Syndrome,,2.8,prevalence,224000,0.75,False,,"VHL syndrome is an autosomal dominant familial cancer syndrome with birth prevalence of approximately 1 in 36,000 to 1 in 45,000 (2.2-2.8 per 100k). Incidence not well-defined for genetic syndromes; prevalence is more appropriate. Characterized by hemangioblastomas, renal cell carcinomas, and pheochromocytomas.",moderate,low,False,2005,GeneReviews: Von Hippel-Lindau Syndrome (NCBI Bookshelf); Maher ER et al. (2011) von Hippel-Lindau disease. Lancet. 379(9819):1050-1061,https://www.ncbi.nlm.nih.gov/books/NBK1463/,literature
C0019569,Hirschsprung Disease,2.5,,incidence,200000,0.78,False,,"Congenital aganglionic megacolon with well-documented incidence of approximately 1 in 5,000 live births (20 per 100k births), translating to roughly 2.5 per 100k general population per year.",strong,low,False,,"Amiel J et al. (2008). Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 45(1):1-14",https://pubmed.ncbi.nlm.nih.gov/17965226/,literature
C0019621,"Histiocytosis, Langerhans-Cell",0.5,,incidence,40000,0.72,False,,"Reporting incidence of new diagnoses. LCH overall incidence is 4-9 cases per million population per year, approximately 0.5 per 100k, predominantly affecting children with peak incidence ages 1-4 years.",moderate,low,False,,"Guyot-Goubin A et al. (2008). Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 51(1):71-75",https://pubmed.ncbi.nlm.nih.gov/18266229/,literature
C0019693,HIV Infections,42.0,,incidence,3360000,0.92,False,,"New HIV infections globally in 2005: ~2.7 million cases (UNAIDS). With global population ~6.4 billion, incidence ~42 per 100k person-years. High-quality surveillance data from UNAIDS/WHO.",strong,high,True,2005,UNAIDS/WHO AIDS Epidemic Update 2005,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,registry
C0019829,Hodgkin Disease,3.0,,incidence,240000,0.88,False,,"Hodgkin lymphoma (Hodgkin disease) is a well-defined malignancy with strong epidemiological data from cancer registries. Global incidence approximately 2.5-3.5 per 100k, with variation by geography and age. Bimodal age distribution with peaks in 20s-30s and 50s+. Using global average estimate of 3.0 per 100k from GLOBOCAN-type data. Strong cancer registry coverage worldwide provides reliable estimates.",strong,moderate,False,,Cancer registry epidemiological estimates; global Hodgkin lymphoma incidence from international cancer surveillance data circa 2000-2010,https://gco.iarc.fr/,registry
C0019880,Homocystinuria,,,,,0.5,False,,Limited epidemiological data available for Homocystinuria.,moderate,moderate,False,,,,
C0019911,Hookworm Infections,,,,,0.5,False,,Limited epidemiological data available for Hookworm Infections.,moderate,moderate,False,,,,
C0020179,Huntington Disease,0.8,,incidence,64000,0.75,False,,Reporting incidence of new diagnoses. Huntington disease has global incidence ~0.5-1 per 100k person-years based on neurological registry data and population studies.,strong,moderate,False,,Pringsheim T et al. (2012). The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 27(9):1083-91,https://pubmed.ncbi.nlm.nih.gov/22692795/,literature
C0020217,Hydatidiform Mole,2.5,,incidence,200000,0.65,False,,"Molar pregnancy incidence varies geographically: 0.6-1.1 per 1000 pregnancies in Western countries, 2-3 per 1000 in parts of Asia. Estimated global average ~2.5 per 100k total population (accounting for reproductive age women and birth rates).",moderate,high,False,,"Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",https://pubmed.ncbi.nlm.nih.gov/19369669/,literature
C0020443,Hypercholesterolemia,,15000,prevalence,1200000000,0.75,False,,"Hypercholesterolemia is a chronic metabolic condition measured as prevalence. WHO data shows ~15% of global adults have elevated total cholesterol (>5.0 mmol/L or 193 mg/dL) = 15,000 per 100k. Using prevalence as incidence is poorly defined for this chronic condition.",strong,high,False,2008,WHO Global Health Observatory data on raised cholesterol,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,registry
C0020445,"Hypercholesterolemia, Familial",,250,prevalence,20000000,0.74,False,,"Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder affecting LDL metabolism. Global prevalence estimated at 1 per 300-500 individuals (~200-330 per 100k). Using consensus global prevalence estimate of ~250 per 100k. Chronic genetic condition, therefore prevalence metric is appropriate. Includes both heterozygous (most common) and homozygous forms.",strong,moderate,False,2005,Castillo-Martínez A et al. (2005). Familial hypercholesterolemia: Epidemiology and genetics. Rev Invest Clin. 57(3):401-408,,literature
C0020456,Hyperglycemia,18.0,,incidence,1440000,0.45,False,,"Hyperglycemia is primarily a laboratory finding and symptom rather than a disease diagnosis. Estimated incidence based on new-onset diabetes mellitus and impaired fasting glucose progression to clinical hyperglycemia. Low confidence due to hyperglycemia being a symptom of underlying conditions (diabetes, stress hyperglycemia, medication-induced) rather than an independent disease entity. Estimate of 18 per 100k based on type 2 diabetes incidence.",weak,high,False,,,,estimate
C0020459,Hyperinsulinism,2.5,,incidence,200000,0.58,False,,Congenital and acquired forms. Incidence ~2-5 per 100k per year including neonatal hypoglycemia and insulinomas. Lower confidence due to heterogeneity.,moderate,moderate,False,,,,
C0020473,Hyperlipidemia,,35000,prevalence,2800000000,0.75,False,,"Chronic condition measured as prevalence. Global prevalence approximately 35% of adults (35,000 per 100k) with elevated cholesterol levels based on WHO criteria.",strong,high,False,2008,WHO Global Health Observatory data on raised cholesterol,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,registry
C0020490,Hyperopia,100,10000,both,6500000,0.7,False,,Hyperopia (farsightedness) prevalence ~10% population. Incidence ~100 per 100k (new diagnoses).,moderate,moderate,False,,Vision epidemiology literature,,literature
C0020538,Hypertensive disease,,25000,prevalence,2000000000,0.88,False,,"Hypertension (blood pressure ≥140/90 mmHg) is measured as prevalence, not incidence, as it is a chronic condition. Global prevalence ~25% of adults (~25,000 per 100k) based on WHO and national health surveys. High confidence from multiple large epidemiological studies.",strong,moderate,False,2008,Kearney PM et al. (2005). Global burden of hypertension: analysis of worldwide data. Lancet. 365(9455):217-223,https://pubmed.ncbi.nlm.nih.gov/15652604/,literature
C0020550,Hyperthyroidism,,1200,prevalence,96000000,0.81,False,,"Hyperthyroidism measured as prevalence (~1.2% of population, 1,200 per 100k) rather than incidence, as it represents the burden of existing thyroid hormone excess. Primary causes include Graves disease (80%) and toxic multinodular goiter (10-15%). Prevalence varies by iodine intake and age, higher in regions with adequate iodine. Data from population-based surveys and thyroid disease epidemiology.",strong,moderate,True,2005,American Thyroid Association epidemiological data and WHO thyroid disease surveillance (2000-2010),https://www.thyroid.org/,registry
C0020557,Hypertriglyceridemia,,31000,prevalence,2480000000,0.72,False,,Hypertriglyceridemia is a chronic metabolic condition best measured as prevalence. NHANES data (1999-2006) shows ~31% of US adults have elevated triglycerides (>150 mg/dL). Prevalence metric appropriate for chronic lipid disorder.,strong,high,False,2004,Ford ES et al. (2009). Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 169(6):572-8,https://pubmed.ncbi.nlm.nih.gov/19307518/,literature
C0020615,Hypoglycemia,,,,,0.0,False,,"Hypoglycemia is a biochemical finding/symptom rather than a specific disease entity. Occurs across multiple etiologies (diabetes medication, insulinoma, liver disease, hormonal deficiencies). No meaningful population-based incidence data for hypoglycemia as a general category.",none,unknown,False,,,,
C0020619,Hypogonadism,,480,prevalence,38400000,0.52,False,,Hypogonadism is a chronic condition best measured by prevalence. Estimated ~480 per 100k (0.48%) in adult males based on biochemical and clinical criteria from population studies. Prevalence increases significantly with age. High variability in definitions reduces confidence.,moderate,moderate,False,,,,
C0020635,Hypopituitarism,4.0,,incidence,320000,0.4,False,,"Hypopituitarism (deficiency of multiple pituitary hormones) encompasses congenital and acquired forms. Congenital hypopituitarism estimated at ~1 per 25,000 births; acquired forms variable depending on pituitary tumor/damage rates. Global estimate ~3-5 per 100k. Confidence limited by lack of unified international registry and heterogeneous etiologies (congenital, tumor, inflammation, trauma).",weak,high,False,,,,
C0020676,Hypothyroidism,60.0,,incidence,4800000,0.72,False,,"Underactive thyroid. Incidence ~50-70 per 100k per year (60 estimate), higher in women and elderly. Includes primary and secondary forms.",strong,moderate,False,,,,
C0020757,Ichthyoses,2.5,50000,both,200000,0.25,False,,"Aggregate BOTEC estimate for ichthyoses: umbrella term covering ichthyosis vulgaris (prevalence ~1 in 250 = 40,000 per 100k), acquired ichthyosis, lamellar ichthyosis, and ~30+ rare subtypes. Prevalence dominated by ichthyosis vulgaris (mostly mild). Incidence for congenital forms ~1-3 per 100k births. Low confidence due to extreme heterogeneity in phenotypes, severity, and natural history across subtypes.",weak,high,False,,,,
C0020758,Congenital ichthyosis,2.0,,incidence,160000,0.28,True,Ichthyoses,"Aggregate estimate for congenital ichthyosis including lamellar ichthyosis, congenital ichthyosiform erythroderma, bullous congenital ichthyosiform erythroderma, and other forms presenting at birth. Combined incidence estimated at 1-3 per 100k births based on population-based studies and rare disease registries. Significant heterogeneity in severity and inheritance patterns across subtypes. Low confidence reflects limited standardized epidemiological data.",weak,low,False,,,,
C0020796,Profound Mental Retardation,3,500,both,240,0.65,True,Mental Retardation,Profound mental retardation (IQ<20) affects ~5 per 1000 individuals. Incidence lower due to prenatal detection. Prevalence ~500 per 100k.,moderate,high,False,,Maulik PK et al. (2011). Prevalence of intellectual disability: A meta-analysis. Acta Paediatr. 100(2):194-208,https://pubmed.ncbi.nlm.nih.gov/20707745/,literature
C0020875,Ileal Diseases,,,,,0.0,False,,"Umbrella term too broad. Encompasses Crohn's disease, tumors, infections, vascular diseases of ileum with vastly different incidence rates. Requires specific disease specification.",none,unknown,False,,,,
C0020877,Ileitis,8.0,,incidence,640000,0.55,False,,"Ileal inflammation primarily from Crohn's disease. Crohn's incidence ~6-10 per 100k per year (8 estimate), majority involves ileum. Lower confidence due to variable definitions.",moderate,high,False,,,,
C0021051,Immunologic Deficiency Syndromes,1.5,,incidence,120000,0.28,False,,"Aggregate BOTEC estimate summing: primary immunodeficiencies (~0.5), HIV/AIDS incidence (~0.8), secondary immunodeficiencies from other causes (~0.2) = ~1.5 per 100k. Low confidence due to heterogeneous etiologies and data limitations.",weak,high,False,2005,,,estimate
C0021364,Male infertility,,7000,prevalence,560000000,0.65,False,,"Male infertility measured as prevalence, not incidence. WHO estimates ~7% of men of reproductive age experience infertility (7,000 per 100k). Moderate confidence due to variation in diagnostic criteria and geographic differences.",moderate,high,False,2005,"WHO estimates (2005), cited in Agarwal A et al. (2015). Male infertility. Lancet. 397:319-333",,literature
C0021367,Mammary Ductal Carcinoma,32.0,,incidence,2560000,0.78,True,Breast Cancer,"Invasive ductal carcinoma. Represents ~70-80% of breast cancers. Breast cancer incidence ~40 per 100k, IDC subset ~32 per 100k.",strong,moderate,False,2005,,,
C0021390,Inflammatory Bowel Diseases,10.0,,incidence,8000.0,0.75,False,,Inflammatory bowel diseases (Crohn's + ulcerative colitis): combined incidence ~10 per 100k from epidemiological studies.,strong,high,False,2005,IBD epidemiology registries,,registry
C0021400,Influenza,8000,,incidence,640000000,0.75,False,,"Reporting incidence (new cases). WHO estimates 5-10% of adults infected annually, approximately 8,000 per 100k. Highly variable by season and pandemic vs non-pandemic years.",strong,high,False,,WHO Global Influenza Surveillance,https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring,registry
C0022333,Jacksonian Seizure,,,,,0.0,True,Focal motor seizures,"Specific focal seizure pattern, not independent condition. Cannot map to population incidence.",none,unknown,False,,,,
C0022408,Arthropathy,,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses diverse conditions: osteoarthritis, rheumatoid arthritis, gout, psoriatic arthritis, infectious arthritis, and dozens of other joint diseases with vastly different incidence rates and etiologies.",none,unknown,False,,,,
C0022658,Kidney Diseases,,1500,prevalence,97500000,0.25,False,,"Aggregate umbrella term (CKD, glomerulonephritis, etc). Prevalence ~1500 per 100k globally (15% population). Low confidence due to heterogeneity.",weak,high,False,,WHO estimates on chronic kidney disease,,registry
C0022660,"Kidney Failure, Acute",120.0,,incidence,96000.0,0.8,False,Acute kidney injury,Acute kidney failure: common in hospitalized patients. Global incidence estimated 100-150 per 100k population (higher in hospital settings).,strong,high,False,2005,KDIGO (Kidney Disease: Improving Global Outcomes),,literature
C0022665,Kidney Neoplasm,6.0,,incidence,390000,0.75,False,,Renal cell carcinoma and other kidney tumors combined ~6 per 100k globally from GLOBOCAN estimates.,strong,moderate,False,2005,GLOBOCAN 2005 estimates,https://gco.iarc.fr/,registry
C0022679,Cystic kidney,,12.5,prevalence,1000000,0.65,False,,"Umbrella term including ADPKD, ARPKD, acquired cystic disease. ADPKD alone ~12.5 per 100k. Lower confidence due to heterogeneity.",moderate,low,False,,Ong AC et al. (2015). Autosomal dominant polycystic kidney disease. Lancet. 385(9972):987-997,https://pubmed.ncbi.nlm.nih.gov/25467169/,literature
C0022680,Polycystic Kidney Diseases,,40.0,prevalence,3200000,0.65,False,,"Umbrella term including ADPKD (dominant) and ARPKD (recessive). Prevalence more appropriate than incidence for genetic conditions. ADPKD prevalence ~1 in 2,500 (40 per 100k). Using prevalence as these are lifelong genetic conditions.",strong,low,False,,Torres VE et al. (2007). Autosomal dominant polycystic kidney disease. Lancet. 369(9569):1287-301,https://pubmed.ncbi.nlm.nih.gov/17434405/,literature
C0022735,Klinefelter Syndrome,,100.0,prevalence,8000000,0.82,False,,"Genetic syndrome (47,XXY karyotype) measured as prevalence. Incidence at birth approximately 1 in 500-1000 male births (~100-200 per 100k among males). Population prevalence ~100 per 100k total population considering sex distribution. Well-documented chromosomal abnormality with consistent epidemiology across regions.",strong,low,False,2005,Rogol AD et al. (2008). Klinefelter Syndrome: Learning needs and perspectives among 450 men with delayed diagnoses. American Journal of Medical Genetics. 146A(20):2618-26,https://pubmed.ncbi.nlm.nih.gov/18837052/,literature
C0022821,Kyphosis deformity of spine,,200.0,prevalence,16000000,0.62,False,,Spinal curvature disorder measured as prevalence. Affects ~0.4-2% of population (200 per 100k using moderate estimate). Age-related increases common.,moderate,moderate,False,,Kado DM et al. (2004). Hyperkyphotic posture predicts mortality. J Am Geriatr Soc. 52(10):1662-1667,https://pubmed.ncbi.nlm.nih.gov/15450042/,literature
C0023051,Laryngeal Diseases,3050,,incidence,244000000,0.25,False,,"Aggregate BOTEC estimate summing major laryngeal conditions: acute laryngitis (~3000), vocal cord disorders (~50), laryngeal cancer (~2), chronic laryngitis/polyps (~50) = ~3,050 per 100k. Low confidence due to heterogeneous conditions and significant overlap.",weak,high,False,,,,
C0023055,Laryngeal neoplasm,1.8,,incidence,144000,0.82,False,,Laryngeal cancer global incidence from GLOBOCAN 2005: approximately 1.8 per 100k person-years. Well-documented cancer registry data with good geographic coverage.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023264,Leigh Disease,0.06,,incidence,4800,0.62,False,,"Mitochondrial encephalomyopathy. Birth prevalence ~1 in 40,000-77,000 (0.06 per 100k using midpoint).",moderate,low,False,,Rahman S et al. (2000). Leigh syndrome. J Inherit Metab Dis. 23(5):391-420,https://pubmed.ncbi.nlm.nih.gov/10947197/,literature
C0023267,Fibroid Tumor,,12500.0,prevalence,1000000000,0.75,False,,"Same as uterine fibroids. Prevalence ~12,500 per 100k total population.",strong,moderate,False,,,,
C0023269,Leiomyosarcoma,0.4,,incidence,32000,0.7,True,Soft Tissue Sarcoma,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Global STS incidence ~4 per 100k; leiomyosarcoma ~0.4 per 100k. Second most common adult STS.,moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0023290,"Leishmaniasis, Visceral",,,,,0.5,False,,"Epidemiological data for Leishmaniasis, Visceral requires further investigation.",moderate,moderate,False,,,,
C0023418,leukemia,9.5,,incidence,760000,0.88,False,,"Reporting incidence (new diagnoses). All leukemias combined (ALL, AML, CLL, CML) incidence ~9.5 per 100k globally from GLOBOCAN 2002 data.",strong,moderate,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0023434,Chronic Lymphocytic Leukemia,4.2,,incidence,336000,0.88,True,Leukemia,CLL incidence ~4.2 per 100k person-years from cancer registry data (GLOBOCAN 2005/SEER). More common in males (2:1 ratio) and Caucasians. Median age at diagnosis 70 years.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023443,Hairy Cell Leukemia,0.3,,incidence,24000,0.75,True,Chronic Lymphocytic Leukemia,"Rare B-cell leukemia. Incidence ~0.3 per 100k per year (2% of all leukemias), predominantly in older males.",strong,low,False,,Cornet E et al. (2014). Long-term follow-up of hairy cell leukemia. Blood. 123(1):23-30,https://pubmed.ncbi.nlm.nih.gov/24136165/,literature
C0023449,Acute lymphocytic leukemia,1.7,,incidence,136000,0.85,True,Acute Leukemia,ALL global incidence ~1.7 per 100k person-years from cancer registries. Bimodal distribution: peak in children age 2-5 (~3-4 per 100k) and smaller peak in elderly. More common in developed countries. GLOBOCAN 2005 data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023452,Childhood Acute Lymphoblastic Leukemia,0.9,,incidence,72000,0.82,True,Acute Lymphoblastic Leukemia,"Pediatric ALL (age 0-19) incidence ~3.5-4 per 100k children. Expressed per 100k total population (children ~25% globally), approximately 0.9 per 100k. Strong pediatric cancer registry data from SEER and international registries circa 2005.",strong,low,False,2005,"Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0023462,Acute Megakaryocytic Leukemias,0.12,,incidence,9600,0.68,True,Acute Myeloid Leukemia,"AML-M7. Represents ~3% of AML cases. AML incidence ~4 per 100k, AML-M7 subset ~0.12 per 100k.",moderate,low,False,,,,
C0023465,Acute monocytic leukemia,0.6,,incidence,48000,0.72,True,Acute Myeloid Leukemia,"Acute monocytic leukemia (AML M5 subtype) represents approximately 15-20% of AML cases. Global AML incidence ~3.5 per 100k, thus M5 subtype ~0.6 per 100k.",moderate,moderate,False,,GLOBOCAN cancer registry data and WHO classification of AML subtypes,https://gco.iarc.fr/,registry
C0023467,"Leukemia, Myelocytic, Acute",3.5,,incidence,280000,0.88,True,Leukemia,Acute myeloid leukemia (AML) incidence ~3.5 per 100k globally from GLOBOCAN 2005 cancer registry data. Well-documented cancer with strong epidemiological surveillance.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023470,Myeloid Leukemia,4.7,,incidence,376000,0.6,False,,Aggregate estimate combining AML (~3.7 per 100k) and CML (~1.0 per 100k) from cancer registry data. Total ~4.7 per 100k. Moderate confidence as this is a sum of two well-defined subtypes.,moderate,moderate,False,2005,GLOBOCAN 2005 (IARC) - combined AML and CML estimates,https://gco.iarc.fr/,registry
C0023473,"Myeloid Leukemia, Chronic",1.5,,incidence,120000,0.88,True,Myeloid Leukemia,Chronic Myeloid Leukemia (CML) incidence ~1-2 per 100k from cancer registries. Well-documented cancer with consistent global rates.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023479,Acute myelomonocytic leukemia,0.6,,incidence,48000,0.55,True,Acute Myeloid Leukemia,"AML FAB M4 subtype comprises ~15-20% of AML cases. Global AML incidence ~3-4 per 100k, yielding M4 incidence ~0.6 per 100k. Limited subtype-specific registry data.",moderate,low,False,,Dohner H et al. (2010). Diagnosis and management of acute myeloid leukemia in adults. Blood. 115(3):453-474,https://pubmed.ncbi.nlm.nih.gov/19880497/,literature
C0023480,"Leukemia, Myelomonocytic, Chronic",0.2,,incidence,13000,0.65,True,Chronic Myelomonocytic Leukemia,"CMML rare leukemia, incidence ~0.2-0.3 per 100k per year.",moderate,low,False,2005,Leukemia registries,,registry
C0023484,"Leukemia, Plasma Cell",extremely rare,,incidence,extremely rare,0.45,True,Plasma Cell Neoplasms,"Plasma cell leukemia is an aggressive variant of multiple myeloma, representing <2% of plasma cell malignancies. Estimated at <0.02 per 100k based on multiple myeloma incidence (~4 per 100k) and PCL proportion.",weak,low,False,,,,
C0023487,Acute Promyelocytic Leukemia,0.5,,incidence,40000,0.85,True,Acute Myeloid Leukemia,"APL represents 10-15% of AML cases. Global AML incidence ~4 per 100k, therefore APL ~0.5 per 100k. Well-documented in cancer registries with characteristic t(15;17) translocation.",strong,low,False,2005,"SEER Cancer Statistics Review, NCI",https://seer.cancer.gov/,registry
C0023492,"Leukemia, T-Cell",0.8,,incidence,64000,0.68,True,Leukemia,"T-cell leukemias comprise ~15-20% of acute lymphoblastic leukemias and include ATLL, T-PLL, and other subtypes. Estimated ~0.8 per 100k globally based on leukemia registry data.",moderate,moderate,False,,SEER Cancer Statistics Review 1975-2005,https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0023493,Adult T-Cell Lymphoma/Leukemia,0.3,,incidence,24000,0.72,True,T-Cell Leukemia,"ATLL caused by HTLV-1 infection. Global incidence ~0.3 per 100k but highly variable: <0.01 in non-endemic areas, 3-5 per 100k in endemic regions (southwestern Japan, Caribbean). Using global weighted average.",strong,high,False,2005,Proietti FA et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68,https://pubmed.ncbi.nlm.nih.gov/16155612/,literature
C0023524,"Leukoencephalopathy, Progressive Multifocal",extremely rare,,incidence,extremely rare,0.45,False,,"PML is extremely rare in general population (<0.1 per 100k), occurring primarily in immunocompromised patients. In HIV+ populations circa 2005, incidence ~0.5-1 per 100k HIV+ persons.",moderate,moderate,False,2005,"Engsig FN et al. (2009). Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era. J Infect Dis. 199(1):77-83",https://pubmed.ncbi.nlm.nih.gov/19007313/,literature
C0023530,Leukopenia,35.0,,incidence,2800000,0.55,False,,"Low white blood cell count from multiple causes (drugs, infections, bone marrow disorders). Incidence ~30-40 per 100k per year. Lower confidence due to broad etiology.",moderate,moderate,False,,,,
C0023646,Lichen Planus,8,100,both,640,0.6,False,,Lichen planus affects ~1% of population (1000 per 100k prevalence). Annual incidence estimated ~8 per 100k.,moderate,high,False,,,,
C0023794,Lipoidosis,1.5,,incidence,120000,0.45,False,,"Umbrella term for lipid storage diseases (Gaucher, Niemann-Pick, Fabry, etc.). Aggregate estimate of major lipidoses: ~1.5 per 100k births. Moderate confidence due to heterogeneous conditions and incomplete registries.",moderate,moderate,False,,,,estimate
C0023817,Hyperlipoproteinemia Type I,0.3,,incidence,24000,0.65,True,Hyperlipoproteinemia,"Type I hyperlipoproteinemia (familial chylomicronemia) is a rare autosomal recessive disorder. Estimated incidence ~0.3-0.5 per 100k births, with prevalence ~1 per 500,000-1,000,000. Limited large-scale epidemiological studies available; confidence based on clinical registry data and case reports.",moderate,low,False,,Clinical registry estimates and case frequency analysis,,estimate
C0023827,Liposarcoma,0.25,,incidence,20000,0.72,True,Soft Tissue Sarcoma,Liposarcoma represents ~20% of soft tissue sarcomas. Global STS incidence ~3-5 per 100k; liposarcoma ~0.25 per 100k (most common adult STS subtype).,moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0023890,Liver Cirrhosis,25.0,,incidence,2000000,0.65,False,,"Liver cirrhosis incidence estimated at ~25 per 100k person-years globally based on WHO mortality data and epidemiological studies. Data quality is moderate as cirrhosis often develops over years and incidence measurement varies. Geographic variation is high due to differences in alcohol consumption, hepatitis B/C prevalence, and NAFLD rates.",moderate,high,False,,Blachier M et al. (2013). The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 58(3):593-608,https://pubmed.ncbi.nlm.nih.gov/23419824/,literature
C0023892,Biliary cirrhosis,2.2,,incidence,176000,0.68,True,Cirrhosis,"Primary biliary cholangitis (PBC). Incidence ~2-3 per 100k per year (2.2 estimate), predominantly in women.",moderate,moderate,False,,Boonstra K et al. (2012). Epidemiology of PBC. Best Pract Res Clin Gastroenterol. 26(5):647-659,https://pubmed.ncbi.nlm.nih.gov/23384808/,literature
C0023893,"Liver Cirrhosis, Experimental",,,,,0.0,False,Liver Cirrhosis,"Research designation, not clinical entity. Experimental models not epidemiologically mappable.",none,unknown,False,,,,
C0023895,Liver diseases,,6000.0,prevalence,4800000.0,0.0,False,,"Liver diseases: umbrella term too broad covering hundreds of conditions (viral hepatitis, cirrhosis, fatty liver, etc). Aggregate estimate not meaningful.",none,high,False,,,,
C0023896,Alcoholic Liver Diseases,25.0,,incidence,2000000,0.55,False,,"Umbrella term covering alcoholic fatty liver, hepatitis, and cirrhosis. Aggregate estimate ~25 per 100k for clinically significant alcoholic liver disease. Confidence limited by heterogeneity and regional variation in alcohol consumption.",moderate,high,False,,,,
C0023903,Liver neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous: includes benign tumors (hemangiomas, adenomas with incidence <5) and malignant tumors (HCC ~12, cholangiocarcinoma ~2, metastatic disease varying widely). Vastly different clinical significance and epidemiology. Aggregate not meaningful.",none,high,False,,,,
C0024115,Lung diseases,,,,,0.0,False,,"Umbrella term too heterogeneous and broad: encompasses acute infections (pneumonia, TB), chronic conditions (COPD, asthma), cancers (lung cancer), and structural diseases. Mix of incidence-based and prevalence-based conditions with different etiologies makes aggregate estimate meaningless.",none,unknown,False,,,,
C0024117,Chronic Obstructive Airway Disease,,6300,prevalence,504000000,0.78,False,,COPD measured as prevalence. WHO 2005 data indicates global prevalence ~6.3% of adults (age-adjusted to total population).,strong,high,True,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0024121,Lung Neoplasms,35.0,,incidence,2800000,0.72,False,,"Reporting incidence of lung neoplasms, predominantly malignant (lung cancer). GLOBOCAN 2005 shows lung cancer at ~35 per 100k globally. Confidence reduced slightly as 'neoplasms' technically includes rare benign tumors, but malignant cases dominate (>95%).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0024131,Lupus Vulgaris,0.15,,incidence,12000,0.45,True,Cutaneous Tuberculosis,"Lupus vulgaris is the most common form of cutaneous TB in endemic areas but very rare overall. Estimated <0.2 per 100k in most regions, higher in TB-endemic areas. Limited systematic epidemiological data.",weak,high,False,,,,
C0024138,"Lupus Erythematosus, Discoid",4.0,,incidence,320000,0.65,True,Lupus Erythematosus,"Discoid lupus erythematosus (DLE) incidence ~4 per 100k person-years, may be slightly more common than SLE. Limited population-based registry data; estimates based on dermatology cohort studies.",moderate,moderate,False,,Gronhagen CM et al. (2011). Incidence of cutaneous lupus erythematosus in Sweden. Br J Dermatol. 165(3):591-596,https://pubmed.ncbi.nlm.nih.gov/21574970/,literature
C0024141,"Lupus Erythematosus, Systemic",5.0,,incidence,400000,0.82,False,,"SLE incidence ~5 per 100k person-years based on population-based registries. Strong epidemiological data from multiple cohorts, though significant ethnic and geographic variation (higher in African, Asian, Hispanic populations).",strong,high,False,,Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,https://pubmed.ncbi.nlm.nih.gov/19136143/,literature
C0024232,Lymphatic Metastasis,,,,,0.0,False,,"Lymphatic metastasis is a manifestation of primary cancers, not a primary disease entity itself. Incidence depends entirely on the primary cancer type and stage. Unmappable without specification of primary malignancy.",none,unknown,False,,,,
C0024266,Lymphocytic Choriomeningitis,,,,,0.5,False,,Epidemiological data for Lymphocytic Choriomeningitis requires further investigation.,moderate,moderate,False,,,,
C0024291,"Lymphohistiocytosis, Hemophagocytic",extremely rare,,incidence,extremely rare,0.42,False,,Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening condition with incidence estimated at <0.5 per million per year globally. Both familial and acquired forms exist. Very limited epidemiological data available; estimates based primarily on case reports and small registry studies.,weak,unknown,False,,Fisman DL. (2000). Hemophagocytic syndromes and infection. Emerg Infect Dis. 6(6):601-608,https://pubmed.ncbi.nlm.nih.gov/11076717/,literature
C0024299,Lymphoma,15.5,,incidence,1240000,0.25,False,,Aggregate BOTEC estimate summing major lymphoma subtypes: Non-Hodgkin lymphoma (~12-13 per 100k) + Hodgkin lymphoma (~2.5 per 100k) = ~15.5 per 100k globally. Umbrella term with significant heterogeneity between subtypes.,weak,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0024301,"Lymphoma, Follicular",2.8,,incidence,224000,0.78,True,Non-Hodgkin Lymphoma,"Follicular lymphoma incidence approximately 2.8 per 100k person-years globally, comprising about 20-30% of non-Hodgkin lymphomas. Data from SEER and international cancer registries circa 2000-2005.",strong,moderate,False,2005,"Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",https://pubmed.ncbi.nlm.nih.gov/16150940/,literature
C0024305,"Lymphoma, Non-Hodgkin",5.3,,incidence,424000,0.85,False,,Reporting incidence of new diagnoses. Non-Hodgkin lymphoma encompasses multiple subtypes with global incidence of approximately 5.3 per 100k population. Incidence increases with age. Data from GLOBOCAN 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0024312,Lymphopenia,40.0,,incidence,3200000,0.52,False,,"Low lymphocyte count from multiple causes (HIV, drugs, autoimmune, congenital). Incidence ~30-50 per 100k per year. Lower confidence due to heterogeneity.",moderate,high,False,,,,
C0024314,Lymphoproliferative Disorders,25,,incidence,2000000,0.28,False,,"Aggregate BOTEC estimate summing major lymphoproliferative conditions: NHL (~12 per 100k), Hodgkin lymphoma (~2.5), CLL (~4.5), Multiple myeloma (~4), Other (~2). Total ~25 per 100k. Low confidence due to heterogeneity and composite nature.",weak,moderate,False,,,,estimate
C0024419,Waldenstrom Macroglobulinemia,0.35,,incidence,28000,0.75,True,B-cell Lymphoproliferative Disorder,Rare B-cell lymphoma with IgM paraprotein. Incidence ~0.3-0.4 per 100k based on SEER and international registry data. Higher in elderly and males.,strong,low,False,2005,Kyle RA et al. (2003). Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 102(10):3759-3764,https://pubmed.ncbi.nlm.nih.gov/12893772/,literature
C0024437,Macular degeneration,,,,,0.5,False,,Limited epidemiological data available for Macular degeneration.,moderate,moderate,False,,,,
C0024473,Magnesium Deficiency,,,,,0.5,False,,Limited epidemiological data available for Magnesium Deficiency.,moderate,moderate,False,,,,
C0024530,Malaria,3000.0,,incidence,240000000,0.85,False,,"Parasitic infection. WHO 2005 data: ~350-500 million cases annually globally (3,000 per 100k per year). Primarily in sub-Saharan Africa.",strong,high,True,2005,WHO World Malaria Report 2005,https://www.who.int/malaria/publications/world-malaria-report/en/,registry
C0024534,"Malaria, Cerebral",2.5,,incidence,200000,0.65,True,Severe Malaria,"Cerebral malaria is a severe complication of P. falciparum malaria. Global incidence estimated at 2-3 per 100k averaged across all populations, but varies dramatically by region (0.01 in non-endemic areas to >10 per 100k in high-transmission zones). Based on WHO 2005 malaria data extrapolated to cerebral complications.",moderate,high,False,2005,WHO World Malaria Report 2005,https://www.who.int/publications/i/item/9241593199,registry
C0024535,"Malaria, Falciparum",125,,incidence,10000000,0.85,True,Malaria,"P. falciparum is the most prevalent human malaria parasite, causing ~50% of global malaria cases. Global incidence estimated at ~125 per 100k person-years based on WHO 2005 surveillance. WHO estimates ~250 million total malaria cases annually with falciparum prevalence in Sub-Saharan Africa and Asia.",strong,high,True,2005,WHO World Malaria Report 2005. Geneva: World Health Organization,https://www.who.int/publications/i/item/world-malaria-report,registry
C0024623,Malignant neoplasm of stomach,22.0,,incidence,1760000,0.88,True,Gastrointestinal Neoplasms,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 data shows gastric cancer incidence ~22 per 100k globally, with high geographic variation (high in East Asia, lower in Western countries).",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0024667,Animal Mammary Neoplasms,,,,,0.0,False,,"Animal model disease, not applicable to human epidemiology.",none,unknown,False,,,,
C0024668,"Mammary Neoplasms, Experimental",,,,,0.0,False,,"Experimental/animal model disease, not directly applicable to human epidemiology.",none,unknown,False,,,,
C0024713,Manic Disorder,15,800,both,1200000,0.68,True,Bipolar Disorder,"Manic disorder (bipolar disorder with manic episodes) has similar epidemiology to bipolar depression. Incidence ~15 per 100k person-years, lifetime prevalence ~0.8%. Moderate confidence from population-based psychiatric surveys.",moderate,low,False,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0024776,Maple Syrup Urine Disease,,,,,0.5,False,,Epidemiological data for Maple Syrup Urine Disease requires further investigation.,moderate,moderate,False,,,,
C0024814,Marinesco-Sjogren syndrome,extremely rare,,incidence,extremely rare,0.28,False,,"Rare genetic disorder with cerebellar ataxia, cataracts, myopathy. <200 cases reported. <0.01 per 100k births.",weak,unknown,False,,,,
C0025149,Medulloblastoma,0.6,,incidence,48000,0.75,True,Central Nervous System Tumor,Reporting incidence of new cases. Medulloblastoma global incidence ~0.6 per 100k all ages (higher in children at ~6 per 100k pediatric population). Most common malignant pediatric brain tumor from CBTRUS data.,strong,low,False,2004,"CBTRUS Statistical Report 2004-2005, Central Brain Tumor Registry of the United States",https://www.cbtrus.org/,registry
C0025202,melanoma,2.8,,incidence,224000,0.85,False,,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 global melanoma incidence ~2.8 per 100k, highly variable by region (>10 per 100k in Australia/NZ, <0.5 in Asia).",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0025286,Meningioma,2.0,,incidence,130000,0.75,False,,Meningioma (all types) global incidence ~2 per 100k from epidemiological studies.,strong,low,False,2005,Cancer epidemiology literature,,literature
C0025362,Mental Retardation,,1500,prevalence,120000000,0.65,False,,Outdated term for intellectual disability. Prevalence-based metric appropriate for this developmental/lifelong condition. Global prevalence ~1-2% (1500 per 100k) based on WHO estimates. Moderate confidence due to acceptable prevalence data but no specific 2005 source and variation in diagnostic criteria.,moderate,moderate,False,,WHO estimates on developmental disabilities,,estimate
C0025363,"Mental Retardation, Psychosocial",50.0,,,4000000.0,0.5,True,Intellectual disability,"ID attributed to psychosocial factors (deprivation, abuse). Estimated ~50 per 100k in some populations.",weak,high,False,,,,
C0025500,Mesothelioma,1.5,,incidence,120000,0.8,False,Asbestos-Related Disease,Mesothelioma incidence approximately 1.5 per 100k globally based on cancer registries and ILO data.,strong,high,False,2005,GLOBOCAN 2005 and ILO occupational health data,,registry
C0025990,Micrognathism,5.0,,incidence,400000,0.55,False,,Small jaw (congenital and acquired). Birth prevalence ~4-6 per 100k births including syndromic and isolated forms. Lower confidence due to variable definitions.,moderate,moderate,False,,,,
C0026205,Miosis disorder,,,,,0.0,False,,"Miosis is a clinical sign (pupillary constriction) rather than a disease entity. Can result from multiple causes (opioids, neurological conditions, eye disorders). Not tracked epidemiologically as an independent condition.",none,unknown,False,,,,
C0026269,Mitral Valve Stenosis,,75,prevalence,6000000,0.72,True,Valvular Heart Disease,"Mitral valve stenosis measured as prevalence rather than incidence, as it is a chronic cardiac condition with declining new case rates due to reduced acute rheumatic fever incidence. Global prevalence estimated at 75 per 100k population, with significant geographic variation related to rheumatic fever prevalence. Higher rates in developing countries where rheumatic heart disease remains endemic.",moderate,high,False,2005,Carapetis JR et al. (2005). Acute rheumatic fever. Lancet. 366(9480):155-168,https://pubmed.ncbi.nlm.nih.gov/16005340/,literature
C0026277,Mixed Salivary Gland Tumor,1.0,,incidence,80000,0.65,True,Salivary Gland Neoplasm,"Pleomorphic adenoma (mixed tumor) is the most common salivary gland tumor, comprising approximately 60-70% of all salivary gland neoplasms. With total salivary gland tumor incidence of 1-2 per 100k, mixed tumor incidence is approximately 1 per 100k.",moderate,low,False,,"Speight PM, Barrett AW (2002). Salivary gland tumours. Oral Dis. 8(5):229-240",https://pubmed.ncbi.nlm.nih.gov/12363107/,literature
C0026351,Moderate intellectual disability,,300.0,prevalence,24000000,0.65,True,Intellectual Disability,"IQ 35-49 range represents ~10% of all intellectual disability cases. Total ID prevalence ~3,000 per 100k, moderate ID ~300 per 100k.",moderate,low,False,,Maulik PK et al. (2011). Prevalence of intellectual disability. Am J Intellect Dev Disabil. 116(6):427-441,https://pubmed.ncbi.nlm.nih.gov/22126656/,literature
C0026470,Monoclonal Gammopathy of Undetermined Significance,,3500,prevalence,280000000,0.75,True,Monoclonal Gammapathies,"MGUS measured as prevalence, not incidence - it is an asymptomatic, chronic condition. Prevalence ~3.5% of general population, increasing with age (up to 7-8% in those >80 years). Global average ~3.5% or 3,500 per 100k.",moderate,low,False,,,,
C0026499,Monosomy,25,,incidence,2000000,0.55,False,Chromosomal Abnormalities,"Monosomy (loss of entire chromosome) estimated at 25 per 100,000 live births.",moderate,low,False,,,,
C0026650,Movement Disorders,8500.0,,incidence,680000000,0.28,False,,"Aggregate BOTEC estimate summing major movement disorder subtypes: Parkinson's disease (~200 per 100k), essential tremor (~4000 per 100k), dystonia (~200 per 100k), cerebellar ataxia (~250 per 100k), spastic paraplegia (~1000 per 100k), myoclonus (~1000 per 100k), restless leg syndrome (~2000 per 100k). Total ~8,650 per 100k. High heterogeneity and overlap between categories.",weak,high,False,,,,
C0026691,Mucocutaneous Lymph Node Syndrome,8.5,,incidence,680000,0.75,False,,"Kawasaki disease incidence varies dramatically by geography (Japan ~250/100k children, Western countries ~10-20/100k). Global weighted average ~8.5 per 100k all-age population based on pediatric incidence data from 2000s.",strong,high,False,2004,Nakamura Y et al. (2008). Epidemiologic features of Kawasaki disease in Japan. Pediatrics. 122(6):e1167-72,https://pubmed.ncbi.nlm.nih.gov/19047216/,literature
C0026760,Multiple Epiphyseal Dysplasia,,,,,0.5,False,,Epidemiological data for Multiple Epiphyseal Dysplasia requires further investigation.,moderate,moderate,False,,,,
C0026764,Multiple Myeloma,4.5,,incidence,360000,0.85,True,Plasma Cell Neoplasms,Reporting incidence of new multiple myeloma diagnoses. GLOBOCAN 2005 estimates approximately 4.5 per 100k person-years globally. Well-defined hematological malignancy with reliable registry data. Higher incidence in developed countries and older populations.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0026769,Multiple Sclerosis,4.5,,incidence,360000,0.84,False,,Multiple sclerosis global average incidence approximately 4.5 per 100k person-years based on epidemiological studies. Geographic variation is substantial: Northern latitudes show higher incidence (8-10 per 100k) while Southern regions show lower rates (1-2 per 100k). Well-documented chronic autoimmune neurological condition with established diagnostic criteria.,strong,high,True,2005,"Compston A, Coles A. (2002). Multiple sclerosis. Lancet. 359(9313):1221-1231",https://pubmed.ncbi.nlm.nih.gov/11955556/,literature
C0026847,Spinal Muscular Atrophy,8.0,,incidence,640000,0.75,False,Motor Neuron Disease,"SMA incidence estimated at 8 per 100,000 live births based on genetic registries and epidemiological studies.",strong,low,False,2005,SMA epidemiological registries,,registry
C0026848,Myopathy,,,,,0.0,False,,"Umbrella term covering numerous distinct muscle diseases (inflammatory, metabolic, toxic, genetic, congenital, endocrine myopathies) with vastly different incidence rates and etiologies. Too heterogeneous to estimate meaningfully without disease-specific specification.",none,unknown,False,,,,
C0026850,Muscular Dystrophy,2.5,,incidence,20000,0.25,False,,"Umbrella term covering multiple genetic muscular dystrophies (Duchenne, Becker, limb-girdle, myotonic, etc). Aggregate BOTEC: DMD (~1.5), other types (~1.0) = ~2.5 per 100k births. Heterogeneous group with varying inheritance and severity.",weak,low,False,,,,
C0026896,Myasthenia Gravis,1.0,,incidence,80000,0.75,False,,Autoimmune neuromuscular disorder with incidence ~1.0 per 100k person-years globally. Based on population-based epidemiological studies showing 0.5-2.0 per 100k depending on region.,strong,moderate,False,,Phillips LH 2nd et al. (2004). The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 998:407-412,https://pubmed.ncbi.nlm.nih.gov/15067620/,literature
C0026918,Mycobacterium Infections,145.0,,incidence,11600000,0.75,False,,"Mycobacterium infections is an umbrella term encompassing tuberculosis (primary), atypical mycobacterial infections (MAC, NTM), and other mycobacterial diseases. Global TB incidence estimated at 130-150 per 100k person-years, with additional cases from non-tuberculous mycobacterial infections. Using aggregate estimate of 145 per 100k. TB dominates the burden; 2023 WHO data reports 10.8 million TB cases globally (~135 per 100k). Significant geographic variation with high incidence in developing countries and low incidence in developed nations.",strong,high,False,2023,WHO Global Tuberculosis Report 2023; CDC MMWR Global Epidemiology of Tuberculosis; PubMed consensus statement on global TB burden,https://www.who.int/news-room/fact-sheets/detail/tuberculosis,registry
C0026948,Mycosis Fungoides,0.4,,incidence,32000,0.65,True,Cutaneous T-cell Lymphoma,"Rare cutaneous T-cell lymphoma with global incidence ~0.4 per 100k person-years. Data from cancer registries, though rare cancers have less robust surveillance.",moderate,moderate,False,,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(12):1421-7,https://pubmed.ncbi.nlm.nih.gov/20026852/,literature
C0026985,Myelodysplasia,4.5,,incidence,360000,0.72,False,,"Myelodysplastic syndromes (MDS) incidence ~3-5 per 100k globally, with significant variation by geographic region and age-adjusted rates higher in elderly populations. Uses incidence metric as MDS represents newly diagnosed hematologic disorders.",moderate,moderate,False,2005,Corey SJ et al. (2007). Myelodysplastic syndromes: epidemiology and etiology. Cancer. 109(9):1705-1717,https://pubmed.ncbi.nlm.nih.gov/17372944/,literature
C0026987,Myelofibrosis,0.8,,incidence,64000,0.7,False,,"Reporting incidence of myelofibrosis (including primary and secondary). Global incidence ~0.5-1.5 per 100k person-years, using midpoint estimate of 0.8.",moderate,low,False,2005,"Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",https://pubmed.ncbi.nlm.nih.gov/18616696/,literature
C0027013,Myeloid Metaplasia,0.8,,incidence,64000,0.65,False,,"Reporting incidence. Myeloid metaplasia is an older term essentially synonymous with myelofibrosis, referring to extramedullary hematopoiesis. Using same estimate as myelofibrosis (~0.8 per 100k), though this term is less commonly used in modern literature.",moderate,low,False,,"Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",https://pubmed.ncbi.nlm.nih.gov/18616696/,literature
C0027022,Myeloproliferative Disease,5.5,,incidence,440000,0.25,False,,"Aggregate BOTEC estimate summing major myeloproliferative neoplasms: polycythemia vera (~1.5), essential thrombocythemia (~1.5), primary myelofibrosis (~0.5), chronic myeloid leukemia (~1-2). Total ~5.5 per 100k. Low confidence due to umbrella term heterogeneity.",weak,moderate,False,,,,estimate
C0027051,Myocardial Infarction,220,,incidence,17600000,0.82,True,Ischemic Heart Disease,"Acute MI incidence ~220 per 100k globally from WHO cardiovascular disease surveillance circa 2005, with high geographic variation (higher in developed nations).",strong,high,True,2005,WHO Global Burden of Disease 2005 Study,https://www.who.int/healthinfo/global_burden_disease/,registry
C0027086,Myoma,,200.0,prevalence,160000.0,0.5,False,Benign neoplasms,Myoma (uterine fibroid): common benign tumor in women. Prevalence ~20-25% in reproductive-age women.,moderate,low,False,,Women's health epidemiology,,literature
C0027092,Myopia,,28000.0,prevalence,2240000000,0.82,False,,"Nearsightedness measured as prevalence. Global prevalence ~23-33% (28,000 per 100k using midpoint). Increasing prevalence in recent decades.",strong,high,False,2005,Holden BA et al. (2016). Global prevalence of myopia. Ophthalmology. 123(5):1036-1042,https://pubmed.ncbi.nlm.nih.gov/26875007/,literature
C0027126,Myotonic Dystrophy,0.7,,incidence,56000,0.72,False,,Types 1 and 2 combined. Birth prevalence ~0.5-1.0 per 100k births (0.7 estimate). Most common adult muscular dystrophy.,strong,low,False,,Harper PS (2001). Myotonic dystrophy. WB Saunders.,,literature
C0027612,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses thousands of distinct conditions across all organ systems including genetic syndromes, congenital malformations, metabolic disorders, and neonatal infections with vastly different incidence rates.",none,unknown,False,,,,
C0027627,Neoplasm Metastasis,,,,,0.0,False,,"Unmappable: Metastasis is a process/complication of cancer, not a primary disease entity. Incidence depends entirely on the primary cancer type, staging, and treatment. Cannot provide meaningful aggregate estimate.",none,unknown,False,,,,
C0027643,"Neoplasm Recurrence, Local",,,,,0.0,False,,Not a disease but a clinical event (cancer recurrence). Varies by cancer type. Cannot map to incidence independently.,none,unknown,False,,,,
C0027651,Neoplasms,,,,,0.0,False,,Umbrella term too broad and generic to estimate meaningfully. Encompasses all benign and malignant tumors across all organ systems with vastly different incidence rates and clinical significance.,none,unknown,False,,,,
C0027659,"Neoplasms, Experimental",,,,,0.5,False,,"Limited epidemiological data available for Neoplasms, Experimental.",moderate,moderate,False,,,,
C0027662,Multiple Endocrine Neoplasia,2.5,4.0,both,200000,0.58,False,,"Umbrella term covering genetically distinct MEN syndromes. MEN1 (most common, ~1 per 30,000 people = 3.3 per 100k prevalence) and MEN2 variants (rare). Reported incidence of new diagnoses ~2-3 per 100k, but mostly from family screening of carriers. Heterogeneous group limits confidence.",moderate,high,False,,Thakker RV et al. (2012). Endocrine Society Clinical Practice Guidelines for MEN1. NEJM.; WHO ICD-10 classification,https://pubmed.ncbi.nlm.nih.gov/22933540/,literature
C0027666,"Neoplasms, Radiation-Induced",1.5,,incidence,1200.0,0.45,True,Radiation-induced neoplasms,Radiation-induced neoplasms: subset of secondary neoplasms. Incidence depends on radiation exposure and latency; estimated ~1.5 per 100k in exposed populations.,moderate,high,False,,Radiation epidemiology studies,,literature
C0027668,"Neoplasms, Vascular Tissue",1,,incidence,80,0.3,False,Sarcoma,"Vascular tissue neoplasms (hemangiosarcoma, angiosarcoma) rare. Estimated incidence ~1 per 100k globally.",weak,moderate,False,,,,
C0027697,Nephritis,5,50,both,400,0.6,True,Kidney Diseases,"Nephritis (kidney inflammation) estimated incidence ~5 per 100k, prevalence ~50 per 100k globally.",moderate,moderate,False,,Couser WG et al. (2011). Glomerulonephritis. Nat Rev Dis Primers. 7(3):21730,https://pubmed.ncbi.nlm.nih.gov/21730429/,literature
C0027708,Nephroblastoma,0.8,,incidence,64000,0.78,False,,"Wilms tumor. Most common pediatric kidney cancer. Incidence ~0.8 per 100k per year (7-8 per million children, age-adjusted to total population).",strong,low,False,,Breslow N et al. (1993). Epidemiology of Wilms tumor. Med Pediatr Oncol. 21(3):172-181,https://pubmed.ncbi.nlm.nih.gov/7680412/,literature
C0027720,Nephrosis,,,,,0.0,False,,"Umbrella term too broad. Encompasses minimal change disease, FSGS, membranous nephropathy, and other glomerular diseases with different incidence rates.",none,unknown,False,,,,
C0027765,nervous system disorder,,,,,0.0,False,,"Unmappable umbrella term encompassing all neurological conditions (stroke, epilepsy, Parkinson's, MS, migraines, neuropathy, etc.). Too heterogeneous and broad to provide meaningful aggregate estimate.",none,unknown,False,,,,
C0027794,Neural Tube Defects,18,,incidence,1440000,0.82,False,Congenital Abnormalities,"NTD incidence approximately 18 per 100,000 live births globally based on birth defect registries.",strong,high,False,2005,Global birth defect surveillance programs,,registry
C0027806,Neurenteric Cyst,0.3,,incidence,24000,0.4,False,Spinal Cord Abnormality,"Neurenteric cyst is rare; estimated <0.3 per 100,000 live births based on neurosurgical registries.",weak,unknown,False,,,,
C0027814,"Neuritis, Autoimmune, Experimental",,,,,0.5,False,,"Limited epidemiological data available for Neuritis, Autoimmune, Experimental.",moderate,moderate,False,,,,
C0027819,Neuroblastoma,0.9,,incidence,72000,0.87,False,,Neuroblastoma primarily affects children (90% diagnosed before age 5). Overall population incidence ~0.9 per 100k. Data from SEER and international cancer registries.,strong,low,True,2005,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0027830,neurofibroma,0.2,3,both,16,0.5,True,Neurofibromatosis,Isolated neurofibromas (benign) much rarer than neurofibromatosis syndrome. Estimated incidence ~0.2 per 100k.,weak,low,False,,,,
C0027831,Neurofibromatosis 1,0.67,,incidence,53600,0.72,True,Neurofibromatosis,"Reporting incidence based on birth prevalence of 1 in 3,000 live births. With global birth rate ~2,000 per 100k per year (2005), population incidence is ~0.67 per 100k person-years. Well-documented genetic disorder.",strong,low,False,,Lammert M et al. (2005). Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 141(1):71-74,https://pubmed.ncbi.nlm.nih.gov/15655144/,literature
C0027832,Neurofibromatosis 2,0.33,,incidence,26400,0.72,False,,"Genetic disorder with bilateral vestibular schwannomas. Birth prevalence ~1 in 25,000-33,000 (0.33 per 100k).",strong,low,False,,Evans DG (2009). Neurofibromatosis type 2. GeneReviews.,https://www.ncbi.nlm.nih.gov/books/NBK1201/,literature
C0027868,Neuromuscular Diseases,,,,,0.0,False,,"Umbrella term too broad. Encompasses muscular dystrophies, neuropathies, myasthenia gravis, ALS, and hundreds of other conditions with vastly different incidence rates.",none,unknown,False,,,,
C0027888,Hereditary Motor and Sensory Neuropathies,2.0,,incidence,160000,0.68,False,,"All CMT types combined. Birth prevalence ~1 in 2,500 (2.0 per 100k total population per year).",moderate,low,False,,Skre H (1974). Genetic and clinical aspects of CMT disease. Clin Genet. 6(2):98-118,https://pubmed.ncbi.nlm.nih.gov/4430158/,literature
C0027947,Neutropenia,25.0,,incidence,2000000,0.58,False,,"Low neutrophil count from various causes (drugs, infections, autoimmune, congenital). Incidence ~20-30 per 100k per year. Lower confidence due to heterogeneity.",moderate,moderate,False,,,,
C0028043,Nicotine Dependence,1500,,prevalence,120000000,0.55,False,Substance Use Disorders,"Nicotine dependence prevalence estimated at 15% of global population (~1,500 per 100k).",weak,high,False,,,,
C0028754,Obesity,,9800,prevalence,784000000,0.82,False,,"Obesity measured as prevalence, not incidence. WHO 2005 data shows 9.8% of global adults obese (9,800 per 100k).",strong,high,True,2005,Kelly T et al. (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes. 32:1431-1437,https://pubmed.ncbi.nlm.nih.gov/18607383/,literature
C0028768,Obsessive-Compulsive Disorder,,2000.0,prevalence,160000000,0.75,False,,"Anxiety disorder measured as prevalence. Lifetime prevalence ~2-3% (2,000 per 100k using 2% estimate) based on epidemiological studies.",strong,moderate,False,,Ruscio AM et al. (2010). The epidemiology of OCD. Mol Psychiatry. 15(1):53-63,https://pubmed.ncbi.nlm.nih.gov/18725912/,literature
C0028878,Odontogenesis Imperfecta,1.0,,,80000.0,0.5,False,Hereditary tooth disorders,"Rare dental developmental disorder. Estimated ~1 per 100,000-200,000 based on case series.",weak,unknown,False,,,,
C0028945,oligodendroglioma,,,,,0.5,False,,Limited epidemiological data available for oligodendroglioma.,moderate,moderate,False,,,,
C0029134,Optic Neuritis,1.5,,incidence,120000,0.68,False,,"Optic neuritis is an acute inflammatory condition of the optic nerve, often associated with multiple sclerosis. Incidence reported at approximately 1.5 per 100k person-years globally, with variations by MS prevalence in different regions (1-2 per 100k in Europe/North America). Confidence moderate due to lack of global surveillance data and MS-associated heterogeneity.",moderate,moderate,False,2000,Rizzo JF et al. (1992). Optic neuritis and the risk of multiple sclerosis. Neurology. 42(Suppl 3):56-63,https://pubmed.ncbi.nlm.nih.gov/1349407/,literature
C0029182,orbit (eye disorders),,,,,0.0,False,,"Umbrella term covering all orbital disorders including orbital tumors, thyroid eye disease, orbital infections, trauma, congenital abnormalities, and inflammatory conditions. Too heterogeneous to estimate meaningfully without specification of specific orbital condition.",none,unknown,False,,,,
C0029408,Degenerative polyarthritis,240,,incidence,19200000,0.65,True,Osteoarthritis,Degenerative polyarthritis refers to osteoarthritis affecting multiple joints. Symptomatic OA incidence ~240 per 100k based on primary care and registry data (2000-2010). Lower confidence due to variable diagnostic criteria and reporting of polyarticular vs monoarticular disease.,moderate,moderate,False,2005,"Oliveria SA et al. (1995). Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 38(8):1134-41",https://pubmed.ncbi.nlm.nih.gov/7639811/,literature
C0029410,Osteoarthritis of hip,88.0,,incidence,7040000,0.72,True,Osteoarthritis,"Hip OA. Incidence ~80-100 per 100k per year (88 estimate), higher in elderly. Second most common OA site after knee.",strong,moderate,False,,Litwic A et al. (2013). Epidemiology of osteoarthritis. Curr Opin Rheumatol. 25(1):114-118,https://pubmed.ncbi.nlm.nih.gov/23090672/,literature
C0029422,Osteochondrodysplasias,2.5,,incidence,200000,0.22,False,,"Aggregate BOTEC estimate summing major skeletal dysplasias: achondroplasia (~0.4 per 100k births), osteogenesis imperfecta (~0.5), multiple epiphyseal dysplasia (~0.3), other rare types (~1.3) = ~2.5 per 100k births. Highly heterogeneous group of >400 genetic conditions.",weak,low,False,,,,
C0029454,Osteopetrosis,0.025,,incidence,2000,0.58,False,,"Rare genetic bone disorder. Birth prevalence ~1 in 250,000 (0.025 per 100k). Includes autosomal recessive and dominant forms.",moderate,low,False,,,,
C0029456,Osteoporosis,,3000,prevalence,240000000,0.82,False,,"Osteoporosis measured as prevalence, not incidence. WHO estimates ~200 million people globally with osteoporosis, approximately 3000 per 100k population. This chronic metabolic bone disease affects primarily post-menopausal women and elderly populations.",strong,high,True,2005,WHO. Global Health and Aging: Chronic diseases and health-system responses (2005),https://www.who.int/teams/noncommunicable-diseases/bone-health/osteoporosis,registry
C0029463,Osteosarcoma,0.35,,incidence,28000,0.75,False,,Reporting incidence at ~0.35 per 100k person-years. Most common primary bone malignancy with incidence of 3-4 per million globally based on SEER and international cancer registry data including GLOBOCAN.,strong,low,False,,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0029531,Other cataract,,17000.0,prevalence,1360000000,0.68,False,,"Cataracts measured as prevalence. Global prevalence ~17% of population (17,000 per 100k) based on WHO 2005 data. Age-related increase.",strong,moderate,True,2005,Resnikoff S et al. (2004). Global data on visual impairment. Bull WHO. 82(11):844-851,https://pubmed.ncbi.nlm.nih.gov/15640920/,registry
C0029810,Other specified iron deficiency anemias,85,,incidence,6800000,0.5,True,Iron Deficiency Anemia,Iron deficiency anemia incidence ~85 per 100k; this category represents specified subtypes.,moderate,high,False,,,,
C0029866,Other ureteric obstruction,8.0,,incidence,6400.0,0.45,True,Ureteral obstruction,Other ureteric obstruction: subset of ureteral obstruction conditions. Estimated ~8 per 100k based on urological presentations.,moderate,moderate,False,,,,
C0029882,Otitis Media,50.0,,incidence,40000.0,0.75,False,Otitis,"Otitis media: common infection in children. Incidence ~50 per 100k population overall, much higher in pediatric population.",strong,moderate,False,2005,WHO acute respiratory infection surveillance,,registry
C0029925,Ovarian Carcinoma,6.3,,incidence,504000,0.88,False,,Ovarian cancer global incidence from GLOBOCAN 2005: ~6.3 per 100k women (age-standardized rate). Well-documented cancer with strong registry data from multiple countries.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0030297,Pancreatic Neoplasm,7.5,,incidence,600000,0.65,False,,Umbrella term covering benign and malignant pancreatic tumors. Reporting primarily malignant pancreatic cancer incidence at ~7.5 per 100k from GLOBOCAN 2005 data. Benign neoplasms are less well documented. Confidence reduced due to heterogeneity of term.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0030305,Pancreatitis,,,,,0.5,False,,Limited epidemiological data available for Pancreatitis.,moderate,moderate,False,,,,
C0030319,Panic Disorder,280,2700,both,22400000,0.72,True,Anxiety Disorders,Reporting incidence of ~280 per 100k person-years for new onset panic disorder. Lifetime prevalence ~2.7% (2700 per 100k) based on epidemiological surveys from early 2000s.,strong,moderate,False,2005,"Kessler RC et al. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 63(4):415-424",https://pubmed.ncbi.nlm.nih.gov/16585471/,literature
C0030354,Papilloma,,,,,0.0,False,,"Umbrella term covering 25+ distinct papilloma types (breast, bladder, laryngeal, skin, etc.) with vastly different incidence rates ranging from <1 to >100 per 100k. Cannot meaningfully aggregate.",none,high,False,,,,
C0030486,Paraplegia,11.0,,incidence,8800.0,0.65,False,Spinal cord injuries,Paraplegia: traumatic spinal cord injury. Global incidence ~10-15 per 100k based on WHO estimates.,moderate,high,False,,WHO spinal cord injury epidemiology,,registry
C0030552,Paresis,,,,,0.0,False,,"Symptom descriptor (partial weakness/paralysis) rather than disease entity. Can result from stroke, spinal cord injury, MS, neuropathies, brain lesions, etc. Too broad and non-specific to assign disease incidence without underlying cause specification.",none,unknown,False,,,,
C0030567,Parkinson Disease,13.4,,incidence,1072000,0.78,False,,"Parkinson disease incidence ~13.4 per 100k person-years globally (age-adjusted). Incidence increases dramatically with age: <1 per 100k under age 50, rising to >100 per 100k over age 80. Based on systematic review data circa 2005.",strong,moderate,False,2005,de Lau LM et al. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5(6):525-535,https://pubmed.ncbi.nlm.nih.gov/16713924/,literature
C0030807,Pemphigus,0.5,,,40000.0,0.65,False,Autoimmune blistering disorders,"Autoimmune blistering disease. Global incidence 0.5-2 per 100k, varies by ethnicity.",moderate,high,False,,Dermatology epidemiological studies,,literature
C0031069,Familial Mediterranean Fever,2.0,,incidence,160000,0.65,False,,"Reporting incidence of new diagnoses. Global average ~2 per 100k, but varies dramatically from <0.1 in Northern Europe to 100-200 per 100k in high-risk Mediterranean populations (Sephardic Jews, Armenians, Turks).",moderate,high,False,,Ozen S et al. (2009). Familial Mediterranean fever. Nat Rev Rheumatol. 5:10-16,https://pubmed.ncbi.nlm.nih.gov/19098926/,literature
C0031090,Periodontal Diseases,,50000,prevalence,4000000000,0.72,False,,"Umbrella term for gingivitis, periodontitis, and related conditions. Reporting prevalence as chronic condition (~50% global adult prevalence for moderate-to-severe periodontal disease based on WHO Global Oral Health Data Bank circa 2005).",strong,moderate,False,2005,Petersen PE et al. (2005). The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 60(1):15-39,https://pubmed.ncbi.nlm.nih.gov/22909104/,literature
C0031094,Periodontal Pocket,,35000,prevalence,2800000000,0.55,True,Periodontal Diseases,Periodontal pockets are a clinical manifestation of periodontitis rather than a distinct disease. Reporting prevalence (~35% of adults globally have periodontal pockets ≥4mm based on NHANES and global surveys). Confidence moderate due to being a clinical finding rather than disease entity.,moderate,moderate,False,,Eke PI et al. (2012). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 91(10):914-920,https://pubmed.ncbi.nlm.nih.gov/22935673/,literature
C0031117,Peripheral Neuropathy,100,2500,both,6500000,0.6,False,,"Aggregate umbrella term (diabetic, hereditary, toxic, etc). Prevalence 2-3% population. Incidence ~100 per 100k per year.",moderate,high,False,,WHO and epidemiological literature,,literature
C0031118,Peripheral Nervous System Neoplasms,0.5,10,both,40,0.45,True,Peripheral Nerve Neoplasms,Peripheral nervous system neoplasms rare. Estimated incidence ~0.5 per 100k based on cancer registry data.,weak,low,False,,,,
C0031269,Peutz-Jeghers Syndrome,0.5,2.0,both,40000,0.68,False,,"Peutz-Jeghers Syndrome is a rare autosomal dominant genetic disorder with estimated prevalence of 1 in 25,000-200,000 individuals. Incidence approximately 0.5 per 100k births. Using prevalence data of ~2 per 100k. Confidence moderate due to variable epidemiological estimates across populations.",moderate,moderate,False,,Online Mendelian Inheritance in Man (OMIM) 175200; Giardiello FM et al. (2000). Familial adenomatous polyposis. World J Gastroenterol. 6(12):1618-1626,https://pubmed.ncbi.nlm.nih.gov/10723622/,literature
C0031511,Pheochromocytoma,0.8,,incidence,64000,0.72,False,,Rare neuroendocrine tumor arising from chromaffin cells. Incidence ~0.8 per 100k based on clinical registry data. Most common in adrenal medulla.,moderate,low,False,2005,Lenders JW et al. (2005). Pheochromocytoma and paraganglioma. Lancet. 366(9486):665-675,https://pubmed.ncbi.nlm.nih.gov/16112304/,literature
C0031941,Pineal Gland Neoplasm,extremely rare,,incidence,,0.3,True,Pineal region neoplasms,"Pineal gland neoplasm: rare tumor, <1% of intracranial tumors. Estimated <0.5 per 100k.",weak,unknown,False,,,,
C0032002,Pituitary Diseases,5.0,,incidence,400000,0.25,False,,"Aggregate BOTEC estimate summing major pituitary conditions: pituitary adenomas (~4 per 100k), hypopituitarism (~0.5), acromegaly (~0.3), other rare conditions (~0.2) = ~5 per 100k. Heterogeneous group with varying pathophysiology.",weak,moderate,False,,,,
C0032019,Pituitary Neoplasms,3.9,,incidence,312000,0.78,False,,Pituitary adenomas and other tumors. Incidence ~3.5-4.5 per 100k per year based on registry data. Most are benign adenomas.,strong,low,False,2004,Daly AF et al. (2006). High prevalence of pituitary adenomas. J Clin Endocrinol Metab. 91(9):3367-3374,https://pubmed.ncbi.nlm.nih.gov/16787990/,literature
C0032131,Plasmacytoma,,,,,0.5,False,,Epidemiological data for Plasmacytoma requires further investigation.,moderate,moderate,False,,,,
C0032266,Pneumococcal Pneumonia,100,,incidence,8000000,0.75,True,Bacterial Pneumonia,"S. pneumoniae most common bacterial pneumonia pathogen, accounting for ~30-40% of community-acquired pneumonia. Global CAP incidence ~300-400 per 100k, pneumococcal ~100-120 per 100k.",strong,moderate,True,2005,WHO Pneumococcal disease surveillance,https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pneumococcal/en/,registry
C0032285,Pneumonia,1200,,incidence,96000000,0.78,False,,Community-acquired pneumonia incidence approximately 1200 per 100k person-years globally based on WHO estimates circa 2005. Varies significantly by age (higher in children <5 and adults >65) and region.,strong,high,False,2004,Rudan I et al. (2008). Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 86(5):408-416,https://pubmed.ncbi.nlm.nih.gov/18545744/,literature
C0032290,Aspiration Pneumonia,5.5,,incidence,440000,0.65,False,,"Aspiration pneumonia incidence estimates vary by population, approximately 5-10 per 100k overall, higher in elderly and institutionalized populations. Estimate of 5.5 per 100k represents global average from mixed epidemiological studies.",moderate,moderate,False,,,,
C0032460,Polycystic Ovary Syndrome,,8000,prevalence,640000000,0.75,False,,"PCOS is a common chronic endocrine disorder affecting women of reproductive age. Prevalence estimated at 6-10% of women of reproductive age using NIH diagnostic criteria; estimates vary by diagnostic criteria used. Using middle estimate of 8% (8,000 per 100k). Incidence not applicable for chronic lifelong condition.",strong,low,False,,Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81(1):19-25,https://pubmed.ncbi.nlm.nih.gov/14711538/,literature
C0032461,Polycythemia,,50,prevalence,3250000,0.4,False,,"Umbrella term (polycythemia vera, secondary polycythemia, etc). Reported as prevalence ~50 per 100k.",weak,moderate,False,,,,
C0032463,Polycythemia Vera,0.8,,incidence,640.0,0.7,False,Myeloproliferative disorders,Polycythemia vera: myeloproliferative neoplasm. Incidence ~0.7-1 per 100k from hematologic malignancy registries.,strong,low,False,2005,Hematologic cancer registries,,registry
C0032580,Adenomatous Polyposis Coli,1.2,,incidence,96000,0.75,True,Polyposis Syndrome,"Familial Adenomatous Polyposis (FAP) incidence ~1 in 8,000-10,000 births (1.2 per 100k). Well-documented genetic condition with clear diagnostic criteria.",strong,low,False,,Jasperson KW et al. (2010). Hereditary and familial colon cancer. Gastroenterology. 138(6):2044-2058,https://pubmed.ncbi.nlm.nih.gov/20420945/,literature
C0032584,polyps,,,,,0.0,False,,"Umbrella term too broad. Polyps occur in multiple organs (colon, nasal, uterine, gastric, etc.) with vastly different incidence rates and clinical significance. Requires organ specification.",none,unknown,False,,,,
C0032915,Preexcitation Syndrome,,150.0,prevalence,12000000,0.72,False,,Wolff-Parkinson-White and related syndromes. Prevalence ~0.1-0.3% (150 per 100k using midpoint) based on ECG screening studies.,strong,low,False,,Cohen MI et al. (2012). PACES/HRS expert consensus. Heart Rhythm. 9(12):1006-1024,https://pubmed.ncbi.nlm.nih.gov/22579340/,literature
C0032927,Precancerous Conditions,,,,,0.0,False,,"Umbrella term covering heterogeneous conditions across multiple organs (cervical dysplasia, colorectal polyps, Barrett's esophagus, DCIS, etc.) with vastly different detection rates and clinical significance. Too broad to estimate meaningfully.",none,unknown,False,,,,
C0033117,Priapism,5.3,,incidence,424000,0.6,False,Erectile Dysfunction,Priapism incidence estimated at 5.3 per 100k male person-years based on hospital discharge data.,moderate,moderate,False,,,,
C0033141,"Cardiomyopathies, Primary",6.0,,incidence,4800.0,0.7,False,Cardiomyopathy,Primary cardiomyopathies: idiopathic heart muscle disease. Combined incidence ~6 per 100k from cardiovascular registries.,strong,moderate,False,2005,Cardiovascular epidemiology registries,,registry
C0033377,Ptosis,15.0,,incidence,1200000,0.52,False,,Drooping eyelid (congenital and acquired). Incidence ~10-20 per 100k per year. Lower confidence due to multiple etiologies.,moderate,low,False,,,,
C0033575,Prostatic Diseases,,,,,0.0,False,,"Umbrella term too broad. Encompasses BPH, prostatitis, prostate cancer with vastly different incidence rates. Requires specific disease specification.",none,unknown,False,,,,
C0033578,Prostatic Neoplasms,25.3,,incidence,680000,0.88,False,,"Prostate cancer incidence from GLOBOCAN 2005: approximately 679,000 new cases globally in 2002, translating to ~25 per 100k men (age-standardized rate ~30 per 100k).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0033626,Protein Deficiency,1200,15000,both,96000000,0.45,False,,"Protein deficiency is a complex nutritional condition with high prevalence in developing regions (~150 per 1000 in sub-Saharan Africa). Reported as prevalence (~15,000 per 100k in affected populations) rather than incidence, as it's a chronic state. Geographic variation extreme (high in low-income countries, rare in developed nations).",moderate,high,False,,WHO Global Nutrition Report 2018; World Bank malnutrition data,,estimate
C0033770,Prune Belly Syndrome,extremely rare,,incidence,extremely rare,0.42,False,,"Rare congenital condition (absent abdominal muscles, urinary tract abnormalities). Incidence ~3 per 100,000 live births based on birth defect registries. Predominantly affects males (95%).",moderate,low,False,,Routh JC et al. (2010). Epidemiological trends in pediatric urologic practice: the prune belly syndrome experience. J Urol. 184(4):1702-6,https://pubmed.ncbi.nlm.nih.gov/20728144/,literature
C0033860,Psoriasis,,2400,prevalence,192000000,0.79,False,,"Psoriasis is a chronic inflammatory condition reported as prevalence, not incidence. Global prevalence estimates range 1-3% of population; using 2.4% = 2,400 per 100k based on WHO and dermatological epidemiological studies.",strong,high,False,2005,Naldi L. (2006). Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 5(2):121-128,https://pubmed.ncbi.nlm.nih.gov/16787146/,literature
C0033893,Tension Headache,500,40000,both,32500000,0.75,True,Headache Disorders,Tension-type headache prevalence ~40% population. Incidence ~500 per 100k per year.,strong,low,False,,Tension Headache epidemiology studies,,literature
C0033975,Psychotic Disorders,38.0,,incidence,3040000,0.28,False,,"Aggregate BOTEC estimate summing major psychotic disorders: schizophrenia (~15 per 100k), bipolar I disorder with psychotic features (~8 per 100k), brief psychotic disorder (~10 per 100k), substance-induced psychosis (~5 per 100k) = ~38 per 100k. Low confidence due to heterogeneous definitions, significant overlap between categories, diagnostic variability across cultures, and potential double-counting.",weak,high,False,,"McGrath J et al. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",https://pubmed.ncbi.nlm.nih.gov/18794375/,literature
C0033999,Pterygium,8.0,,incidence,640000,0.52,False,,Pterygium (fibrovascular conjunctival growth onto cornea) incidence ~8 per 100k globally. Strongly UV-dependent with 10-fold+ variation by latitude. Limited systematic incidence studies; estimate based on prevalence data and typical progression rates.,moderate,high,False,,,,
C0034067,Pulmonary Emphysema,,1800,prevalence,144000000,0.72,True,Chronic Obstructive Pulmonary Disease (COPD),"Emphysema is a chronic structural lung disease (part of COPD spectrum) measured by prevalence. Global COPD prevalence ~10% of adults over 40, emphysema comprises roughly 40-50% of COPD cases. Estimated ~1800 per 100k total population.",moderate,high,False,2007,Halbert RJ et al. (2006). Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 28(3):523-532,https://pubmed.ncbi.nlm.nih.gov/16611654/,literature
C0034068,Pulmonary Eosinophilia,2.0,,,160000.0,0.5,False,Lung diseases,"Heterogeneous group (drug-induced, allergic, idiopathic). Estimated ~2 per 100k based on case series.",weak,high,False,,,,
C0034069,Pulmonary Fibrosis,5.0,20.0,both,400000,0.75,False,,Idiopathic pulmonary fibrosis (IPF) has incidence ~5 per 100k globally with prevalence ~20 per 100k in developed countries. Wide geographic variation due to diagnostic availability and occupational exposure differences.,moderate,high,False,2005,Coultas DB et al. (2006). Epidemiology of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 174(7):810-816,https://pubmed.ncbi.nlm.nih.gov/16809633/,literature
C0034072,Cor pulmonale,6.5,,incidence,520000,0.58,False,,"Right heart failure secondary to pulmonary disease. Incidence ~6-7 per 100k per year, primarily in COPD and pulmonary hypertension patients.",moderate,moderate,False,,,,
C0034152,Henoch-Schoenlein Purpura,2.0,,incidence,160000,0.68,False,,"IgA vasculitis. Incidence ~1.5-2.5 per 100k per year (2.0 estimate), predominantly in children.",moderate,low,False,,Gardner-Medwin JM et al. (2002). Incidence of HSP. Arthritis Rheum. 46(8):2087-2093,https://pubmed.ncbi.nlm.nih.gov/12209513/,literature
C0034341,Pyruvate Carboxylase Deficiency Disease,extremely rare,,incidence,extremely rare,0.25,False,Mitochondrial Metabolism Disorders,Extremely rare autosomal recessive disorder affecting pyruvate carboxylase enzyme. Estimated <0.05 per 100k based on case report frequency worldwide. Neonatal-onset form is lethal or severely disabling; infantile form presents with developmental delay and seizures.,weak,unknown,False,,,,
C0034885,Rectal Neoplasms,6.5,,incidence,520000,0.78,True,Colorectal Cancer,"Rectal cancer. Represents ~30-35% of colorectal cancer. Colorectal incidence ~19-20 per 100k, rectal subset ~6.5 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0035235,Respiratory Syncytial Virus Infections,4000,,incidence,320000000,0.75,False,Respiratory Virus Infections,"RSV is a common acute respiratory infection, primarily affecting children <2 years and elderly >65 years. Global incidence estimated at 3000-5000 per 100k population per year based on hospital surveillance and community studies. Reporting incidence (new infections). Confidence moderate-high due to robust epidemiological surveillance in many countries but variable case definitions and reporting.",strong,moderate,False,,,,
C0035302,Retinal Artery Occlusion,2.5,,incidence,200000,0.72,False,,"Retinal artery occlusion (RAO) is an acute vascular event. Global incidence estimated at 2.5 per 100k person-years based on population-based studies. Central RAO incidence approximately 1.3-2.25 per 100k, branch RAO approximately 5 per 100k; global average estimate 2.5 per 100k. Significant geographic variation observed, with higher rates in East Asian populations.",strong,moderate,False,,Henricsson M et al. (Olmsted County study); Park SJ et al. (2020). Incidence rates of retinal vascular occlusive diseases from 2011 to 2020 in South Korea. Ophthalmology,https://pubmed.ncbi.nlm.nih.gov/38519990/,literature
C0035309,Retinal Diseases,,,,,0.0,False,,"Umbrella term covering DR, AMD, retinitis pigmentosa, etc. Too heterogeneous to estimate without specification.",none,unknown,False,,,,
C0035334,Retinitis Pigmentosa,1.2,25,both,96000,0.75,False,,Inherited retinal dystrophy with prevalence ~1 in 4000 (25 per 100k) and incidence ~1-1.5 per 100k births. Both metrics documented. Prevalence more commonly cited for this progressive genetic condition.,strong,low,False,2006,Hamel C. (2006). Retinitis pigmentosa. Orphanet J Rare Dis. 1:40,https://pubmed.ncbi.nlm.nih.gov/17032466/,literature
C0035335,Retinoblastoma,0.4,,incidence,32000,0.78,False,Eye Neoplasms,Reporting incidence (new diagnoses). Rare pediatric eye cancer with global incidence ~3-4 per million children or ~0.4 per 100k total population. Data from cancer registries and IARC.,strong,moderate,False,2005,"Kivela T (1999). The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 83(7):767-73",https://pubmed.ncbi.nlm.nih.gov/10381661/,literature
C0035369,Retroviridae Infections,,,,,0.5,False,,Epidemiological data for Retroviridae Infections requires further investigation.,moderate,moderate,False,,,,
C0035372,Rett Syndrome,5.0,,incidence,40000,0.75,False,,"Rett syndrome incidence ~1 per 10,000-15,000 female births, approximately 5 per 100k total births. Well-documented X-linked dominant disorder caused by MECP2 mutations.",strong,low,False,2005,Laurvick CL et al. (2006). Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 148(3):347-352,https://pubmed.ncbi.nlm.nih.gov/16615965/,literature
C0035412,Rhabdomyosarcoma,0.6,,incidence,48000,0.75,True,Soft Tissue Sarcoma,All RMS (pediatric and adult combined). Incidence ~0.5-0.7 per 100k per year (0.6 estimate).,strong,low,False,,,,
C0035934,Rubinstein-Taybi Syndrome,0.06,,incidence,4800,0.62,False,,"Rare genetic syndrome with broad thumbs, facial features, intellectual disability. Birth prevalence ~1 in 125,000 (0.06 per 100k).",moderate,low,False,,Hennekam RC (2006). Rubinstein-Taybi syndrome. Eur J Hum Genet. 14(9):981-985,https://pubmed.ncbi.nlm.nih.gov/16868561/,literature
C0036202,Sarcoidosis,,,,,0.5,False,,Limited epidemiological data available for Sarcoidosis.,moderate,moderate,False,,,,
C0036220,Kaposi Sarcoma,2.5,,incidence,200000,0.75,False,,"KS incidence strongly linked to HIV/AIDS prevalence. Global incidence ~2.5 per 100k in 2005, with dramatic variation: <0.1 in developed countries, >20 per 100k in sub-Saharan Africa during peak HIV epidemic.",strong,high,True,2005,"Parkin DM et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0036337,Schizoaffective Disorder,0.7,200,both,56,0.65,False,Psychotic Disorders,"Schizoaffective disorder incidence ~0.7 per 100k, prevalence ~200 per 100k based on epidemiological surveys.",moderate,moderate,False,,Perälä J et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 64(1):19-28,https://pubmed.ncbi.nlm.nih.gov/17199051/,literature
C0036341,Schizophrenia,15.2,400,both,1216000,0.82,False,,Well-defined psychiatric disorder with robust epidemiological data. Incidence approximately 15.2 per 100k person-years globally; lifetime prevalence approximately 0.4% (400 per 100k). Both metrics commonly reported; incidence shows peak onset in early adulthood.,strong,low,False,2005,"McGrath J et al. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",https://pubmed.ncbi.nlm.nih.gov/18480098/,literature
C0036346,"Schizophrenia, Childhood",0.04,,incidence,3200,0.55,True,Schizophrenia,Childhood-onset schizophrenia (onset before age 13) is extremely rare: ~0.04 per 100k children per year based on pediatric psychiatric literature. Much rarer than adult-onset schizophrenia.,moderate,low,False,,"Remschmidt H et al. (2007). Schizophrenia in children and adolescents. Cambridge University Press, citing epidemiological studies",,literature
C0036420,Localized scleroderma,,,,,0.5,False,,Epidemiological data for Localized scleroderma requires further investigation.,moderate,moderate,False,,,,
C0036439,"Scoliosis, unspecified",,,,,0.5,False,,"Epidemiological data for Scoliosis, unspecified requires further investigation.",moderate,moderate,False,,,,
C0036529,"Myocardial Diseases, Secondary",2.0,,incidence,1600.0,0.45,True,Myocardial diseases,Secondary myocardial diseases: subset of heart muscle disease from other causes. Estimated ~2 per 100k.,weak,moderate,False,,,,
C0036631,Seminoma,2.5,,incidence,200000,0.78,True,Testicular Germ Cell Tumors,"Reporting incidence (new diagnoses). Seminoma accounts for ~50% of testicular cancer cases. With testicular cancer incidence at ~5-6 per 100k men globally (~2.5-3 per 100k total population), seminoma is ~2.5 per 100k.",strong,moderate,False,2005,McGlynn KA et al. (2005). Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 97(1):63-70,https://pubmed.ncbi.nlm.nih.gov/12491506/,literature
C0036646,Age-related cataract,,8500,prevalence,680000000,0.68,True,Cataract,"Age-related cataract measured as prevalence (chronic condition). WHO 2004-2005 data indicates cataract affects ~8-9% of global population over age 40, representing the largest cause of blindness globally. Prevalence more appropriate than incidence for this progressive condition.",strong,moderate,False,2004,"Pascolini D, Mariotti SP. (2012). Global estimates of visual impairment: 2010. Br J Ophthalmol. 96(5):614-618",https://pubmed.ncbi.nlm.nih.gov/22133988/,literature
C0036690,Septicemia,75,,incidence,6000000,0.62,True,Sepsis,Septicemia (bloodstream infection) is a specific subtype of sepsis. Incidence estimated ~75 per 100k based on blood culture-confirmed bacteremia rates from hospital registries.,moderate,high,False,,,,
C0036920,Sezary Syndrome,extremely rare,,incidence,extremely rare,0.35,True,Cutaneous T-Cell Lymphoma,Rare leukemic variant of cutaneous T-cell lymphoma. Estimated <0.1 per 100k based on SEER and registry data. Represents ~5% of CTCL cases.,weak,unknown,False,,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(8):870-6,https://pubmed.ncbi.nlm.nih.gov/19687417/,literature
C0037116,Silicosis,2.5,,incidence,200000,0.62,False,,"Occupational lung disease from silica exposure. Global incidence ~2-3 per 100k per year, varying widely by industrial exposure and protective measures.",moderate,high,False,2003,WHO (2003). Elimination of silicosis. GOHNET Newsletter.,https://www.who.int/occupational_health/publications/newsletter/en/gohnet12e.pdf,registry
C0037274,Dermatologic disorders,,,,,0.0,False,,Dermatologic disorders is umbrella term too broad to estimate. Would require specification of disease type.,none,unknown,False,,,,
C0037284,Skin lesion,,,,,0.0,False,,"Skin lesion is an overly generic, descriptive term covering benign lesions (moles, tags, warts), inflammatory conditions (dermatitis, eczema), infections (fungal, bacterial), and malignant neoplasms (melanoma, non-melanoma skin cancer). Too heterogeneous and non-specific to estimate meaningfully. Requires specification of lesion type and etiology for epidemiological mapping.",none,unknown,False,,,,
C0037299,Skin Ulcer,450,,incidence,36000000,0.35,False,,"Broad umbrella term including pressure ulcers, venous ulcers, arterial ulcers, diabetic ulcers. Aggregate estimate ~450 per 100k. Low confidence due to heterogeneity and varying definitions.",weak,moderate,False,,,,
C0037315,Sleep Apnea Syndromes,,6000,prevalence,480000000,0.72,False,,"Sleep apnea is a chronic condition best measured by prevalence rather than incidence. Global prevalence estimated at 5-7% of adult population (~6000 per 100k) based on meta-analyses of population studies. Includes obstructive (OSA), central (CSA), and mixed subtypes.",moderate,high,False,,Benjafield AV et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 7(8):687-698,https://pubmed.ncbi.nlm.nih.gov/31219791/,literature
C0037354,Smallpox,0.0,,incidence,0,1.0,False,,Eradicated disease. Last natural case in 1977. WHO certified eradication in 1980. Current incidence is zero.,strong,low,False,2005,WHO smallpox eradication programme,https://www.who.int/news-room/feature-stories/detail/the-smallpox-eradication-programme,registry
C0037579,Soft Tissue Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous: includes benign soft tissue tumors (lipomas, hemangiomas - extremely common) and malignant sarcomas (rare, ~5 per 100k). Vastly different clinical significance and epidemiology make aggregate estimate meaningless.",none,high,False,,,,
C0038013,Ankylosing spondylitis,7.3,,,584000.0,0.75,False,Spondyloarthropathies,Well-characterized autoimmune arthritis. Global incidence ~7-8 per 100k based on population studies.,moderate,moderate,False,,Population-based epidemiological studies,,literature
C0038160,Staphylococcal Infections,2000.0,,incidence,160000000,0.62,False,,"All staph infections (skin, soft tissue, bacteremia, endocarditis). Very common. Incidence ~1,500-2,500 per 100k per year. Lower confidence due to broad category.",moderate,moderate,False,,,,
C0038165,Staphylococcal Scalded Skin Syndrome,0.5,,incidence,40,0.45,False,Staphylococcal Infections,Staphylococcal scalded skin syndrome is rare acute condition. Estimated incidence ~0.5 per 100k based on case reports.,weak,moderate,False,,,,
C0038354,Stomach Diseases,,,,,0.0,False,,"Umbrella term covering vastly different conditions (gastritis, peptic ulcers, gastric cancer, gastroparesis, etc.) with different incidence rates, severities, and clinical significance. Too heterogeneous to estimate meaningfully.",none,high,False,,,,
C0038356,Stomach Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully: includes gastric adenocarcinoma (most common, ~10-15 per 100k), gastric lymphoma (<1 per 100k), GISTs (~1-2 per 100k), benign polyps, and other rare tumors with vastly different incidence rates and clinical significance.",none,high,False,,,,
C0038358,Gastric ulcer,40.0,,incidence,3200000,0.68,True,Peptic Ulcer Disease,Stomach ulcers. Incidence ~30-50 per 100k per year (40 estimate). Declining with H. pylori treatment.,moderate,high,False,,,,
C0038436,Post-Traumatic Stress Disorder,,350,prevalence,28000000,0.65,False,,PTSD primarily measured as prevalence (~3.5% or 350 per 100k adults). Incidence poorly documented as onset varies widely after trauma exposure. Using prevalence data from epidemiological studies.,moderate,high,False,2005,Kessler RC et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders. Arch Gen Psychiatry. 62(6):593-602,https://pubmed.ncbi.nlm.nih.gov/15939837/,literature
C0038443,"Stress, Psychological",,,,,0.5,False,,"Epidemiological data for Stress, Psychological requires further investigation.",moderate,moderate,False,,,,
C0038454,Cerebrovascular accident,200.0,,incidence,16000000,0.85,False,,"Reporting incidence (new strokes per year). WHO STEPS Stroke 2005 data shows global stroke incidence ~200 per 100k person-years, with significant geographic variation.",strong,high,True,2005,Strong K et al. (2007). Preventing stroke: saving lives around the world. Lancet Neurol. 6(2):182-187,https://pubmed.ncbi.nlm.nih.gov/17239805/,literature
C0038525,Subarachnoid Hemorrhage,9.1,,incidence,728000,0.85,True,Hemorrhagic Stroke,"Acute cerebrovascular event. Global incidence ~9 per 100k per year based on systematic reviews. Higher in certain regions (Japan, Finland).",strong,high,False,2007,de Rooij NK et al. (2007). Incidence of subarachnoid haemorrhage. Stroke. 38(5):1537-1542,https://pubmed.ncbi.nlm.nih.gov/17395864/,literature
C0038587,Substance Withdrawal Syndrome,100.0,,incidence,8000000,0.52,False,,"Withdrawal from alcohol, opioids, benzodiazepines, etc. Incidence ~80-120 per 100k per year. Lower confidence due to heterogeneity and underreporting.",moderate,high,False,,,,
C0038644,Sudden infant death syndrome,7.5,,incidence,6000,0.75,False,,"SIDS incidence ~0.55 per 1000 live births globally in 2005 (post Back-to-Sleep era). With ~133M births/year globally, approximately 73,000 SIDS deaths/year. Reported per 100k infants (0-1 year population ~133M, or ~1.7% of 8B = 136M) = ~54 per 100k infants. Converted to general population incidence: ~7.5 per 100k person-years. High geographic variation (0.2-0.8 per 1000 births).",strong,high,True,2005,Hauck FR et al. (2008). International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics. 122(3):660-666,https://pubmed.ncbi.nlm.nih.gov/18762537/,literature
C0038826,Superinfection,50,,incidence,4000,0.4,False,Infections,Superinfection (secondary infection) is outcome of various conditions. Estimated incidence ~50 per 100k as clinical event.,weak,high,False,,,,
C0039483,Giant Cell Arteritis,10.0,,incidence,800000,0.82,True,Vasculitis,"GCA incidence varies by age and geography. Population-adjusted global average ~10 per 100k, with peak incidence 15-25 per 100k in populations >50 years. Strong registry data from Northern Europe and North America.",strong,high,False,2004,Salvarani C et al. (2004). Epidemiology of giant cell arteritis. Clin Exp Rheumatol. 22(6 Suppl 36):S23-7,https://pubmed.ncbi.nlm.nih.gov/15675131/,literature
C0039538,Teratoma,2.0,,incidence,160000,0.65,True,Germ Cell Tumor,"All teratomas combined (mature and immature, all sites). Incidence ~2 per 100k per year across all ages.",moderate,low,False,,,,
C0039585,Androgen-Insensitivity Syndrome,,2.0,prevalence,160000,0.55,False,,"Genetic condition present from birth, so prevalence is more appropriate than incidence. Complete AIS prevalence ~1-2 per 100k; partial AIS may be slightly higher. Limited population-based studies; confidence moderate due to underdiagnosis.",moderate,low,False,,Hughes IA et al. (2006). Consensus statement on management of intersex disorders. Arch Dis Child. 91(7):554-563,https://pubmed.ncbi.nlm.nih.gov/16624884/,literature
C0039730,Thalassemia,,25,prevalence,2000000,0.65,False,,"Umbrella term for alpha and beta thalassemia. Reporting prevalence of symptomatic disease (thalassemia major/intermedia) at ~25 per 100k globally. Well-studied genetic hemoglobinopathy with established epidemiology, though incidence varies dramatically by region (much higher in Mediterranean, Southeast Asia, Middle East). Carrier prevalence is much higher (~1500-3000 per 100k).",moderate,high,False,,WHO guidelines on thalassemia and hemoglobinopathies,,literature
C0039841,Thiamine Deficiency,5.0,,incidence,400000,0.52,False,,"Beriberi and Wernicke-Korsakoff syndrome. Incidence ~3-7 per 100k per year (5 estimate), higher in alcoholism. Lower confidence due to variable definitions.",moderate,high,False,,,,
C0040028,"Thrombocythemia, Essential",1.5,,incidence,120000,0.75,False,,Myeloproliferative neoplasm. Incidence ~1-2 per 100k per year (1.5 estimate) based on cancer registries.,strong,low,False,,Titmarsh GJ et al. (2014). Incidence of myeloproliferative neoplasms. Haematologica. 99(9):1472-1479,https://pubmed.ncbi.nlm.nih.gov/24790059/,literature
C0040034,Thrombocytopenia,50.0,,incidence,4000000,0.58,False,,"Low platelet count from multiple causes (ITP, drugs, infections, bone marrow disorders). Incidence ~40-60 per 100k per year. Lower confidence due to heterogeneity.",moderate,moderate,False,,,,
C0040100,Thymoma,0.15,,incidence,12000,0.85,True,Malignant neoplasm of thymus,Thymic tumors (thymoma and thymic carcinoma) have global incidence of ~0.15 per 100k person-years from GLOBOCAN 2005 cancer registry data. Thymomas represent approximately 40-50% of anterior mediastinal masses and 30-40% of all thymic neoplasms in adults.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0040115,Thymus Hyperplasia,0.5,,incidence,40000,0.35,False,,Thymic hyperplasia often associated with myasthenia gravis or hyperthyroidism. Estimated ~0.5 per 100k based on imaging studies. Many cases asymptomatic and undetected.,weak,unknown,False,,,,
C0040136,Thyroid Neoplasm,,,,,0.0,False,,Umbrella term too heterogeneous: includes benign thyroid adenomas (prevalence ~5-10% of adults by autopsy/ultrasound) and malignant thyroid cancers (incidence ~10 per 100k). Vastly different clinical significance and epidemiological patterns. Not meaningful to aggregate.,none,high,False,,,,
C0040517,Gilles de la Tourette syndrome,,,,,0.5,False,,Epidemiological data for Gilles de la Tourette syndrome requires further investigation.,moderate,moderate,False,,,,
C0040558,Toxoplasmosis,500.0,,incidence,40000000,0.58,False,,"Parasitic infection. New infections ~5-10 per 1,000 per year globally (500 per 100k). Most asymptomatic. Lower confidence due to underdiagnosis.",moderate,high,False,,,,
C0040559,"Toxoplasmosis, Animal",,,,,0.5,False,,"Limited epidemiological data available for Toxoplasmosis, Animal.",moderate,moderate,False,,,,
C0040963,Tricuspid Valve Stenosis,,,,,0.5,False,,Epidemiological data for Tricuspid Valve Stenosis requires further investigation.,moderate,moderate,False,,,,
C0041207,"Truncus Arteriosus, Persistent",0.1,,,8000.0,0.7,False,Conotruncal defects,"Rare congenital heart defect, <1% of CHD. Estimated ~0.1 per 100k births.",moderate,low,False,,Birth defects registries,,registry
C0041296,Tuberculosis,135,,incidence,10800000,0.88,False,Mycobacterial Infection,TB incidence estimated at 135 per 100k globally based on WHO surveillance data.,strong,high,True,2005,WHO Global Tuberculosis Control 2005,https://www.who.int/publications/2005,registry
C0041341,Tuberous Sclerosis,0.1,2,both,8,0.75,False,Hamartomatoses,Tuberous sclerosis incidence ~1 per 6000 births (~0.1 per 100k per year). Prevalence ~2 per 100k.,strong,low,False,,Curatolo P et al. (2008). Tuberous sclerosis complex: clinical features and diagnosis. Semin Pediatr Neurol. 15(4):196-205,https://pubmed.ncbi.nlm.nih.gov/19218056/,literature
C0041696,Unipolar Depression,370,3300,both,29600000,0.75,True,Depressive Disorders,"Unipolar depression (major depression without bipolar features) has global incidence ~370 per 100k person-years for new episodes, with prevalence ~3.3% (3300 per 100k). WHO 2004-2005 GBD data.",strong,moderate,True,2004,WHO Global Burden of Disease Study 2004,https://www.who.int/healthinfo/global_burden_disease/,registry
C0041848,Unspecified idiopathic peripheral neuropathy,20,,incidence,1300000,0.4,True,Peripheral Neuropathy,Idiopathic cases comprise ~20-30% of peripheral neuropathy. Estimated ~20 per 100k per year.,weak,moderate,False,,,,
C0042133,Uterine Fibroids,,12500.0,prevalence,1000000000,0.78,False,,"Uterine leiomyomas measured as prevalence. Affects ~20-30% of women by age 40 (~12,500 per 100k total population).",strong,moderate,False,,Baird DD et al. (2003). High cumulative incidence of fibroids. Am J Obstet Gynecol. 188(1):100-107,https://pubmed.ncbi.nlm.nih.gov/12548202/,literature
C0042164,Uveitis,,,,,0.5,False,,Epidemiological data for Uveitis requires further investigation.,moderate,moderate,False,,,,
C0042165,Anterior uveitis,12.0,,incidence,960000,0.68,True,Uveitis,"Inflammation of anterior uvea (iris, ciliary body). Most common form of uveitis. Incidence ~10-15 per 100k per year (12 estimate).",moderate,moderate,False,,Gritz DC et al. (2004). Incidence of uveitis. Ophthalmology. 111(8):1531-1537,https://pubmed.ncbi.nlm.nih.gov/15288983/,literature
C0042373,Vascular Diseases,,,,,0.0,False,,"Umbrella term far too broad to estimate meaningfully. Encompasses coronary artery disease, stroke, peripheral artery disease, aneurysms, vasculitis, venous thrombosis - each with distinct epidemiology and clinical significance. Aggregate estimate would not be useful.",none,high,False,,,,
C0042384,Vasculitis,40,,incidence,3200000,0.28,False,,"Aggregate BOTEC estimate summing major vasculitides: Giant cell arteritis (~10), Takayasu arteritis (~2), Polyarteritis nodosa (~2), Microscopic polyangiitis (~3), Granulomatosis with polyangiitis (~5), Eosinophilic granulomatosis (~2), Henoch-Schönlein purpura (~10), Behçet's (~3), other (~3) = ~40 per 100k. Heterogeneous group with overlap and variable diagnostic criteria.",weak,high,False,,,,estimate
C0042514,"Tachycardia, Ventricular",2.5,,incidence,200000,0.45,True,Cardiac Arrhythmias,Reporting incidence of sustained ventricular tachycardia at approximately 2-3 per 100k person-years in general population. Incidence varies significantly based on underlying heart disease prevalence. Limited population-based registry data available.,moderate,moderate,False,,,,
C0042769,Virus Diseases,,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses acute viral infections (influenza, COVID-19), chronic viral infections (HIV, hepatitis), and oncogenic viruses with vastly different epidemiology.",none,unknown,False,,,,
C0042870,Vitamin D Deficiency,,25000,prevalence,2000000000,0.65,False,,"Vitamin D deficiency measured as prevalence, not incidence. Global prevalence estimates ~25-30% of population (25,000 per 100k) with deficiency (<20 ng/mL). Varies by latitude and sun exposure.",moderate,high,False,2005,Holick MF. (2007). Vitamin D deficiency. N Engl J Med. 357(3):266-281,https://pubmed.ncbi.nlm.nih.gov/17634462/,literature
C0043119,Werner Syndrome,extremely rare,,incidence,extremely rare,0.45,False,Progeroid Syndrome,"Werner syndrome is an extremely rare autosomal recessive progeroid disorder. Prevalence estimated at 1-9 per million, translating to incidence <0.01 per 100k. Higher prevalence in Japan (~1 in 50,000) due to founder effect.",weak,high,False,,"Oshima J et al. (2017). Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev. 33:105-114",https://pubmed.ncbi.nlm.nih.gov/27374323/,literature
C0043346,Xeroderma Pigmentosum,extremely rare,,incidence,extremely rare,0.45,False,,"Extremely rare autosomal recessive disorder. Birth incidence ~0.4 per 100k in US/Europe (1 in 250,000), higher in Japan (1 in 40,000). Limited systematic epidemiological data.",weak,high,False,,"Kleijer WJ et al. (2008). Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair. 7(5):744-750",https://pubmed.ncbi.nlm.nih.gov/18329345/,literature
C0079218,"Fibromatosis, Aggressive",0.3,,incidence,24000,0.65,True,Fibromatosis,Desmoid tumors (aggressive fibromatosis) have documented incidence of 2-4 per million per year (0.2-0.4 per 100k). Using midpoint estimate of 0.3 per 100k based on population-based registry data.,moderate,low,False,,"Reitamo JJ et al. (1982). The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 77(6):665-673",https://pubmed.ncbi.nlm.nih.gov/7091046/,literature
C0079298,Epidermolysis Bullosa Simplex,0.3,,incidence,24000,0.65,True,Epidermolysis Bullosa,EBS is the most common form of epidermolysis bullosa with estimated incidence of ~0.3 per 100k births. Based on epidemiological studies and rare disease registries.,moderate,low,False,,Fine JD et al. (2008). The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 58(6):931-950,https://pubmed.ncbi.nlm.nih.gov/18374450/,literature
C0079299,Epidermolysis Bullosa Simplex Kobner,0.18,,incidence,14400,0.55,True,Epidermolysis Bullosa Simplex,"Generalized form of EBS. Total EBS incidence ~0.5 per 100k births, Kobner type represents ~30-40%, so ~0.18 per 100k.",moderate,low,False,,,,
C0079583,"Ichthyosiform Erythroderma, Congenital",0.8,,incidence,64000,0.32,True,Congenital Ichthyosis,"Congenital ichthyosiform erythroderma presents with widespread erythroderma and scaling at birth. Estimated incidence ~0.8-1.5 per 100k births, representing a subset of congenital ichthyosis cases. Includes conditions like non-bullous congenital ichthyosiform erythroderma (NCIE) with autosomal recessive inheritance. Limited epidemiological data; confidence based on clinical series and rare disease registries.",weak,low,False,,,,
C0079588,"Ichthyosis, X-Linked",0.3,,incidence,24000,0.68,True,Ichthyosis,"X-linked ichthyosis affects approximately 1 in 2,000-6,000 males (birth prevalence). Converting to incidence per 100k person-years with global birth rate: ~0.3 per 100k. Moderate confidence based on established genetic prevalence data.",moderate,low,False,,Orphanet and genetic disease registries,,registry
C0079731,B-Cell Lymphomas,12.0,,incidence,960000,0.28,False,,"Aggregate BOTEC estimate summing major B-cell lymphoma subtypes: DLBCL (~4.2), follicular lymphoma (~2.5), marginal zone (~1.5), CLL (~3.0), other B-cell lymphomas (~0.8) = ~12 per 100k. Low confidence due to heterogeneity and potential overlap.",weak,moderate,True,2005,,,estimate
C0079740,High Grade Lymphoma (neoplasm),8.5,,incidence,680000,0.45,True,Lymphoma,"High-grade/aggressive lymphomas comprise ~60-65% of NHL cases. Estimated ~8.5 per 100k based on NHL incidence (~13 per 100k) × proportion high-grade. Includes DLBCL, Burkitt, other aggressive subtypes.",moderate,moderate,False,,,,estimate
C0079744,Diffuse Large B-Cell Lymphoma,4.2,,incidence,336000,0.82,True,Non-Hodgkin Lymphoma,DLBCL is the most common NHL subtype (~30-40% of NHL cases). Global NHL incidence 2005 ~10-12 per 100k; DLBCL accounts for ~4.2 per 100k based on GLOBOCAN and registry data.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0079772,T-Cell Lymphoma,1.5,,incidence,120000,0.72,True,Non-Hodgkin Lymphoma,"Reporting incidence. T-cell lymphomas comprise ~10-15% of Non-Hodgkin lymphomas. Global NHL incidence ~10 per 100k, T-cell subtypes ~1.5 per 100k based on SEER and international registry data.",strong,moderate,False,2005,Vose J et al. (2008). International peripheral T-cell and natural killer/T-cell lymphoma study. J Clin Oncol. 26(25):4124-4130,https://pubmed.ncbi.nlm.nih.gov/18626005/,literature
C0079773,"Lymphoma, T-Cell, Cutaneous",0.6,,incidence,48000,0.72,True,Non-Hodgkin Lymphoma,CTCL including mycosis fungoides and Sezary syndrome. Incidence ~0.5-0.7 per 100k per year (0.6 estimate).,strong,low,False,,Criscione VD et al. (2007). Incidence of cutaneous T-cell lymphoma. JAMA Dermatol. 143(7):854-859,https://pubmed.ncbi.nlm.nih.gov/17638728/,literature
C0079840,Milk Allergy,180,2500,both,14400000,0.65,False,,"Milk allergy incidence ~180 per 100k infants, prevalence ~2-3% of young children (2500 per 100k). Based on pediatric allergy studies circa 2005. Moderate confidence due to diagnostic variation.",moderate,moderate,False,2005,"Host A et al. (2002). Allergy testing in children: why, who, when and how? Allergy. 57(7):591-599",https://pubmed.ncbi.nlm.nih.gov/12100298/,literature
C0080032,"Pleural Effusion, Malignant",15,,incidence,1200000,0.45,True,Cancer (secondary manifestation),Malignant pleural effusion is a secondary complication representing dissemination of underlying malignancy to the pleura. Not a primary disease entity but a manifestation of metastatic cancer. Incidence difficult to estimate as it depends on occurrence and spread patterns of multiple primary cancers. Estimated ~10-15% of cancer patients develop pleural effusions; using rough estimate of ~15 per 100k globally as complication of all malignancies. Confidence limited due to heterogeneity and dependency on underlying cancer incidence.,weak,high,False,,,,
C0080218,Tethered Cord Syndrome,4.0,,incidence,320000,0.58,False,Spinal Cord Malformation,"Tethered cord incidence estimated at 4 per 100,000 live births based on pediatric neurology data.",moderate,low,False,,,,
C0085078,Lysosomal Storage Diseases,1.5,,incidence,120000,0.28,False,,"Aggregate BOTEC summing 50+ rare genetic disorders including Gaucher (0.5), Fabry (0.2), Pompe (0.2), MPS disorders (0.3), others (0.3). Total ~1.5 per 100k. Low confidence due to heterogeneity of conditions.",weak,moderate,False,,,,estimate
C0085110,Severe Combined Immunodeficiency,1.7,,incidence,136000,0.75,False,,"Reporting incidence per 100k births. SCID incidence ~1 in 58,000 live births (~1.7 per 100k births) based on newborn screening data.",strong,low,False,2010,Kwan A et al. (2014). Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 312(7):729-738,https://pubmed.ncbi.nlm.nih.gov/25138334/,literature
C0085129,Bronchial Hyperreactivity,,,,,0.2,False,,"Bronchial hyperreactivity is a pathophysiological mechanism rather than a distinct disease entity. Often measured as a functional characteristic in asthma or other obstructive airway diseases. Cannot be meaningfully separated from underlying conditions (asthma, COPD, hypersensitivity pneumonitis) for epidemiological purposes.",weak,unknown,False,,,,
C0085136,Central Nervous System Neoplasms,18.5,,incidence,1480000,0.78,False,,"Umbrella term covering multiple CNS tumor types. Aggregate estimate ~18.5 per 100k globally, including primary (gliomas, meningiomas) and secondary CNS neoplasms.",moderate,high,False,,,,
C0085207,Gestational Diabetes,,3200,prevalence,256000000,0.78,False,,"Gestational diabetes (GDM) prevalence during pregnancy reported as 3-5% of pregnant women globally, approximately 3.2% or 3,200 per 100k in pregnant populations. Metric is prevalence of affected pregnancies, not incidence, as GDM typically resolves post-delivery. Data from multiple cohort studies and registries.",strong,high,False,,Ferrara A. (2007). Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 30(Suppl 2):S141-S146,https://pubmed.ncbi.nlm.nih.gov/17596462/,literature
C0085215,"Ovarian Failure, Premature",,1000,prevalence,80000000,0.75,False,,"Primary Ovarian Insufficiency (POI) is a chronic condition best measured by prevalence rather than incidence. Affects approximately 1% of women under 40 (1,000 per 100k women). Data from epidemiological studies, though not 2005-specific.",moderate,moderate,False,,Coulam CB et al. (1986). Incidence of premature ovarian failure. Obstet Gynecol. 67(4):604-606,https://pubmed.ncbi.nlm.nih.gov/3960433/,literature
C0085292,Stiff-Person Syndrome,0.08,1.0,both,6400,0.6,False,Autoimmune Neurological Disorders,Stiff-Person syndrome (SPS) is a rare autoimmune neurological disorder characterized by progressive rigidity and spasms. Incidence estimated at 0.08-0.1 per 100k person-years. Prevalence approximately 1 per 100k population. Metric: both incidence (new diagnoses) and prevalence (existing cases). Often anti-GAD65 antibody positive. Data from specialized neurology centers and case series; moderate confidence due to diagnostic variability and potential underdiagnosis.,moderate,low,False,,Dalakas MC. (2001). Stiff Person Syndrome: Pathophysiology and Current Management. CNS Drugs. 15(11):845-853,https://pubmed.ncbi.nlm.nih.gov/11735959/,literature
C0085548,Autosomal Recessive Polycystic Kidney Disease,1.0,,,80000.0,0.65,True,Polycystic Kidney Disease,"ARPKD (infantile form), ~1 per 20,000 births. Estimated ~1-2 per 100k births.",moderate,low,False,,PKD Foundation epidemiological data,,registry
C0085576,Iron-Refractory Iron Deficiency Anemia,extremely rare,,incidence,extremely rare,0.35,True,Iron Deficiency Anemia,Reporting incidence of this rare genetic disorder caused by TMPRSS6 mutations. Extremely rare condition with <0.01 per 100k births based on case report literature. Limited systematic epidemiological data available.,weak,unknown,False,,De Falco L et al. (2013). Iron refractory iron deficiency anemia. Haematologica. 98(6):845-853,https://pubmed.ncbi.nlm.nih.gov/23729726/,literature
C0085580,Essential Hypertension,500,25000,both,32500000,0.85,True,Hypertension,"Essential HTN prevalence ~25% globally (25,000 per 100k). Incidence ~500 per 100k per year.",strong,high,False,2005,WHO Global Burden of Disease,,registry
C0085584,Encephalopathies,,,,,0.0,False,,"Umbrella term too broad and heterogeneous. Encompasses dozens of specific encephalopathies (hepatic, metabolic, toxic, hypoxic, etc.) with vastly different etiologies and incidence rates. Cannot meaningfully aggregate.",none,unknown,False,,,,
C0085605,Liver Failure,15.0,,incidence,1200000,0.62,False,,Acute and chronic liver failure. Incidence ~12-18 per 100k per year (15 estimate) from various causes.,moderate,high,False,,,,
C0085669,Acute leukemia,5.5,,incidence,440000,0.8,False,Leukemia,Combined acute lymphoblastic leukemia (ALL ~1.8 per 100k) and acute myeloid leukemia (AML ~3.7 per 100k) from GLOBOCAN 2005 data. Total ~5.5 per 100k globally.,strong,moderate,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0085682,Hypophosphatemia,,2500,prevalence,200000000,0.55,False,,"Hypophosphatemia is a laboratory finding/metabolic state rather than a discrete disease. Reporting prevalence (~2-3% of general population, ~2500 per 100k) as incidence is poorly defined for this biochemical abnormality. Much higher in hospitalized patients (30-80%).",moderate,moderate,False,,,,
C0085740,Mendelson Syndrome,0.3,,incidence,24000,0.25,True,Aspiration Pneumonitis,"Mendelson syndrome (aspiration pneumonitis from gastric contents) is an iatrogenic complication primarily during anesthesia. Incidence estimated at <0.5 per 100k in general population, much higher in anesthetized populations. Limited systematic epidemiological data.",weak,high,False,,,,
C0085750,Adenosis of Breast,,1000.0,prevalence,80000000,0.52,False,,"Benign breast condition (sclerosing adenosis). Prevalence ~1% of women (1,000 per 100k total population). Lower confidence due to asymptomatic cases.",moderate,moderate,False,,,,
C0085786,Hamman-Rich syndrome,extremely rare,,incidence,extremely rare,0.32,True,Acute interstitial pneumonia,"Hamman-Rich syndrome (acute interstitial pneumonia/AIP) is a rare, severe form of idiopathic pneumonia with extremely high mortality (>50%). Incidence estimated <0.1 per 100k based on case report frequency and clinical series. Limited systematic epidemiological data available.",weak,unknown,False,,,,
C0086438,Hypogammaglobulinemia,,,,,0.5,False,,Limited epidemiological data available for Hypogammaglobulinemia.,moderate,moderate,False,,,,
C0086543,Cataract,15.0,,incidence,12000.0,0.75,False,,"Cataract: major cause of blindness globally. Incidence varies by age and region; ~15 per 100k population overall, much higher in elderly.",strong,high,False,2005,WHO Vision 2020 program statistics,,registry
C0086774,Cold paroxysmal hemoglobinuria,,,,,0.5,False,,Epidemiological data for Cold paroxysmal hemoglobinuria requires further investigation.,moderate,moderate,False,,,,
C0086981,Sicca Syndrome,,600,prevalence,48000000,0.72,False,,"Sicca Syndrome (primary Sjögren's syndrome) is a chronic autoimmune disorder. Prevalence estimated at 0.3-0.6% of population (3,000-6,000 per 100k) from population-based studies. Using middle-range estimate of 0.6% (6,000 per 100k). Incidence not well-defined for chronic condition.",moderate,moderate,False,,Ramos-Casals M et al. (2012). Sjögren syndrome. Nat Rev Dis Primers. 4:8016,https://pubmed.ncbi.nlm.nih.gov/28932415/,literature
C0087012,"Ataxia, Spinocerebellar",0.8,3.0,both,64000,0.72,True,Cerebellar Ataxia,"Spinocerebellar ataxias (SCAs) are hereditary progressive ataxias with prevalence ~3 per 100k. Incidence of new clinical diagnoses ~0.8 per 100k person-years, accounting for typical age of onset (20-40 years) and disease progression.",strong,moderate,False,,Ruano L et al. (2014). The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 42(3):174-83,https://pubmed.ncbi.nlm.nih.gov/24603320/,literature
C0149516,Chronic sinusitis,,12000.0,prevalence,960000000,0.65,True,Rhinosinusitis,"Chronic rhinosinusitis measured as prevalence. Affects ~10-15% of adults (12,000 per 100k using midpoint).",moderate,moderate,False,,Hastan D et al. (2011). Chronic rhinosinusitis in Europe. Allergy. 66(9):1216-1223,https://pubmed.ncbi.nlm.nih.gov/21605125/,literature
C0149530,Congenital heart block,0.3,,incidence,240.0,0.55,True,Congenital heart block,Congenital heart block: rare congenital cardiac condition. Incidence ~0.3 per 100k births in autoimmune context.,moderate,low,False,,Pediatric cardiology registries,,registry
C0149678,Epstein-Barr Virus Infections,500,,incidence,40000000,0.65,False,,"Reporting incidence of symptomatic EBV infection (infectious mononucleosis). Global incidence ~500 per 100k person-years, highest in adolescents/young adults. Most infections are asymptomatic.",moderate,moderate,False,,Ebell MH. (2004). Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 70(7):1279-1287,https://pubmed.ncbi.nlm.nih.gov/15508538/,literature
C0149721,Left Ventricular Hypertrophy,,1500,prevalence,120000000,0.78,False,,"LVH measured as prevalence rather than incidence, as it represents a chronic structural cardiac change. Global prevalence estimated ~1.5% of population (1,500 per 100k) from cardiovascular epidemiology studies, with significant variation based on hypertension control and detection methods (echocardiography vs ECG).",strong,moderate,True,2005,Framingham Heart Study data and WHO cardiovascular epidemiology (2000-2010 period),https://www.framinghamheartstudy.org/,registry
C0149782,Squamous cell carcinoma of lung,5.5,,incidence,440000,0.82,True,Lung cancer,Squamous cell carcinoma comprises ~25-30% of lung cancers. Global lung cancer incidence ~20 per 100k (GLOBOCAN 2005); squamous cell subtype ~5.5 per 100k.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0149871,Deep Vein Thrombosis,48,,incidence,3840000,0.82,False,Venous Thromboembolism,DVT incidence approximately 48 per 100k person-years based on epidemiological cohorts.,strong,moderate,False,2005,Framingham and prospective cohort studies,,registry
C0149925,Small cell carcinoma of lung,3.2,,incidence,256000,0.82,True,Lung Cancer,"Small cell lung cancer represents ~13-15% of all lung cancers. Total lung cancer incidence ~22 per 100k, SCLC subset ~3.2 per 100k based on GLOBOCAN 2005.",strong,high,True,2005,Govindan R et al. (2006). Changing epidemiology of small-cell lung cancer. J Clin Oncol. 24(28):4539-4544,https://pubmed.ncbi.nlm.nih.gov/17008692/,literature
C0149931,Migraine Disorders,200,10000,both,13000000,0.8,False,,"Migraine prevalence ~10% globally (10,000 per 100k). Incidence ~200 per 100k per year.",strong,moderate,False,,WHO headache epidemiology,,literature
C0149939,Obstructive nephropathy,4.5,,incidence,360000,0.45,False,,"Obstructive nephropathy encompasses various etiologies (stones, tumors, BPH, congenital). Estimated ~4-5 per 100k for acute presentations requiring intervention based on urology literature, but lacks systematic population-based tracking.",moderate,moderate,False,,,,
C0149940,Sciatic Neuropathy,5.0,,incidence,400000,0.52,False,,Sciatic nerve injury/compression. Incidence ~4-6 per 100k per year. Lower confidence due to variable definitions and underreporting.,moderate,moderate,False,,,,
C0149958,Complex partial seizures,12,,incidence,960,0.62,True,Focal Seizures,Complex partial seizures (focal to bilateral tonic-clonic) are most common seizure type. Estimated incidence ~12 per 100k.,moderate,moderate,False,,Scheffer IE et al. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 58(4):512-521,https://pubmed.ncbi.nlm.nih.gov/28276062/,literature
C0151449,Primary Sjögren's syndrome,3.9,1100,both,312000,0.72,True,Sjögren's Syndrome,"Primary Sjögren's is a well-defined autoimmune exocrinopathy. Prevalence ~0.4-1.3% (1,100 per 100k) based on population surveys. Incidence ~3-4 per 100k annually. Reported as both metrics in literature.",moderate,moderate,False,2010,Shiboski SC et al. (2016). Primary Sjögren's Syndrome: Review and Recommendations for Management. Arthritis Care Res (Hoboken). 68(4):475-486,https://pubmed.ncbi.nlm.nih.gov/27128452/,literature
C0151517,Complete atrioventricular block,2.5,,incidence,200000,0.62,True,Atrioventricular Block,Third-degree heart block. Incidence ~2-3 per 100k per year (congenital and acquired combined).,moderate,low,False,,,,
C0151546,Oral Cavity Carcinoma,5.5,,incidence,440000,0.82,True,Head and Neck Neoplasms,"Oral cavity cancer. GLOBOCAN 2005 shows incidence ~5-6 per 100k globally (5.5 estimate), higher in regions with tobacco/betel nut use.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0151636,Premature ventricular contractions,,,,,0.5,False,,Epidemiological data for Premature ventricular contractions requires further investigation.,moderate,moderate,False,,,,
C0151650,Renal fibrosis,,,,,0.0,False,,"Renal fibrosis is a pathological process/endpoint rather than a distinct disease entity. It represents the common final pathway of various kidney diseases (CKD, diabetic nephropathy, glomerulonephritis). Cannot meaningfully assign independent incidence/prevalence as it's a histological feature, not a diagnostic category.",none,unknown,False,,,,
C0151744,Myocardial Ischemia,280,4500,both,22400000,0.72,False,,Broader term encompassing acute MI (~130 per 100k) and chronic ischemic heart disease (~150 per 100k). Total incidence ~280 per 100k based on WHO/MONICA data circa 2005. Geographic variation due to risk factors.,moderate,high,False,2005,WHO MONICA Project and Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0151779,Cutaneous Melanoma,,,,,0.5,False,,Limited epidemiological data available for Cutaneous Melanoma.,moderate,moderate,False,,,,
C0152013,Adenocarcinoma of lung (disorder),40,,incidence,3200,0.8,True,Lung Cancer,Lung adenocarcinoma is most common lung cancer type (~40% of lung cancers). Estimated incidence ~40 per 100k globally.,strong,high,False,,GLOBOCAN 2020. World Health Organization,https://gco.iarc.fr/,registry
C0152018,Esophageal carcinoma,7.1,,incidence,568000,0.86,True,Esophageal Neoplasms,"Esophageal carcinoma (malignant) global incidence ~7 per 100k from GLOBOCAN 2005, predominantly squamous cell carcinoma (70%) and adenocarcinoma (30%). High geographic variation with rates >15 per 100k in East/Central Asia vs <5 in Western countries.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0152234,Iniencephaly,0.1,,incidence,8000,0.4,True,Neural Tube Defect,"Iniencephaly is extremely rare malformation; estimated <0.1 per 100,000 live births.",weak,unknown,False,,,,
C0152264,Familial erythrocytosis,extremely rare,,incidence,extremely rare,0.35,False,,"Rare genetic disorder, <0.01 per 100k. Limited epidemiological data.",weak,unknown,False,,,,
C0152426,Craniorachischisis,0.5,,incidence,40000,0.5,True,Neural Tube Defect,"Craniorachischisis (combined anencephaly+spina bifida) estimated <0.5 per 100,000 live births.",moderate,high,False,,,,
C0152427,Polydactyly,16.5,,incidence,1320000,0.75,False,,Congenital limb malformation. Birth prevalence ~10-20 per 100k births (higher in African ancestry). Using 16.5 per 100k population per year globally.,strong,high,False,,Goldfarb CA et al. (2005). Incidence of hand and upper extremity anomalies. J Hand Surg Am. 30(6):1175-1181,https://pubmed.ncbi.nlm.nih.gov/16344173/,literature
C0153014,Non-arthropod borne lymphocytic choriomeningitis,,,,,0.5,False,,Epidemiological data for Non-arthropod borne lymphocytic choriomeningitis requires further investigation.,moderate,moderate,False,,,,
C0153252,Systemic candidiasis,8.5,,incidence,680000,0.68,True,Candidiasis,"Acute invasive fungal infection. Global incidence ~8-10 per 100k per year, higher in immunocompromised populations and ICU settings.",moderate,high,False,2005,Pfaller MA et al. (2007). Epidemiology of invasive candidiasis. Clin Microbiol Rev. 20(1):133-163,https://pubmed.ncbi.nlm.nih.gov/17223626/,literature
C0153381,Malignant neoplasm of mouth,5.8,,incidence,464000,0.79,False,,"Oral/mouth cancer incidence approximately 5.8 per 100k from GLOBOCAN 2005 data. Includes oral cavity, pharyngeal, and related malignancies. Somewhat broad term but with established cancer registry surveillance.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0153452,Malignant neoplasm of gallbladder,1.0,,incidence,65000,0.65,False,,"Gallbladder cancer incidence ~1 per 100k globally, varies by region.",moderate,high,False,2005,Cancer registries,,registry
C0153594,Malignant neoplasm of testis,3.0,,incidence,240000,0.85,False,,Testicular cancer. GLOBOCAN 2005 data shows incidence ~3 per 100k globally (age-adjusted to total population).,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0153633,Malignant neoplasm of brain,5.8,,incidence,464000,0.82,False,,Primary brain cancer. GLOBOCAN 2005 data shows incidence ~5-6 per 100k globally (5.8 estimate).,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0153676,Secondary malignant neoplasm of lung,25,,incidence,2000000,0.35,False,Metastatic Neoplasm,"Lung is the most common site for metastases from breast, colon, kidney, and other cancers. Estimated ~25 per 100k based on autopsy studies showing 30-55% of cancer patients develop lung metastases, but no systematic registry data. Low confidence due to heterogeneous primary sources and lack of population-based incidence studies.",weak,moderate,False,,,,
C0153690,Secondary malignant neoplasm of bone,85,,incidence,6800000,0.55,False,,"Bone metastases occur in ~70% of breast/prostate cancer patients and 30-40% of lung cancer patients. Estimating ~85 per 100k based on primary cancer incidence and metastasis rates, though incidence varies by primary cancer burden.",moderate,moderate,False,,Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-6249s,https://pubmed.ncbi.nlm.nih.gov/17062708/,literature
C0154208,Disorder of endocrine ovary,,8500,prevalence,680000000,0.35,False,,"Disorder of endocrine ovary is a broad umbrella term encompassing polycystic ovary syndrome (PCOS, ~5-15% of women), primary ovarian insufficiency (~1-2% of women), and other endocrine dysfunctions of the ovary. This is a heterogeneous category better measured by prevalence than incidence. Conservative aggregate estimate of ~8.5% of population (8,500 per 100k) based on major subcategories. Low confidence due to definitional heterogeneity and significant overlap between conditions.",weak,high,False,,Aggregate estimate from multiple epidemiological studies of ovarian endocrine disorders,,estimate
C0154251,Lipid Metabolism Disorders,,,,,0.0,False,,"Umbrella term too broad. Encompasses dyslipidemia, lysosomal storage diseases, and many genetic disorders with vastly different prevalence. Requires specific disorder specification.",none,unknown,False,,,,
C0155877,Allergic asthma,,4200.0,prevalence,336000000,0.72,True,Asthma,"Allergic (extrinsic) asthma represents ~50-60% of all asthma cases. Total asthma prevalence ~7,000 per 100k, allergic subset ~4,200 per 100k.",strong,moderate,False,2005,Masoli M et al. (2004). Global burden of asthma. Allergy. 59(5):469-478,https://pubmed.ncbi.nlm.nih.gov/15080825/,literature
C0156344,Endometriosis of ovary,,1200,prevalence,96000000,0.62,True,Endometriosis,"Chronic condition measured as prevalence. Ovarian endometriosis represents ~40-50% of endometriosis cases. Total endometriosis prevalence ~2,500 per 100k, ovarian subset ~1,200 per 100k.",moderate,low,False,,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,https://pubmed.ncbi.nlm.nih.gov/15541453/,literature
C0156353,Uterovaginal prolapse,200.0,,incidence,16000000,0.58,False,,Pelvic organ prolapse. Incidence ~150-250 per 100k per year in women (200 estimate for total population). Lower confidence due to underreporting.,moderate,moderate,False,,,,
C0158266,Intervertebral Disc Degeneration,,8500,prevalence,680000000,0.65,False,,"Chronic degenerative condition measured as prevalence. Symptomatic disc degeneration affects approximately 8.5% of adults globally based on population studies, though radiographic evidence is much higher. Using prevalence as incidence poorly defined for gradual degeneration.",moderate,moderate,False,,Hartvigsen J et al. (2018). What low back pain is and why we need to pay attention. Lancet. 391(10137):2356-2367,https://pubmed.ncbi.nlm.nih.gov/29573870/,literature
C0162359,Christ-Siemens-Touraine syndrome,extremely rare,,,extremely rare,0.25,True,Ectodermal Dysplasia,X-linked recessive hypohidrotic ectodermal dysplasia (HED-ID) characterized by immunodeficiency. Extremely rare genetic disorder with fewer than 100 documented cases worldwide. Incidence estimated at <0.01 per 100k births. Limited systematic epidemiological data available.,weak,unknown,False,,,,
C0162429,Malnutrition,,15000,prevalence,1200000000,0.62,False,,"Malnutrition is better measured by prevalence than incidence. WHO 2005 data shows approximately 15% of global population (15,000 per 100k) affected by various forms of malnutrition including undernutrition and micronutrient deficiencies. Broad umbrella term with significant geographic variation.",moderate,high,True,2005,"WHO Global Database on Child Growth and Malnutrition, 2005",https://www.who.int/nutrition/databases/en/,registry
C0162670,Mitochondrial Myopathies,1.5,,incidence,120000,0.58,False,,All mitochondrial muscle diseases combined. Birth prevalence ~1-2 per 100k births (1.5 estimate). Lower confidence due to heterogeneity.,moderate,low,False,,,,
C0162678,Neurofibromatoses,0.3,5,both,24,0.7,True,Genetic Disorders,Neurofibromatosis type 1 (most common) incidence ~1 per 3000 births (~0.3 per 100k per year). Prevalence ~5 per 100k.,moderate,low,False,,Rasmussen SA et al. (2012). Neurofibromatosis type 1 and tumors: Review of the National Neurofibromatosis Foundation international database. J Child Neurol. 27(5):645-653,https://pubmed.ncbi.nlm.nih.gov/22378655/,literature
C0162835,Hypopigmentation disorder,,100.0,prevalence,80000.0,0.35,False,Pigmentation disorders,Hypopigmentation disorder: umbrella term for depigmented skin conditions. Prevalence varies; using ~1% estimate.,weak,high,False,,,,
C0162871,"Aortic Aneurysm, Abdominal",4.5,,incidence,360000,0.75,True,Aortic Aneurysm,"AAA. Incidence ~4-5 per 100k per year (4.5 estimate), higher in elderly males and smokers.",strong,moderate,False,,Kent KC et al. (2010). Abdominal aortic aneurysms. N Engl J Med. 362(20):1863-1871,https://pubmed.ncbi.nlm.nih.gov/20463340/,literature
C0175695,Sotos' syndrome,2.0,,incidence,160000,0.5,False,Overgrowth Syndrome,"Sotos syndrome incidence estimated at 2 per 100,000 live births based on genetic registries.",moderate,low,False,,,,
C0175704,LEOPARD Syndrome,extremely rare,,incidence,extremely rare,0.3,False,,"Rare genetic disorder (PTPN11 or RAF1 mutations) with lentigines, ECG abnormalities, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, retarded growth, and deafness. <200 cases reported worldwide, <0.01 per 100k births.",weak,unknown,False,,,,
C0175754,Agenesis of corpus callosum,2.6,,incidence,208000,0.8,False,,"Congenital cerebral malformation with birth prevalence of 2.6 per 10,000 live births (26 per 100,000 births) from California population-based study (1983-2003). Complete ACC represents 84.1% of cases. Associated anomalies in 49.5% of cases (musculoskeletal, cardiac, and CNS malformations).",strong,moderate,True,2003,"Agenesis of the Corpus Callosum in California 1983-2003: A Population-Based Study, Birth Defects Research (Part A)",https://pmc.ncbi.nlm.nih.gov/articles/PMC2574703/,registry
C0178664,Glomerulosclerosis (disorder),,,,,0.0,False,,"Glomerulosclerosis is a pathological process (scarring/fibrosis of glomeruli) rather than a specific disease entity. It represents the final common pathway of multiple underlying glomerular diseases (FSGS, membranous GN, IgA nephropathy, diabetic nephropathy, etc.) and is therefore unmappable as a single epidemiological entity. Incidence would require specification of primary disease causing the sclerosis.",none,unknown,False,,,,
C0178874,Tumor Progression,,,,,0.0,False,,"Tumor progression is a pathological process describing how tumors advance and become more aggressive, not a disease entity. Cannot be assigned an incidence rate. This is a biological concept, not a diagnosis.",none,unknown,False,,,,
C0205641,"Adenocarcinoma, Basal Cell",1.0,,incidence,80000,0.35,True,Adenocarcinoma,Basal cell adenocarcinoma is rare variant; estimated 1 per 100k.,weak,unknown,False,,,,
C0205642,"Adenocarcinoma, Oxyphilic",0.8,,incidence,64000,0.35,True,Adenocarcinoma,Oxyphilic adenocarcinoma is rare variant; estimated <0.8 per 100k.,weak,unknown,False,,,,
C0205643,"Carcinoma, Cribriform",1.5,,incidence,120000,0.35,True,Carcinoma,Cribriform carcinoma is rare histological variant; estimated 1.5 per 100k.,weak,unknown,False,,,,
C0205644,"Carcinoma, Granular Cell",0.5,,incidence,40000,0.3,True,Carcinoma,Granular cell carcinoma is extremely rare; estimated <0.5 per 100k based on case reports.,weak,unknown,False,,,,
C0205645,"Adenocarcinoma, Tubular",2.0,,incidence,160000,0.4,True,Adenocarcinoma,Tubular adenocarcinoma is moderate variant; estimated 2 per 100k.,weak,moderate,False,,,,
C0205647,Follicular adenoma,,,,,0.5,False,,Limited epidemiological data available for Follicular adenoma.,moderate,moderate,False,,,,
C0205696,Anaplastic carcinoma,4.5,,incidence,360000,0.45,True,Carcinoma,Anaplastic carcinomas are high-grade malignancies; heterogeneous category with estimated 4.5 per 100k.,weak,high,False,,,,
C0205697,"Carcinoma, Spindle-Cell",2.5,,incidence,200000,0.4,True,Carcinoma,Spindle-cell carcinoma is rare histological variant; estimated <2.5 per 100k based on case frequencies.,weak,unknown,False,,,,
C0205698,Undifferentiated carcinoma,1.5,,incidence,120000,0.35,True,Carcinoma,"Undifferentiated carcinoma (poorly differentiated/anaplastic) occurs in various organs - thyroid, nasopharyngeal, bladder, etc. Estimated ~1.5 per 100k aggregate across sites, but lack of organ specificity limits confidence. No single comprehensive source.",weak,high,False,,,,
C0205699,Carcinomatosis,5.0,,incidence,400000,0.35,False,,Carcinomatosis (metastatic/disseminated cancer) is outcome rather than primary disease; aggregate umbrella estimate ~5 per 100k.,weak,high,False,,,,
C0205713,Roussy-Levy Syndrome (disorder),0.15,,incidence,12000,0.52,True,Charcot-Marie-Tooth Disease,CMT with tremor and ataxia. Rare CMT subtype. Incidence ~0.1-0.2 per 100k births. Lower confidence due to limited data.,moderate,low,False,,,,
C0205748,Dysplastic Nevus,,3500.0,prevalence,280000000,0.68,False,,"Atypical moles. Same as dysplastic nevus syndrome. Prevalence ~2-5% of population (3,500 per 100k using midpoint).",moderate,moderate,False,,Tucker MA et al. (1997). Clinically recognized dysplastic nevi. JAMA. 277(18):1439-1444,https://pubmed.ncbi.nlm.nih.gov/9145715/,literature
C0205825,"Liposarcoma, Pleomorphic",,,,,0.5,False,,"Epidemiological data for Liposarcoma, Pleomorphic requires further investigation.",moderate,moderate,False,,,,
C0205851,Germ cell tumor,2.5,,incidence,200000,0.72,False,,"All germ cell tumors (testicular, ovarian, extragonadal). Combined incidence ~2-3 per 100k per year globally.",strong,moderate,False,,,,
C0206061,"Pneumonia, Interstitial",11,200,both,880,0.7,True,Pneumonia,"Interstitial pneumonia incidence ~11 per 100k, prevalence ~200 per 100k based on GBD 2019 data.",strong,moderate,False,,Global Burden of Disease Study 2019. Lancet. 396(10258):1204-1222,https://pubmed.ncbi.nlm.nih.gov/33069326/,literature
C0206245,"Amyloid Neuropathies, Familial",0.1,,incidence,8000,0.65,True,Hereditary Amyloidosis,"Familial amyloid polyneuropathy (FAP, TTR-related) incidence ~0.1 per 100k globally, higher in endemic areas (Portugal, Sweden, Japan). Rare but well-characterized genetic condition.",moderate,high,False,,Planté-Bordeneuve V et al. (2011). Familial amyloid polyneuropathy. Lancet Neurol. 10(12):1086-1097,https://pubmed.ncbi.nlm.nih.gov/22094129/,literature
C0206247,Amyloid Neuropathies,0.1,,,8000.0,0.5,False,Amyloidosis,Rare complication of amyloidosis. Estimated <0.2 per 100k based on amyloidosis registries.,weak,unknown,False,,,,
C0206623,Adenosquamous carcinoma,1.2,,incidence,96000,0.58,True,Cervical Cancer,"Adenosquamous carcinoma is a histological subtype most commonly identified in cervix, comprising ~5-8% of cervical cancers. Estimated incidence: 15.8 (cervical cancer) × 0.075 = ~1.2 per 100k. Without organ specification, concept coherence is limited. Assuming cervical context based on GLOBOCAN histological data.",moderate,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0206624,Hepatoblastoma,1.5,,incidence,1200.0,0.75,True,Hepatic neoplasms,Hepatoblastoma: most common liver tumor in children. Incidence ~1.5 per 100k children from pediatric cancer registries.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0206630,Endometrial Stromal Sarcoma,0.15,,incidence,12000,0.62,True,Uterine Sarcoma,Rare uterine malignancy representing ~10-15% of uterine sarcomas. Estimated ~0.1-0.2 per 100k women globally based on SEER and cancer registry data.,moderate,low,False,,D'Angelo E et al. (2011). Endometrial stromal sarcomas. Semin Diagn Pathol. 28(4):342-349,https://pubmed.ncbi.nlm.nih.gov/22195412/,literature
C0206638,Giant Cell Tumor of Bone,1.0,,incidence,80000,0.62,False,Bone Tumors,"Giant cell tumor of bone (GCTB) is a specific benign bone tumor with well-defined pathological criteria. Epidemiological literature reports incidence of approximately 0.8-1.2 per 100k per year, with higher rates in skeletally mature populations. Well-defined entity from multiple orthopedic registries.",moderate,low,False,,Orthopedic and bone tumor registry data from multiple institutions,,registry
C0206641,Osteochondromatosis,2.0,,incidence,160000,0.72,False,,"Hereditary multiple osteochondromas (synonymous term) with estimated incidence of 1 in 50,000 (2 per 100,000). Presents in early childhood with median diagnosis age of 3 years; 96% diagnosed by age 12. Autosomal dominant inheritance with EXT1/EXT2 mutations. Geographic variation noted: 1 in 1,000 in Chamorro population of Guam, 1 in 77 in Ojibway Indians of Manitoba. Solitary osteochondromas occur in 85% of lesions; hereditary multiple form in 15%.",strong,high,False,,"Hereditary Multiple Osteochondromas - GeneReviews, NCBI Bookshelf; combined with epidemiological literature on osteochondromas",https://www.ncbi.nlm.nih.gov/books/NBK1235/,literature
C0206650,Fibroadenoma,120,,incidence,9600000,0.58,False,,"Most common benign breast tumor, particularly in women 20-40 years old. Estimated ~120 per 100k based on clinical presentation data. Prevalence higher than incidence suggests, but incidence data from clinical registries. Confidence moderate due to underreporting (many asymptomatic).",moderate,moderate,False,,,,
C0206651,Clear Cell Sarcoma of Soft Tissue,0.8,,incidence,64000,0.45,True,Soft Tissue Sarcoma,"Clear cell sarcoma is a rare soft tissue sarcoma subtype representing approximately 1-2% of all soft tissue sarcomas. Global soft tissue sarcoma incidence ~40-50 per 100k, making clear cell sarcoma ~0.8 per 100k. Limited epidemiological data; estimate based on relative prevalence within soft tissue sarcoma category.",weak,moderate,False,,,,
C0206659,Embryonal Carcinoma,0.4,,incidence,32000,0.62,True,Non-seminomatous Germ Cell Tumors,"Reporting incidence. Embryonal carcinoma comprises ~40% of testicular germ cell tumors. With testicular cancer at ~6 per 100k men (3 per 100k total population), embryonal carcinoma estimated at ~0.4 per 100k.",moderate,moderate,False,,Horwich A et al. (2006). Testicular germ cell cancer. Lancet. 367(9512):754-765,https://pubmed.ncbi.nlm.nih.gov/16517276/,literature
C0206663,"Neuroectodermal Tumor, Primitive",0.4,,incidence,32000,0.45,False,,Primitive neuroectodermal tumors (PNETs) are rare embryonic tumors occurring primarily in children and young adults. Estimated incidence ~0.4 per 100k based on pediatric cancer registries. Includes subtypes with varying incidence profiles.,moderate,moderate,False,,Pediatric cancer registry estimates,,registry
C0206664,Teratocarcinoma,extremely rare,,incidence,,0.25,True,Germ cell neoplasms,Teratocarcinoma: rare germ cell tumor with teratoid features. Very limited epidemiological data.,weak,unknown,False,,,,
C0206677,Adenomatous Polyps,,25000,prevalence,2000000000,0.68,True,Colorectal Polyps,"Reporting prevalence (existing cases), not incidence. Adenomatous polyps are benign precursor lesions found in ~25-30% of adults over age 50 (25,000 per 100k). Prevalence is the appropriate metric for this chronic, often asymptomatic condition.",moderate,moderate,False,,Lieberman DA et al. (2000). Prevalence of polyps greater than 9 mm in a consortium of diverse geographic areas. Clin Gastroenterol Hepatol. 3(8):798-805,https://pubmed.ncbi.nlm.nih.gov/16234009/,literature
C0206682,Follicular thyroid carcinoma,1.5,,incidence,120000,0.78,True,Thyroid Neoplasm,"Follicular thyroid carcinoma comprises ~10-15% of thyroid cancers. Global thyroid cancer incidence ~10-12 per 100k (GLOBOCAN 2005), so FTC ~1.5 per 100k. Second most common thyroid malignancy after papillary type.",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0206686,Adrenocortical carcinoma,0.1,,incidence,8000,0.85,True,Malignant neoplasm of adrenal gland,Rare malignancy with global incidence ~0.1 per 100k person-years based on SEER and population-based registries. SEER data (1973-2014) reported age-adjusted incidence of ~1 per million. Data from Netherlands registry shows similar rates of 1 per million.,strong,moderate,True,2005,"Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute",https://seer.cancer.gov/,registry
C0206687,"Carcinoma, Endometrioid",,,,,0.5,False,,"Epidemiological data for Carcinoma, Endometrioid requires further investigation.",moderate,moderate,False,,,,
C0206692,"Carcinoma, Lobular",5.0,,incidence,400000,0.75,True,Breast Cancer,"Invasive lobular carcinoma. Represents ~10-15% of breast cancers. Breast cancer incidence ~40 per 100k, ILC subset ~5 per 100k.",strong,moderate,False,2005,,,
C0206695,"Carcinoma, Neuroendocrine",3.5,,incidence,280000,0.68,False,,"All neuroendocrine tumors (carcinoid, pancreatic NETs, small cell lung cancer). Combined incidence ~3-4 per 100k per year (3.5 estimate).",moderate,moderate,False,,Yao JC et al. (2008). Epidemiology of NETs. J Clin Oncol. 26(18):3063-3072,https://pubmed.ncbi.nlm.nih.gov/18565894/,literature
C0206698,Cholangiocarcinoma,2.0,,incidence,160000,0.75,False,,Total cholangiocarcinoma (intrahepatic + extrahepatic) incidence ~2.0 per 100k globally circa 2005. Encompasses all bile duct malignancies. Significantly higher in Southeast Asia (Thailand ~85 per 100k) due to liver fluke infection.,strong,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C0206701,"Cystadenocarcinoma, Serous",4.2,,incidence,336000,0.58,True,Ovarian Cancer,"Serous cystadenocarcinoma represents approximately 35-40% of epithelial ovarian cancers. Based on global ovarian cancer incidence of ~12 per 100k, serous histology approximately ~4.2 per 100k. This is a well-defined histological subtype with moderate confidence due to histological specificity and registry data availability.",moderate,moderate,False,,Ovarian cancer incidence estimates derived from multiple cancer registry databases,,registry
C0206704,"Carcinoma, Large Cell",2.5,,incidence,200000,0.75,True,Lung Cancer,"Large cell carcinoma represents ~10-15% of lung cancers. Global lung cancer incidence ~20 per 100k (2005), thus large cell subtype ~2.5 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - lung cancer histological subtypes,https://gco.iarc.fr/,registry
C0206706,Verrucous carcinoma,0.8,,incidence,64000,0.62,True,Squamous Cell Carcinoma,"Low-grade variant of SCC in oral cavity, genital areas. Incidence ~0.5-1.0 per 100k per year (0.8 estimate). Lower confidence due to limited data.",moderate,moderate,False,,,,
C0206708,Cervical Intraepithelial Neoplasia,400,,incidence,32000000,0.75,False,,"CIN (all grades: CIN 1, 2, 3) detection rate from cervical screening programs globally. Estimated ~400 per 100k women screened per year based on WHO/HPV screening data circa 2005. Includes all grades of dysplasia. High geographic variation based on HPV prevalence and screening coverage.",strong,high,False,2005,Schiffman M et al. (2007). Human papillomavirus and cervical cancer. Lancet. 370:890-907,https://pubmed.ncbi.nlm.nih.gov/17826171/,literature
C0206731,Angiofibroma,0.4,,incidence,32000,0.58,False,,Benign vascular tumor (juvenile nasopharyngeal and other sites). Incidence ~0.3-0.5 per 100k per year. Lower confidence due to heterogeneity.,moderate,low,False,,,,
C0206734,Hemangioblastoma,0.18,,incidence,14400,0.7,True,Central Nervous System Neoplasm,Hemangioblastoma is a rare benign vascular tumor primarily of the cerebellum and spinal cord. Incidence approximately 0.15-0.2 per 100k person-years based on CNS tumor registries. Associated with von Hippel-Lindau disease in 20-30% of cases.,moderate,low,False,,CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors,https://www.cbtrus.org/,registry
C0220597,Adult Hodgkin Lymphoma,2.4,,incidence,192000,0.82,True,Hodgkin Lymphoma,Reporting incidence of new diagnoses. Adult Hodgkin lymphoma has global incidence of approximately 2.4 per 100k population. Bimodal age distribution with peaks in young adults and elderly. Data from GLOBOCAN 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0220605,Adult Non-Hodgkin Lymphoma,,,,,0.5,False,,Epidemiological data for Adult Non-Hodgkin Lymphoma requires further investigation.,moderate,moderate,False,,,,
C0220611,Childhood Rhabdomyosarcoma,0.45,,incidence,36000,0.72,True,Rhabdomyosarcoma,Pediatric RMS. Most common soft tissue sarcoma in children. Incidence ~4-5 per million children per year (0.45 per 100k total population).,strong,low,False,,,,
C0220612,Childhood Non-Hodgkin Lymphoma,,,,,0.5,False,,Epidemiological data for Childhood Non-Hodgkin Lymphoma requires further investigation.,moderate,moderate,False,,,,
C0220615,Adult Acute Myeloblastic Leukemia,3.2,,incidence,256000,0.82,True,Acute Myeloid Leukemia,Adult AML incidence approximately 3.2 per 100k globally from GLOBOCAN 2005 data. Acute leukemias measured by incidence (new cases annually) rather than prevalence.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0220620,Gastrointestinal Carcinoid Tumor,1.8,,incidence,144000,0.56,True,Neuroendocrine Tumor,"Gastrointestinal carcinoid tumors (neuroendocrine tumors of GI tract) have variable incidence by anatomic site. Small bowel NETs are most common (~0.8-1.0 per 100k), followed by rectal (~0.4-0.5 per 100k) and gastric (~0.3-0.4 per 100k). Aggregate incidence approximately 1.5-2.0 per 100k. Confidence moderate due to variability in histological classification and geographic reporting differences.",moderate,moderate,False,,Neuroendocrine tumor epidemiology from cancer registry databases,,registry
C0220621,Childhood Acute Myeloid Leukemia,,,,,0.5,False,,Epidemiological data for Childhood Acute Myeloid Leukemia requires further investigation.,moderate,moderate,False,,,,
C0220630,Adult Liver Carcinoma,8.5,,incidence,680000,0.82,True,Hepatocellular Carcinoma,"Adult-onset HCC represents the predominant form of liver cancer globally. Incidence ~8.5 per 100k from GLOBOCAN 2005 data, with geographic variation from <2 in North America to >15 in East Asia.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0220641,Lip and Oral Cavity Carcinoma,3.4,,incidence,272000,0.84,True,Malignant neoplasm of mouth,Lip and oral cavity carcinoma is a specific subtype of oral/mouth cancer. Incidence approximately 3.4 per 100k from cancer registry data. More specific anatomical definition than broader oral cancer category.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0220644,Childhood Hodgkin Lymphoma,0.3,,incidence,24000,0.78,True,Hodgkin Lymphoma,Reporting incidence of new diagnoses. Childhood Hodgkin lymphoma (ages 0-14) has incidence of approximately 0.3 per 100k total population (or 1.5 per 100k children). Data from GLOBOCAN and pediatric cancer registries.,strong,moderate,True,2005,Ferlay J et al. (2007). Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol. 18(3):581-592,https://pubmed.ncbi.nlm.nih.gov/17287242/,literature
C0220650,Metastatic malignant neoplasm to brain,8.5,,incidence,680000,0.65,True,Malignant neoplasm of brain,"Brain metastases represent secondary manifestations of systemic cancers, with estimated incidence ~8.5 per 100k person-years globally. Data from cancer registries and autopsy studies, though actual incidence varies by primary cancer type.",moderate,high,False,2005,Nayak L et al. (2012). The neurologic complications of cancer and cancer treatment. Curr Neurol Neurosci Rep. 12(2):218-226,https://pubmed.ncbi.nlm.nih.gov/22322552/,literature
C0220679,"Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified",extremely rare,200,prevalence,extremely rare,0.62,True,Ehlers-Danlos Syndrome,"EDS autosomal dominant types are rare genetic disorders. Overall EDS prevalence estimated ~1 in 5,000 (200 per 100k), with autosomal dominant forms comprising majority. Limited epidemiological data; estimates based on case reports and clinical registries.",weak,unknown,False,,,,
C0220685,Achondrogenesis type 2,extremely rare,,incidence,extremely rare,0.3,True,Skeletal dysplasia,Lethal skeletal dysplasia caused by COL2A1 mutations. Extremely rare at <0.01 per 100k births based on case report frequency. Most cases are stillborn or die in neonatal period.,weak,unknown,False,,,,
C0220704,Shprintzen syndrome,20,,incidence,1600000,0.68,False,,22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome). Birth incidence ~1 per 4000-6000 (20 per 100k births) based on genetic studies.,moderate,low,False,2005,Botto LD et al. (2003). A population-based study of the 22q11.2 deletion. Pediatrics. 112(1):101-107,https://pubmed.ncbi.nlm.nih.gov/12837874/,literature
C0220810,Congenital defects,,,,,0.0,False,,Umbrella term too broad. Encompasses thousands of birth defects affecting all organ systems. Requires specific defect specification.,none,unknown,False,,,,
C0220994,Hyperammonemia,0.5,,incidence,40000,0.35,False,,"Hyperammonemia as a primary diagnosis is rare, estimated at <0.5 per 100k. Usually secondary to liver disease, urea cycle disorders, or other metabolic conditions. Limited epidemiological data available.",weak,unknown,False,,,,
C0221023,Cyclic neutropenia,,,,,0.5,False,,Limited epidemiological data available for Cyclic neutropenia.,moderate,moderate,False,,,,
C0221273,Juvenile polyp,50,1500,both,4000000,0.55,False,,"Juvenile polyps are benign hamartomatous polyps occurring in 1-2% of children (prevalence ~1500 per 100k). Incidence of clinical detection approximately 50 per 100k person-years based on pediatric gastroenterology studies. Most solitary and sporadic, distinct from juvenile polyposis syndrome.",moderate,moderate,False,,Hyer W et al. (2004). Juvenile polyposis syndrome. J Med Genet. 41(1):1-11,https://pubmed.ncbi.nlm.nih.gov/14729819/,literature
C0221357,Brachydactyly,extremely rare,,incidence,extremely rare,0.4,False,,"Rare skeletal dysplasia, <0.1 per 100k births.",weak,unknown,False,,,,
C0221376,Hydrosalpinx (disease),10.0,,incidence,800000,0.52,False,,"Blocked fallopian tube with fluid. Incidence ~8-12 per 100k per year, primarily from PID. Lower confidence due to asymptomatic cases.",moderate,moderate,False,,,,
C0221405,Pituitary cachexia,extremely rare,,incidence,,0.25,True,Pituitary disorders,Pituitary cachexia: very rare manifestation of advanced pituitary disease. Likely <0.1 per 100k.,weak,unknown,False,,,,
C0221406,Pituitary-dependent Cushing's disease,0.2,,incidence,16000,0.68,True,Cushing Syndrome,Cushing's disease from pituitary adenoma. Represents ~70% of endogenous Cushing's syndrome. Incidence ~0.2 per 100k per year.,moderate,low,False,,Lindholm J et al. (2001). Incidence of Cushing disease. J Clin Endocrinol Metab. 86(1):117-123,https://pubmed.ncbi.nlm.nih.gov/11231987/,literature
C0221715,Intestinal carcinoma,19.5,,incidence,1560000,0.78,False,,Primarily colorectal cancer. GLOBOCAN 2005 data shows colorectal cancer incidence ~19-20 per 100k globally.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0221757,alpha 1-Antitrypsin Deficiency,,25.0,prevalence,2000000,0.72,False,,"Genetic disorder measured as prevalence. Severe deficiency (PiZZ) affects ~1 in 3,000-5,000 (25 per 100k) in populations of European descent.",strong,high,False,,de Serres FJ et al. (2003). Worldwide prevalence of alpha-1 antitrypsin deficiency alleles. Thorax. 58(12):1054-1056,https://pubmed.ncbi.nlm.nih.gov/14645972/,literature
C0234533,Generalized seizures,20.0,,,1600000.0,0.6,True,Seizure disorders,Generalized seizures comprise ~40% of all seizures. Estimated ~20 per 100k among all seizure types.,weak,moderate,False,,,,
C0234535,Clonic Seizures,8,,incidence,640000,0.45,True,Seizure disorders,Purely clonic seizures are relatively uncommon subtype of epilepsy. Estimated ~8 per 100k based on epilepsy incidence (~50-70 per 100k) with clonic seizures representing ~10-15% of seizure types. Limited specific epidemiological data for this seizure classification.,weak,moderate,False,,,,
C0234985,Mental deterioration,,800.0,prevalence,640000.0,0.35,False,Cognitive decline,"Mental deterioration: vague umbrella term. Prevalence varies with age and disease (dementia, normal aging). Using conservative estimate.",weak,high,False,,,,
C0235653,Malignant neoplasm of female breast,45.0,,incidence,2925000,0.9,False,,Global breast cancer incidence ~45 per 100k women from GLOBOCAN 2005.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0235782,Gallbladder Carcinoma,2.5,,incidence,200000,0.82,True,Biliary Tract Cancer,Gallbladder cancer incidence ~2-3 per 100k globally based on GLOBOCAN data. Shows high geographic variation (much higher in South America and South Asia).,strong,high,True,2005,Randi G et al. (2009). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 118(7):1591-1602,https://pubmed.ncbi.nlm.nih.gov/16397865/,literature
C0235831,Renal Cell Dysplasia,2.0,,incidence,160000,0.58,False,,Same as renal dysplasia. Birth prevalence ~2 per 100k births.,moderate,moderate,False,,,,
C0235833,Congenital diaphragmatic hernia,23.0,,incidence,1840000,0.78,False,,"Reporting incidence at birth. CDH occurs in approximately 2.3 per 10,000 live births (23 per 100k) based on congenital anomaly registries. Well-documented birth defect with consistent global data.",strong,low,False,,McGivern MR et al. (2015). Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study. Arch Dis Child Fetal Neonatal Ed. 100(2):F137-44,https://pubmed.ncbi.nlm.nih.gov/25411443/,registry
C0235974,Pancreatic carcinoma,10.8,,incidence,864000,0.85,True,Pancreatic Neoplasm,Pancreatic cancer incidence ~10.8 per 100k globally (GLOBOCAN 2005). High mortality (5-year survival <5%). Well-documented through international cancer registries. Geographic variation moderate (higher in developed nations due to detection/classification).,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0236642,Pick Disease of the Brain,0.8,,incidence,64000,0.55,True,Frontotemporal dementia,Specific subtype of FTD. Incidence ~0.8 per 100k per year based on neuropathological studies showing Pick's represents ~20-30% of FTD cases.,moderate,low,False,,Ratnavalli E et al. (2002). The prevalence of frontotemporal dementia. Neurology. 58(11):1615-1621,https://pubmed.ncbi.nlm.nih.gov/12058088/,literature
C0236663,Alcohol withdrawal syndrome,80.0,,incidence,6400000,0.58,False,,Occurs in ~50% of alcohol-dependent individuals who stop drinking. Global incidence ~80 per 100k per year. Lower confidence due to underreporting.,moderate,high,False,,Schuckit MA (2014). Recognition and management of withdrawal. N Engl J Med. 371:2109-2113,https://pubmed.ncbi.nlm.nih.gov/25427113/,literature
C0236733,Amphetamine-Related Disorders,120,,incidence,9600000,0.4,False,,"Umbrella term including abuse, dependence, and induced disorders. Estimated ~120 per 100k aggregate from UNODC data patterns. Low confidence due to heterogeneity and underreporting.",weak,high,False,,,,
C0236794,Panic disorder without agoraphobia,,,,,0.5,False,,Epidemiological data for Panic disorder without agoraphobia requires further investigation.,moderate,moderate,False,,,,
C0236807,Amphetamine Abuse,85,,incidence,6800000,0.45,True,Amphetamine-Related Disorders,Amphetamine abuse incidence estimated at ~85 per 100k based on NSDUH data patterns. Limited global systematic data for 2005; confidence reduced due to regional variation and reporting differences.,moderate,high,False,,,,
C0236969,Substance-Related Disorders,,5000,prevalence,325000000,0.25,False,,"Aggregate umbrella term (alcohol use, drug abuse, etc). Prevalence ~5% population (5,000 per 100k). Low confidence.",weak,high,False,,,,
C0238052,"Xanthomatosis, Cerebrotendinous",extremely rare,,incidence,extremely rare,0.35,True,Lipid Storage Diseases,Cerebrotendinous xanthomatosis (CTX) is an extremely rare autosomal recessive disorder caused by CYP27A1 mutations. Estimated at <0.1 per 100k births based on case registries and prevalence estimates of 1-9 per million population.,weak,low,False,,,,
C0238461,Anaplastic thyroid carcinoma,0.15,,incidence,12000,0.78,True,Thyroid Carcinoma,"Anaplastic thyroid carcinoma represents 1-2% of all thyroid cancers. With thyroid cancer incidence ~6-8 per 100k globally in 2005, anaplastic subtype incidence ~0.15 per 100k person-years from cancer registry data.",strong,low,True,2005,Kebebew E et al. (2005). Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 103(7):1330-1335,https://pubmed.ncbi.nlm.nih.gov/15739211/,literature
C0238462,Medullary carcinoma of thyroid,0.4,,incidence,32000,0.78,True,Thyroid Cancer,"Medullary thyroid carcinoma (MTC) accounts for approximately 3-5% of all thyroid cancers. Global incidence estimated at 0.4 per 100k person-years based on cancer registry data and WHO estimates. Higher confidence due to availability of cancer registry data from GLOBOCAN and national cancer registries, though less common than papillary/follicular thyroid cancers.",strong,low,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0238463,Papillary Thyroid Carcinoma,5.2,,incidence,416000,0.82,True,Thyroid Cancer,"Papillary thyroid carcinoma accounts for ~80% of thyroid cancers. Total thyroid cancer incidence ~6.5 per 100k globally in 2005, yielding ~5.2 per 100k for papillary subtype. Data from GLOBOCAN 2005.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0238790,bone destruction,,,,,0.0,False,,"Pathological process descriptor, not a disease entity. Too broad to estimate meaningfully.",none,unknown,False,,,,
C0239211,Oedema auricular,,,,,0.0,False,,"Auricular edema is a clinical finding/symptom rather than a distinct disease entity. Can result from multiple etiologies including trauma, infection, allergic reaction, or inflammatory conditions. No meaningful incidence data as it's not tracked as a primary diagnosis.",none,unknown,False,,,,
C0239337,Deformity of limb,,,,,0.0,False,,"Generic descriptor, not a disease entity. Too broad to map meaningfully.",none,unknown,False,,,,
C0239946,"Fibrosis, Liver",,350,prevalence,28000000,0.45,False,,"Liver fibrosis measured as prevalence (chronic pathological process). Global prevalence estimated at 350 per 100k (3.5% of population) based on hepatitis and chronic liver disease burden. Umbrella term covering multiple etiologies (viral hepatitis, alcohol, NAFLD, cirrhosis). Wide geographic variation; confidence limited by heterogeneous etiologies and varying diagnostic thresholds.",moderate,high,False,,,,
C0239981,Hypoalbuminemia,150.0,,incidence,12000000,0.48,False,,"Low serum albumin from multiple causes (malnutrition, liver disease, nephrotic syndrome, inflammation). Incidence ~100-200 per 100k per year. Lower confidence due to heterogeneity.",moderate,high,False,,,,
C0240803,Primary cerebral lymphoma,0.5,,,40000.0,0.6,True,CNS Lymphoma,"Primary CNS lymphoma, rare <1 per 100k. Estimated ~0.5 per 100k based on registry data.",moderate,low,False,,GLOBOCAN lymphoma data,,registry
C0241910,Autoimmune Chronic Hepatitis,1.9,,incidence,152000,0.68,True,Chronic Hepatitis,"Autoimmune hepatitis. Incidence ~1.5-2.3 per 100k per year (1.9 estimate), predominantly in women.",moderate,moderate,False,,Lv T et al. (2019). The global epidemiology of autoimmune hepatitis. J Hepatol. 70(1):e1-e2,https://pubmed.ncbi.nlm.nih.gov/30266283/,literature
C0242339,Dyslipidemias,500,3000,both,40000,0.68,False,Lipid Metabolism Disorders,"Dyslipidemias (abnormal blood lipids) are common findings. Estimated incidence ~500 per 100k, prevalence ~3000 per 100k.",moderate,high,False,,Rettberg H et al. (2009). Dyslipidemias in the metabolic syndrome. Curr Pharm Des. 15(3):360-370,https://pubmed.ncbi.nlm.nih.gov/19199973/,literature
C0242342,Sheehan Syndrome,1.5,,incidence,1200.0,0.65,True,Pituitary disorders,"Sheehan syndrome: postpartum pituitary necrosis, rare in developed countries. Estimated ~1.5 per 100k deliveries in resource-limited settings. Higher in regions with hemorrhagic complications during childbirth.",moderate,high,False,,WHO maternal mortality and morbidity estimates,,registry
C0242343,Panhypopituitarism,1.8,,incidence,1440.0,0.6,False,Pituitary disorders,Panhypopituitarism: total pituitary hormone deficiency. Reported incidence 1-2 per 100k based on pituitary disease registries.,moderate,low,False,,European Registry of Growth Hormone Deficiency in Adults,,registry
C0242350,Erectile dysfunction,250,5000,both,16250000,0.75,False,,Prevalence ~5000 per 100k in adult males (50% of men 40-70 years). Incidence ~250 per 100k per year.,strong,moderate,False,,Massachusetts Male Aging Study,,literature
C0242379,Malignant neoplasm of lung,35.0,,incidence,2800000,0.88,True,Lung Neoplasms,Lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally. Primarily refers to primary lung cancer in epidemiological reporting. Higher in males (~50 per 100k) than females (~20 per 100k).,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0242383,Age related macular degeneration,80,2000,both,6400,0.78,True,Macular Degeneration,Age-related AMD incidence ~80 per 100k in adults >50 years. Prevalence ~2000 per 100k in elderly.,strong,moderate,False,,Wong WL et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040. Lancet Glob Health. 2(2):e106-116,https://pubmed.ncbi.nlm.nih.gov/25104338/,literature
C0242510,Drug usage,,,,,0.0,False,,"Behavioral/social phenomenon, not a disease entity. Cannot meaningfully map to disease incidence.",none,unknown,False,,,,
C0242526,"Gonadal Dysgenesis, 45,X",22.5,,incidence,1800000,0.72,True,Gonadal Dysgenesis,"Turner syndrome (45,X) incidence approximately 1 in 2,500 female live births, equivalent to ~22.5 per 100k female births. Based on multiple population cytogenetic registries and prenatal diagnosis studies from 2000-2005. Confidence limited due to variation in ascertainment (many cases detected prenatally) and mortality in utero.",moderate,low,False,2003,Bondy CA. (2008). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 92(1):10-25,https://pubmed.ncbi.nlm.nih.gov/17945645/,literature
C0242528,Azotemia,,,,,0.5,False,,Limited epidemiological data available for Azotemia.,moderate,moderate,False,,,,
C0242583,Bare Lymphocyte Syndrome,extremely rare,,incidence,,0.3,False,Immunodeficiency Disorders,Bare lymphocyte syndrome is extremely rare primary immunodeficiency with <50 cases documented.,weak,unknown,False,,,,
C0242584,Autoimmune thrombocytopenia,3.3,,incidence,264000,0.72,True,Thrombocytopenia,Immune thrombocytopenic purpura (ITP). Incidence ~3-4 per 100k per year (adults and children combined).,strong,low,False,,Terrell DR et al. (2010). Incidence of ITP. Blood. 115(1):168-173,https://pubmed.ncbi.nlm.nih.gov/19846889/,literature
C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,0.5,,,40000.0,0.55,True,Non-Hodgkin Lymphoma,MALT lymphoma comprises ~5-10% of all NHL. Estimated ~0.5-1 per 100k globally.,moderate,moderate,False,,GLOBOCAN NHL data,,registry
C0243002,Tricuspid Atresia,0.08,,incidence,5200,0.7,False,,"Congenital heart defect, incidence ~0.08-0.1 per 100k births (~1 per 10,000 births).",strong,low,False,,Congenital heart defect registries,,registry
C0243026,Sepsis,189,,incidence,15120000,0.72,False,,"Reporting incidence (new cases). Global estimate ~189 per 100k based on hospital surveillance data. Definition has evolved over time, affecting comparability.",strong,high,False,2017,Fleischmann C et al. (2016). Assessment of global incidence and mortality of hospital-treated sepsis. Am J Respir Crit Care Med. 193(3):259-272,https://pubmed.ncbi.nlm.nih.gov/26414292/,literature
C0259783,mixed gliomas,3.5,,incidence,280000,0.65,True,Glioma,Mixed gliomas (oligoastrocytomas) represent heterogeneous glial tumors with estimated 3.5 per 100k incidence.,moderate,moderate,False,2005,,,
C0260037,Multiple Tumors,,,,,0.0,False,,"Umbrella term too heterogeneous and vague to estimate meaningfully. 'Multiple tumors' could refer to: synchronous primary cancers, metastatic disease, familial cancer syndromes, sequential primaries, benign vs malignant tumors, or organ-specific vs systemic. These entities have vastly different etiologies, incidence rates, and clinical significance. Requires specification of tumor type, anatomical location, and relationship (concurrent vs sequential, related vs unrelated).",none,unknown,False,,,,
C0262401,Carcinoma of ampulla of Vater,0.5,,incidence,40000,0.68,False,,Rare periampullary cancer. Incidence ~0.4-0.6 per 100k per year (0.5 estimate).,moderate,low,False,,Albores-Saavedra J et al. (2009). Cancers of the ampulla of Vater. Cancer. 115(24):5809-5818,https://pubmed.ncbi.nlm.nih.gov/19834960/,literature
C0262584,"Carcinoma, Small Cell",8.5,,incidence,680000,0.45,False,,"Small cell carcinoma without organ specification is problematic. If interpreted as small cell lung cancer (most common form), incidence ~8.5 per 100k. However, lack of anatomical specificity reduces confidence significantly as small cell carcinomas can occur in multiple organs.",moderate,high,True,2005,"GLOBOCAN 2005 lung cancer data, SCLC comprises ~15% of lung cancers",https://gco.iarc.fr/,registry
C0262929,Myxoma of the Endocardium,0.5,,incidence,40000,0.58,True,Cardiac Myxoma,Same as cardiac myxoma. Endocardial location. Incidence ~0.5 per 100k per year.,moderate,low,False,,,,
C0263409,Linear Scleroderma,,,,,0.5,False,,Epidemiological data for Linear Scleroderma requires further investigation.,moderate,moderate,False,,,,
C0264133,Acquired flat foot,,2400,prevalence,192000000,0.45,True,Foot deformities,"Acquired flatfoot (posterior tibial tendon dysfunction) measured as prevalence, not incidence. Estimated ~2-3% adult prevalence (2,400 per 100k) based on orthopedic screening studies, but no systematic population-based registries.",moderate,moderate,False,,,,
C0264408,Childhood asthma,,8000.0,prevalence,640000000,0.78,True,Asthma,"Pediatric asthma measured as prevalence. Affects ~10-15% of children globally (8,000 per 100k children, ~4,000 per 100k total population).",strong,moderate,False,2005,Asher MI et al. (2006). Worldwide time trends in asthma. Thorax. 61(5):447-452,https://pubmed.ncbi.nlm.nih.gov/16648353/,literature
C0264694,Chronic myocardial ischemia,150,4200,both,12000000,0.68,True,Myocardial Ischemia,"Chronic ischemic heart disease incidence ~150 per 100k, prevalence ~4200 per 100k (WHO 2005 estimates). Both metrics relevant for chronic condition. Moderate confidence due to diagnostic variability and limited 2005-specific sources.",moderate,high,False,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0265218,Neu-Laxova syndrome,,,,,0.5,False,,Limited epidemiological data available for Neu-Laxova syndrome.,moderate,moderate,False,,,,
C0265253,Stickler syndrome (disorder),,,,,0.5,False,,Limited epidemiological data available for Stickler syndrome (disorder).,moderate,moderate,False,,,,
C0265274,"Achondrogenesis, type IB (disorder)",,,,,0.5,False,,"Epidemiological data for Achondrogenesis, type IB (disorder) requires further investigation.",moderate,moderate,False,,,,
C0265286,Dyggve-Melchior-Clausen syndrome,,,,,0.5,False,,Epidemiological data for Dyggve-Melchior-Clausen syndrome requires further investigation.,moderate,moderate,False,,,,
C0265962,Ichthyosis linearis circumflexa,extremely rare,,incidence,extremely rare,0.22,True,"Ichthyosiform Erythroderma, Congenital","Ichthyosis linearis circumflexa is a rare form of atypical congenital ichthyosiform erythroderma characterized by linear erythematous plaques with migratory inflammatory borders and ichthyosis. Fewer than 100 cases documented in medical literature. Incidence likely <0.1 per 100k births, possibly <0.01. Autosomal recessive inheritance. Extremely limited epidemiological data; confidence based on case reports and clinical descriptions.",weak,unknown,False,,,,
C0266039,Taurodontism,,300,prevalence,24000000,0.55,False,,"Dental anomaly measured as prevalence. Affects ~0.5-5% of population depending on criteria, using 3% estimate (300 per 100k).",moderate,moderate,False,,Shifman A et al. (1983). Taurodontism prevalence. J Dent Res. 62(10):1004-1007,https://pubmed.ncbi.nlm.nih.gov/6578240/,literature
C0266159,Pyloric Atresia,0.06,,incidence,4800,0.58,True,Intestinal Atresia,"Rare congenital obstruction. Birth prevalence ~1 in 100,000 births (0.06 per 100k total population per year).",moderate,low,False,,,,
C0266362,Ambiguous Genitalia,50.0,,incidence,4000000,0.35,False,,"Ambiguous genitalia is a clinical finding/symptom resulting from multiple underlying conditions including disorders of sex development (DSD), CAH, and other intersex conditions. Aggregate BOTEC estimate: CAH ~1 per 10-15k births (~6-10 per 100k), other DSDs ~1-2 per 100k. Total estimate ~50 per 100k births. Low confidence due to heterogeneity and variable definitions.",weak,high,False,,Lee PA et al. (2006). Global Disorders of Sex Development Review Panel. Consensus Statement on Management of Intersex Disorders. Pediatrics. 118(2):e488-e500,https://pubmed.ncbi.nlm.nih.gov/16882788/,literature
C0266449,Congenital anomaly of brain,30.0,,incidence,39000,0.25,False,,"Aggregate BOTEC estimate summing major congenital brain malformations per 100k births: neural tube defects (10), hydrocephalus (8), microcephaly (5), holoprosencephaly (1), other malformations (6) = ~30 per 100k births. Heterogeneous group with significant geographic variation.",weak,high,False,,,,
C0266453,Exencephaly,1.0,,incidence,80000,0.55,True,Neural Tube Defect,"Exencephaly (exposed brain tissue) estimated at 1 per 100,000 live births.",moderate,high,False,,,,
C0266815,Cow milk allergy,180,2500,both,14400000,0.65,False,,"Cow milk allergy is synonymous with milk allergy in pediatric context. Incidence ~180 per 100k infants, prevalence ~2-3% of children. Based on pediatric literature.",moderate,moderate,False,2005,"Host A et al. (2002). Allergy testing in children: why, who, when and how? Allergy. 57(7):591-599",https://pubmed.ncbi.nlm.nih.gov/12100298/,literature
C0266929,Chronic Periodontitis,,8500,prevalence,680000000,0.75,True,Periodontitis,"Chronic condition measured as prevalence. Moderate to severe periodontitis affects ~10-15% of adults globally (~8,500 per 100k total population).",strong,moderate,False,2005,Petersen PE et al. (2005). The global burden of periodontal disease. Periodontology 2000. 39:8-20,https://pubmed.ncbi.nlm.nih.gov/16498961/,literature
C0268074,Indian childhood cirrhosis,,,,,0.5,False,,Limited epidemiological data available for Indian childhood cirrhosis.,moderate,moderate,False,,,,
C0268147,"Glycogen storage disease, type IX",extremely rare,,incidence,,0.35,True,Glycogen Storage Disease,GSD type IX (phosphorylase deficiency) is extremely rare; <0.1 per 100k based on case reports.,weak,unknown,False,,,,
C0268164,"Primary hyperoxaluria, type I",extremely rare,,incidence,extremely rare,0.45,True,Primary hyperoxaluria,Extremely rare autosomal recessive metabolic disorder. Estimated incidence <1 per million births (<0.1 per 100k) based on registry data from Europe. PH1 is the most common and severe form of primary hyperoxaluria.,moderate,moderate,False,,Cochat P et al. (1995). Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 10(11):1746-53,https://pubmed.ncbi.nlm.nih.gov/8559471/,literature
C0268181,"Lactose Intolerance, Adult Type",,68000.0,prevalence,5440000000,0.78,True,Lactose Intolerance,Adult-onset lactase deficiency measured as prevalence. Affects ~68% of global population (varies from 5% in Northern Europe to >90% in East Asia).,strong,high,False,,Itan Y et al. (2010). The origins of lactase persistence in Europe. PLoS Comput Biol. 6(8):e1000491,https://pubmed.ncbi.nlm.nih.gov/20808874/,literature
C0268243,"Niemann-Pick Disease, Type B",0.025,,incidence,2000,0.58,True,Niemann-Pick Disease,"Chronic visceral form. Rarer than Type A. Birth prevalence ~1 in 250,000 (0.025 per 100k).",moderate,low,False,,,,
C0268287,Deficiency of steroid 21-monooxygenase,50,,incidence,4000000,0.68,True,Congenital adrenal hyperplasia,"21-hydroxylase deficiency is most common form of CAH; incidence ~50 per 100,000 live births.",strong,moderate,False,2005,WHO/NCCLS endocrine data,,registry
C0268381,Primary amyloidosis,1.0,,incidence,80000,0.65,True,Amyloidosis,AL (primary) amyloidosis incidence ~1.0 per 100k based on population-based studies. Rare plasma cell disorder with monoclonal light chain deposition.,moderate,low,False,,"Kyle RA et al. (2003). Incidence of AL amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 101(7):2462-3",https://pubmed.ncbi.nlm.nih.gov/12433690/,literature
C0268398,Familial lichen amyloidosis,extremely rare,,,,0.3,True,Amyloidosis,"Rare hereditary amyloidosis affecting skin. <0.1 per 100k, sparse familial cases reported.",weak,unknown,False,,,,
C0268413,Adult hypophosphatasia (disorder),extremely rare,,incidence,,0.3,True,Alkaline phosphatase deficiency,Adult hypophosphatasia: late-onset variant of rare genetic enzyme deficiency. Very limited case reports.,weak,unknown,False,,,,
C0268494,Oculocutaneous albinism type 1,0.35,,incidence,28000,0.65,True,Oculocutaneous Albinism,"OCA1 represents ~40-50% of all oculocutaneous albinism cases. Total OCA ~0.7-1 per 100k births, OCA1 subset ~0.35 per 100k.",moderate,moderate,False,,Gronskov K et al. (2007). Oculocutaneous albinism. Orphanet J Rare Dis. 2:43,https://pubmed.ncbi.nlm.nih.gov/17980020/,literature
C0268747,Diffuse mesangial sclerosis (disorder),extremely rare,,incidence,extremely rare,0.32,True,Congenital Nephrotic Syndrome,Rare genetic kidney disorder. <100 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C0268790,Renal vascular disorder,1.2,,incidence,96000,0.52,False,,"Renal vascular disorders include renal artery stenosis (atherosclerotic and fibromuscular), renal artery thrombosis, and other vascular kidney conditions. This is an umbrella term with heterogeneous causes and variable incidence. Atherosclerotic renal artery stenosis ~1 per 100k, fibromuscular dysplasia ~0.2 per 100k. Aggregate estimate ~1.2 per 100k. Limited by heterogeneity of underlying conditions.",weak,high,False,,Safian RD et al. (2003). Renal-artery stenosis. N Engl J Med. 344(6):431-442,https://pubmed.ncbi.nlm.nih.gov/12556476/,literature
C0269102,Endometrioma,,700,prevalence,56000000,0.65,True,Endometriosis,Endometrioma is a chronic condition measured by prevalence. Occurs in ~25% of endometriosis cases. Endometriosis affects ~10% of reproductive-age women; endometriomas estimated at ~700 per 100k total population (all ages/sexes).,moderate,moderate,False,,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,https://pubmed.ncbi.nlm.nih.gov/15541453/,literature
C0270549,Generalized Anxiety Disorder,,,,,0.5,False,,Epidemiological data for Generalized Anxiety Disorder requires further investigation.,moderate,moderate,False,,,,
C0270715,Degenerative Disorder,,,,,0.0,False,,"Umbrella term covering all degenerative diseases of nervous system, joints, organs, etc. Too broad to estimate - includes Alzheimer's, Parkinson's, osteoarthritis, COPD, and many other unrelated conditions.",none,unknown,False,,,,
C0270736,Essential Tremor,,400.0,prevalence,32000000,0.75,False,,Movement disorder measured as prevalence. Affects ~0.4-5% of population (400 per 100k using conservative estimate). Age-related increase.,strong,low,False,,Louis ED et al. (1998). Prevalence of essential tremor. Mov Disord. 13(1):5-10,https://pubmed.ncbi.nlm.nih.gov/9452318/,literature
C0270824,Visual seizure,5.2,,incidence,416000,0.35,True,Epilepsy,"Visual seizures are symptom manifestations of underlying seizure disorders (e.g., occipital lobe epilepsy), not independent diseases. Estimated incidence ~5 per 100k based on proportion of seizures with visual phenomena (~5-10% of all seizures). Low confidence due to symptom-based classification rather than etiology-based disease entity.",weak,low,False,,,,
C0270844,Tonic Seizures,50,,incidence,4000,0.55,True,Seizures,Tonic seizures are a subtype of generalized seizures. Global incidence estimated ~50 per 100k based on seizure epidemiology studies.,moderate,moderate,False,,Hauser WA et al. (1993). Prevalence of seizure disorders in Iceland. Epilepsia. 34(5):802-806,https://pubmed.ncbi.nlm.nih.gov/8405395/,literature
C0270846,Epileptic drop attack,,,,,0.0,False,Seizure disorders,"Ictal symptom (atonic seizure manifestation), not independent diagnosis. Cannot estimate incidence.",none,unknown,False,,,,
C0270850,Idiopathic generalized epilepsy,8.0,,incidence,640000,0.65,True,Generalized Epilepsy,Idiopathic generalized epilepsy incidence estimated at 8 per 100k person-years.,moderate,low,False,,,,
C0270855,Early myoclonic encephalopathy,extremely rare,,incidence,extremely rare,0.3,False,,"Early infantile epileptic encephalopathy with myoclonias (EME) is an extremely rare neonatal-onset condition, <0.01 per 100k births. Limited to scattered case reports and small case series.",weak,unknown,False,,,,
C0271055,Rhegmatogenous retinal detachment,12.5,,incidence,1000000,0.72,True,Retinal Detachment,Most common type of retinal detachment. Incidence ~10-15 per 100k per year (12.5 estimate) based on ophthalmology registry data.,strong,low,False,,Mitry D et al. (2010). The epidemiology of rhegmatogenous retinal detachment. Eye. 24:678-687,https://pubmed.ncbi.nlm.nih.gov/19927164/,literature
C0271093,Stargardt's disease,,,,,0.5,False,,Limited epidemiological data available for Stargardt's disease.,moderate,moderate,False,,,,
C0271577,Isolated gonadotropin deficiency,extremely rare,0.1,prevalence,extremely rare,0.35,True,Hypogonadism,Isolated gonadotropin deficiency (idiopathic hypogonadotropic hypogonadism) is a rare endocrine disorder affecting gonadotropin-releasing hormone production. Incidence <0.1 per 100k person-years. Prevalence estimates approximately 0.1 per 100k based on case frequency in infertility clinics. Limited epidemiological data; most information derived from clinical case series.,weak,unknown,False,,Raivio T & Toppari J (2005). Pathophysiology of Kallmann syndrome. Pediatr Endocrinol Rev. 2(Suppl 4):609-618,,literature
C0271650,Impaired glucose tolerance,,3500,prevalence,280000000,0.68,False,,"Impaired glucose tolerance (IGT) is a metabolic category, not a specific disease. Reported as prevalence of individuals with fasting glucose 110-125 mg/dL or 2-hour post-glucose 140-199 mg/dL. Global IGT prevalence estimated at 3-5% of population (~3.5 per 100k). Concept coherence reduced due to classification vs disease distinction.",moderate,high,False,,IDF Diabetes Atlas 2005 (estimating from prediabetes prevalence),https://diabetesatlas.org/,registry
C0271994,Hereditary persistence of fetal hemoglobin thalassemia,,50,prevalence,4000000,0.45,True,Thalassemia,"HPFH with thalassemia is a genetic hemoglobinopathy. Prevalence-based metric appropriate for lifelong genetic condition. Estimated ~50 per 100k globally, but varies significantly by ethnicity (higher in Mediterranean, African, and Asian populations). Limited comprehensive global epidemiological data.",weak,high,False,,,,
C0272170,Shwachman syndrome,extremely rare,,incidence,extremely rare,0.3,False,,"Rare genetic disorder (SBDS mutation), estimated <0.01 per 100k births.",weak,unknown,False,,,,
C0272286,Thrombocytopenia due to platelet alloimmunization,10.5,,incidence,840000,0.62,True,Thrombocytopenia,Neonatal alloimmune and post-transfusion thrombocytopenia. Combined incidence ~10 per 100k per year.,moderate,low,False,,,,
C0275518,Acute infectious disease,,,,,0.0,False,,"Umbrella term too broad to estimate meaningfully - encompasses all acute bacterial, viral, fungal, and parasitic infections across all organ systems. Would require specification of pathogen type or organ system.",none,unknown,False,,,,
C0276199,Canarypox (disorder),0.0,,incidence,0,0.85,False,,"Avian poxvirus affecting canaries, not humans. Human incidence is zero.",strong,low,False,,,,
C0276535,AIDS with Kaposi's sarcoma,2.1,,incidence,168000,0.45,True,Acquired Immunodeficiency Syndrome,"Kaposi's sarcoma (KS) in AIDS patients reflects opportunistic infection rates. By 2005 with ART availability, KS rates had declined from pre-1996 peaks of 20-30% to approximately 2-3% of AIDS populations. Incidence highly context-dependent on ART coverage and CD4 counts.",weak,high,False,,,,
C0278488,Carcinoma breast stage IV,4.5,,incidence,360000,0.82,True,Breast Cancer,Stage IV (metastatic) breast cancer represents ~5-10% of incident breast cancer cases at diagnosis. Global breast cancer incidence ~45 per 100k (women) from GLOBOCAN 2005; estimated stage IV incidence at diagnosis ~4.5 per 100k based on stage distribution.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC) + American Cancer Society stage distribution data,https://gco.iarc.fr/,registry
C0278510,Childhood Medulloblastoma,0.5,,incidence,40000,0.72,True,Medulloblastoma,"Reporting incidence of pediatric cases. Childhood medulloblastoma represents ~85% of all medulloblastomas, with incidence of ~6 per 100k in pediatric population (0-14 years), which equals ~0.5 per 100k when calculated against total population.",strong,low,False,2005,"Rickert CH, Paulus W (2001). Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst. 17:503-511",https://pubmed.ncbi.nlm.nih.gov/11585301/,literature
C0278595,Adult Fibrosarcoma,0.25,,incidence,20000,0.62,True,Fibrosarcoma,Adult form of fibrosarcoma. Represents ~80% of all fibrosarcoma cases. Incidence ~0.25 per 100k per year in adults.,moderate,low,False,,,,
C0278607,Adult Leiomyosarcoma,0.3,,incidence,24000,0.55,True,Soft Tissue Sarcoma,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Estimated adult incidence ~0.3 per 100k based on SEER and European cancer registry data.,moderate,low,False,,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0278608,Adult Liposarcoma,0.4,,incidence,32000,0.6,True,Soft Tissue Sarcoma,"Most common soft tissue sarcoma in adults, representing ~20% of cases. Estimated incidence ~0.4 per 100k based on SEER registry data from early 2000s.",moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0278619,Extramedullary Plasmacytoma,0.3,,incidence,24000,0.42,True,Plasmacytoma,Rare malignant plasma cell neoplasm occurring outside bone marrow. Estimated ~0.3 per 100k based on case series and cancer registry reports. Comprises ~5% of plasmacytomas.,moderate,moderate,False,,,,
C0278660,Adult Synovial Sarcoma,0.3,,incidence,19500,0.65,True,Synovial Sarcoma,"Rare soft tissue sarcoma affecting adolescents and young adults, ~0.3 per 100k. Limited epidemiological data.",moderate,low,False,,"SEER Cancer Statistics, estimated from case frequency",,registry
C0278694,Disseminated neuroblastoma,0.5,,incidence,40000,0.65,True,Neuroblastoma,Same as metastatic neuroblastoma (stage 4). Incidence ~0.5 per 100k per year.,moderate,low,False,,,,
C0278701,Gastric Adenocarcinoma,21.3,,incidence,1704000,0.88,True,Gastric cancer,Gastric adenocarcinoma is the most common histological type of gastric cancer. Global incidence ~21.3 per 100k from GLOBOCAN 2005 cancer registry data. Incidence includes all new cases regardless of stage or outcome.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0278764,Adult Burkitt Lymphoma,0.3,,incidence,24000,0.65,True,Burkitt Lymphoma,Adult-onset Burkitt lymphoma represents ~20-30% of all Burkitt cases. Estimated ~0.3 per 100k adults in Western populations.,moderate,high,False,,Molyneux EM et al. (2012). Burkitt's lymphoma. Lancet. 379(9822):1234-44,https://pubmed.ncbi.nlm.nih.gov/22333947/,literature
C0278802,Recurrent Endometrial Cancer,,,,,0.5,False,,Epidemiological data for Recurrent Endometrial Cancer requires further investigation.,moderate,moderate,False,,,,
C0278876,Adult Medulloblastoma,extremely rare,,incidence,extremely rare,0.55,True,Medulloblastoma,"Reporting incidence of adult cases. Adult medulloblastoma represents only ~10-15% of all medulloblastomas, with incidence <0.05 per 100k adults. Extremely rare with limited epidemiological data.",moderate,unknown,False,,Brandes AA et al. (2003). Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol. 66:223-246,https://pubmed.ncbi.nlm.nih.gov/18406622/,literature
C0278877,Adult Meningioma,1.8,,incidence,117000,0.7,True,Meningioma,Adult meningiomas (age 20+) incidence ~2 per 100k from tumor registries.,moderate,low,False,2005,Cancer registries,,registry
C0278878,Adult Glioblastoma,4.0,,incidence,320000,0.82,True,Glioma,"Adult-onset glioblastoma (grade IV astrocytoma), most aggressive primary brain tumor. Global incidence approximately 4 per 100k person-years based on cancer registry data. Reporting incidence (new diagnoses). Well-documented malignancy with established epidemiological surveillance from GLOBOCAN and national cancer registries. Confidence reflects moderate data quality despite good registry coverage.",strong,low,False,,GLOBOCAN 2020 (IARC),https://gco.iarc.fr/,registry
C0278879,Childhood Burkitt Lymphoma,1.2,,incidence,96000,0.68,True,Burkitt Lymphoma,Childhood form represents 70-80% of Burkitt cases. Endemic areas (equatorial Africa): 5-10 per 100k children. Sporadic (Western): 0.2-0.5 per 100k. Global average ~1.2 per 100k children.,moderate,high,False,2005,Mbulaiteye SM et al. (2012). Burkitt lymphoma: beyond discoveries. Infect Agent Cancer. 7:3,https://pubmed.ncbi.nlm.nih.gov/22289355/,literature
C0278883,Metastatic melanoma,1.5,,incidence,120000,0.68,True,Melanoma,"Stage IV melanoma. Represents ~5-10% of melanoma at diagnosis. Melanoma incidence ~15 per 100k, stage IV ~1.5 per 100k.",moderate,moderate,False,,,,
C0278987,Metastatic non-small cell lung cancer,10.0,,incidence,800000,0.68,True,Non-Small Cell Lung Cancer,"Stage IV NSCLC. Represents ~50% of NSCLC at diagnosis. NSCLC incidence ~20 per 100k, metastatic ~10 per 100k.",moderate,high,False,,,,
C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,,,,,0.0,False,,"Umbrella term too heterogeneous: includes benign hemangiomas, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma with vastly different epidemiologies, incidence rates, and clinical significance. Aggregate estimate not meaningful without specifying histological type and malignancy status.",none,high,False,,,,
C0279070,Adult Oligodendroglioma,0.28,,incidence,22400,0.68,True,Oligodendroglioma,"Adult oligodendroglioma. Represents ~90% of all oligodendrogliomas. Total oligodendroglioma ~0.3 per 100k, adult subset ~0.28 per 100k.",moderate,low,False,,,,
C0279550,Adult Rhabdomyosarcoma,0.15,,incidence,12000,0.62,True,Rhabdomyosarcoma,RMS in adults. Less common than pediatric form. Incidence ~0.1-0.2 per 100k per year in adults.,moderate,low,False,,,,
C0279583,Childhood T Acute Lymphoblastic Leukemia,0.35,,incidence,28000,0.72,True,Acute Lymphoblastic Leukemia,"Pediatric T-cell ALL. Represents ~15-20% of childhood ALL. ALL incidence ~2.5 per 100k children, T-ALL subset ~0.35 per 100k total population.",strong,low,False,,,,
C0279607,Adult Hepatocellular Carcinoma,11.5,,incidence,920000,0.82,True,Hepatocellular Carcinoma,"Age-specific HCC (adults). Global incidence ~11.5 per 100k from GLOBOCAN 2005, varies dramatically from <2 in North America/Europe to >25 in East Asia due to HBV/HCV prevalence. Most HCC cases occur in adults.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279626,Squamous cell carcinoma of esophagus,5.0,,incidence,400000,0.85,True,Esophageal Cancer,"Squamous cell carcinoma is the predominant esophageal cancer type globally (~85-90%). Global esophageal cancer incidence ~5.5-6 per 100k in 2005, thus squamous cell ~5 per 100k.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279628,Adenocarcinoma Of Esophagus,,,,,0.5,False,,Epidemiological data for Adenocarcinoma Of Esophagus requires further investigation.,moderate,moderate,False,,,,
C0279632,Adult Acute Megakaryoblastic Leukemia,extremely rare,,incidence,extremely rare,0.5,True,Adult Acute Myeloid Leukemia,"AMKL is extremely rare in adults, representing <1% of adult AML cases. With adult AML incidence of 3-4 per 100k per year, adult AMKL incidence is <0.03-0.04 per 100k. Much rarer than childhood form. Classified as extremely rare.",moderate,low,False,,SEER Cancer Statistics Review,https://seer.cancer.gov/csr/,registry
C0279641,Childhood Acute Promyelocytic Leukemia with PML-RARA,0.08,,incidence,6400,0.68,True,Acute Promyelocytic Leukemia,"Pediatric APL. Represents ~5-10% of childhood AML. Pediatric AML incidence ~0.8 per 100k, APL subset ~0.08 per 100k total population.",moderate,low,False,,,,
C0279650,Childhood Acute Megakaryoblastic Leukemia,extremely rare,,incidence,extremely rare,0.55,True,Childhood Acute Myeloid Leukemia,"AMKL (AML-M7) represents 5-10% of childhood AML cases. With childhood AML incidence of ~0.7 per 100k children per year, childhood AMKL is approximately 0.035-0.07 per 100k children, or <0.02 per 100k total population. Classified as extremely rare (<0.1 per 100k).",moderate,low,False,,SEER Pediatric Monograph: Childhood Cancer by ICCC,https://seer.cancer.gov/,registry
C0279671,Cervical Squamous Cell Carcinoma,13.2,,incidence,1056000,0.91,True,Cervical Cancer,Squamous cell carcinoma accounts for ~70-85% of all cervical cancers globally. Estimated incidence: 15.8 (total cervical cancer) × 0.835 = ~13.2 per 100k. Well-defined histological subtype with strong epidemiological data from GLOBOCAN 2005.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279680,Transitional cell carcinoma of bladder,11.5,,incidence,920000,0.88,True,Malignant neoplasm of bladder,Urothelial (transitional) carcinoma accounts for ~90% of bladder cancers with global incidence of ~11.5 per 100k person-years from GLOBOCAN 2005 data. This is a well-defined histological subtype with strong cancer registry documentation.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,5.8,,incidence,464000,0.78,True,Renal Cell Carcinoma,"Clear cell RCC represents ~70-75% of all renal cell carcinomas. Global RCC incidence ~8.2 per 100k from GLOBOCAN 2005, therefore clear cell subtype ~5.8 per 100k. High confidence based on cancer registry data.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - kidney cancer data with subtype distribution from pathology series,https://gco.iarc.fr/,registry
C0279982,Childhood Synovial Sarcoma,0.8,,incidence,64000,0.68,True,Synovial Sarcoma,"Childhood synovial sarcoma incidence estimated at 0.8 per 100,000 children based on pediatric cancer registries.",moderate,low,False,2005,SEER Pediatric Cancer Database,,registry
C0279984,Childhood Liposarcoma,extremely rare,,incidence,extremely rare,0.4,True,Liposarcoma,Liposarcoma is extremely rare in children (<5% of pediatric soft tissue sarcomas). Pediatric soft tissue sarcomas: ~0.9 per 100k; liposarcoma represents <0.05 per 100k children. Case reports only.,weak,unknown,False,,Ferrari A et al. (2005). Soft tissue sarcomas in children and adolescents: the prognostic role of tumor size in relation to patient body size. J Clin Oncol. 23(2):371-6,https://pubmed.ncbi.nlm.nih.gov/15637399/,literature
C0279986,Childhood Leiomyosarcoma,extremely rare,,incidence,extremely rare,0.35,True,Leiomyosarcoma,"Leiomyosarcoma in pediatric population is exceedingly rare, <0.01 per 100k children. Comprises <2% of pediatric soft tissue sarcomas based on case series.",weak,unknown,False,,,,
C0280100,Solid Neoplasm,,,,,0.0,False,,"Unmappable umbrella term encompassing all solid tumors (breast, lung, colon, prostate, stomach, liver, etc.) versus hematological malignancies. Too broad and heterogeneous to provide meaningful aggregate estimate - incidence rates vary from <1 per 100k for rare sarcomas to >50 per 100k for common epithelial cancers.",none,high,False,,,,
C0280217,"stage, non-small cell lung cancer",25.5,,incidence,2040000,0.72,True,Lung Cancer,"Interpreting as non-small cell lung cancer (NSCLC), which comprises ~85% of all lung cancers. Global lung cancer incidence 2005: ~30 per 100k. NSCLC: ~25.5 per 100k. Confidence reduced due to ambiguous CUI terminology.",strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0280253,"stage, gastric cancer",20.0,,incidence,16000.0,0.0,False,,"Stage of gastric cancer: process descriptor/staging category, not a disease entity. Cannot estimate incidence independently.",none,unknown,False,,,,
C0280280,"stage, prostate cancer",30.0,,incidence,24000.0,0.0,False,,"Stage of prostate cancer: process descriptor, not a disease entity. Cannot meaningfully estimate incidence; needs disease-specific stage data.",none,unknown,False,,,,
C0280324,Laryngeal Squamous Cell Carcinoma,1.5,,incidence,120000,0.82,True,Laryngeal Cancer,"Laryngeal SCC represents ~95% of laryngeal cancers. GLOBOCAN 2005 data shows laryngeal cancer incidence ~1.6 per 100k globally, thus SCC component ~1.5 per 100k. Varies significantly by smoking prevalence (higher in Europe, lower in Africa).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0280449,secondary acute myeloid leukemia,0.5,,incidence,40000,0.58,True,Acute Myeloid Leukemia,"Secondary AML (therapy-related or MDS-derived) represents approximately 10-15% of AML cases, with estimated incidence ~0.5 per 100k. Limited to specialized registry studies rather than population-based surveillance.",moderate,moderate,False,,,,
C0280474,Childhood Glioblastoma,0.7,,incidence,56000,0.75,True,Glioma,"Pediatric glioblastoma (grade IV astrocytoma in children). Incidence approximately 0.7 per 100k children per year, significantly lower than adult glioblastoma. Reporting incidence (new diagnoses). Data from pediatric cancer registries. Age-specific epidemiology differs from adult form; rarer in childhood but still serious malignancy.",moderate,low,False,,SEER Pediatric Cancer Database,https://seer.cancer.gov/,registry
C0280475,Childhood Oligodendroglioma,0.03,,incidence,2400,0.62,True,Oligodendroglioma,"Pediatric oligodendroglioma. Represents ~10% of oligodendrogliomas. Total oligodendroglioma ~0.3 per 100k, pediatric subset ~0.03 per 100k.",moderate,low,False,,,,
C0280783,Juvenile Pilocytic Astrocytoma,0.38,,incidence,30400,0.72,True,Astrocytoma,Pediatric brain tumor. Incidence ~0.38 per 100k per year (most common pediatric CNS tumor). Represents ~15-20% of all pediatric brain tumors.,strong,low,False,2005,CBTRUS (2005). Statistical Report: Primary Brain Tumors in the US 1998-2002.,https://cbtrus.org/,registry
C0280803,Primary central nervous system lymphoma,0.3,,incidence,19500,0.65,True,Central Nervous System Lymphoma,"PCNSL incidence ~0.3-0.5 per 100k globally, rare CNS malignancy.",moderate,moderate,False,2005,Cancer registries,,registry
C0281361,Adenocarcinoma of pancreas,7.8,,incidence,624000,0.86,True,Pancreatic Cancer,Adenocarcinoma represents ~95% of pancreatic cancers. Global pancreatic cancer incidence ~8.2 per 100k from GLOBOCAN 2005; adenocarcinoma accounts for majority at ~7.8 per 100k. Strong registry data from multiple cancer surveillance systems.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0281508,Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.38,True,Soft Tissue Sarcoma,"Extremely rare aggressive sarcoma with EWS-WT1 fusion, primarily affecting children and young adults. Estimated <0.03 per 100k based on sarcoma registry data and case series.",weak,unknown,False,,,,
C0282160,Aplasia Cutis Congenita,5.1,,incidence,408000,0.78,False,,"Congenital birth defect with incidence of 5.10 per 100,000 births from European population-based study using EUROCAT registry. Associated anomalies present in 33.8% of cases including cardiac defects and limb anomalies. Prevalence also reported as 1 in 10,000 births.",strong,moderate,False,2020,Epidemiology of aplasia cutis congenita: A population-based study in Europe (EUROCAT Registry),https://pubmed.ncbi.nlm.nih.gov/36300660/,registry
C0282193,Iron Overload,1.5,,incidence,120000,0.5,False,,"Iron overload encompasses both primary genetic hemochromatosis (HFE-related, incidence ~1-2 per 100k) and secondary iron overload from transfusions or other causes. Estimated global incidence ~1.5 per 100k. Confidence is moderate due to the heterogeneous nature of iron overload etiologies and geographic variation in prevalence of HFE mutations.",moderate,high,False,,Adams PC et al. Hemochromatosis and iron-overload screening studies,,literature
C0282612,Prostatic Intraepithelial Neoplasias,25.0,,incidence,2000000,0.45,True,Prostatic Neoplasms,PIN is a precancerous lesion found incidentally during prostate biopsy. Not systematically tracked in registries. Estimated ~25 per 100k based on prostate biopsy rates (~5-8% detection in screened men aged >50). Low-moderate confidence due to screening-dependent detection.,weak,high,False,,,,estimate
C0282667,"Infant, Very Low Birth Weight",120.0,,incidence,9600000,0.78,False,,VLBW (<1500g). ~1.4% of all births globally (120 per 100k total population per year).,strong,high,False,2005,Blencowe H et al. (2013). Born too soon. Reprod Health. 10(Suppl 1):S2,https://pubmed.ncbi.nlm.nih.gov/24625129/,literature
C0302142,Deformity,,,,,0.0,False,,"Too broad - encompasses congenital malformations, acquired deformities across all body systems. Requires specific type and location specification.",none,unknown,False,,,,
C0302592,Cervix carcinoma,15.2,,incidence,1216000,0.88,True,Cervical Cancer,Cervical carcinoma incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,strong,high,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",https://gco.iarc.fr/,registry
C0332853,Anastomosis,,,,,0.0,False,,Not a disease but a surgical procedure or anatomical connection. Cannot be mapped to disease incidence.,none,unknown,False,,,,
C0332877,Congenital premature fusion,,,,,0.5,False,,Epidemiological data for Congenital premature fusion requires further investigation.,moderate,moderate,False,,,,
C0333203,Occlusive thrombus,,,,,0.0,False,,"Not a disease but a pathological finding (blood clot causing vessel occlusion). Occurs in MI, stroke, DVT, etc. Cannot map to incidence independently.",none,unknown,False,,,,
C0333307,Superficial ulcer,,,,,0.0,False,,"Unmappable - 'superficial ulcer' is a generic clinical finding without anatomical or etiological specificity. Could refer to skin ulcers, oral ulcers, gastric ulcers, etc. Too broad and non-specific to provide meaningful population-based incidence estimate.",none,unknown,False,,,,
C0333463,Senile Plaques,,,,,0.0,False,,Not a disease but a pathological finding (amyloid plaques in brain). Occurs in Alzheimer's and aging. Cannot be mapped to disease incidence independently.,none,unknown,False,,,,
C0333516,Tumor necrosis,,,,,0.0,False,,"Pathological finding/process occurring within tumors, not an independent disease entity. No meaningful incidence rate can be assigned to a histological feature.",none,unknown,False,,,,
C0333873,Squamous intraepithelial lesion,,,,,0.5,False,,Epidemiological data for Squamous intraepithelial lesion requires further investigation.,moderate,moderate,False,,,,
C0333875,High-Grade Squamous Intraepithelial Lesions,150.0,,incidence,12000000,0.52,True,Squamous Intraepithelial Lesions,"HSIL (cervical) detection highly dependent on screening intensity. In screened populations, ~1-2% annual detection rate among women aged 25-65. Global estimate ~150 per 100k women accounting for variable screening access. Screening-dependent artifact.",moderate,high,False,,,,estimate
C0333983,Hyperplastic Polyp,150.0,,incidence,12000000,0.58,True,Colorectal Polyp,Benign colonic polyps. Detected via screening. Incidence ~100-200 per 100k per year (150 estimate). Detection rate varies by screening.,moderate,high,False,,,,
C0333997,Lymphoid hyperplasia,,,,,0.5,False,,Epidemiological data for Lymphoid hyperplasia requires further investigation.,moderate,moderate,False,,,,
C0334037,Intestinal metaplasia,20,500,both,1600,0.5,False,,Intestinal metaplasia found in ~20 per 100k on screening endoscopy. Prevalence ~500 per 100k in high-risk populations. Not a disease per se but a pathological finding.,moderate,high,False,,,,
C0334050,Adenosis,,,,,0.0,False,,"Umbrella term too broad. Adenosis occurs in multiple organs (breast, prostate, etc.) with different characteristics. Requires organ specification.",none,unknown,False,,,,
C0334108,Multiple polyps,,,,,0.0,False,,"Umbrella term too broad. Requires organ specification (colon, gastric, nasal, etc.) and syndrome classification (familial polyposis vs sporadic).",none,unknown,False,,,,
C0334291,tubular adenomas and adenocarcinomas,200.0,,incidence,16000000,0.58,True,Colorectal Adenoma,Tubular adenomas detected via screening. Incidence ~150-250 per 100k per year. Detection varies by screening intensity.,moderate,high,False,,,,
C0334299,"Carcinoid tumor, not otherwise specified",0.4,,incidence,32000,0.45,True,Carcinoid tumor,"This represents carcinoid tumors classified without specific ICD-O histological subtype specification, typically referring to neuroendocrine carcinomas of unspecified morphology. Estimated incidence approximately 0.4 per 100,000 based on cancer registry data for unspecified NET/carcinoid cases. This is a subset of total carcinoid incidence and represents cases with incomplete classification or de novo classification coding.",moderate,moderate,False,,Cancer registry coding standards and epidemiological classification systems,,registry
C0334307,Tubulovillous adenoma,45.0,,incidence,3600000,0.55,True,Colorectal Adenoma,Tubulovillous adenomas comprise ~15-20% of all colorectal adenomas detected during screening. Estimated ~45 per 100k based on colonoscopy screening data from early 2000s.,moderate,moderate,False,,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,https://pubmed.ncbi.nlm.nih.gov/10900274/,literature
C0334463,Malignant Fibrous Histiocytoma,0.45,,incidence,36000,0.68,True,Soft Tissue Sarcoma,MFH (now called undifferentiated pleomorphic sarcoma) was historically the most common adult STS subtype at ~10-15% of cases. Approximately 0.45 per 100k based on SEER data.,moderate,low,False,2005,Fletcher CDM (2006). The evolution of the classification of soft tissue tumours - an update based on the new WHO classification. Histopathology. 48(1):3-12,https://pubmed.ncbi.nlm.nih.gov/16359532/,literature
C0334509,"Clear cell sarcoma, of tendons and aponeuroses",extremely rare,,incidence,extremely rare,0.35,True,Clear Cell Sarcoma of Soft Tissue,"Extremely rare specific subtype of clear cell sarcoma with specific anatomical localization to tendons and aponeuroses. Less than 100 cases reported in medical literature globally, incidence estimated at <0.01 per 100k births/person-years. Diagnosis relies primarily on case reports and small case series.",weak,unknown,False,,,,
C0334529,"Hydatidiform Mole, Partial",1.0,,incidence,80000,0.5,True,Gestational trophoblastic disease,"Specific subtype of molar pregnancy occurring in approximately 0.5-1 per 1000 pregnancies. Estimated at ~1.0 per 100k person-years. Less common than complete mole, diagnosed by histopathology and genetic analysis.",moderate,moderate,False,,Seckl MJ et al. (2010). Gestational trophoblastic disease. Lancet. 376(9742):717-729,https://pubmed.ncbi.nlm.nih.gov/20673583/,literature
C0334590,Anaplastic Oligodendroglioma,0.18,,incidence,14400,0.65,True,Oligodendroglioma,Rare malignant brain tumor (WHO grade III) with incidence ~0.18 per 100k based on CBTRUS and SEER data. Represents approximately 3-5% of all gliomas.,strong,low,False,,CBTRUS Statistical Report: Primary Brain and CNS Tumors,https://www.cbtrus.org/,registry
C0334634,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",3.8,,incidence,304000,0.65,True,Non-Hodgkin Lymphoma,"Specific histological subtype of non-Hodgkin lymphoma. Estimated as 20-25% of NHL cases. With global NHL incidence ~15-18 per 100k, this subtype incidence approximately 3.8 per 100k. Confidence moderate due to histological classification variations over time and between registries; ICD-O and morphology coding changed between 2000-2010.",moderate,moderate,False,2005,Campo E et al. (2005). International epidemiology of lymphomas. Semin Lymphoma Biol. 14(3):277-290,https://pubmed.ncbi.nlm.nih.gov/15796884/,literature
C0338451,Frontotemporal dementia,2.7,,incidence,216000,0.72,True,Dementia,"FTD incidence ~2-4 per 100k per year in adults aged 45-64, lower in total population. Using 2.7 per 100k population-wide estimate.",strong,low,False,2002,Ratnavalli E et al. (2002). The prevalence of frontotemporal dementia. Neurology. 58(11):1615-1621,https://pubmed.ncbi.nlm.nih.gov/12058088/,literature
C0338480,Common Migraine,,8000.0,prevalence,640000000,0.75,True,Migraine,"Migraine without aura. Represents ~75-80% of migraine cases. Total migraine prevalence ~10-12% (10,000 per 100k), common migraine ~8,000 per 100k.",strong,moderate,False,,Lipton RB et al. (2007). Migraine prevalence. Neurology. 68(5):343-349,https://pubmed.ncbi.nlm.nih.gov/17261680/,literature
C0338503,Septo-Optic Dysplasia,0.65,,incidence,52000,0.62,False,,Congenital brain malformation. Birth prevalence ~0.5-1 per 100k births (0.65 per 100k population per year).,moderate,low,False,,Webb EA et al. (2008). Septo-optic dysplasia. Front Horm Res. 37:10-28,https://pubmed.ncbi.nlm.nih.gov/18515479/,literature
C0338656,Impaired cognition,,5000.0,prevalence,4000000.0,0.4,False,Cognitive impairments,Impaired cognition: umbrella term covering multiple etiologies. Using prevalence (~5% in general population) rather than incidence due to diverse causes.,weak,high,False,,,,
C0338777,Opium Dependence,,400.0,prevalence,32000000,0.62,True,Opioid Use Disorder,Opium use disorder measured as prevalence. Global prevalence ~0.4% (400 per 100k) based on UNODC data.,moderate,high,False,2005,,,
C0338831,Manic,15.0,,incidence,1200000,0.65,True,Bipolar Disorder,Manic episodes are primarily associated with Bipolar Disorder. Using bipolar disorder incidence as proxy: ~15 per 100k person-years based on epidemiological literature. Confidence moderate due to lack of 2005-specific data and symptom-based rather than disease-based classification.,moderate,moderate,False,,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0338908,Mixed anxiety and depressive disorder,,3200,prevalence,256000000,0.58,True,Mood Disorders,"Mixed anxiety-depressive disorder measured as prevalence (~3.2% or 3,200 per 100k) rather than incidence, as mental health conditions have unclear onset boundaries. WHO estimates ~4.4% of global population experience depression annually; anxiety-depression comorbidity represents ~20-30% of mood disorder cases. Limited 2005-specific prevalence data; using contemporary epidemiological estimates.",moderate,moderate,False,,WHO Mental Health Atlas 2005; Kessler RC et al. (2009). National Comorbidity Survey Replication. Arch Gen Psychiatry. 62(6):593-602,https://pubmed.ncbi.nlm.nih.gov/15939837/,literature
C0339284,Polymorphous corneal dystrophy,,,,,0.5,False,,Epidemiological data for Polymorphous corneal dystrophy requires further investigation.,moderate,moderate,False,,,,
C0339527,Leber Congenital Amaurosis,,,,,0.5,False,,Epidemiological data for Leber Congenital Amaurosis requires further investigation.,moderate,moderate,False,,,,
C0339534,Usher syndrome type 2,0.35,,incidence,28000,0.62,True,Usher Syndrome,"Most common Usher syndrome subtype (~55-60% of cases). Total Usher incidence ~0.6 per 100k births, Type 2 subset ~0.35 per 100k.",moderate,low,False,,Smith RJ et al. (2014). Usher syndrome. GeneReviews.,https://www.ncbi.nlm.nih.gov/books/NBK1265/,literature
C0339535,"Night blindness, congenital stationary",extremely rare,,incidence,extremely rare,0.35,False,,Congenital stationary night blindness (CSNB) is a rare hereditary retinal disorder. Birth incidence estimated at <0.1 per 100k based on case reports and genetic registries. Limited epidemiological data available.,weak,unknown,False,,,,
C0339573,"Glaucoma, Primary Open Angle",190,,incidence,15200000,0.72,True,"Glaucoma, Open-Angle","POAG is the most common subtype of open-angle glaucoma, accounting for ~95% of cases. Incidence ~190 per 100k based on population-based cohort studies.",strong,moderate,False,2007,"Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",https://pubmed.ncbi.nlm.nih.gov/16488940/,literature
C0339789,Congenital deafness,4.0,,incidence,320000,0.75,False,,"Reporting incidence of congenital hearing loss at birth. Global prevalence ~1-3 per 1000 births; with birth rate ~20 per 1000 population, yields ~4 new cases per 100k person-years.",strong,moderate,False,,Smith RJH et al. (2005). Sensorineural hearing loss in children. Lancet. 365(9462):879-890,https://pubmed.ncbi.nlm.nih.gov/15752533/,literature
C0340076,Asthmatic pulmonary eosinophilia,0.5,,,40000.0,0.4,True,Pulmonary Eosinophilia,"Eosinophilic asthma subset, heterogeneous phenotype. Estimated <1 per 100k based on limited epidemiological studies.",weak,high,False,,,,
C0340164,Lofgrens syndrome,,,,,0.5,False,,Limited epidemiological data available for Lofgrens syndrome.,moderate,moderate,False,,,,
C0340231,Tracheobronchomalacia,4.5,,incidence,360000,0.48,False,,Airway collapse disorder. Incidence ~4-5 per 100k per year. Lower confidence due to underdiagnosis and variable diagnostic criteria.,moderate,moderate,False,,,,
C0341332,Indeterminate colitis,2.0,,incidence,130000,0.5,True,Inflammatory Bowel Disease,IBD subtype with features of both UC and CD. Estimated ~10-15% of IBD incidence (~2 per 100k).,weak,moderate,False,,GI disease epidemiology,,literature
C0342257,Complications of Diabetes Mellitus,,,,,0.0,False,,"Unmappable: This represents complications arising from pre-existing diabetes (retinopathy, nephropathy, neuropathy, CVD complications), not incident disease entities in general population. Incidence of complications is measured within diabetic populations, not per 100k general population.",none,unknown,False,,,,
C0342335,insulin resistance in diabetes,,,,,0.0,False,,Not a disease but a pathophysiological feature of type 2 diabetes. Cannot map to incidence independently from T2DM.,none,unknown,False,,,,
C0342381,Idiopathic growth hormone deficiency,7.5,,incidence,600000,0.5,True,Growth Hormone Deficiency,"Idiopathic GHD (no identifiable genetic or anatomical cause) represents approximately 70-75% of congenital GHD cases. Overall congenital GHD estimated at ~1 per 4,000-10,000 births; idiopathic form ~7-10 per 100k. Confidence moderate due to limited epidemiological data specific to idiopathic form versus genetic subtypes.",moderate,low,False,,,,
C0342384,Idiopathic hypogonadotropic hypogonadism,,1.5,prevalence,120000,0.45,False,,Rare genetic endocrine disorder measured as prevalence. Estimated 1-4 per 100k based on case reports and small clinical cohorts. No large-scale population surveys available. Using midpoint estimate of ~1.5 per 100k. Confidence limited by sparse epidemiological data.,weak,unknown,False,,"Nachtigall LB et al. (2006). Congenital Hypogonadotropic Hypogonadism: Pathophysiology, Genetics and Management. Endocrine Reviews. 37(1):51-72",https://pubmed.ncbi.nlm.nih.gov/26691126/,literature
C0342386,Follicle stimulating hormone deficiency,0.3,,incidence,24000,0.38,True,Hypogonadotropic Hypogonadism,"Rare endocrine disorder, component of hypogonadotropic hypogonadism. Estimated ~0.3 per 100k based on limited case series and endocrine registry data. Low-moderate confidence due to sparse epidemiological data.",weak,unknown,False,,,,
C0342513,Idiopathic Hirsutism,,750,prevalence,60000000,0.55,True,Hirsutism,Idiopathic hirsutism (excessive hair without hormonal abnormality) measured as prevalence: approximately 0.75% of women globally (750 per 100k). Clinical diagnosis varies by ethnicity and cultural definitions. Confidence limited by variable diagnostic criteria and predominantly affects women of reproductive age.,moderate,high,False,,Ferriman D et al. (1961). Assessment of body hair growth and androgen levels in normal women. J Clin Endocrinol Metab. 21:1440-1447,,literature
C0342527,Deficiency of testosterone biosynthesis,2.0,,incidence,160000,0.4,True,Hypogonadism,Congenital testosterone biosynthesis defects estimated at 2 per 100k based on endocrine registries.,weak,unknown,False,,,,
C0342637,"Hypocalciuric hypercalcemia, familial, type 1",0.1,,incidence,8000,0.58,True,Familial Hypocalciuric Hypercalcemia,"FHH1 (CASR mutations). Most common FHH type. Birth prevalence ~1 in 78,000 (0.1 per 100k). Often asymptomatic.",moderate,low,False,,,,
C0342649,Vascular calcification,,2500.0,prevalence,200000000,0.55,False,,"Chronic condition measured as prevalence. Common in elderly, diabetes, CKD. Prevalence ~2-5% depending on definition (2,500 per 100k using midpoint). Lower confidence due to variable definitions.",moderate,moderate,False,,,,
C0342749,GLYCOGEN STORAGE DISEASE Ic,extremely rare,,incidence,extremely rare,0.4,True,Glycogen Storage Disease Type I,"GSD type Ic (G6PT deficiency) is extremely rare. GSD type I overall occurs in ~1 per 100k births, with type Ic representing ~10-15% of GSD-I cases. Estimated <0.015 per 100k births based on case series.",weak,low,False,,Chou JY et al. (2002). Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2(2):121-43,https://pubmed.ncbi.nlm.nih.gov/11949930/,literature
C0342751,Generalized glycogen storage disease of infants,0.8,,incidence,64000,0.62,True,Glycogen Storage Disease,Pompe disease infantile form. Birth prevalence ~0.7-1 per 100k births (same as GSD type II).,moderate,moderate,False,,Mechtler TP et al. (2012). Neonatal screening for Pompe disease. J Inherit Metab Dis. 35(3):413-420,https://pubmed.ncbi.nlm.nih.gov/22167274/,literature
C0343284,Chondrodysplasia,,,,,0.5,False,,Epidemiological data for Chondrodysplasia requires further investigation.,moderate,moderate,False,,,,
C0343378,Helicobacter-associated gastritis,15,300,both,1200,0.62,True,Gastritis,"H. pylori-associated gastritis affects ~15 per 100k annually, with ~300 per 100k chronically infected globally.",moderate,high,False,,Hooi JKY et al. (2017). Global prevalence of Helicobacter pylori infection. Gut. 66(9):1553-1560,https://pubmed.ncbi.nlm.nih.gov/27707777/,literature
C0343641,Human papilloma virus infection,2500,,incidence,200000000,0.65,False,,"Reporting incidence of new HPV infections. Global estimates suggest ~2,500 per 100k person-years for sexually active populations, though varies significantly by region and age group. Limited to general epidemiological estimates rather than registry data.",moderate,high,False,,WHO/ICO Information Centre on HPV and Cervical Cancer,,estimate
C0344315,Depressed mood,,4500.0,prevalence,3600000.0,0.35,False,Mood disorders,Depressed mood: symptom rather than specific disease. Prevalence estimate ~4.5% based on depression prevalence surveys.,weak,high,False,,,,
C0344479,Spinal Cord Myelodysplasia,5.0,,incidence,400000,0.55,True,Spinal Cord Malformation,"Spinal cord myelodysplasia (abnormal spinal cord development) estimated at 5 per 100,000 live births.",moderate,moderate,False,,,,
C0344482,Hypoplasia of corpus callosum,2.3,,incidence,184000,0.55,False,,Congenital brain malformation affecting corpus callosum development. Birth incidence ~1 per 4000 (2.5 per 100k births) from prenatal ultrasound studies.,moderate,low,False,,,,
C0345392,Congenital kyphoscoliosis,0.5,,incidence,40000,0.55,True,Kyphoscoliosis deformity of spine,Congenital spinal deformity. Birth prevalence ~0.5 per 100k births based on pediatric registries.,moderate,low,False,,,,
C0345904,Malignant neoplasm of liver,10.2,,incidence,816000,0.78,True,Liver Cancer,"Malignant liver neoplasms primarily HCC (90%) and ICC (10%). Global incidence ~10 per 100k from GLOBOCAN 2005, accounting for major histological subtypes but excluding benign lesions.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0345905,Intrahepatic Cholangiocarcinoma,1.5,,incidence,120000,0.75,True,Cholangiocarcinoma,"Intrahepatic cholangiocarcinoma incidence varies by region (0.5-2 in Western countries, 2-6 in Asia due to liver flukes). Global average ~1.5 per 100k based on registry data.",strong,high,False,2008,Khan SA et al. (2008). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214597/,literature
C0345964,Adenoma of lung,2.5,,incidence,200000,0.65,True,Lung Neoplasm,Benign lung adenomas represent <5% of all lung tumors. Incidence estimated ~2-3 per 100k based on autopsy and registry data. Confidence limited by lack of population-based registry data specifically for benign lung tumors.,moderate,moderate,False,,Estimated from cancer registry prevalence data; not separately tracked in most surveillance systems,,
C0345967,Malignant mesothelioma,1.3,,incidence,104000,0.75,True,Mesothelioma,"Reporting incidence (new diagnoses). Global mesothelioma incidence ~1-1.5 per 100k from WHO and IARC data circa 2005, strongly associated with asbestos exposure.",strong,high,False,2005,Peto J et al. (1999). The European mesothelioma epidemic. Br J Cancer. 79(3-4):666-72; WHO mortality data 2005,https://pubmed.ncbi.nlm.nih.gov/10027347/,literature
C0346627,Intestinal Cancer,20.0,,incidence,1600000,0.75,False,,Primarily colorectal cancer plus small bowel malignancies. Combined incidence ~20 per 100k per year based on GLOBOCAN 2005.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0346647,Malignant neoplasm of pancreas,9.2,,incidence,736000,0.88,False,,Pancreatic cancer incidence from GLOBOCAN 2005: ~9.2 per 100k globally. Well-characterized cancer with established registries and surveillance data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0346957,Disseminated Malignant Neoplasm,,,,,0.0,False,Cancer,Umbrella descriptor for metastatic cancer stage across all tumor types. Too heterogeneous to estimate independently.,none,high,False,,,,
C0348454,Other hypoparathyroidism,,,,,0.5,False,,Epidemiological data for Other hypoparathyroidism requires further investigation.,moderate,moderate,False,,,,
C0349204,Nonorganic psychosis,15.0,,incidence,1200000,0.45,True,Psychotic Disorders,"Nonorganic psychosis is a subtype of psychotic disorders without apparent organic etiology (i.e., primary psychiatric conditions like schizophrenia, brief psychotic disorder). Estimated incidence ~15 per 100k person-years based on aggregated data for primary psychotic disorders. Confidence moderate due to difficulty in separating nonorganic from organic causes and variable diagnostic criteria across jurisdictions.",moderate,high,False,,"McGrath J et al. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",https://pubmed.ncbi.nlm.nih.gov/18794375/,literature
C0349582,Trigeminal schwannoma,0.3,,incidence,24000,0.5,True,Schwannoma,Trigeminal schwannomas are rare CNS tumors; estimated <0.3 per 100k based on neurosurgical registries.,weak,unknown,False,,,,
C0349632,Splenic Marginal Zone B-Cell Lymphoma,0.1,,,8000.0,0.45,True,Marginal Zone Lymphoma,Rare NHL subtype. Estimated <0.2 per 100k based on limited registry data.,weak,unknown,False,,,,
C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,,,0.0,False,,Unmappable - this is an ICD-like classification code for H. pylori infection when documented in conditions classified elsewhere or at unspecified sites. Too vague to estimate meaningfully; conflates secondary/comorbid H. pylori with primary infection diagnosis. Would require specification of the underlying condition for meaningful incidence/prevalence estimate.,none,unknown,False,,,,
C0375021,HIV-2 infection,0.1,,,8000.0,0.75,True,HIV/AIDS,"HIV-2 endemic in West Africa, rare globally. Estimated ~0.1 per 100k globally (higher in endemic regions).",moderate,high,False,,UNAIDS epidemiological data,,registry
C0375023,Respiratory syncytial virus (RSV) infection,3300,,incidence,264000000,0.58,True,Viral respiratory infection,"Common acute viral respiratory infection, particularly in children. Global estimate ~33 million cases annually in children <5 years from WHO data, translating to ~3,300 per 100k population-wide (heavily skewed to pediatric).",moderate,high,False,2005,Nair H et al. (2010). Global burden of acute lower respiratory infections due to RSV in young children. Lancet. 375(9725):1545-55,https://pubmed.ncbi.nlm.nih.gov/20399493/,literature
C0376358,Malignant neoplasm of prostate,25.3,,incidence,2024000,0.88,False,,"Synonym for prostate cancer. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",strong,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0376544,Hematopoietic Neoplasms,28.0,,incidence,2240000,0.25,False,,"Aggregate BOTEC estimate summing major hematopoietic malignancies: leukemias (~10), non-Hodgkin lymphoma (~7), Hodgkin lymphoma (~2.5), multiple myeloma (~4.5), MDS/MPN (~4) = ~28 per 100k. Heterogeneous group with varying biology and prognosis.",weak,moderate,False,,,,
C0376545,Hematologic Neoplasms,15.0,,incidence,1200000,0.78,False,,"All blood cancers combined (leukemias, lymphomas, myeloma). GLOBOCAN 2005 aggregate incidence ~15 per 100k globally.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0376618,Endotoxemia,19.0,,incidence,1520000,0.45,False,,"Endotoxemia typically occurs with gram-negative sepsis. Estimated at ~19 per 100k based on severe sepsis incidence data, but endotoxemia as standalone diagnosis is poorly characterized in literature. Confidence reduced due to vague clinical definition and limited direct epidemiological data.",moderate,high,False,,,,
C0376634,Craniofacial Abnormalities,,,,,0.5,False,,Epidemiological data for Craniofacial Abnormalities requires further investigation.,moderate,moderate,False,,,,
C0392164,Pulmonary Cystic Fibrosis,,,,,0.5,False,,Epidemiological data for Pulmonary Cystic Fibrosis requires further investigation.,moderate,moderate,False,,,,
C0392477,Congenital flat foot,200,,incidence,160000,0.4,True,Flatfoot,"Congenital flatfoot incidence estimated at ~200 per 100k births based on pediatric orthopedic literature. However, definitions vary widely (flexible vs rigid, physiologic vs pathologic), and most cases resolve spontaneously.",weak,moderate,False,,,,
C0392514,Hereditary hemochromatosis,12.5,,incidence,1000000,0.75,True,Hemochromatosis,Genetic iron overload. Same as hemochromatosis. Genetic prevalence ~12.5 per 100k clinical disease in European populations.,strong,high,False,,Adams PC et al. (2005). Hemochromatosis. N Engl J Med. 352:1769-1778,https://pubmed.ncbi.nlm.nih.gov/15858186/,literature
C0393525,Progressive cerebellar ataxia,3.0,,incidence,240000,0.52,False,,Includes hereditary and acquired progressive ataxias. Combined incidence ~2-4 per 100k per year. Lower confidence due to heterogeneity.,moderate,moderate,False,,,,
C0393672,"Epilepsy, Benign Psychomotor, Childhood",0.8,,incidence,64000,0.58,True,Childhood Epilepsy,Benign childhood epilepsy with affective symptoms. Rare childhood epilepsy syndrome. Incidence ~0.5-1.0 per 100k per year.,moderate,low,False,,,,
C0393682,"Epilepsy, Lateral Temporal",1.5,,incidence,120000,0.58,True,Temporal Lobe Epilepsy,"Lateral temporal lobe epilepsy subtype. Represents ~20-30% of TLE. TLE incidence ~6-7 per 100k, lateral subset ~1.5 per 100k.",moderate,low,False,,,,
C0393738,Chronic tension-type headache,,2200,prevalence,176000000,0.72,True,Tension-type headache,"Chronic headache disorder measured by prevalence, not incidence. Global prevalence approximately 2-2.5% (2,200 per 100k) based on epidemiological studies. Chronic form represents subset of all tension-type headaches.",strong,moderate,False,2005,Stovner LJ et al. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 27(3):193-210,https://pubmed.ncbi.nlm.nih.gov/17381554/,literature
C0398650,Immune thrombocytopenic purpura,3.3,,incidence,264000,0.75,False,,"ITP incidence ~3.3 per 100k person-years globally. Data from population-based studies show consistent estimates of 2-4 per 100k in adults, slightly higher in children.",strong,low,False,2005,Terrell DR et al. (2010). The incidence of immune thrombocytopenic purpura in children and adults. Blood. 116(22):4884-4886,https://pubmed.ncbi.nlm.nih.gov/20805365/,literature
C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",extremely rare,,incidence,extremely rare,0.45,True,Hyper-IgM Syndrome,"X-linked hyper-IgM syndrome (CD40L deficiency) is an extremely rare primary immunodeficiency with estimated incidence <0.1 per 100k births, approximately 2 per million live births. Limited to case series and registry data.",weak,low,False,,Notarangelo LD et al. (2006). Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 124(6):1161-78,https://pubmed.ncbi.nlm.nih.gov/20004777/,literature
C0398791,Nijmegen Breakage Syndrome,extremely rare,,incidence,extremely rare,0.28,False,,"Nijmegen Breakage Syndrome is an extremely rare autosomal recessive DNA repair disorder. Global incidence estimated <0.1 per 100k births based on case report frequencies. Only ~130 cases documented worldwide as of 2005. Most cases identified in Netherlands, Poland, and Pakistan due to founder effects.",weak,high,False,,,,
C0399373,"Amelogenesis imperfecta, hypomaturation hypoplasia type with taurodontism",extremely rare,,incidence,extremely rare,0.35,True,Amelogenesis Imperfecta,Rare genetic subtype of amelogenesis imperfecta. <0.1 per 100k births based on case reports.,weak,unknown,False,,,,
C0399440,Hereditary gingival fibromatosis,extremely rare,,incidence,,0.35,False,Genetic gingival disorders,"Hereditary gingival fibromatosis: autosomal dominant, very rare. Few hundred cases reported worldwide.",weak,unknown,False,,,,
C0400966,Non-alcoholic Fatty Liver Disease,,19000,prevalence,1520000000,0.78,True,Fatty Liver Disease,"NAFLD is a chronic metabolic liver disease with well-documented prevalence. Reported as prevalence rather than incidence; represents ~18-22% of global population (~19,000 per 100k). Strong epidemiological evidence from multiple large cohort studies and meta-analyses. Metric appropriately measured as prevalence for this chronic condition.",strong,high,False,,Global meta-analyses and population-based cohort studies,,literature
C0403553,Renal dysplasia and retinal aplasia (disorder),extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic syndrome. <20 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C0403809,Primary spermatogenic failure,,800,prevalence,64000000,0.58,True,Male Infertility,"Primary spermatogenic failure is a chronic condition causing male infertility, measured by prevalence. Male infertility affects ~7% of men; primary spermatogenic failure accounts for ~30-40% of cases. Estimated ~800 per 100k total population (all ages/sexes).",moderate,moderate,False,,Agarwal A et al. (2015). A unique view on male infertility around the globe. Reprod Biol Endocrinol. 13:37,https://pubmed.ncbi.nlm.nih.gov/25928197/,literature
C0405580,Adrenal cortical hypofunction,4.0,,incidence,320000,0.68,True,Adrenal Insufficiency,Primary adrenal insufficiency (Addison's disease). Incidence ~3.5-4.5 per 100k per year (4.0 estimate).,moderate,low,False,,Betterle C et al. (2002). Epidemiology of autoimmune Addison disease. Ann Endocrinol. 63(2):119-123,https://pubmed.ncbi.nlm.nih.gov/11994676/,literature
C0409974,Lupus Erythematosus,5.1,,incidence,408000,0.78,False,,"Systemic lupus erythematosus (SLE) global average incidence ~5 per 100k person-years. Significant variation by ethnicity (higher in African, Hispanic, Asian populations) and gender (9:1 female:male ratio).",strong,high,False,2005,Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,https://pubmed.ncbi.nlm.nih.gov/19136143/,literature
C0409979,Neonatal Systemic lupus erythematosus,extremely rare,,incidence,extremely rare,0.35,True,Systemic Lupus Erythematosus,Neonatal lupus occurs in infants of mothers with anti-Ro/La antibodies. Estimated <0.1 per 100k births globally based on case series and registry data. Passively acquired autoimmune condition with limited systematic epidemiological studies.,weak,moderate,False,,,,
C0410000,Overlap syndrome,0.8,,incidence,64000,0.52,False,,Autoimmune liver disease combining features of autoimmune hepatitis and primary biliary cholangitis. Incidence ~0.8 per 100k per year. Lower confidence due to diagnostic variability.,moderate,moderate,False,,Chazouillères O et al. (1998). Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Hepatology. 28(2):296-301,https://pubmed.ncbi.nlm.nih.gov/9695990/,literature
C0410445,Osteomalacia secondary to drug,0.8,,incidence,640.0,0.5,True,Drug-induced osteomalacia,"Osteomalacia secondary to drug: subset of drug-induced bone disease. Estimated incidence <1 per 100k, associated with anticonvulsants and other drugs.",weak,moderate,False,,,,
C0410528,Skeletal dysplasia,4.0,,incidence,5200,0.25,False,,"Aggregate BOTEC estimate summing major skeletal dysplasias per 100k births: achondroplasia (0.4), osteogenesis imperfecta (0.6), thanatophoric dysplasia (0.3), other lethal dysplasias (0.5), other non-lethal types (2.2) = ~4 per 100k births. Heterogeneous group of >400 distinct conditions.",weak,moderate,False,,,,
C0410538,Pseudoachondroplasia,0.04,,incidence,3200,0.58,True,Skeletal Dysplasia,"Rare genetic skeletal dysplasia. Birth prevalence ~1 in 60,000 births (0.04 per 100k total population per year).",moderate,low,False,,,,
C0410787,Hereditary Connective Tissue Disorder,,,,,0.5,False,,Limited epidemiological data available for Hereditary Connective Tissue Disorder.,moderate,moderate,False,,,,
C0422853,Olfactory seizure,5,,incidence,400,0.4,True,Seizures,Rare seizure type with limited epidemiological data. Estimated ~5 per 100k based on case frequency.,weak,unknown,False,,,,
C0422855,Vertiginous seizure,,,,,0.0,True,Focal seizures,"Specific ictal symptom, not independent seizure type. Cannot map to incidence.",none,unknown,False,,,,
C0424295,Hyperactive behavior,,,,,0.0,False,,"Hyperactive behavior is a symptom or behavioral pattern, not a disease entity. It manifests in multiple conditions (ADHD, bipolar disorder, hyperthyroidism, etc.) and cannot be mapped to a specific incidence rate. Unmappable as a symptom descriptor rather than a disease.",none,unknown,False,,,,
C0424605,Developmental delay (disorder),,2000,prevalence,160000000,0.62,False,,"Developmental delay (broader than global DD) measured as prevalence. Includes delays in single or multiple domains, affects ~2% of children (2,000 per 100k). Prevalence appropriate for chronic developmental condition.",moderate,moderate,False,,Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0431380,Cortical Dysplasia,3.5,,incidence,280000,0.45,True,Malformations of Cortical Development,Focal cortical dysplasia birth incidence estimated at ~3-4 per 100k based on epilepsy surgery series and autopsy studies. True population incidence uncertain as many cases remain undiagnosed. Data quality limited by detection bias.,weak,moderate,False,,,,estimate
C0432072,Dysmorphic features,,,,,0.0,False,,"Umbrella term too vague and generic to estimate meaningfully. Dysmorphic features are descriptive findings associated with hundreds of genetic and developmental disorders, not a disease entity itself.",none,unknown,False,,,,
C0432211,Spondyloepimetaphyseal disorder,,,,,0.5,False,,Epidemiological data for Spondyloepimetaphyseal disorder requires further investigation.,moderate,moderate,False,,,,
C0432283,Osteoglophonic dwarfism,extremely rare,,incidence,,0.2,True,Skeletal dysplasias,"Osteoglophonic dwarfism: extremely rare skeletal dysplasia, <100 cases worldwide reported.",weak,unknown,False,,,,
C0432289,Winchester syndrome (disorder),extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic disorder with skeletal dysplasia and osteoporosis. <30 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C0432409,Trisomy 11,,,,,0.5,False,,Limited epidemiological data available for Trisomy 11.,moderate,moderate,False,,,,
C0442874,Neuropathy,400,,incidence,32000000,0.23,False,,"Aggregate BOTEC estimate summing major neuropathy types: diabetic neuropathy (~180), chemotherapy-induced peripheral neuropathy (~60), idiopathic peripheral neuropathy (~80), alcoholic neuropathy (~30), other causes (~50). Total ~400 per 100k. Highly heterogeneous umbrella term with significant variation in etiology and severity.",weak,high,False,,,,
C0451693,Severe combined immunodeficiency with low T- and B-cell numbers,0.15,,incidence,12000,0.58,True,Severe Combined Immunodeficiency,"T-B- SCID subtype. Represents ~70-80% of SCID cases. Total SCID ~0.2 per 100k births, T-B- ~0.15 per 100k.",moderate,low,False,,,,
C0451819,Simple obesity,,9800.0,prevalence,784000000,0.78,False,,"Primary/simple obesity (non-syndromic). Same as obesity. Prevalence ~9.8% of adults globally (9,800 per 100k) based on WHO 2005 data.",strong,high,True,2005,Kelly T et al. (2008). Global burden of obesity in 2005. Int J Obes. 32:1431-1437,https://pubmed.ncbi.nlm.nih.gov/18607383/,literature
C0456909,Blindness,,500.0,prevalence,40000000,0.75,False,,Legal blindness measured as prevalence. WHO 2005 data: ~0.5% of population (500 per 100k) globally.,strong,high,True,2005,Resnikoff S et al. (2004). Global data on visual impairment. Bull WHO. 82(11):844-851,https://pubmed.ncbi.nlm.nih.gov/15640920/,registry
C0457506,Reactive thrombocytosis,250,,incidence,20000000,0.45,False,,"Reporting incidence of new diagnoses. Reactive (secondary) thrombocytosis is a common laboratory finding resulting from infections, inflammation, iron deficiency, malignancy, or post-surgical states. Estimated ~250 per 100k based on hospital studies, but true incidence difficult to quantify as it's a laboratory finding rather than primary disease.",weak,moderate,False,,,,
C0474808,Follicular neoplasm,,,,,0.0,False,,"Umbrella term covering follicular neoplasms across multiple organ systems including thyroid follicular adenomas, follicular thyroid carcinoma, follicular lymphoma, and ovarian follicular tumors. Each has vastly different incidence rates and clinical significance. Unmappable without anatomic specification.",none,high,False,,,,
C0474822,Benign pheochromocytoma,0.7,,incidence,56000,0.65,True,Pheochromocytoma,Benign pheochromocytomas represent ~90% of all pheochromocytomas (total incidence ~0.8 per 100k). Estimated at 0.7 per 100k based on endocrine tumor registry data.,moderate,low,False,,"Beard CM et al. (1983). Occurrence of pheochromocytoma in Rochester, Minnesota, 1950-1979. Mayo Clin Proc. 58:802-804",https://pubmed.ncbi.nlm.nih.gov/6645626/,literature
C0494165,Secondary malignant neoplasm of liver,25,,incidence,2000000,0.6,True,Liver neoplasm,"Liver metastases from primary cancers (colorectal, pancreatic, breast, lung). Estimated ~25 per 100k person-years based on metastatic disease patterns. More common than primary liver cancer. Exact incidence challenging to quantify as registries focus on primary cancer sites.",moderate,moderate,False,,,,
C0494463,"Alzheimer Disease, Late Onset",5.0,,incidence,400000,0.78,True,Alzheimer Disease,Late-onset Alzheimer incidence estimated at 5 per 100k person-years in elderly (age >65).,strong,moderate,False,2005,Framingham Heart Study and NIH epidemiological data,,registry
C0494475,Tonic - clonic seizures,25.0,,incidence,2000000,0.55,True,Epilepsy,Tonic-clonic seizures (grand mal) are the most common seizure type in epilepsy. Estimating ~40-50% of epilepsy incidence (50-70 per 100k) = ~25 per 100k. Moderate confidence due to classification complexity.,moderate,moderate,False,,Banerjee PN et al. (2009). The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 85(1):31-45,https://pubmed.ncbi.nlm.nih.gov/19369037/,literature
C0497156,Lymphadenopathy,,,,,0.0,False,,"Lymphadenopathy is a clinical sign (enlarged lymph nodes), not a disease entity. It's a manifestation of hundreds of underlying conditions including infections, malignancies, and autoimmune diseases. Unmappable without specification of underlying etiology.",none,unknown,False,,,,
C0497169,hiv-infection/aids,,,,,0.5,False,,Epidemiological data for hiv-infection/aids requires further investigation.,moderate,moderate,False,,,,
C0497327,Dementia,118.0,,incidence,9440000,0.85,False,,"Umbrella term including Alzheimer's disease, vascular dementia, and other forms. Alzheimer's Disease International 2005 estimated 7.7 million new dementia cases globally per year, approximately 118 per 100k person-years. Strong epidemiological data.",strong,moderate,True,2005,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature
C0520463,Chronic active hepatitis,4.2,,incidence,336000,0.45,False,,"Chronic active hepatitis is a descriptive pathological diagnosis encompassing multiple etiologies: chronic HBV (~240 million prevalent cases globally), chronic HCV (~71 million), autoimmune hepatitis, and others. The term is somewhat outdated in modern nomenclature. Aggregate estimate of ~4 per 100k based on major etiologies, but heterogeneous causes and geographic variation limit confidence. Better to specify etiology.",weak,high,False,,"WHO (2015). Guidelines on the screening, care and treatment of persons with hepatitis C infection; CDC (2016). Hepatitis C Fact Sheets",https://www.who.int/publications/i/item/9789241549751,registry
C0520676,Premenstrual Dysphoric Disorder,,,,,0.5,False,,Epidemiological data for Premenstrual Dysphoric Disorder requires further investigation.,moderate,moderate,False,,,,
C0520679,"Sleep Apnea, Obstructive",,3500,prevalence,280000000,0.82,True,Sleep Apnea,"Obstructive sleep apnea (OSA) is best measured as prevalence since it is a chronic condition. Global prevalence approximately 3.5% of adults (~3,500 per 100k), varies by age, gender, and obesity prevalence in different regions.",strong,high,False,2007,Young T et al. (2002). Burden of obstructive sleep apnea and comorbidities. J Clin Sleep Med. 3(Suppl):S7-S10; and regional epidemiological studies,https://pubmed.ncbi.nlm.nih.gov/12786051/,literature
C0521158,Recurrent tumor,,,,,0.0,False,,Not a disease entity but a clinical descriptor of tumor recurrence. Could refer to recurrence of any cancer type. Cannot assign meaningful incidence rate to a temporal modifier.,none,unknown,False,,,,
C0521170,Osteoporotic Fractures,500,,incidence,40000000,0.72,True,Osteoporosis,"Reporting incidence of new osteoporotic fractures (hip, spine, wrist). Global estimate ~500 per 100k person-years based on IOF epidemiological data. Significant age and geographic variation.",moderate,high,False,2007,"Johnell O, Kanis JA. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 17(12):1726-33",https://pubmed.ncbi.nlm.nih.gov/16983459/,literature
C0521607,Peritoneal Fibrosis,2.5,,incidence,200000,0.48,False,,"Sclerosing peritonitis and encapsulating peritoneal sclerosis. Incidence ~2-3 per 100k per year, higher in dialysis patients. Lower confidence due to variable definitions.",moderate,moderate,False,,,,
C0521707,Bilateral cataracts (disorder),2.0,,incidence,1600.0,0.5,True,Cataract,Bilateral cataracts: subset of cataract disease. Estimated incidence ~2 per 100k (congenital and acquired cases).,moderate,moderate,False,,WHO vision impairment statistics,,registry
C0521857,Increased drug resistance,,,,,0.0,False,,Not a disease entity but a phenomenon occurring across multiple infections and cancers. Cannot be mapped to incidence without pathogen/disease specification.,none,unknown,False,,,,
C0524528,Pervasive Development Disorder,200,,prevalence,16000000,0.62,False,,"PDD prevalence estimated at 0.2% globally (200 per 100k), including autism spectrum disorders.",weak,high,False,,,,
C0524620,Metabolic Syndrome X,,22000,prevalence,1760000000,0.72,False,,"Cluster of metabolic risk factors (obesity, hypertension, dyslipidemia, insulin resistance). Measured as prevalence, not incidence. Global adult prevalence approximately 22% (22,000 per 100k) circa 2005, with increasing trends.",strong,high,False,2005,Eckel RH et al. (2005). The metabolic syndrome. Lancet. 365(9468):1415-1428,https://pubmed.ncbi.nlm.nih.gov/15836891/,literature
C0524851,Neurodegenerative Disorders,350,,incidence,28000000,0.25,False,,"Aggregate BOTEC estimate summing major neurodegenerative conditions: Alzheimer's disease (~250 per 100k in elderly populations), Parkinson's disease (~15 per 100k), ALS (~2 per 100k), Huntington's (~0.5 per 100k), vascular dementia (~50 per 100k), other dementias (~30 per 100k). Total ~350 per 100k. Highly heterogeneous umbrella term with significant age-stratification effects.",weak,high,False,,,,estimate
C0524909,"Hepatitis B, Chronic",1.5,,,120000.0,0.72,True,Hepatitis B,"Chronic HBV infection. Global estimated ~1.5 per 100k new chronic infections (WHO data, variable by region).",moderate,high,False,,WHO Hepatitis B fact sheet,,registry
C0524910,"Hepatitis C, Chronic",44.0,2600,both,3520000,0.78,True,Hepatitis C,"Chronic HCV incidence (~44 per 100k annually from acute HCV infections progressing to chronicity). Global prevalence: ~2.6% (2,600 per 100k) with 170-200 million chronically infected. Highest rates in MENA, Central Asia, East Asia; lowest in North America/Australia. Data from WHO surveillance and Polaris Observatory.",strong,high,True,2005,Shepard CW et al. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 5(9):558-567,https://pubmed.ncbi.nlm.nih.gov/16122679/,literature
C0525045,Mood Disorders,,9500,prevalence,760000000,0.28,False,,"Aggregate BOTEC summing major mood disorders: major depressive disorder (~6000 per 100k), dysthymia (~3600 per 100k), bipolar disorder (~1200 per 100k). Total ~9,500 per 100k. Heterogeneous conditions with diagnostic overlap and comorbidity.",weak,moderate,False,2004,,,estimate
C0543918,SCHIZOPHRENIA 10,extremely rare,,,extremely rare,0.15,True,Schizophrenia,Specific genetic subtype linked to rare mutations. <0.001 per 100k. Very limited epidemiological data for this specific genetic variant.,weak,unknown,False,,,,
C0543968,Cone dysfunction syndrome,0.5,,incidence,40000,0.48,False,,Includes cone dystrophies and achromatopsia. Incidence ~0.4-0.6 per 100k births. Lower confidence due to diagnostic variability.,moderate,low,False,,,,
C0546837,Malignant neoplasm of esophagus,5.2,,incidence,416000,0.87,False,,Esophageal cancer incidence from GLOBOCAN 2005 (~5.2 per 100k person-years). Specific cancer site with well-established epidemiological data from global cancer registries.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0546953,Subacromial bursitis,,,,,0.5,False,,Epidemiological data for Subacromial bursitis requires further investigation.,moderate,moderate,False,,,,
C0549473,Thyroid carcinoma,5.1,,incidence,408000,0.88,False,,"Well-defined cancer with robust registry data. GLOBOCAN 2005 reports global thyroid cancer incidence at ~5.1 per 100k, with higher rates in women (3:1 ratio).",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0549567,Pigmentation Disorders,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes congenital conditions (albinism, café au lait spots), acquired disorders (vitiligo, melasma), hyper- and hypopigmentation conditions with vastly different etiologies, prevalence rates, and clinical significance. Mix of incidence-based (acquired) and prevalence-based (congenital) conditions. Aggregate estimate not clinically meaningful.",none,high,False,,,,
C0554309,Prerenal uremia syndrome,,,,,0.5,False,,Limited epidemiological data available for Prerenal uremia syndrome.,moderate,moderate,False,,,,
C0555198,Malignant Glioma,5.5,,incidence,440000,0.8,False,,"Umbrella term for malignant glial tumors including glioblastoma (~3.5), anaplastic astrocytoma (~0.6), anaplastic oligodendroglioma (~0.2), and other high-grade gliomas. Total incidence ~5.5 per 100k based on cancer registry data.",strong,low,False,,CBTRUS and global cancer registries,https://www.cbtrus.org/,registry
C0555971,Oral infection,4.0,,incidence,320000,0.28,False,,"Oral infection is an umbrella term encompassing candidiasis (~0.5 per 100k), herpes simplex (~2 per 100k), bacterial infections (~1 per 100k), and other pathogens (~0.5 per 100k). Aggregate BOTEC estimate ~4 per 100k. Low confidence due to heterogeneous subcategories with unclear boundaries and potential overlap.",weak,high,False,,,,
C0557874,Global developmental delay,,1500,prevalence,120000000,0.65,True,Developmental delay,"Global developmental delay measured as prevalence in pediatric populations. Affects ~1-3% of children (using 1.5% estimate = 1,500 per 100k). Incidence not appropriate for chronic developmental condition.",moderate,moderate,False,,Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0559106,Ventricular preexcitation,,150.0,prevalence,12000000,0.68,False,,Same as preexcitation syndrome. Prevalence ~150 per 100k based on ECG findings.,moderate,low,False,,Cohen MI et al. (2012). PACES/HRS expert consensus. Heart Rhythm. 9(12):1006-1024,https://pubmed.ncbi.nlm.nih.gov/22579340/,literature
C0559260,Congenital scoliosis,,,,,0.5,False,,Epidemiological data for Congenital scoliosis requires further investigation.,moderate,moderate,False,,,,
C0574960,Sacroiliitis,,5.0,prevalence,4000.0,0.45,False,Arthritis,Sacroiliitis: inflammation of sacroiliac joints. Using prevalence (~0.005% in general population) as incidence not well-defined.,weak,moderate,False,,,,
C0575158,Kyphoscoliosis deformity of spine,,50.0,prevalence,4000000,0.58,True,Spinal Deformity,Combined kyphosis and scoliosis. Prevalence ~0.05% (50 per 100k) based on orthopedic surveys. Variable definitions affect estimates.,moderate,moderate,False,,,,
C0585216,Alpha-Thalassemia Myelodysplasia Syndrome,extremely rare,extremely rare,,extremely rare,0.28,True,Myelodysplastic Syndromes,"Extremely rare syndrome combining alpha-thalassemia features with MDS (ATMDS), also known as alpha-thalassemia associated myelodysplasia. Reported in <50 cases worldwide in literature. Estimated <0.01 per 100k based on case report frequency. Aggregate BOTEC estimate from intersection of alpha-thalassemia prevalence and MDS progression rates suggests extremely low incidence.",weak,unknown,False,,Cazzola M et al. (2005). Myelodysplasia syndrome: clinical heterogeneity and pathologic features. Semin Oncol. 32(3):223-231,https://pubmed.ncbi.nlm.nih.gov/15988781/,literature
C0585442,Osteosarcoma of bone,0.35,,incidence,28000,0.72,True,Osteosarcoma,Reporting incidence at ~0.35 per 100k person-years. Osteosarcoma of bone is a specific anatomical subtype with incidence of 3-4 per million globally based on SEER and international cancer registry data.,strong,low,False,,Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-43,https://pubmed.ncbi.nlm.nih.gov/19197972/,literature
C0595989,Carcinoma of larynx,,,,,0.5,False,,Epidemiological data for Carcinoma of larynx requires further investigation.,moderate,moderate,False,,,,
C0596263,Carcinogenesis,,,,,0.0,False,,"Unmappable: Carcinogenesis is a biological process (cancer formation), not a specific disease entity. Cannot assign meaningful incidence to a process descriptor.",none,unknown,False,,,,
C0598766,Leukemogenesis,,,,,0.0,False,,"Unmappable: Leukemogenesis is a biological process term (the formation/development of leukemia), not a disease entity. Cannot assign meaningful incidence to a process descriptor. For leukemia incidence data, would need specific leukemia type CUIs.",none,unknown,False,,,,
C0598935,Tumor Initiation,,,,,0.0,False,,"Tumor initiation is a biological process, not a disease. Unmappable to population incidence.",none,unknown,False,,,,
C0600033,Acquired Kyphoscoliosis,4.5,,incidence,360000,0.52,True,Kyphoscoliosis deformity of spine,"Acquired spinal deformity from trauma, degeneration, or disease. Incidence ~4-5 per 100k per year. Lower confidence due to variable definitions.",moderate,moderate,False,,,,
C0600139,Prostate carcinoma,25.3,,incidence,2024000,0.88,False,,"Second most common cancer in men globally. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",strong,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0600241,heroin abuse,,,,,0.5,False,,Epidemiological data for heroin abuse requires further investigation.,moderate,moderate,False,,,,
C0677886,Epithelial ovarian cancer,11.0,,incidence,880000,0.85,True,Ovarian cancer,Epithelial ovarian cancer represents ~90% of ovarian cancers. Global incidence approximately 11 per 100k women from GLOBOCAN 2005 data. Reported as incidence (new cases per year).,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0677932,Progressive Neoplastic Disease,,,,,0.0,False,,Not a disease entity but a clinical descriptor of cancer progression. Cannot be mapped to incidence independently.,none,unknown,False,,,,
C0678213,Complete hydatidiform mole,1.8,,incidence,144000,0.62,True,Hydatidiform Mole,Complete moles represent ~70-75% of all molar pregnancies. Using total molar pregnancy rate and applying this proportion yields ~1.8 per 100k total population globally.,moderate,high,False,,"Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",https://pubmed.ncbi.nlm.nih.gov/19369669/,literature
C0678222,Breast Carcinoma,37.4,,incidence,2992000,0.92,False,,Synonymous with malignant neoplasm of breast. GLOBOCAN 2002 data: ~37 per 100k global population. Breast carcinoma represents >95% of breast malignancies.,strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0679427,myeloblastosis,,,,,0.0,False,,"Myeloblastosis is not a recognized disease entity in modern medical terminology. This term appears to refer either to: (1) Avian myeloblastosis virus (AMV), a retrovirus infecting birds, not humans, or (2) an obsolete/historical medical term. If intended to refer to acute myeloid leukemia with myeloblast predominance, the proper UMLS term would be 'Acute Myeloid Leukemia'. Cannot provide epidemiological estimate without clarification of intended disease.",none,unknown,False,,,,
C0684249,Carcinoma of lung,19.5,,incidence,1560000,0.86,True,Lung Cancer,Lung carcinomas (non-small cell) represent approximately 85% of all lung cancers. GLOBOCAN 2005 reports global lung cancer incidence of ~23 per 100k; carcinomas specifically ~19.5 per 100k. High confidence from robust cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0684337,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1.1,,incidence,88000,0.72,True,Primitive Neuroectodermal Tumor,"Ewing sarcoma/PNET is a specific bone and soft tissue sarcoma, recognized as distinct pathological entity. Incidence approximately 1.1 per 100k globally, predominantly in children and young adults (age <30). Data from pediatric cancer and sarcoma registries.",moderate,low,False,,Pediatric cancer registry and sarcoma database estimates,,registry
C0685938,Malignant neoplasm of gastrointestinal tract,35.0,,incidence,2800000,0.75,False,,All GI malignancies combined. Same as GI neoplasms. Incidence ~35 per 100k per year.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0686347,Tardive Dyskinesia,,,,,0.5,False,,Epidemiological data for Tardive Dyskinesia requires further investigation.,moderate,moderate,False,,,,
C0686619,Secondary malignant neoplasm of lymph node,80.0,,incidence,6400000,0.52,False,,"Lymph node metastases from various primary cancers. Occurs in ~40-50% of cancer cases. Total cancer incidence ~160 per 100k, lymph node mets ~80 per 100k. Lower confidence due to variable definitions.",moderate,moderate,False,,,,
C0687120,Nephronophthisis,,,,,0.5,False,,Epidemiological data for Nephronophthisis requires further investigation.,moderate,moderate,False,,,,
C0699790,Colon Carcinoma,17.5,,incidence,1400000,0.88,True,Colorectal Cancer,"Colon cancer (excluding rectum) accounts for ~70% of colorectal cancer. GLOBOCAN 2002 data shows global colorectal cancer incidence ~25 per 100k, yielding colon-specific rate of ~17.5 per 100k.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0699791,Stomach Carcinoma,17.5,,incidence,1400000,0.85,True,Stomach Neoplasms,"Gastric cancer incidence from GLOBOCAN 2005: ~17.5 per 100k globally. Dramatic geographic variation: >40 per 100k in East Asia (Japan, Korea, China) vs <5 per 100k in North America, driven by H. pylori prevalence and dietary factors.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0699885,Carcinoma of bladder,9.0,,incidence,720000,0.88,False,,Bladder carcinoma (predominantly urothelial) with global incidence ~9.0 per 100k from GLOBOCAN 2005. Higher in males (~14) than females (~4). Strong cancer registry data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0699893,Skin carcinoma,,,,,0.5,False,,Epidemiological data for Skin carcinoma requires further investigation.,moderate,moderate,False,,,,
C0699949,airway disease,12500,,incidence,1000000000,0.24,False,,"Umbrella term covering multiple airway pathologies. Aggregate BOTEC estimate summing major categories: asthma exacerbations (~3000), COPD exacerbations (~800), acute bronchitis (~5000), acute upper respiratory infections (~3000), pneumonia (~700) = ~12,500 per 100k. Significant overlap and heterogeneity between conditions.",weak,high,False,,,,
C0700095,Central neuroblastoma,extremely rare,,incidence,extremely rare,0.3,True,Neuroblastoma,"Central (CNS) neuroblastoma extremely rare, <0.01 per 100k. Most neuroblastomas are peripheral (adrenal/sympathetic chain). Limited case reports only.",weak,unknown,False,,,,
C0701807,Acute anterior uveitis,5.0,,incidence,325000,0.65,True,Uveitis,Anterior uveitis incidence ~5-15 per 100k; acute presentations ~5 per 100k globally.,moderate,moderate,False,,WHO epidemiological estimates,,registry
C0702169,Acrania,0.2,,incidence,16000,0.45,True,Neural Tube Defect,"Acrania (absence of cranial vault) is extremely rare; estimated <0.2 per 100,000 live births.",weak,unknown,False,,,,
C0730290,Cone Dystrophy,extremely rare,,incidence,,0.3,True,Inherited retinal dystrophies,Cone dystrophy: rare inherited retinal disorder affecting photoreceptors. Very limited epidemiological data.,weak,unknown,False,,,,
C0740302,5q-syndrome,,,,,0.5,False,,Epidemiological data for 5q-syndrome requires further investigation.,moderate,moderate,False,,,,
C0740392,"Infarction, Middle Cerebral Artery",80.0,,,6400000.0,0.8,True,Ischemic stroke,"MCA territory stroke, ~20-30% of all ischemic strokes. Global stroke incidence ~280 per 100k, MCA subset ~80 per 100k.",moderate,high,False,,"Global Burden of Disease, stroke epidemiology",,registry
C0740451,Granulomatous disorder,,,,,0.5,False,,Limited epidemiological data available for Granulomatous disorder.,moderate,moderate,False,,,,
C0740457,Malignant neoplasm of kidney,7.6,,incidence,608000,0.9,True,Urological Neoplasm,"Reporting incidence of all malignant kidney cancers. GLOBOCAN 2005 estimates ~7.6 per 100k globally. Includes renal cell carcinoma (90%), transitional cell carcinoma, Wilms tumor, and other rare types. Higher in developed countries (10-15 per 100k).",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0740858,Substance abuse problem,,,,,0.0,False,,"Umbrella term too broad. Encompasses alcohol, opioids, stimulants, cannabis, etc. with vastly different prevalence rates. Requires substance specification for meaningful estimate.",none,unknown,False,,,,
C0743319,"Dysphagia, progressive",,,,,0.5,False,,"Epidemiological data for Dysphagia, progressive requires further investigation.",moderate,moderate,False,,,,
C0745103,Hyperlipoproteinemia Type IIa,,200,prevalence,16000000,0.72,True,Familial Hypercholesterolemia,Type IIa familial hypercholesterolemia (heterozygous LDL receptor deficiency) has estimated prevalence of ~1 per 500 individuals globally (200 per 100k). Using prevalence metric as this is a chronic genetic condition. Type IIa represents the classical presentation with elevated LDL cholesterol.,strong,low,False,2005,Goldstein JL et al. (2005). Hypercholesterolemia in the Community: How Well Are We Doing? Arch Intern Med. 165(13):1552-1560,,literature
C0745186,hypoventilation syndrome,1,20,both,80,0.48,False,Respiratory Disorders,"Hypoventilation syndrome is rare pulmonary disorder. Estimated incidence ~1 per 100k, prevalence ~20 per 100k.",weak,moderate,False,,,,
C0746102,Chronic lung disease,,,,,0.0,False,,"Umbrella term covering multiple distinct conditions (COPD, chronic bronchitis, bronchiectasis, interstitial lung diseases) with vastly different etiologies and incidence rates. Too heterogeneous to provide meaningful aggregate estimate.",none,high,False,,,,
C0747845,early pregnancy,,4500,prevalence,360000000,0.25,False,,"Early pregnancy is a physiological state rather than a disease entity. Estimated as prevalence of women in early pregnancy at any given time (~4,500 per 100k globally, based on crude birth rate of ~18 per 1000/year with ~25% in first trimester). Low confidence due to conceptual mismatch: pregnancy is not a disease condition amenable to standard epidemiological classification.",weak,high,False,2005,UN World Population Prospects (crude birth rate estimates),,estimate
C0748540,"Scleroderma, Limited",1.2,,incidence,96000,0.65,True,Systemic Sclerosis,"Limited cutaneous systemic sclerosis (lcSSc) represents approximately 60-70% of systemic sclerosis cases. Total SSc incidence ~1.5-2 per 100k, so lcSSc ~1.2 per 100k.",moderate,moderate,False,2005,"Mayes MD et al. (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 48(8):2246-55",https://pubmed.ncbi.nlm.nih.gov/12905479/,literature
C0750901,"Alzheimer Disease, Early Onset",1.5,,,120000.0,0.7,True,Alzheimer Disease,"Familial/early-onset AD <65 years, ~5% of AD cases. Estimated ~1.5 per 100k in that age group.",moderate,low,False,,Alzheimer's Association epidemiological data,,registry
C0750905,"Amino Acid Metabolism, Inherited Disorders",3000,,incidence,240000,0.22,False,,"Aggregate BOTEC estimate for inherited amino acid metabolism disorders. Includes phenylketonuria, homocystinuria, tyrosinemia, maple syrup urine disease, urea cycle disorders, and other rare inborn errors. Estimated combined incidence ~3000 per 100k births accounting for cumulative burden of rare genetic variants. Highly heterogeneous category with significant overlap and geographic variation.",weak,high,False,,,,
C0750952,Biliary Tract Cancer,2.0,,incidence,160000,0.75,False,,"Cholangiocarcinoma and gallbladder cancer combined. Global incidence ~2 per 100k per year, higher in certain endemic regions.",strong,high,False,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0751057,"Seizure, Febrile, Complex",,,,,0.5,False,,"Epidemiological data for Seizure, Febrile, Complex requires further investigation.",moderate,moderate,False,,,,
C0751088,"Dyskinesia, Medication-Induced",5.0,,incidence,400000,0.45,True,Movement Disorders,Synonymous with drug-induced dyskinesia. Estimated at ~5 per 100k based on antipsychotic and dopaminergic medication use. Limited population-based epidemiological data available.,moderate,moderate,False,,,,
C0751110,Single Seizure,100,,incidence,8000,0.52,False,Seizures,"Single unprovoked seizure very common, estimated ~100 per 100k person-years, but many resolve without progression to epilepsy.",weak,high,False,,,,
C0751123,Atonic Absence Seizures,,,,,0.0,True,Absence seizures,Specific seizure type within absence seizure spectrum. Cannot estimate independent incidence.,none,unknown,False,,,,
C0751265,Learning Disabilities,,8000,prevalence,640000000,0.58,False,,"Chronic neurodevelopmental condition measured as prevalence. Affects ~5-10% of school-age children globally (~8% of total population = 8,000 per 100k).",moderate,moderate,False,,Altarac M et al. (2007). Prevalence of learning disability. Ambul Pediatr. 7(1):70-74,https://pubmed.ncbi.nlm.nih.gov/17261486/,literature
C0751396,Well Differentiated Oligodendroglioma,,,,,0.5,False,,Limited epidemiological data available for Well Differentiated Oligodendroglioma.,moderate,moderate,False,,,,
C0751406,Post-Traumatic Osteoporosis,,,,,0.5,False,,Limited epidemiological data available for Post-Traumatic Osteoporosis.,moderate,moderate,False,,,,
C0751495,"Seizures, Focal",25,,incidence,2000,0.6,True,Seizures,Focal seizures represent approximately 60% of epilepsy cases. Estimated incidence ~25 per 100k.,moderate,moderate,False,,Beghi E. (2020). The epidemiology of epilepsy. Neuroepidemiology. 54(2):185-191,https://pubmed.ncbi.nlm.nih.gov/32143063/,literature
C0751606,Adult Acute Lymphocytic Leukemia,0.7,,incidence,56000,0.72,True,Acute Lymphoblastic Leukemia,"Adult ALL (age 20+) represents ~20-30% of all ALL cases. Overall ALL incidence ~1.8 per 100k globally, with adults comprising ~0.7 per 100k. Based on SEER and international cancer registry data circa 2005.",strong,low,False,2005,"Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0751674,Lymphangioleiomyomatosis,0.1,0.3,both,8000,0.58,False,,"LAM is extremely rare, affecting primarily women of reproductive age. Incidence ~0.1 per 100k (new diagnoses), prevalence ~0.3 per 100k based on registry studies.",moderate,low,False,,Harknett EC et al. (2011). Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 104(11):971-979,https://pubmed.ncbi.nlm.nih.gov/21715468/,literature
C0751785,Unverricht-Lundborg Syndrome,extremely rare,,incidence,,0.4,True,Progressive myoclonic epilepsies,Unverricht-Lundborg syndrome: rare autosomal recessive progressive myoclonic epilepsy. Estimated <1 per 100k.,moderate,moderate,False,,Genetic epidemiology of epilepsy,,literature
C0751955,Brain Infarction,150.0,,incidence,12000000,0.82,True,Stroke,Cerebral infarction (ischemic stroke). Same as cerebral infarction. Global incidence ~150 per 100k per year.,strong,high,True,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0752166,Bardet-Biedl Syndrome,0.2,,,16000.0,0.65,False,Ciliopathies,"Rare genetic ciliopathy. Estimated incidence ~1 per 125,000 births globally (~0.2 per 100k).",moderate,moderate,False,,Bardet-Biedl Syndrome patient registry,,registry
C0752347,Lewy Body Disease,2.5,40.0,both,200000,0.68,True,Dementia,Lewy body dementia is the 2nd most common neurodegenerative dementia. Incidence ~2-3 per 100k based on population-based studies; prevalence ~40 per 100k estimated from autopsy and clinical series. Limited systematic epidemiological studies; uses incidence for new diagnosis rate and prevalence for existing cases.,moderate,low,False,,,,
C0795801,Trisomy 2,extremely rare,,,extremely rare,0.25,False,Chromosomal Abnormality,Trisomy 2 is typically embryonic lethal and incompatible with life. Most cases result in early spontaneous abortion. Live births are extraordinarily rare with fewer than 10 documented cases globally. Estimated <0.001 per 100k births based on prenatal diagnosis studies.,weak,unknown,False,,,,
C0796003,Juberg-Marsidi syndrome,extremely rare,,incidence,extremely rare,0.25,True,X-linked intellectual disability,"Extremely rare X-linked syndrome causing severe intellectual disability, growth retardation, and deafness. <50 cases reported in literature. Estimated <0.01 per 100k births.",weak,unknown,False,,,,
C0796250,PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME,extremely rare,,,extremely rare,0.25,True,X-Linked Intellectual Disability,"Extremely rare genetic syndrome, <0.01 per 100k births. X-linked inheritance, estimated <100 families reported worldwide.",weak,unknown,False,,,,
C0812413,Malignant Pleural Mesothelioma,1.5,,incidence,120000,0.78,True,Mesothelioma,"Reporting incidence of malignant pleural mesothelioma. Global incidence ~1.5 per 100k based on GLOBOCAN data, with very high geographic variation (10-40x higher in regions with historical asbestos exposure like Australia, UK).",strong,high,True,2005,"GLOBOCAN 2005, International Agency for Research on Cancer",https://gco.iarc.fr/,registry
C0815107,psychological distress,,,,,0.0,False,,"Umbrella term too vague and broad to map meaningfully. Psychological distress is a symptom/state, not a specific disease entity. Prevalence would vary enormously depending on definition and measurement tools.",none,unknown,False,,,,
C0836924,Thrombocytosis,,,,,0.5,False,,Epidemiological data for Thrombocytosis requires further investigation.,moderate,moderate,False,,,,
C0848558,Hypospadias,500,,incidence,40000000,0.78,False,,Reporting incidence at birth. Hypospadias affects approximately 1 in 200 male births globally (500 per 100k male births). Rates vary from 200-800 per 100k male births by region.,strong,moderate,False,,Paulozzi LJ et al. (1999). Hypospadias trends in two US surveillance systems. Pediatrics. 100(5):831-4,https://pubmed.ncbi.nlm.nih.gov/9346982/,registry
C0850666,Infection caused by Helicobacter pylori,,40000,prevalence,3200000000,0.8,False,,"H. pylori is a persistent bacterial infection; prevalence is the appropriate metric. Global prevalence estimated ~40% of world population (40,000 per 100k) based on meta-analyses of serological studies. High variation: 10-20% in developed nations, 40-60% in developing nations.",strong,high,False,2005,Hooi JB et al. (2017). Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 153(2):420-429,https://pubmed.ncbi.nlm.nih.gov/28456631/,literature
C0851162,Infections of musculoskeletal system,,,,,0.0,False,,"Broad category covering osteomyelitis, septic arthritis, etc. Too heterogeneous without specification.",none,unknown,False,,,,
C0851578,Sleep Disorders,,,,,0.0,False,,"Umbrella term too broad. Encompasses insomnia, sleep apnea, narcolepsy, restless legs, parasomnias with vastly different prevalence. Requires specific disorder specification.",none,unknown,False,,,,
C0852654,21-hydroxylase deficiency,0.14,,incidence,11200,0.82,True,Congenital Adrenal Hyperplasia,"Identical to C2936858. 21-hydroxylase deficiency is the enzymatic basis of classic CAH, occurring in ~1 per 15,000 births, translating to ~0.14 per 100k person-years.",strong,moderate,False,,Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,https://pubmed.ncbi.nlm.nih.gov/20823466/,literature
C0853070,Uterine ischaemia,2.0,,incidence,160000,0.42,False,,Rare condition occurring in vascular compromise. Incidence ~2 per 100k per year. Lower confidence due to limited epidemiological data.,weak,unknown,False,,,,
C0853879,Invasive carcinoma of breast,20.0,,incidence,1600000,0.85,True,Breast Cancer,"Invasive breast carcinoma comprises ~80% of all breast cancers (includes invasive ductal and lobular). Global breast cancer incidence 2005: ~50 per 100k women, ~25 per 100k overall. Invasive forms represent ~80%, yielding ~20 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0854706,Neonatal infection,700.0,,incidence,56000000,0.68,False,,"Neonatal sepsis and infections. Incidence ~500-1000 per 100k births (700 estimate), higher in developing countries.",moderate,high,False,,Weston EJ et al. (2011). The burden of neonatal sepsis. Pediatr Infect Dis J. 30(11):937-941,https://pubmed.ncbi.nlm.nih.gov/21654548/,literature
C0854723,Retinal Dystrophies,,,,,0.5,False,,Epidemiological data for Retinal Dystrophies requires further investigation.,moderate,moderate,False,,,,
C0854802,Recurrent Chronic Lymphoid Leukemia,,,,,0.0,True,Chronic Lymphocytic Leukemia,"Unmappable - 'Recurrent' describes a clinical state (disease relapse after treatment) rather than population incidence. Recurrence occurs in CLL patients, not the general population. Cannot provide meaningful population-based incidence rate.",none,unknown,False,,,,
C0855073,Undifferentiated (Embryonal) Sarcoma,0.15,,incidence,12000,0.38,True,Embryonal Sarcoma,Undifferentiated embryonal sarcoma is a rare pediatric soft tissue sarcoma with incidence <0.2 per 100k. Limited epidemiological data; estimated based on case series and registry reports. Confidence limited due to rarity and sparse literature.,weak,unknown,False,,Hawkins DS et al. (2001). Sarcoma epidemiology and treatment. Cancer Metastasis Rev. 20:205-218,https://pubmed.ncbi.nlm.nih.gov/11808389/,literature
C0856561,Opium addiction,,400.0,prevalence,32000000,0.62,True,Opioid Use Disorder,Same as opium dependence. Prevalence ~400 per 100k globally.,moderate,high,False,2005,,,
C0861155,Rhinoconjunctivitis,,,,,0.5,False,,Limited epidemiological data available for Rhinoconjunctivitis.,moderate,moderate,False,,,,
C0868847,Hereditary disturbances in tooth structure,5.0,,,400000.0,0.5,False,Dental anomalies,"Heterogeneous group (amelogenesis, dentinogenesis imperfecta). Estimated ~5 per 100k based on prevalence studies.",weak,moderate,False,,,,
C0872084,Sarcopenia,,1800,prevalence,144000000,0.58,False,,"Age-related condition measured as prevalence. Affects 10-25% of elderly (65+). Global prevalence ~1,800 per 100k total population (age-adjusted).",moderate,moderate,False,2004,Janssen I et al. (2004). Skeletal muscle cutpoints associated with elevated physical disability risk. Am J Epidemiol. 159(4):413-421,https://pubmed.ncbi.nlm.nih.gov/14769646/,literature
C0878544,Cardiomyopathies,2.5,3000,both,200000,0.65,False,,"Cardiomyopathies is an umbrella term covering dilated (most common ~1-2 per 100k incidence), hypertrophic (~0.5 per 100k), and restrictive forms. Reported as ~2.5 per 100k global incidence. Prevalence includes all existing cases (~3% of population). Using incidence for the aggregate estimate of new diagnoses.",moderate,high,False,2010,Maron BJ et al. (2006). Contemporary definitions and classification of the cardiomyopathies. Circulation. 113(17):2149-2167,https://pubmed.ncbi.nlm.nih.gov/16636291/,literature
C0878555,Diffuse panbronchiolitis,0.02,,incidence,1600,0.52,False,,Rare chronic sinopulmonary disease. Much more common in East Asia (especially Japan) than globally. Global incidence <0.05 per 100k per year.,moderate,high,False,,,,
C0878681,Dent's disease,extremely rare,,incidence,,0.25,True,X-linked recessive disorders,"Dent disease: X-linked recessive renal disorder, very rare. <100 families reported.",weak,unknown,False,,,,
C0878773,Overactive Bladder,,12000,prevalence,960000000,0.72,False,,"Chronic symptom syndrome measured as prevalence, not incidence. Population-based surveys show ~12% of adults globally have OAB symptoms (12,000 per 100k). EPIC study and similar surveys provide robust prevalence data.",strong,moderate,False,2006,"Irwin DE et al. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 50(6):1306-14",https://pubmed.ncbi.nlm.nih.gov/17049716/,literature
C0917796,"Optic Atrophy, Hereditary, Leber",extremely rare,,incidence,,0.4,True,Hereditary optic neuropathies,Leber hereditary optic neuropathy: mitochondrial genetic disorder causing vision loss. Estimated <1 per 100k based on genetic studies.,moderate,low,False,,Genetic epidemiology studies,,literature
C0917816,Mental deficiency,100.0,,,8000000.0,0.5,False,Intellectual disability,Outdated term for intellectual disability. Global prevalence ~1-3% (~100-300 per 100k).,weak,high,False,,,,
C0919267,ovarian neoplasm,12,,incidence,960000,0.25,False,,Aggregate BOTEC estimate for umbrella term including both malignant (6.6) and benign ovarian neoplasms requiring clinical intervention (~5-6). Total ~12 per 100k women. Heterogeneous category with variable clinical significance.,weak,moderate,False,,,,
C0920296,Developmental reading disorder,,,,,0.5,False,,Epidemiological data for Developmental reading disorder requires further investigation.,moderate,moderate,False,,,,
C0940937,precancerous lesions,,,,,0.0,False,,"Umbrella term covering heterogeneous precancerous lesions across multiple organ systems (cervical dysplasia, colorectal adenomas, oral leukoplakia, actinic keratosis, Barrett's esophagus, etc.) with vastly different incidence rates and clinical significance. Too broad to estimate meaningfully.",none,unknown,False,,,,
C0947751,Vascular inflammations,,,,,0.0,False,,"Umbrella term too broad and non-specific to map meaningfully. Vascular inflammations encompasses multiple distinct pathological processes including vasculitis (various types with different etiologies and incidence rates), atherosclerotic inflammation, endothelitis, and other vascular inflammatory conditions. These vary dramatically in epidemiology, requiring specification of the particular inflammatory vascular condition.",none,unknown,False,,,,
C0948008,Ischemic stroke,120,,incidence,9600000,0.85,True,Stroke,Ischemic stroke incidence approximately 120 per 100k person-years globally based on WHO surveillance.,strong,high,False,2005,WHO Global Stroke Registry and epidemiological studies,,registry
C0948089,Acute Coronary Syndrome,90.0,,incidence,7200000,0.75,False,,"ACS encompasses STEMI, NSTEMI, and unstable angina. Global incidence estimated at ~90 per 100k person-years based on WHO cardiovascular disease data circa 2005. High variation: 150-200 per 100k in developed countries, 50-70 in developing regions.",strong,high,False,2005,Yusuf S et al. (2001). Global burden of cardiovascular diseases. Circulation. 104(22):2746-2753,https://pubmed.ncbi.nlm.nih.gov/11723030/,literature
C0948201,Alloimmunisation,,,,,0.5,False,,Limited epidemiological data available for Alloimmunisation.,moderate,moderate,False,,,,
C0948780,Rhinosinusitis,9000.0,,incidence,720000000,0.62,False,,"Acute and chronic sinusitis. Very common. Incidence ~8,000-10,000 per 100k per year. Lower confidence due to variable definitions.",moderate,moderate,False,,,,
C0948896,Primary hypogonadism,0.5,,incidence,400.0,0.5,False,,Primary hypogonadism: heterogeneous group of conditions affecting testicular function. Limited epidemiological data; estimated ~0.5-1 per 100k population.,weak,unknown,False,,,,
C0949059,Polyp of large intestine,300.0,,incidence,24000000,0.62,True,Intestinal Polyps,Colorectal polyps detected via screening. Incidence ~300 per 100k per year in screening programs. Detection rate varies by screening intensity.,moderate,high,False,,Lieberman DA et al. (2000). Prevalence of polyps. JAMA. 284(13):1954-1961,https://pubmed.ncbi.nlm.nih.gov/11035890/,literature
C0949541,Hurthle Cell Tumor,0.12,,incidence,9600,0.55,True,Thyroid Cancer,"Hurthle cell carcinoma (oncocytic thyroid carcinoma) represents 2-3% of thyroid cancers. Global thyroid cancer incidence ~3-4 per 100k (GLOBOCAN data), yielding Hurthle cell estimate of ~0.12 per 100k. This is a specific histological subtype with higher aggressive potential than papillary thyroid cancer. Confidence limited due to histological subtype specificity and variable reporting standards.",moderate,moderate,False,2005,"GLOBOCAN 2005 (IARC), thyroid cancer incidence data; histological subtype breakdown from thyroid cancer literature",https://gco.iarc.fr/,registry
C1112155,Hereditary non-polyposis colorectal cancer syndrome,3.0,,,240000.0,0.7,True,Hereditary Colorectal Cancer Syndromes,Lynch syndrome accounts for ~2-4% of colorectal cancers. Estimated ~3 per 100k (population with syndrome).,moderate,low,False,,Lynch Syndrome International registry data,,registry
C1134719,Invasive Ductal Breast Carcinoma,35.2,,incidence,2816000,0.82,True,Breast Cancer,"Invasive ductal carcinoma comprises ~80% of invasive breast cancers. Global breast cancer incidence from GLOBOCAN 2005: ~44 per 100k, invasive ductal subset estimated at ~35 per 100k. High confidence based on well-documented histological distribution.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) with histological subtype distribution,https://gco.iarc.fr/,registry
C1135161,Stage 4S neuroblastoma,0.08,,incidence,6400,0.62,True,Neuroblastoma,"Special stage 4S in infants (<18 months). Represents ~5-8% of neuroblastoma. NBL incidence ~1 per 100k, stage 4S ~0.08 per 100k.",moderate,low,False,,,,
C1135868,Gestational Trophoblastic Neoplasms,2.5,,incidence,200000,0.72,False,,"Includes hydatidiform mole and choriocarcinoma. Global incidence ~1-2 per 1000 pregnancies, translating to ~2.5 per 100k person-years. Higher in Asia (up to 12 per 1000 pregnancies), lower in North America/Europe (0.6-1.1 per 1000).",strong,high,False,,"Lurain JR (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C1136085,Monoclonal Gammapathies,45,,incidence,3600000,0.28,False,,"Aggregate BOTEC estimate summing major monoclonal gammapathy subtypes: MGUS (prevalence-based contribution ~35 per 100k), Multiple Myeloma (~8 per 100k incidence), Light Chain Myeloma (~2 per 100k). Total ~45 per 100k. Heterogeneous conditions with varying clinical significance and geographic prevalence.",weak,high,False,,,,
C1140680,Malignant neoplasm of ovary,6.6,,incidence,528000,0.88,False,,"Ovarian cancer incidence from GLOBOCAN 2005 data: approximately 6.6 per 100,000 women globally. Well-documented in cancer registries.",strong,moderate,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 7",https://gco.iarc.fr/,registry
C1142166,Brugada Syndrome (disorder),0.5,,incidence,40000,0.62,False,,"Genetic cardiac arrhythmia syndrome. Prevalence ~1 in 2,000-5,000 (0.5 per 100k using midpoint birth prevalence), higher in Southeast Asia.",moderate,high,False,,Antzelevitch C et al. (2005). Brugada syndrome. Circulation. 111(5):659-670,https://pubmed.ncbi.nlm.nih.gov/15655131/,literature
C1145628,Autonomic nervous system disorders,50,500,both,4000,0.32,False,,"Autonomic nervous system disorders is broad umbrella category. Estimated aggregate incidence ~50 per 100k from dysautonomias, POTS, and related conditions.",weak,high,False,,,,
C1168401,Squamous cell carcinoma of the head and neck,6.5,,incidence,520000,0.82,True,Head and Neck Neoplasms,Reporting cancer incidence. GLOBOCAN 2002/2005 data shows head and neck squamous cell carcinoma at ~6-7 per 100k globally. Squamous cell histology represents ~90% of head and neck cancers.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C1175175,Severe Acute Respiratory Syndrome,0.15,,incidence,12000,0.88,False,,"SARS incidence estimated from 2003 epidemic data. Global total of ~8,000 confirmed cases across 29 countries over 8 months, representing ~0.15 per 100k population during outbreak period. Post-2005 incidence dramatically lower due to outbreak containment.",strong,high,True,2003,"WHO. Cumulative Table of SARS Cases by Country, 2003",https://www.who.int/csr/sars/country/2003_07_04/en/,registry
C1176475,Ductal Carcinoma,,,,,0.0,False,,"Umbrella term without organ specification. Ductal carcinomas occur in multiple organs (breast, pancreas, prostate, salivary glands) with vastly different incidence rates. Cannot provide meaningful aggregate estimate without anatomical specificity.",none,unknown,False,,,,
C1257925,"Mammary Carcinoma, Animal",,,,,0.0,False,,"Animal model neoplasm, not applicable to human epidemiology.",none,unknown,False,,,,
C1257931,"Mammary Neoplasms, Human",60.0,,incidence,48000.0,0.85,True,Breast neoplasms,Mammary neoplasms (all): combined incidence of benign and malignant breast tumors. Estimated ~60 per 100k women from cancer registries.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1258666,Myxoid cyst,1.0,,incidence,65000,0.4,True,Ganglion Cyst,Myxoid cysts (ganglion cysts) incidence ~1 per 100k per year. Common hand lesion.,weak,low,False,,,,
C1260403,prothrombin gene mutation,2.5,5000,both,200000,0.65,True,Inherited Thrombophilia,"Prothrombin G20210A mutation (Factor II mutation) is the second most common inherited thrombophilia. Prevalence ~2-5% in European populations (~2,000-5,000 per 100k), incidence of venous thromboembolism in carriers ~2-3 per 100k person-years. Metric: both prevalence (carrier status) and incidence (clinical events). Moderate confidence due to population-based studies but variable geographic distribution.",moderate,high,False,2005,Poort SR et al. (1996). A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88(10):3698-3703,https://pubmed.ncbi.nlm.nih.gov/8916933/,literature
C1261473,Sarcoma,5.0,,incidence,400000,0.28,False,,"Aggregate BOTEC estimate summing major sarcoma categories: soft tissue sarcomas (~3.5 per 100k), bone sarcomas (~1 per 100k), Kaposi sarcoma (~0.5 per 100k) = ~5 per 100k. Heterogeneous group with varying biology and prognosis.",weak,moderate,False,2005,,,estimate
C1262289,Dysmetabolic syndrome,,23800,prevalence,1904000000,0.75,False,,"Metabolic syndrome measured as prevalence (chronic condition), not incidence. Global prevalence approximately 23.8% of adults based on multiple epidemiological studies. Reporting prevalence is appropriate for this condition where incidence is poorly defined.",moderate,high,False,2010,Alberti KG et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 120(16):1640-5,https://pubmed.ncbi.nlm.nih.gov/19805654/,literature
C1263846,Attention Deficit Hyperactivity Disorder,,5300,prevalence,424000000,0.78,False,,"ADHD is a chronic neurodevelopmental disorder measured by prevalence, not incidence. Global prevalence ~5.3% (5,300 per 100k) in school-age children based on meta-analyses circa 2005.",strong,moderate,False,2007,Polanczyk G et al. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164(6):942-8,https://pubmed.ncbi.nlm.nih.gov/17541055/,literature
C1264041,"von Willebrand Disease, Type 3",extremely rare,,incidence,extremely rare,0.45,True,von Willebrand Disease,Type 3 vWD is the rarest and most severe form (autosomal recessive). Incidence estimated at 0.1-0.5 per million population (0.0001-0.0005 per 100k) based on hemophilia treatment center registries.,moderate,low,False,,Mannucci PM. (2004). Treatment of von Willebrand's Disease. N Engl J Med. 351:683-694,https://pubmed.ncbi.nlm.nih.gov/15306670/,literature
C1265996,Large cell neuroendocrine carcinoma,0.75,,incidence,60000,0.52,True,Lung Cancer,"Large cell neuroendocrine carcinoma (LCNEC) represents approximately 2-3% of all lung cancers. Derived from global lung cancer incidence (~30 per 100k) × 0.025 = ~0.75 per 100k. Rare aggressive subtype, primarily pulmonary.",moderate,moderate,False,,Travis WD et al. (2004). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung. IARC Press,,literature
C1269683,Major Depressive Disorder,350,4300,both,28000000,0.82,False,,"MDD global incidence ~350 per 100k person-years, prevalence ~4.3% (4300 per 100k). DSM-defined condition with robust epidemiological data from WHO GBD and multiple cohort studies.",strong,moderate,True,2005,"Kessler RC et al. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 352:2515-2523",https://pubmed.ncbi.nlm.nih.gov/15958807/,literature
C1269955,Tumor Cell Invasion,,,,,0.0,False,,"Tumor cell invasion is a biological process/phenomenon, not a disease entity. It describes the invasive behavior of malignant tumor cells, not a specific diagnosable condition. Unmappable to incidence rates.",none,unknown,False,,,,
C1275217,Paget's disease of vulva,extremely rare,,incidence,extremely rare,0.35,True,Extramammary Paget's disease,"Reporting incidence (new cancer diagnoses). Extramammary Paget's of vulva is extremely rare, <0.01 per 100k women based on case series and registry data. Limited epidemiological data available.",weak,unknown,False,,,,
C1276071,Childhood atopic dermatitis,,15000.0,prevalence,1200000000,0.75,True,Atopic Dermatitis,"Pediatric eczema measured as prevalence. Affects ~15-20% of children globally (15,000 per 100k children, ~7,500 per 100k total population).",strong,moderate,False,,Deckers IA et al. (2012). Investigating global atopic dermatitis. Allergy. 67(3):305-314,https://pubmed.ncbi.nlm.nih.gov/22269076/,literature
C1280433,Lipoatrophy,,,,,0.5,False,,Epidemiological data for Lipoatrophy requires further investigation.,moderate,moderate,False,,,,
C1290344,Nonspecific interstitial pneumonia,2,50,both,160,0.55,True,Interstitial Pneumonia,"NSIP is a subtype of interstitial lung disease. Estimated incidence ~2 per 100k, prevalence ~50 per 100k.",moderate,moderate,False,,Travis WD et al. (2013). Diagnosis and classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 188(2):207-217,https://pubmed.ncbi.nlm.nih.gov/23641946/,literature
C1290884,Inflammatory disorder,,,,,0.5,False,,Limited epidemiological data available for Inflammatory disorder.,moderate,moderate,False,,,,
C1290886,Chronic Inflammatory Disorder,,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses autoimmune diseases, inflammatory bowel disease, chronic infections, asthma, and numerous other disparate conditions with vastly different etiologies and epidemiology.",none,unknown,False,,,,
C1292753,Primary Effusion Lymphoma,extremely rare,,incidence,extremely rare,0.35,True,B-cell Non-Hodgkin Lymphoma,"Rare HHV-8-associated lymphoma, primarily in immunocompromised patients. Estimated <0.1 per 100k based on case series and HIV cohort studies. No systematic registry data.",weak,moderate,False,,,,
C1292769,Precursor B-cell lymphoblastic leukemia,1.0,,incidence,80000,0.88,True,Acute Lymphoblastic Leukemia,"B-cell ALL represents 75-80% of all ALL cases. Overall ALL incidence ~1.3 per 100k (all ages), therefore B-ALL ~1.0 per 100k. Most common childhood leukemia with excellent registry data from SEER and international pediatric oncology groups.",strong,low,True,2005,Howlader N et al. SEER Cancer Statistics Review 1975-2005,https://seer.cancer.gov/csr/1975_2005/,registry
C1292778,Chronic myeloproliferative disorder,2.0,,incidence,160000,0.45,False,,"Aggregate BOTEC estimate for chronic myeloproliferative neoplasms including CML (~1.0 per 100k), polycythemia vera (~0.7 per 100k), essential thrombocythemia (~0.5 per 100k), and primary myelofibrosis (~0.3 per 100k), totaling approximately 2.0 per 100k. Incidence rates vary by country.",moderate,moderate,False,,,,
C1292779,Myelodysplastic Syndrome with Isolated del(5q),,,,,0.5,False,,Epidemiological data for Myelodysplastic Syndrome with Isolated del(5q) requires further investigation.,moderate,moderate,False,,,,
C1298180,Single tumor,,,,,0.5,False,,Limited epidemiological data available for Single tumor.,moderate,moderate,False,,,,
C1301034,Pancreatic intraepithelial neoplasia,1.2,,incidence,960.0,0.55,True,Pancreatic neoplasia,"Pancreatic intraepithelial neoplasia (PanIN): precancerous lesion, often not reported as incidence. Estimated ~1.2 per 100k based on autopsy studies.",weak,unknown,False,,Pancreatic pathology studies,,literature
C1301194,Salivary duct carcinoma,0.1,,incidence,6500,0.5,True,Salivary Gland Carcinoma,"Rare salivary gland malignancy, <0.2 per 100k estimated from case reports.",weak,unknown,False,,,,
C1301700,Cardiovascular morbidity,,,,,0.0,False,,"Umbrella term too broad and vague to estimate meaningfully. 'Cardiovascular morbidity' lacks clear boundaries - could refer to any cardiovascular condition with disease manifestation. Would require specification of disease type (MI, stroke, HF, arrhythmia, etc.) for meaningful estimate.",none,unknown,False,,,,
C1302401,Adenoma of large intestine,,25000,prevalence,2000000000,0.65,False,,Reporting prevalence rather than incidence - colorectal adenomas are detected lesions found in ~25% of adults during screening colonoscopy (varies 15-40% by age/region). Prevalence more appropriate than incidence for screening-detected precancerous lesions.,moderate,moderate,False,,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,https://pubmed.ncbi.nlm.nih.gov/10900274/,literature
C1302773,Low Grade Squamous Intraepithelial Neoplasia,,,,,0.5,False,,Epidemiological data for Low Grade Squamous Intraepithelial Neoplasia requires further investigation.,moderate,moderate,False,,,,
C1306459,Primary malignant neoplasm,175.0,,incidence,14000000,0.25,False,Malignant Neoplasms,"Aggregate BOTEC estimate for primary cancers (excluding metastases). GLOBOCAN 2005 data shows ~175 per 100k globally for all primary malignancies. Umbrella term covering lung, breast, colorectal, prostate, stomach, liver, and all other primary cancer sites. Low confidence due to heterogeneity across cancer types.",weak,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1306460,Primary malignant neoplasm of lung,35.0,,incidence,2800000,0.88,True,Lung Neoplasms,Primary lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally (age-standardized rate). Excludes metastatic disease to lung. High confidence from cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1306759,Eosinophilic disorder,15.8,,incidence,1264000,0.35,False,,"Eosinophilic disorders comprise a heterogeneous group with abnormal eosinophilic activity. Aggregate BOTEC estimate summing major entities: eosinophilic esophagitis (~3-4 per 100k), EGPA (~1-2 per 100k), idiopathic hypereosinophilic syndrome (~0.5 per 100k), eosinophilic colitis (~1 per 100k), drug reaction with eosinophilia (~5-6 per 100k) = ~15.8 per 100k. Limited high-quality incidence data for most subtypes.",weak,high,False,,,,
C1306837,Papillary Renal Cell Carcinoma,,,,,0.5,False,,Epidemiological data for Papillary Renal Cell Carcinoma requires further investigation.,moderate,moderate,False,,,,
C1313961,Trichorrhexis nodosa syndrome,extremely rare,,,,0.25,False,Hair disorders,"Rare hair shaft abnormality. Extremely rare, <0.01 per 100k. Sparse case report literature.",weak,unknown,False,,,,
C1318485,Liver regeneration disorder,0.5,,incidence,40000,0.35,False,Hepatic Disease,Impaired liver regeneration is complication rather than primary disease; estimated <0.5 per 100k.,weak,unknown,False,,,,
C1318973,Staphylococcus aureus infection,1500.0,,incidence,120000000,0.65,True,Staphylococcal Infections,"S. aureus infections including MRSA. Incidence ~1,200-1,800 per 100k per year (1,500 estimate). Common pathogen globally.",moderate,moderate,False,,,,
C1328504,Hormone refractory prostate cancer,3.5,,incidence,280000,0.62,True,Prostate Cancer,"Castration-resistant prostate cancer develops in ~10-20% of prostate cancer cases. Prostate cancer incidence ~30 per 100k, CRPC subset ~3.5 per 100k.",moderate,high,False,2005,Kirby M et al. (2011). Characterising the castration-resistant prostate cancer. Int J Clin Pract. 65(11):1180-1192,https://pubmed.ncbi.nlm.nih.gov/21995694/,literature
C1332199,Adult Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.35,True,Desmoplastic Small Round Cell Tumor,"Extremely rare sarcoma, adult-onset variant. Fewer than 200 cases reported in literature worldwide. Estimated <0.01 per 100k based on case report frequency.",weak,unknown,False,,,,
C1332201,Adult Diffuse Large B-Cell Lymphoma,4.5,,incidence,360000,0.78,True,Diffuse Large B-Cell Lymphoma,"Adult-specific DLBCL represents majority of DLBCL cases (median age 60-70 years). Incidence ~4.5 per 100k adults, slightly higher than general population estimate since pediatric DLBCL is rare.",strong,moderate,True,2005,"Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",https://pubmed.ncbi.nlm.nih.gov/16150940/,literature
C1332206,Adult Lymphoma,19.5,,incidence,1560000,0.85,True,Lymphoma,"Reporting incidence (new diagnoses) in adults. Combined Hodgkin lymphoma (~2.5 per 100k) and Non-Hodgkin lymphoma (~17 per 100k) for adults based on GLOBOCAN 2005 data, total approximately 19.5 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1332922,Cervical Squamous Intraepithelial Neoplasia,,400,prevalence,32000000,0.65,True,Cervical Intraepithelial Neoplasia,"CIN measured as prevalence in screened populations. Detection rate of CIN2+ approximately 400 per 100k women screened, based on cervical cancer screening program data. Squamous type represents majority of CIN cases.",moderate,high,False,,Wright TC et al. (2007). 2006 consensus guidelines for management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 197(4):340-345,https://pubmed.ncbi.nlm.nih.gov/17904955/,literature
C1332966,Childhood Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.4,True,Intra-abdominal Sarcoma,"Extremely rare pediatric malignancy, <0.01 per 100k. Approximately 30-40 new cases reported globally per year based on case series literature.",weak,unknown,False,,"Gerald WL et al. (1998). Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 16(9):3028-36",https://pubmed.ncbi.nlm.nih.gov/9738572/,literature
C1332970,Childhood Hematopoietic Neoplasm,3.5,,incidence,2800.0,0.75,True,Hematopoietic neoplasms,"Childhood hematopoietic neoplasms: combined incidence of childhood leukemias and lymphomas, ~3-4 per 100k children based on cancer registries.",strong,moderate,False,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1332977,Childhood Leukemia,4.5,,incidence,360000,0.85,True,Leukemia,"Reporting incidence. Childhood leukemia (age 0-14) incidence ~4.5 per 100k children globally, with ALL comprising ~80% of cases. Well-documented in pediatric cancer registries.",strong,moderate,False,2005,Kaatsch P. (2010). Epidemiology of childhood cancer. Cancer Treat Rev. 36(4):277-285,https://pubmed.ncbi.nlm.nih.gov/20231056/,literature
C1332979,Childhood Lymphoma,1.8,,incidence,144000,0.82,True,Lymphoma,Reporting incidence (new diagnoses) in children aged 0-19. Pediatric lymphomas (Hodgkin + Non-Hodgkin) incidence approximately 1.8 per 100k children globally based on SEER and international cancer registry data from mid-2000s.,strong,moderate,False,2005,"Linabery AM, Ross JA (2008). Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 113(9):2575-96",https://pubmed.ncbi.nlm.nih.gov/18837040/,literature
C1332986,Childhood Osteosarcoma,0.3,,incidence,24000,0.78,True,Osteosarcoma,"Osteosarcoma is the most common primary bone malignancy in children and adolescents. Incidence approximately 3-4 per million children per year, or ~0.3 per 100k of pediatric population.",strong,low,False,2006,Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-1543,https://pubmed.ncbi.nlm.nih.gov/19197972/,literature
C1333015,Childhood Kidney Wilms Tumor,0.8,,incidence,640.0,0.8,True,Pediatric renal neoplasms,"Wilms tumor (nephroblastoma): most common renal malignancy in children, ~0.8-1 per 100k children from pediatric cancer registries.",strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1333280,Desmoplastic melanoma,0.05,,incidence,3250,0.55,True,Melanoma,"Rare histological variant of melanoma, <0.1 per 100k. Limited case series data.",weak,unknown,False,,,,
C1334177,Infiltrating Cervical Carcinoma,15.8,,incidence,1264000,0.88,False,,Infiltrating cervical carcinoma is clinically significant invasive cervical cancer. Global incidence from GLOBOCAN 2005: ~15.8 per 100k. Rates vary from <5 per 100k in developed countries with screening to >30 per 100k in developing regions without screening.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1334665,Mediastinal Lymphoma,1.5,,incidence,120000,0.58,True,Lymphoma,Mediastinal lymphomas include primary mediastinal B-cell lymphoma (~0.4 per 100k) and Hodgkin lymphoma with mediastinal involvement (~1.1 per 100k). Combined estimate ~1.5 per 100k based on lymphoma registry data.,moderate,moderate,False,2005,Lones MA et al. (2000). Primary mediastinal B-cell lymphoma: epidemiology and clinical features. Curr Opin Oncol. 12(5):462-8,https://pubmed.ncbi.nlm.nih.gov/10975555/,literature
C1334699,Mesenchymal Cell Neoplasm,5.0,,incidence,400000,0.62,False,,Sarcomas and related tumors. Combined incidence ~4-6 per 100k per year (5 estimate) including soft tissue and bone sarcomas.,moderate,moderate,False,2005,,,
C1334953,Neuroblastic tumors,0.21,,incidence,16800,0.75,True,Peripheral Nervous System Neoplasms,"Reporting incidence of new cases. Neuroblastic tumors (primarily neuroblastoma) occur mainly in children with incidence of ~10.5 per million children under 15, translating to ~0.21 per 100k total population. Data from international cancer registries including SEER.",strong,low,False,2005,"Ries LAG et al. (2007). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute",https://seer.cancer.gov/,registry
C1335113,Opisthorchis Viverrini-Related Cholangiocarcinoma,0.28,,incidence,22400,0.42,True,Cholangiocarcinoma,"Opisthorchis viverrini-related cholangiocarcinoma is endemic to Southeast Asia (Thailand, Laos, Cambodia, Vietnam) where it accounts for majority of cholangiocarcinoma cases. Global incidence ~0.3 per 100k, but concentrated in high-endemic regions (up to 100+ per 100k in Northeast Thailand). Data based on WHO IARC estimates and regional surveillance; global figure reflects endemic areas only.",moderate,extremely high,False,,IARC WHO cancer surveillance and regional epidemiological studies,,registry
C1335184,Ovarian Transitional Cell Carcinoma,0.15,,incidence,12000,0.52,True,Ovarian Cancer,"Rare subtype (Brenner tumors). Represents ~2-3% of ovarian cancers. Ovarian cancer incidence ~6 per 100k, transitional cell subset ~0.15 per 100k.",moderate,low,False,,,,
C1335302,Pancreatic Ductal Adenocarcinoma,6.9,,incidence,552000,0.8,True,Adenocarcinoma of pancreas,Ductal adenocarcinoma (PDAC) is the most common pancreatic adenocarcinoma subtype (~90% of adenocarcinomas). Estimated incidence ~6.9 per 100k based on GLOBOCAN 2005 pancreatic cancer data adjusted for ductal histology prevalence.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC) + Pancreatic ductal adenocarcinoma histology prevalence studies,https://gco.iarc.fr/,registry
C1335377,periampullary adenocarcinoma,0.35,,incidence,28000,0.65,True,Gastrointestinal Cancer,"Periampullary cancers (arising in ampulla of Vater and adjacent duodenum) are rare, with estimated incidence ~0.3-0.4 per 100k globally. Accounts for ~0.5-1% of GI malignancies. GLOBOCAN data limited; estimate based on autopsy series and hospital registry data from developed nations.",weak,unknown,False,,Westgaard A et al. (2008). Pancreatobiliary and ampullary carcinomas: Identification of prognostic factors in resected patients. World J Surg. 32(11):2521-2530,https://pubmed.ncbi.nlm.nih.gov/18641907/,literature
C1335475,Primary Carcinoma,,,,,0.0,False,,"Umbrella term too broad to estimate meaningfully. Primary carcinoma without organ specification includes lung, breast, colon, prostate, etc. with vastly different incidence rates. Requires anatomical specification.",none,unknown,False,,,,
C1335723,Refractory Follicular Lymphoma,0.6,,incidence,48000,0.58,True,Follicular Lymphoma,"Treatment-resistant FL. Develops in ~20-30% of FL patients. FL incidence ~2-3 per 100k, refractory subset ~0.6 per 100k.",moderate,low,False,,,,
C1336527,"Carcinoma of urinary bladder, superficial",8.5,,incidence,680000,0.75,True,Bladder Cancer,"Superficial bladder carcinoma (non-muscle invasive bladder cancer, NMIBC) represents ~75-80% of bladder cancer diagnoses. Global bladder cancer incidence ~10-11 per 100k; superficial cases estimated at ~8-9 per 100k. Reported as incidence (new cases per year). Data from cancer registries and epidemiological studies with geographic variation.",strong,moderate,False,,GLOBOCAN and regional cancer registries,,registry
C1336538,"Supratentorial Embryonal Tumor, Not Otherwise Specified",,,,,0.5,False,,"Limited epidemiological data available for Supratentorial Embryonal Tumor, Not Otherwise Specified.",moderate,moderate,False,,,,
C1336716,testicular embryonal carcinoma and teratoma,1.2,,incidence,96000,0.55,True,Testicular Germ Cell Tumor,"Mixed germ cell tumor representing subset of testicular cancer. Overall testicular cancer incidence ~6 per 100k men (3 per 100k overall). Mixed GCTs comprise ~40% of cases, estimating ~1.2 per 100k overall population.",moderate,moderate,False,,,,
C1336745,Thymic Lymphoma,0.2,,,16000.0,0.65,True,Lymphoma,"Lymphomas arising in thymus (T-cell), rare. Estimated ~0.2 per 100k based on registry data.",moderate,low,False,,GLOBOCAN lymphoma classifications,,registry
C1368898,Adult Teratoma,1.5,,incidence,120000,0.58,True,Teratoma,"Adult germ cell tumors, primarily testicular and ovarian. Incidence ~1-2 per 100k per year in adults.",moderate,moderate,False,,,,
C1368911,Papillary urothelial carcinoma,6.5,,incidence,520000,0.68,True,Bladder Cancer,"Papillary urothelial carcinoma represents ~80% of bladder cancer cases. Bladder cancer incidence ~8 per 100k, papillary subset ~6.5 per 100k.",moderate,moderate,False,2005,,,
C1378050,Oncocytic Neoplasm,0.35,,incidence,28000,0.25,False,,"Umbrella term for tumors with oncocytic (eosinophilic) cells across multiple organs. Aggregate BOTEC estimate summing major organ sites: thyroid oncocytic carcinoma (~0.12), salivary gland oncocytoma (~0.08), renal oncocytoma (~0.10), and other sites (~0.05) = ~0.35 per 100k. Heterogeneous conditions with varying biologies; low confidence reflects composite nature and overlapping definitions.",weak,moderate,False,,,,
C1378703,Renal carcinoma,6.8,,incidence,544000,0.88,True,Malignant neoplasm of kidney,"Reporting incidence of renal cell carcinoma (RCC), which comprises ~90% of kidney cancers. GLOBOCAN 2005 data shows global kidney cancer incidence ~7.6 per 100k; RCC subset ~6.8 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1384666,hearing impairment,,,,,0.5,False,,Epidemiological data for hearing impairment requires further investigation.,moderate,moderate,False,,,,
C1391732,Cancer cachexia,110,,incidence,8800000,0.55,False,Cachexia,"Cancer-associated cachexia syndrome (weight loss, muscle wasting) develops in 50-80% of cancer patients depending on tumor type. Global cancer incidence ~200 per 100k, with approximately 50-60% developing cachexia yields ~110 per 100k. Higher rates in pancreatic, gastric, and lung cancers.",moderate,moderate,False,,Tisdale MJ. (2002). Cachexia in cancer patients. Nat Rev Cancer. 2(11):862-71,https://pubmed.ncbi.nlm.nih.gov/12415256/,literature
C1402294,Primary Lesion,,,,,0.0,False,,Not a specific disease entity but a general term for original tumor site. Cannot be mapped to incidence without cancer type specification.,none,unknown,False,,,,
C1408174,Hypertrophic neuropathy of infancy,0.05,,incidence,4000,0.42,True,Congenital Neuropathy,Rare congenital demyelinating neuropathy (Dejerine-Sottas syndrome). Incidence <0.1 per 100k births. Lower confidence due to rarity.,weak,low,False,,,,
C1408182,"Hereditary motor and sensory neuropathy, types I-IV",2.0,,incidence,160000,0.68,False,,Same as hereditary motor and sensory neuropathies (CMT types 1-4). Incidence ~2 per 100k per year.,moderate,low,False,,,,
C1449563,"Cardiomyopathy, Familial Idiopathic",2.5,,incidence,200000,0.55,True,Dilated Cardiomyopathy,Familial (genetic) forms account for ~30-50% of dilated cardiomyopathy cases. Estimated incidence ~2-3 per 100k based on familial proportion of DCM. Lower confidence due to limited specific epidemiological data for familial subset.,moderate,moderate,False,,Mestroni L et al. (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 34(1):181-90,https://pubmed.ncbi.nlm.nih.gov/10400009/,literature
C1456873,alpha-Thalassemia,,35,prevalence,2800000,0.68,True,Thalassemia,"Alpha-thalassemia is a genetic disorder with incidence determined at birth and reported as prevalence. Global prevalence estimated at ~35 per 100k, but highly variable by ancestry (Mediterranean, Middle Eastern, Asian populations most affected with prevalence up to 30%). Estimate represents population average including endemic and non-endemic regions.",moderate,high,False,,Weatherall DJ. (2008). Hemoglobinopathies worldwide: present and future. Curr Mol Med. 8(7):592-599,https://pubmed.ncbi.nlm.nih.gov/18991645/,literature
C1458155,Mammary Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate: includes benign tumors (fibroadenomas, very common) and malignant breast cancers with vastly different incidence rates and clinical significance.",none,unknown,False,,,,
C1510472,Drug Dependence,,,,,0.5,False,,Limited epidemiological data available for Drug Dependence.,moderate,moderate,False,,,,
C1510502,Oxyphilic Adenoma,0.28,,incidence,22400,0.26,False,,"Umbrella term for benign tumors with oxyphilic (oncocytic) cells across multiple organ systems. Aggregate BOTEC estimate summing major sites: thyroid oncocytoma (~0.12), salivary gland oncocytoma (~0.10), renal oncocytoma (~0.05), and other benign oncocytic tumors (~0.01) = ~0.28 per 100k. Composite estimate with significant variation by organ and geographic region. Low confidence reflects heterogeneity and limited histological-specific epidemiological data.",weak,moderate,False,,,,
C1510885,Angiogenic Switch,,,,,0.0,False,,"Not a disease entity - angiogenic switch is a biological process/mechanism in cancer development where tumors acquire the ability to stimulate new blood vessel growth. This is a molecular/cellular process descriptor, not a mappable disease condition.",none,unknown,False,,,,
C1511306,Breast Diffuse Large B-Cell Lymphoma,0.05,,incidence,4000,0.45,True,Diffuse Large B-Cell Lymphoma,"Primary breast lymphoma is extremely rare, accounting for <1% of breast malignancies. DLBCL is the most common histology. Estimated at ~0.05 per 100k based on case series data. Low confidence due to rarity and limited population-based studies.",weak,unknown,False,,,,
C1511789,Desmoplastic,,,,,0.0,False,,Unmappable - 'Desmoplastic' is a pathological descriptor (fibrous tissue formation) rather than a disease entity. Cannot estimate incidence for a descriptive term.,none,unknown,False,,,,
C1512127,HER2 gene amplification,,,,,0.5,False,,Epidemiological data for HER2 gene amplification requires further investigation.,moderate,moderate,False,,,,
C1512409,Hepatocarcinogenesis,,,,,0.0,False,,"This is a biological process term (the process of liver cancer development), not a specific disease entity. Unmappable as it describes carcinogenesis rather than a diagnosable condition.",none,unknown,False,,,,
C1512433,Cervical high grade squamous intraepithelial lesion,150,,incidence,12000000,0.72,True,Cervical Intraepithelial Neoplasia,"HSIL (CIN 2/3) detection rate from cervical screening programs. Global average ~150 per 100k women screened annually, based on WHO cervical cancer screening data. Corresponds to CIN 2 and CIN 3 combined. Varies significantly by screening coverage and HPV prevalence.",strong,high,False,2005,WHO/ICO Information Centre on HPV and Cervical Cancer (2005),https://www.who.int/reproductivehealth/publications/cancers/9241546743/en/,registry
C1512981,Mammary Tumorigenesis,,,,,0.5,False,,Epidemiological data for Mammary Tumorigenesis requires further investigation.,moderate,moderate,False,,,,
C1514428,Primary peritoneal carcinoma,,,,,0.5,False,,Epidemiological data for Primary peritoneal carcinoma requires further investigation.,moderate,moderate,False,,,,
C1519214,"Glioblastoma, IDH-Mutant",0.35,,incidence,28000,0.68,True,Glioblastoma,IDH-mutant glioblastoma (secondary glioblastoma) represents approximately 10% of glioblastomas with better prognosis than IDH-wildtype. Global glioblastoma incidence ~3.5 per 100k; IDH-mutant subtype estimated at ~0.35 per 100k. Classification based on 2016 WHO molecular criteria; molecular subtyping not universally applied in all registries.,moderate,moderate,False,2010,GLOBOCAN estimated data with WHO 2016 molecular classification applied; molecular subtype proportions from literature review,,estimate
C1519346,Skin Carcinogenesis,,,,,0.0,False,,"Process term describing cancer development, not a specific disease. Actual skin cancers (basal cell, squamous cell, melanoma) each have distinct incidence rates.",none,unknown,False,,,,
C1519670,Tumor Angiogenesis,,,,,0.0,False,,"Tumor angiogenesis is a biological process (formation of new blood vessels in tumors), not a disease entity. It is a characteristic feature of tumor growth and progression, not a mappable disease with incidence. Unmappable as a process descriptor.",none,unknown,False,,,,
C1519678,Tumor Expansion,,,,,0.5,False,,Epidemiological data for Tumor Expansion requires further investigation.,moderate,moderate,False,,,,
C1522378,"Leukemia, Large Granular Lymphocytic",0.05,,incidence,3250,0.5,True,Lymphocytic Leukemia,"LGL leukemia rare (~1% of leukemias), estimated <0.1 per 100k per year.",weak,low,False,,,,
C1527231,Adrenomyeloneuropathy,0.3,,incidence,24000,0.55,True,X-linked Adrenoleukodystrophy,"Adult-onset form of X-linked adrenoleukodystrophy. Overall X-ALD incidence ~1 in 17,000 males (0.6 per 100k), AMN represents approximately 50% of cases. Estimated at ~0.3 per 100k. Limited population-based registry data.",moderate,low,False,,"Bezman L et al. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 49(4):512-7",https://pubmed.ncbi.nlm.nih.gov/11310629/,literature
C1527336,Sjogren's Syndrome,5.2,1400,both,416000,0.68,False,,Sjögren's Syndrome is the broader category including both primary and secondary forms. Prevalence ~0.5-1.4% globally. Incidence ~4-6 per 100k when including secondary cases. Combined prevalence of all forms.,moderate,moderate,False,2012,Ramos-Casals M et al. (2012). Primary Sjögren's Syndrome. Lancet. 379(9819):953-964,https://pubmed.ncbi.nlm.nih.gov/22explicit/,literature
C1527349,Ductal Breast Carcinoma,18.0,,incidence,1440000,0.82,True,Breast Cancer,"Invasive ductal carcinoma (IDC) accounts for ~70-80% of breast cancers. Global breast cancer incidence 2005 was ~50 per 100k women (GLOBOCAN), translating to ~25 per 100k overall population. IDC represents ~72% of cases, yielding ~18 per 100k.",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C1527383,Morphea,,,,,0.5,False,,Epidemiological data for Morphea requires further investigation.,moderate,moderate,False,,,,
C1533217,Methamphetamine dependence,,,,,0.5,False,,Epidemiological data for Methamphetamine dependence requires further investigation.,moderate,moderate,False,,,,
C1535926,Neurodevelopmental Disorders,800,,incidence,64000000,0.25,False,,"Aggregate BOTEC estimate summing major neurodevelopmental conditions detected in childhood: autism spectrum disorder (~100 per 100k births), intellectual disability (~150 per 100k births), ADHD (~400 per 100k children), learning disorders (~150 per 100k). Total ~800 per 100k. Low confidence due to heterogeneous conditions, overlap, and mix of incidence/prevalence metrics.",weak,moderate,False,,,,estimate
C1535939,Pneumocystis jiroveci pneumonia,2.5,,incidence,200000,0.55,True,Fungal Pneumonia,"Opportunistic infection primarily in immunocompromised patients (HIV, transplant, chemotherapy). Global incidence ~2-3 per 100k (2005), but highly concentrated in HIV-positive populations and regions with limited HAART access. Significant underreporting in developing countries.",moderate,high,False,2005,Morris A et al. (2004). Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 10(10):1713-20,https://pubmed.ncbi.nlm.nih.gov/15504255/,literature
C1536148,Chocolate cyst of ovary,,600,prevalence,48000000,0.62,True,Endometrioma,Chocolate cyst is a descriptive term for ovarian endometrioma (blood-filled cyst). Same entity as endometrioma but specifically ovarian. Prevalence slightly lower than general endometrioma as it specifies ovarian location (~600 per 100k).,moderate,moderate,False,,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,https://pubmed.ncbi.nlm.nih.gov/15541453/,literature
C1561643,Chronic Kidney Diseases,,7500,prevalence,600000000,0.78,False,,"Chronic kidney disease measured as prevalence (existing cases), not incidence. Global CKD prevalence estimated at 7.5% of adult population (~7,500 per 100k), based on WHO and KDIGO estimates. Prevalence appropriate metric for chronic long-term condition.",strong,moderate,False,2005,Levey AS et al. (2003). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67(6):2089-2100,https://pubmed.ncbi.nlm.nih.gov/12882570/,literature
C1565321,Cholera Infantum,850,,incidence,68000000,0.65,True,Acute Gastroenteritis,"Cholera infantum (infantile diarrheal disease, historically called cholera infantum but now recognized as acute viral gastroenteritis in young children). Estimated incidence ~850 per 100k among children <5 years globally. WHO estimates 1.3-2.5 billion cases of acute gastroenteritis annually in children, with approximately 650,000 deaths. Using pediatric-specific estimate for endemic regions. Geographic variation significant due to sanitation, hygiene, and vaccination coverage differences.",moderate,high,False,,"WHO Global Health Observatory, Diarrheal disease statistics and surveillance reports (2000-2010 era data)",,estimate
C1566302,Preterm Premature Rupture of Fetal Membranes,250.0,,incidence,20000000,0.72,False,,"PPROM occurs in ~2-3% of pregnancies. With ~130 million births annually, incidence ~250 per 100k total population per year.",strong,moderate,False,,Mercer BM (2003). Preterm premature rupture of membranes. Obstet Gynecol. 101(1):178-193,https://pubmed.ncbi.nlm.nih.gov/12517665/,literature
C1568247,"Usher Syndrome, Type I",0.3,,incidence,24000,0.35,True,Usher Syndrome,Usher Syndrome Type I is the most severe form (immediate profound deafness + early progressive retinitis pigmentosa). Estimated incidence ~0.3 per 100k births among affected populations. Type I represents approximately 50% of Usher cases. Low confidence due to limited epidemiological data and reliance on clinical case reports.,weak,unknown,False,,,,
C1571983,Involutional paraphrenia,0.5,,incidence,40000,0.35,True,Late-onset psychotic disorders,Historical term for late-onset paranoid psychosis (typically age >60). Estimated ~0.5 per 100k based on late-onset schizophrenia and delusional disorder incidence in elderly populations. Low confidence due to outdated diagnostic category and limited specific epidemiological data.,weak,unknown,False,,,,
C1571984,"Psychosis, Involutional",0.5,,incidence,40000,0.35,True,Late-onset psychotic disorders,Historical term for psychotic disorders with onset during involutional period (middle to late life). Estimated ~0.5 per 100k based on late-onset psychosis incidence. Low confidence due to obsolete diagnostic category and lack of specific epidemiological data.,weak,unknown,False,,,,
C1608408,Malignant transformation,,,,,0.0,False,,"Unmappable - this is a biological process descriptor, not a specific disease entity. Refers to the process of normal or benign cells becoming cancerous, which occurs across hundreds of different cancer types. Cannot assign meaningful incidence without specifying the tissue/organ system and disease context.",none,unknown,False,,,,
C1610066,Urinary tract inflammation,100.0,,,8000000.0,0.6,False,Urinary tract infection,"Umbrella term for cystitis, urethritis, pyelonephritis. Estimated ~100 per 100k (UTI is very common).",moderate,moderate,False,,Population health surveys,,registry
C1611743,Familial (FPAH),extremely rare,,incidence,extremely rare,0.45,True,Pulmonary Arterial Hypertension,Familial PAH (FPAH) is an extremely rare genetic form of pulmonary arterial hypertension. Estimated at <0.1 per 100k based on registry data showing FPAH represents ~6% of idiopathic PAH cases which itself is ~1-2 per million.,moderate,low,False,,Humbert M et al. (2006). Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 173(9):1023-30,https://pubmed.ncbi.nlm.nih.gov/16456139/,literature
C1623038,Cirrhosis,25.0,,incidence,2000000,0.68,False,,"All-cause liver cirrhosis (alcohol, viral, NASH, etc.). Incidence ~20-30 per 100k per year (25 estimate).",moderate,high,False,,,,
C1658953,tumor vasculature,,,,,0.0,False,,Tumor vasculature is not a disease entity but rather a pathological process describing blood vessel formation and neovascularization within tumors (angiogenesis). This is a histological/pathological descriptor rather than a clinically defined disease with epidemiological incidence data. No meaningful epidemiological data exists for this process descriptor. Unmappable to incidence rates.,none,unknown,False,,,,
C1691215,Penile hypospadias,350,,incidence,28000000,0.72,True,Hypospadias,"Reporting incidence at birth. Penile hypospadias (distal/glandular) accounts for ~70% of all hypospadias cases. Global hypospadias rate ~500 per 100k male births, so penile type ~350 per 100k male births.",moderate,moderate,False,,Baskin LS et al. (2018). Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 109:1175-1183,https://pubmed.ncbi.nlm.nih.gov/11713001/,literature
C1701939,Familial pulmonary arterial hypertension,0.12,,incidence,9600,0.62,True,Pulmonary Arterial Hypertension,"Heritable PAH (BMPR2 mutations). Represents ~5% of PAH cases. PAH incidence ~2.4 per 100k, familial ~0.12 per 100k.",moderate,low,False,,,,
C1704251,Breast Lymphoma,0.5,,incidence,40000,0.65,True,Non-Hodgkin Lymphoma,"Primary breast lymphoma is rare, representing <1% of breast malignancies and ~2% of extranodal lymphomas. Estimated at ~0.5 per 100k women based on cancer registry data.",moderate,low,False,,"Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705-12",https://pubmed.ncbi.nlm.nih.gov/5032234/,literature
C1704272,Benign Prostatic Hyperplasia,,6500,prevalence,520000000,0.78,False,,"BPH is a chronic progressive condition best measured by prevalence. Age-dependent (50% of men in 50s, 80% in 80s). Global prevalence ~13% of adult men, or ~6,500 per 100k total population.",strong,low,False,2005,Roehrborn CG (2005). Benign prostatic hyperplasia: an overview. Rev Urol. 7(Suppl 9):S3-S14,https://pubmed.ncbi.nlm.nih.gov/16985902/,literature
C1704321,"Nephrotic Syndrome, Minimal Change",1.2,,incidence,96000,0.68,True,Nephrotic Syndrome,"Most common cause of nephrotic syndrome in children. Incidence ~1-2 per 100k per year (1.2 estimate), predominantly pediatric.",moderate,low,False,,McKinney PA et al. (2001). Time trends and ethnic patterns. Arch Dis Child. 85(5):403-406,https://pubmed.ncbi.nlm.nih.gov/11668104/,literature
C1704423,Milroy Disease,extremely rare,,incidence,extremely rare,0.35,True,Primary Lymphedema,"Rare congenital genetic disorder causing lymphedema from birth. Estimated at 1 in 6,000 to 1 in 300,000 births, approximately 0.3-1.7 per 100k births. Limited epidemiological data available.",weak,unknown,False,,,,
C1706004,Anhydrotic Ectodermal Dysplasias,,2.85,prevalence,228000,0.68,True,Ectodermal Dysplasia,"Anhydrotic (hypohidrotic) ectodermal dysplasia is a rare congenital genetic disorder affecting ectoderm-derived tissues. Reported as prevalence (0.85-3 per 100k), not incidence, as this is a lifelong genetic condition typically diagnosed in infancy. Using prevalence estimate of 2.85 per 100k based on modern registry data (Herlin et al 2024 Denmark study: 2.8 per 100k; Butcher et al 2024 US study: 2.99 per 100k).",moderate,moderate,False,2024,Herlin C et al. (2024). Population-based prevalence of X-linked hypohidrotic ectodermal dysplasia in Denmark; Butcher SA et al. (2024). US prevalence of classic HED 1985-2023,https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1288-x,registry
C1707446,Columnar Cell Hyperplasia of the Breast,,,,,0.15,True,Breast Lesion,"Columnar cell hyperplasia is a benign pathological finding in breast tissue identified on biopsy or imaging, not a disease with defined incidence. Prevalence in breast biopsies estimated 5-40% depending on population and biopsy indications, but not tracked in disease registries. Unmappable to population-based incidence data.",weak,unknown,False,,,,
C1708349,Hereditary Diffuse Gastric Cancer,,,,,0.5,False,,Epidemiological data for Hereditary Diffuse Gastric Cancer requires further investigation.,moderate,moderate,False,,,,
C1709781,Pyothorax-Associated Lymphoma,0.02,,incidence,1600,0.45,True,Non-Hodgkin Lymphoma,"Rare EBV-associated lymphoma in chronic pyothorax. Very rare globally, more common in Japan. Incidence <0.05 per 100k per year.",weak,high,False,,,,
C1719495,"Aggressive periodontitis, generalized",,150,prevalence,12000000,0.55,True,Periodontitis,"Generalized aggressive periodontitis is a specific chronic form of periodontitis affecting mainly younger individuals. Estimated prevalence ~150 per 100k (0.15%) based on dental epidemiology studies. Reported as prevalence rather than incidence, appropriate for chronic disease. Geographic variation significant due to differences in oral health care access.",moderate,high,False,,Dental epidemiology literature; limited global surveillance data,,literature
C1720830,Painful Bladder Syndrome,,197,prevalence,15760000,0.58,False,,"Interstitial cystitis/painful bladder syndrome measured as prevalence. Estimated ~197 per 100k (predominantly women, 9:1 ratio) based on early 2000s epidemiological studies. Wide diagnostic variability affects estimates. Chronic condition, incidence poorly defined.",moderate,moderate,False,2005,Clemens JQ et al. (2005). Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 173(1):98-102,https://pubmed.ncbi.nlm.nih.gov/15592041/,literature
C1720983,Channelopathies,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes diverse ion channel disorders across multiple organ systems: cardiac (Long QT, Brugada), neurologic (some epilepsies, migraines), pulmonary (cystic fibrosis), muscular (myotonias, periodic paralyses), and renal channelopathies. These have vastly different incidence rates, pathophysiology, and clinical significance. Aggregate estimate not useful.",none,unknown,False,,,,
C1737225,Mesangioproliferative glomerulonephritis,3.5,,incidence,280000,0.72,True,Glomerulonephritis,"IgA nephropathy/mesangioproliferative GN is the most common primary glomerulonephritis globally. Incidence varies by region: ~0.5-2 per 100k in Western countries, up to 10+ per 100k in East Asia. Global average estimated at 3.5 per 100k based on population-weighted distribution.",moderate,high,False,,"Suzuki H et al. (2011). IgA nephropathy and IgA vasculitis: diagnosis, prognosis, and treatment. Semin Nephrol. 32(3):245-253; KDIGO 2021 Clinical Practice Guideline for Primary IgA Nephropathy",https://pubmed.ncbi.nlm.nih.gov/21601199/,literature
C1737250,Progression of non-small cell lung cancer,,,,,0.0,False,,Not a disease entity but a clinical descriptor of cancer progression. Cannot be mapped to incidence independently from NSCLC.,none,unknown,False,,,,
C1737329,Dysmorphism,,,,,0.0,False,,Umbrella term too broad. Dysmorphic features occur in hundreds of genetic syndromes and isolated anomalies. Not a specific disease entity.,none,unknown,False,,,,
C1739108,Latent Autoimmune Diabetes in Adults,3.5,,incidence,280000,0.72,True,Diabetes Mellitus,"LADA (Type 1.5 diabetes) incidence approximately 3-4 per 100k person-years globally based on longitudinal population studies. Distinct from Type 1 and Type 2 diabetes, characterized by adult-onset autoimmune destruction.",moderate,moderate,False,,Tuomi T et al. (1999). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes. 48(3):460-465,https://pubmed.ncbi.nlm.nih.gov/10078544/,literature
C1739363,Prostatic Hypertrophy,,6500.0,prevalence,520000000,0.72,False,,"Benign prostatic hyperplasia (BPH) measured as prevalence. Affects ~50% of men over 50 (~6,500 per 100k total population age-adjusted).",strong,moderate,False,2003,Berry SJ et al. (1984). The development of human benign prostatic hyperplasia. J Urol. 132(3):474-479,https://pubmed.ncbi.nlm.nih.gov/6206240/,literature
C1762616,"Meningioma, benign, no ICD-O subtype",1.5,,incidence,97500,0.65,True,Meningioma,Benign meningiomas comprise ~80% of meningiomas; overall incidence ~2 per 100k.,moderate,low,False,,Cancer registry data,,registry
C1800706,Idiopathic Pulmonary Fibrosis,6.8,,incidence,544000,0.72,True,Interstitial Lung Disease,"Progressive fibrotic lung disease. Incidence ~6-8 per 100k per year, higher in older adults and males.",strong,moderate,False,2006,Raghu G et al. (2006). Incidence and prevalence of IPF. Am J Respir Crit Care Med. 174(7):810-816,https://pubmed.ncbi.nlm.nih.gov/16809633/,literature
C1802398,"Chromosome 5, trisomy 5q",,,,,0.5,False,,"Epidemiological data for Chromosome 5, trisomy 5q requires further investigation.",moderate,moderate,False,,,,
C1827849,IgE-mediated allergic asthma,,3500,prevalence,280000000,0.58,True,Asthma,"IgE-mediated allergic asthma represents approximately 35% of all asthma cases globally (prevalence ~3500 per 100k). Using WHO 2005 asthma prevalence of ~10% (10,000 per 100k) multiplied by proportion of allergic etiology. Incidence not well-defined for this specific phenotype; prevalence is more appropriate for chronic respiratory condition.",moderate,high,False,2005,WHO asthma prevalence estimates; Global Allergy and Asthma Network (GAAN) 2005 data on allergic phenotype distribution,,estimate
C1832386,"Diabetes Mellitus, Transient Neonatal, 1",,,,,0.5,False,,"Epidemiological data for Diabetes Mellitus, Transient Neonatal, 1 requires further investigation.",moderate,moderate,False,,,,
C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,extremely rare,,incidence,,0.2,True,Developmental anomalies,Anophthalmia and pulmonary hypoplasia: rare congenital anomaly syndrome. Very few cases reported.,weak,unknown,False,,,,
C1832916,Timothy syndrome,,,,,0.5,False,,Epidemiological data for Timothy syndrome requires further investigation.,moderate,moderate,False,,,,
C1833429,D-2-hydroxyglutaric aciduria,0.05,,incidence,4000,0.4,True,Hydroxyglutaric Aciduria,D-2-hydroxyglutaric aciduria is a rare genetic metabolic disorder caused by mutations in D2HGDH gene. Estimated incidence approximately 0.05 per 100k based on limited case reports and registry data. No systematic epidemiological studies available.,weak,unknown,False,,,,
C1833683,"Nephrolithiasis, Calcium Oxalate",120,,incidence,9600000,0.72,True,Nephrolithiasis,"Calcium oxalate stones comprise ~80% of all kidney stones. Total kidney stone incidence approximately 150 per 100k person-years in developed countries, so calcium oxalate subset ~120 per 100k.",moderate,moderate,False,2005,Stamatelou KK et al. (2003). Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63(5):1817-1823,https://pubmed.ncbi.nlm.nih.gov/12675858/,literature
C1835933,"Glaucoma 1, Open Angle, G",extremely rare,,incidence,extremely rare,0.28,True,Primary Open-Angle Glaucoma,Rare genetic form of POAG linked to OPTN gene. <100 families reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1836122,"SARCOIDOSIS, EARLY-ONSET",1.5,,incidence,120000,0.55,True,Sarcoidosis,"Reporting incidence of early-onset sarcoidosis (pediatric/young adult). Overall sarcoidosis incidence is 10-20 per 100k in high-incidence populations; early-onset represents approximately 10-15% of cases, estimated at 1-2 per 100k. Limited specific epidemiological data for early-onset subtype.",moderate,high,False,,"Henke CE et al. (1986). The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study. Am J Epidemiol. 123(5):840-845",https://pubmed.ncbi.nlm.nih.gov/3962966/,literature
C1836330,ERYTHROKERATODERMIA VARIABILIS 3 (disorder),extremely rare,,incidence,extremely rare,0.28,True,Erythrokeratodermia Variabilis,Rare genetic skin disorder. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1836517,Senior-Loken Syndrome 5,,,,,0.5,False,,Epidemiological data for Senior-Loken Syndrome 5 requires further investigation.,moderate,moderate,False,,,,
C1838625,Warburg Sjo Fledelius syndrome,extremely rare,,incidence,extremely rare,0.22,False,,Extremely rare genetic syndrome. <5 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1839839,MAJOR AFFECTIVE DISORDER 2,extremely rare,,,extremely rare,0.25,True,Major Affective Disorders,Genetic variant designation (likely OMIM-based) for familial mood disorder. Extremely rare monogenic form. No population-based incidence data; estimated <0.01 per 100k based on genetic case reports.,weak,unknown,False,,,,
C1840061,SMALL PATELLA SYNDROME,extremely rare,,incidence,extremely rare,0.2,False,Skeletal Dysplasias,Small patella syndrome is an extremely rare autosomal dominant skeletal dysplasia characterized by patella hypoplasia/aplasia associated with multiple skeletal abnormalities. Fewer than 100 families reported in medical literature. Estimated incidence <0.01 per 100k births. Aggregate BOTEC consideration: subtype of broader skeletal dysplasia group.,weak,unknown,False,,,,
C1840333,Barakat syndrome,extremely rare,,incidence,extremely rare,0.25,False,,"Extremely rare genetic syndrome (hypoparathyroidism, deafness, renal dysplasia). <100 cases reported. <0.01 per 100k births.",weak,unknown,False,,,,
C1842160,"MYOPATHY, MYOSIN STORAGE (disorder)",extremely rare,,incidence,extremely rare,0.25,True,Congenital Myopathy,Rare genetic myopathy with myosin accumulation. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1842937,"AURAL ATRESIA, CONGENITAL",extremely rare,,incidence,,0.25,True,Ear developmental anomalies,Aural atresia (congenital): rare congenital ear canal absence. Estimated <1 per 100k births.,weak,unknown,False,,,,
C1843013,"Alzheimer disease, familial, type 3",extremely rare,,prevalence,extremely rare,0.35,True,Familial Alzheimer disease,"Familial Alzheimer disease (FAD) type 3 (PSEN1-associated) is extremely rare, with fewer than 100 documented pedigrees worldwide. Estimated prevalence <0.01 per 100k. Limited epidemiological data; confidence reflects rarity and case-report dependent knowledge.",weak,unknown,False,,,,
C1843156,Progressive sensorineural hearing impairment,5.0,,,400000.0,0.6,False,Hearing disorders,Progressive SNHL heterogeneous. Estimated ~5 per 100k based on audiology clinic data.,weak,moderate,False,,,,
C1843851,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",extremely rare,,incidence,extremely rare,0.32,False,,SANDO syndrome - rare mitochondrial disorder. <100 cases reported worldwide. <0.01 per 100k births.,weak,unknown,False,,,,
C1843920,COENZYME Q10 DEFICIENCY,extremely rare,,incidence,extremely rare,0.32,False,,Rare mitochondrial disorder. Primary CoQ10 deficiency <0.1 per 100k births based on case reports.,weak,unknown,False,,,,
C1845235,"Heterotopia, Periventricular, Ehlers-Danlos Variant",extremely rare,,incidence,extremely rare,0.28,True,Periventricular Heterotopia,Extremely rare genetic variant combining periventricular heterotopia and EDS features. <20 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1846006,"Ectodermal dysplasia, hypohidrotic, with immune deficiency",extremely rare,,incidence,extremely rare,0.2,True,Ectodermal Dysplasia,Extremely rare X-linked genetic disorder affecting multiple organ systems. Fewer than 200 cases worldwide documented in medical literature. Combined immunodeficiency component (EDAR gene mutations) makes this subtype exceptionally rare with incidence <0.01 per 100k births.,weak,unknown,False,,,,
C1846142,Hoyeraal-Hreidarsson syndrome,extremely rare,,incidence,extremely rare,0.35,True,Dyskeratosis congenita,"Hoyeraal-Hreidarsson is an extremely rare variant of dyskeratosis congenita, an inherited bone marrow failure syndrome. Fewer than 100 cases have been reported worldwide, with estimated incidence <0.01 per 100k. It represents a specific autosomal recessive form of DC characterized by early onset features.",weak,unknown,False,,,,
C1848634,"USHER SYNDROME, TYPE IIA",0.35,,incidence,28000,0.62,True,Usher Syndrome,Same as Usher syndrome type 2. Birth prevalence ~0.35 per 100k births.,moderate,low,False,,Smith RJ et al. (2014). Usher syndrome. GeneReviews.,https://www.ncbi.nlm.nih.gov/books/NBK1265/,literature
C1850900,Familial primary gastric lymphoma,extremely rare,,,,0.2,True,Gastric Lymphoma,"Extremely rare familial form of gastric lymphoma. <0.01 per 100k, case report basis only.",weak,unknown,False,,,,
C1852197,MAJOR AFFECTIVE DISORDER 1,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD1) on chromosome 18q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C1853710,"HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC (disorder)",extremely rare,,incidence,extremely rare,0.28,True,Charcot-Marie-Tooth Disease,Rare subtype of CMT disease. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1853926,NONAKA MYOPATHY,extremely rare,,incidence,extremely rare,0.28,True,Distal Myopathy,Rare genetic distal myopathy. Higher frequency in Japanese population but globally rare. <0.1 per 100k births.,weak,high,False,,,,
C1855465,STARGARDT DISEASE 1 (disorder),,,,,0.5,False,,Limited epidemiological data available for STARGARDT DISEASE 1 (disorder).,moderate,moderate,False,,,,
C1856934,Epidermolysis bullosa with pyloric atresia,extremely rare,,incidence,,0.2,True,Epidermolysis Bullosa,Epidermolysis bullosa with pyloric atresia is extremely rare subtype (<100 cases reported). <0.01 per 100k.,weak,unknown,False,,,,
C1857276,Trichohepatoenteric Syndrome,,,,,0.5,False,,Epidemiological data for Trichohepatoenteric Syndrome requires further investigation.,moderate,moderate,False,,,,
C1857586,CONOTRUNCAL HEART MALFORMATIONS (disorder),5.0,,,400000.0,0.7,False,Congenital heart defects,"Conotruncal defects (Tetralogy of Fallot, transposition) comprise ~8-10% of all CHD. ~5 per 100k births.",moderate,low,False,,"Birth defects registries (CDC, EUROCAT)",,registry
C1859301,Cerebellar hypoplasia with endosteal sclerosis,extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic syndrome. <10 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1859405,Bowen-Conradi syndrome,extremely rare,,incidence,extremely rare,0.35,False,,"Extremely rare autosomal recessive disorder, primarily in Hutterite populations. <0.01 per 100k globally based on case report literature. Fewer than 100 cases reported worldwide.",weak,high,False,,,,
C1859592,ATRICHIA WITH PAPULAR LESIONS,extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic hair loss disorder. <50 cases reported worldwide. <0.01 per 100k births.,weak,unknown,False,,,,
C1859598,"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA",,,,,0.5,False,,"Epidemiological data for ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA requires further investigation.",moderate,moderate,False,,,,
C1861172,Venous Thromboembolism,117.0,,incidence,9360000,0.82,False,,VTE encompasses DVT and PE. Incidence data from multiple population-based studies shows ~100-200 per 100k in Western populations. Using mid-range estimate of 117 per 100k based on pooled epidemiological data circa 2005.,strong,moderate,False,2006,Heit JA et al. (2005). The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 21(1):23-29,https://pubmed.ncbi.nlm.nih.gov/16475038/,literature
C1861305,TARSAL-CARPAL COALITION SYNDROME,extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic syndrome characterized by fusion of carpal and tarsal bones. <100 cases reported in medical literature worldwide. Estimated <0.01 per 100k based on case report frequency only.,weak,unknown,False,,,,
C1861453,Pseudohyperkalemia Cardiff,0.01,,incidence,0,0.2,True,Hyperkalemia,Pseudohyperkalemia Cardiff is extremely rare genetic variant. Estimated <0.01 per 100k based on case reports.,weak,unknown,False,,,,
C1863012,"Amelogenesis Imperfecta, Type IV",extremely rare,,incidence,extremely rare,0.38,True,Amelogenesis Imperfecta,Rare genetic subtype (hypomaturation/hypoplasia). Represents small fraction of AI cases. <0.1 per 100k births.,weak,unknown,False,,,,
C1863512,"Hypercholesterolemia, autosomal recessive",0.2,,incidence,16000,0.55,True,Familial hypercholesterolemia,"Autosomal recessive hypercholesterolemia (ARH) is a rare genetic disorder of lipid metabolism. Birth incidence estimated at approximately 0.2 per 100,000 births based on case reports and clinical registries. ARH is much rarer than autosomal dominant familial hypercholesterolemia (prevalence 1 in 250-500), representing less than 5% of familial hypercholesterolemia cases.",weak,moderate,False,,Familial hypercholesterolemia clinical registries and GeneReviews,,literature
C1863767,Light Fixation Seizure Syndrome,extremely rare,,incidence,extremely rare,0.15,True,Seizure Disorders,"Extremely rare genetic seizure syndrome triggered by light fixation behavior. Fewer than 50 cases described in medical literature worldwide. This is an ultra-rare developmental/genetic seizure disorder with incidence <0.001 per 100k, identifiable only through case reports and genetic studies.",none,unknown,False,,,,
C1864040,Cerebral Cavernous Malformations 3,extremely rare,,incidence,extremely rare,0.3,True,Cerebral Cavernous Malformations,"CCM3 is a specific genetic subtype caused by PDCD10 gene mutations, one of three CCM genes (CCM1/KRIT1, CCM2, CCM3/PDCD10). CCM3 represents ~10-15% of familial CCM cases. With overall familial CCM birth incidence <0.1 per 100k, CCM3 incidence is <0.01 per 100k. Limited population-based data for specific genetic subtypes.",weak,unknown,False,,,,
C1864738,"Corneal Dystrophy, Congenital Stromal",extremely rare,,incidence,extremely rare,0.28,True,Corneal Dystrophy,Rare genetic corneal disorder. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1864801,TRICHILEMMAL CYST 1,0.5,,incidence,40000,0.3,True,Trichilemmal cyst,Genetic form of trichilemmal cyst; estimated <0.5 per 100k based on case frequency.,weak,unknown,False,,,,
C1865371,"SEVERE COMBINED IMMUNODEFICIENCY, ATHABASKAN-TYPE",extremely rare,,incidence,extremely rare,0.28,True,Severe Combined Immunodeficiency,Rare SCID variant in Athabaskan Native Americans. <50 cases reported. <0.01 per 100k births.,weak,high,False,,,,
C1865373,"SEVERE COMBINED IMMUNODEFICIENCY, PARTIAL",0.03,,incidence,2400,0.45,True,Severe Combined Immunodeficiency,"Leaky SCID with partial immune function. Represents ~10-15% of SCID cases. Total SCID ~0.2 per 100k births, partial ~0.03 per 100k.",moderate,low,False,,,,
C1865384,"Amyotrophy, monomelic",extremely rare,,incidence,extremely rare,0.25,True,Motor Neuron Disease,"Rare variant of motor neuron disease, <0.1 per 100k.",weak,unknown,False,,,,
C1867441,Pterygium Of Conjunctiva And Cornea,8.0,,incidence,640000,0.52,False,Pterygium,"Pterygium of conjunctiva and cornea (full anatomical description of same condition as C0033999 and C4520843). Incidence ~8 per 100k globally with extreme geographic variation (UV-dependent, 0.3-29% prevalence by latitude).",moderate,high,False,,,,
C1867743,Premature coronary artery atherosclerosis,15.5,,incidence,1240000,0.58,True,Coronary artery disease,"Incidence estimate ~15.5 per 100k for premature coronary atherosclerosis (age <50-55 years). Based on population studies, but limited specific epidemiological data for this age-specific subset. Varies significantly by gender and definition of 'premature'.",moderate,high,False,,Pooled analysis of coronary artery disease epidemiology studies (pre-2005),,estimate
C1868081,Juvenile Polyposis Coli,extremely rare,,incidence,extremely rare,0.35,True,Juvenile Polyposis Syndrome,"Extremely rare hereditary condition, subset of juvenile polyposis syndrome affecting primarily the colon. Estimated <0.1 per 100k births based on case reports and genetic registry data. Limited systematic epidemiological studies.",weak,unknown,False,,,,
C1868310,Pigmented Paravenous Chorioretinal Atrophy,extremely rare,,incidence,extremely rare,0.25,False,Retinal Dystrophy,"Pigmented paravenous chorioretinal atrophy (PPCRA) is an extremely rare inherited retinal condition. Estimated incidence <0.01 per 100k based on case report frequency in ophthalmology literature, with fewer than 100 families documented worldwide.",weak,unknown,False,,,,
C1868598,PARIETAL FORAMINA,,,,,0.5,False,,Limited epidemiological data available for PARIETAL FORAMINA.,moderate,moderate,False,,,,
C1868681,DYSTONIA 12,extremely rare,,incidence,extremely rare,0.3,True,Dystonia,DYT12 (rapid-onset dystonia-parkinsonism) is an extremely rare autosomal dominant genetic disorder caused by ATP1A3 mutations. Estimated <0.01 per 100k based on case report frequency. Only dozens of families reported worldwide.,weak,unknown,False,,,,
C1868683,"B-CELL MALIGNANCY, LOW-GRADE",3.5,,incidence,280000,0.28,False,,"Aggregate BOTEC estimate summing major low-grade B-cell malignancies: CLL (~2.0), follicular lymphoma (~1.0), MALT/marginal zone lymphomas (~0.5) = ~3.5 per 100k. Heterogeneous umbrella term with variable prognosis.",weak,moderate,False,2005,GLOBOCAN 2005 NHL data (aggregated subtypes),https://gco.iarc.fr/,registry
C1868938,End stage cardiac failure,35,,incidence,2800000,0.55,True,Heart failure,End-stage heart failure represents advanced disease (NYHA Class IV). Estimated at ~15-20% of incident heart failure cases progress to end-stage. Approximate incidence ~35 per 100k person-years. Limited population-based data for this specific stage.,moderate,moderate,False,,,,
C1876187,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL",extremely rare,,incidence,extremely rare,0.35,True,Tumoral calcinosis,"Rare genetic disorder with hyperphosphatemia and ectopic calcification. Associated with GALNT3, FGF23, and KLOTHO mutations. Estimated <0.01 per 100k based on rare case reports in literature. Limited epidemiological data.",weak,unknown,False,,,,
C1955634,Kaposi's sarcoma-associated herpesvirus infection,2.5,,incidence,200000,0.65,False,,"Reporting Kaposi's sarcoma incidence as proxy for clinically significant HHV-8 infection. GLOBOCAN 2005 data shows ~2.5 per 100k globally, with high geographic variation (much higher in sub-Saharan Africa due to HIV co-infection).",moderate,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C1955934,Trichothiodystrophy Syndromes,extremely rare,,,,0.3,False,Genetic hair and skin disorders,"Group of rare genetic disorders affecting hair, skin, and nails. <0.1 per 100k births based on case reports.",weak,unknown,False,,,,
C1956346,Coronary Artery Disease,268,3700,both,21440000,0.78,True,Atherosclerosis,"CAD is atherosclerosis of coronary arteries. Reporting incidence of ~268 per 100k based on WHO Global Burden of Disease 2005 data for ischemic heart disease events. Prevalence ~3.7% (3,700 per 100k) in adults. Subtype of atherosclerosis with strong epidemiological data.",strong,high,True,2005,WHO Global Burden of Disease Study 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C1960272,Latent autoimmune diabetes mellitus in adult,3.5,,incidence,280000,0.72,True,Diabetes Mellitus,Synonymous with LADA (C1739108). Incidence approximately 3-4 per 100k person-years. Adult-onset form of autoimmune diabetes with slower progression than classic Type 1 diabetes.,moderate,moderate,False,,Tuomi T et al. (1999). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes. 48(3):460-465,https://pubmed.ncbi.nlm.nih.gov/10078544/,literature
C1960546,Myxoma of heart,0.5,,incidence,40000,0.62,True,Cardiac Tumor,Most common primary cardiac tumor. Incidence ~0.4-0.6 per 100k per year (0.5 estimate). Most are atrial myxomas.,moderate,low,False,,,,
C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.35,,incidence,28000,0.58,True,Acute Lymphoblastic Leukemia,"T-cell immunophenotype represents ~15-25% of ALL/LBL cases. Overall ALL incidence ~1.8 per 100k, T-cell subset estimated at ~0.35 per 100k. Moderate confidence due to limited immunophenotype-specific registry data for 2005.",moderate,low,False,,Pui CH et al. (2008). Acute lymphoblastic leukemia. N Engl J Med. 350:1535-1548,https://pubmed.ncbi.nlm.nih.gov/15071128/,literature
C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,1.5,,incidence,120000,0.85,True,Leukemia,Acute lymphoblastic leukemia (ALL) incidence ~1.5 per 100k globally. Well-documented in cancer registries with consistent reporting across populations.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1963943,Atherothrombosis,,,,,0.0,False,,"Pathophysiological process descriptor rather than discrete disease entity. Atherothrombosis describes the mechanism underlying MI, stroke, and peripheral arterial disease, not a separate diagnosis. Would create complete overlap with these specific conditions.",none,unknown,False,,,,
C1969623,"NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME",extremely rare,,incidence,extremely rare,0.28,True,Neurofibromatosis Type 1,Rare genetic variant. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C1970943,MAJOR AFFECTIVE DISORDER 4,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD4) on chromosome 5q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C1970945,MAJOR AFFECTIVE DISORDER 6,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD6) on chromosome 15q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2004493,"Leukemia, B-Cell",3.8,,incidence,304000,0.78,True,Leukemia,"B-cell leukemias (CLL, B-cell ALL, B-cell prolymphocytic leukemia, hairy cell leukemia) represent ~50% of all leukemia cases. Global leukemia incidence ~7-8 per 100k; B-cell leukemias ~3.8 per 100k. Based on cancer registry data and epidemiological estimates.",strong,moderate,False,,Siegel RL et al. (2013). Cancer statistics for different races and ethnicities in the United States using methods modified from the SEER database. Cancer Epidemiol Biomarkers Prev. 22(11):1993-2001,https://pubmed.ncbi.nlm.nih.gov/24042210/,literature
C2062441,Influenza A,3000,,incidence,240000000,0.7,True,Influenza,Influenza A virus accounts for majority of seasonal flu cases. Global attack rates ~5-10% annually. Estimated ~3000 per 100k per year (3% population) based on WHO surveillance data.,strong,moderate,True,2005,WHO Global Influenza Surveillance Network,https://www.who.int/influenza/surveillance_monitoring/en/,registry
C2145472,Urothelial Carcinoma,9.2,,incidence,736000,0.82,True,Bladder Cancer,"Urothelial carcinoma (transitional cell carcinoma) accounts for ~90% of bladder cancers. Global incidence ~9.2 per 100k (GLOBOCAN 2005). Well-documented in cancer registries. Geographic variation moderate, higher incidence in developed nations.",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C2239176,Liver carcinoma,10.8,,incidence,864000,0.87,True,Liver Cancer,Hepatocellular carcinoma (HCC) incidence from GLOBOCAN 2002 data (closest to 2005): ~10.8 per 100k globally. Geographic variation is substantial: <2 per 100k in North America/Europe versus >20 per 100k in East Asia and sub-Saharan Africa due to hepatitis B and C prevalence.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C2266788,Trichilemmal cyst,5.0,,incidence,400000,0.45,False,Scalp Cyst,Trichilemmal cyst (sebaceous cyst variant) estimated at 5 per 100k based on dermatology data.,weak,low,False,,,,
C2347761,Childhood Myelodysplastic Syndrome,1.0,,,80000.0,0.7,True,Myelodysplastic Syndromes,"Pediatric MDS, rare. Estimated ~1 per 100k children based on pediatric cancer registries.",moderate,low,False,,Pediatric cancer registries,,registry
C2347762,Childhood Teratoma,0.5,,incidence,40000,0.58,True,Teratoma,Pediatric germ cell tumors. Incidence ~0.4-0.6 per 100k children per year (0.5 estimate age-adjusted to total population).,moderate,low,False,,,,
C2348101,Destructive Arthritis,,,,,0.0,False,,"Pathological descriptor covering multiple arthritides (RA, erosive OA, etc). Umbrella term too heterogeneous to estimate.",none,unknown,False,,,,
C2350344,Chronic Lung Injury,,,,,0.0,False,,"Umbrella term too heterogeneous and vague to estimate meaningfully. Could encompass COPD, pulmonary fibrosis, chronic ARDS sequelae, occupational lung disease, and many other conditions with vastly different etiologies, prevalences, and clinical significance.",none,unknown,False,,,,
C2362324,Pediatric Obesity,,3200,prevalence,256000000,0.78,True,Obesity,"Chronic condition measured as prevalence. WHO data from 2005 shows approximately 3.2% of children globally were obese (3,200 per 100k). Prevalence is the appropriate metric for this chronic condition.",strong,high,True,2005,de Onis M et al. (2010). Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 92(5):1257-64,https://pubmed.ncbi.nlm.nih.gov/20861173/,literature
C2363741,HIV-1 infection,43.0,,incidence,3440000,0.88,True,HIV infection,"HIV-1 is the most common HIV type globally. UNAIDS 2005 report estimated 2.8 million new HIV infections globally, approximately 43 per 100k person-years. High geographic variation with Sub-Saharan Africa having much higher rates.",strong,high,True,2005,UNAIDS/WHO AIDS Epidemic Update 2005,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,registry
C2363973,Chronic thromboembolic pulmonary hypertension,2.0,,incidence,160000,0.62,True,Pulmonary Hypertension,CTEPH incidence estimated at 2 per 100k person-years based on pulmonary hypertension registries.,moderate,moderate,False,,,,
C2607914,Allergic rhinitis (disorder),,12000,prevalence,960000000,0.76,False,,"Allergic rhinitis measured as prevalence - chronic condition with episodic symptoms. Global prevalence ~12% (12,000 per 100k) with significant regional variation (higher in developed countries). Incidence poorly defined for this condition.",moderate,high,False,,,,
C2609253,Macrovascular disease,,,,,0.0,False,,"Too broad umbrella term: includes CAD, peripheral arterial disease, stroke. Not specific enough to estimate meaningfully.",none,unknown,False,,,,
C2609259,Symphysis Pubis Dysfunction,50,200,both,3250000,0.5,False,,Pregnancy-related pelvic pain condition. Incidence in pregnancy ~50 per 100k pregnancies; prevalence ~0.2% population.,weak,unknown,False,,,,
C2675519,Hypoadiponectinemia,,,,,0.5,False,,Epidemiological data for Hypoadiponectinemia requires further investigation.,moderate,moderate,False,,,,
C2676033,Hepatoblastoma Caused By Somatic Mutation,0.08,,incidence,5200,0.5,True,Hepatoblastoma,Hepatoblastoma rare tumor ~0.8 per 100k children <5 years; somatic mutation subtype estimated ~10% of cases.,weak,moderate,False,,,,
C2697636,Hyperdiploid B Acute Lymphoblastic Leukemia,1.2,,incidence,96000,0.65,True,B-cell Acute Lymphoblastic Leukemia,"Reporting incidence of new diagnoses. Hyperdiploid B-ALL represents ~25-30% of childhood B-ALL cases. With pediatric ALL incidence ~4 per 100k children and hyperdiploid being 25-30% of B-ALL cases, estimated ~1.2 per 100k overall population.",moderate,low,False,,Pui CH et al. (2004). Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 22(15):2902-2913,https://pubmed.ncbi.nlm.nih.gov/15254062/,literature
C2699746,"Syndactyly, type 2",0.3,,incidence,19500,0.6,True,Syndactyly,"Syndactyly overall ~3-4 per 10,000 births; type 2 (simple SD) ~50% of cases.",moderate,low,False,,Birth defect registries,,registry
C2700438,MAJOR AFFECTIVE DISORDER 7,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD7) on chromosome 1q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2700439,MAJOR AFFECTIVE DISORDER 8,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD8), not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2700440,MAJOR AFFECTIVE DISORDER 9,extremely rare,,,extremely rare,0.25,True,Major Affective Disorders,"Genetic variant designation for familial mood disorder, likely another rare monogenic form. No systematic epidemiological data; estimated <0.01 per 100k based on genetic literature.",weak,unknown,False,,,,
C2700553,Omenn Syndrome,extremely rare,,incidence,extremely rare,0.32,True,Severe Combined Immunodeficiency,Rare variant of SCID with erythroderma and eosinophilia. <100 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C2711227,Steatohepatitis,,3000.0,prevalence,240000000,0.7,False,,"Encompasses NASH and alcoholic steatohepatitis. Chronic liver condition measured by prevalence rather than incidence. Global NASH prevalence circa 2005 estimated at 2-5% of adults, approximately 3,000 per 100k (3%). Incidence data poorly documented.",moderate,high,False,2005,Browning JD et al. (2004). Prevalence of hepatic steatosis in an urban population. Hepatology. 40(6):1387-1395,https://pubmed.ncbi.nlm.nih.gov/15565570/,literature
C2717836,Steroid Sulfatase Deficiency Disease,0.3,,incidence,24000,0.68,False,,"Steroid sulfatase deficiency causes X-linked ichthyosis. Same epidemiology as X-linked ichthyosis with birth prevalence 1 in 2,000-6,000 males, converting to ~0.3 per 100k person-years incidence.",moderate,low,False,,Orphanet and genetic disease registries,,registry
C2717961,Thrombotic Microangiopathies,1.2,,incidence,96000,0.58,False,,"Umbrella term including TTP, HUS, and related microangiopathies. Aggregate estimate ~1-1.5 per 100k based on registry data for major subtypes.",moderate,moderate,False,,,,
C2721731,Burkholderia multivorans infection,0.1,,incidence,8000,0.42,True,Burkholderia Infection,Opportunistic infection primarily in cystic fibrosis patients. Incidence ~0.1 per 100k per year. Lower confidence due to limited surveillance.,weak,moderate,False,,,,
C2745900,Promyelocytic leukemia,0.15,,incidence,12000,0.68,True,Acute myeloid leukemia,"Reporting incidence at ~0.15 per 100k person-years. Acute promyelocytic leukemia (APL) represents 10-15% of AML cases. Global AML incidence ~1-1.5 per 100k, making APL ~0.1-0.2 per 100k based on cancer registry data.",strong,moderate,False,,Lehmann S et al. (2011). Continuing improvement in survival in acute promyelocytic leukemia. Blood. 118(11):e1-9,https://pubmed.ncbi.nlm.nih.gov/21768301/,literature
C2745959,"Spondyloepiphyseal dysplasia, congenita",extremely rare,,incidence,extremely rare,0.35,True,Skeletal Dysplasia,"Spondyloepiphyseal dysplasia congenita (SED congenita) is a rare autosomal dominant hereditary skeletal dysplasia. Estimated at <1 per 100,000 births based on case reports and genetic databases. Extremely limited epidemiological data available.",weak,unknown,False,,,,
C2746066,Combined D-2- and L-2-hydroxyglutaric aciduria,extremely rare,,incidence,extremely rare,0.3,True,Hydroxyglutaric Aciduria,"Combined form of hydroxyglutaric aciduria is extremely rare, with fewer than 20 documented cases worldwide. Estimated <0.01 per 100k births. Specific metabolic phenotype combining D-2 and L-2 forms.",weak,unknown,False,,,,
C2747816,Complicated malaria,150.0,,incidence,12000000,0.68,True,Malaria,"Severe/complicated malaria (cerebral, severe anemia, organ failure). Represents ~5% of malaria cases. Total malaria 3,000 per 100k, complicated ~150 per 100k.",moderate,high,False,2005,,,
C2748918,Otopalatodigital Spectrum Disorder,extremely rare,,incidence,,0.3,False,,Otopalatodigital spectrum disorders are rare X-linked skeletal dysplasias with <500 cases reported.,weak,unknown,False,,,,
C2749757,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1,extremely rare,,incidence,extremely rare,0.35,True,Bronchiectasis,Rare genetic form of bronchiectasis associated with SCNN1B gene mutations. Specific incidence unknown but estimated <0.1 per 100k based on rarity in genetic databases and case report frequency.,weak,unknown,False,,,,
C2750078,"Hypophosphatemic Rickets, Autosomal Recessive, 2",extremely rare,,incidence,extremely rare,0.25,True,Hypophosphatemic Rickets,"Extremely rare monogenic disorder affecting phosphate metabolism. Autosomal recessive inheritance with fewer than 100 documented cases worldwide, estimated <0.01 per 100k births.",weak,unknown,False,,,,
C2751310,"Hyperuricemic Nephropathy, Familial Juvenile 2",extremely rare,,incidence,extremely rare,0.3,True,Familial Juvenile Hyperuricemic Nephropathy,Extremely rare autosomal dominant disorder with juvenile-onset hyperuricemia and progressive renal failure. Caused by UMOD gene mutations. <0.01 per 100k based on genetic registry data and case reports.,weak,unknown,False,,Hart TC et al. (2002). Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 39(12):882-892,https://pubmed.ncbi.nlm.nih.gov/12471200/,literature
C2751492,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",extremely rare,,incidence,extremely rare,0.68,True,Hereditary Amyloidosis,"Hereditary transthyretin amyloidosis (ATTRv or familial amyloid polyneuropathy) is extremely rare, <0.1 per 100k globally. Higher in endemic areas (Portugal, Sweden, Japan) due to founder mutations. Incidence of symptomatic disease estimated <0.01 per 100k in non-endemic populations.",moderate,high,False,,"Schmidt HH et al. (2003). Roswell Park Cancer Institute, hereditary amyloidosis review. Amyloid. 10(Suppl 1):85-93",,literature
C2826323,Refractory Cytopenia of Childhood,0.1,,incidence,8000,0.52,True,Myelodysplastic Syndrome,Pediatric MDS subtype. Very rare. Incidence ~0.1 per 100k per year in children. Lower confidence due to rarity.,moderate,low,False,,,,
C2827362,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,extremely rare,,incidence,extremely rare,0.35,True,Myeloid and Lymphoid Neoplasms with Recurrent Genetic Abnormality,Extremely rare hematologic malignancy defined by FGFR1 rearrangement (WHO 2016 classification). Estimated <0.1 per 100k based on cytogenetic registry data. Confidence limited by reliance on specialized genetic testing registries and small case series; not captured in population-based cancer registries.,weak,unknown,False,,Swerdlow SH et al. (2016). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC,,literature
C2874188,Isolated deficiency of pituitary hormone,15.0,,incidence,1200000,0.35,False,,"Umbrella term covering isolated deficiency of any single pituitary hormone (GH, ACTH, TSH, prolactin, or gonadotropins). Aggregate BOTEC estimate summing major forms: isolated GHD (~10 per 100k), isolated ACTH deficiency (~2 per 100k), isolated gonadotropin deficiency (~2 per 100k), others (~1 per 100k) = ~15 per 100k total. Low confidence due to heterogeneity and lack of unified epidemiological data.",weak,high,False,,,,
C2874190,Pituitary short stature,10.0,,incidence,800000,0.45,True,Growth Hormone Deficiency,"Pituitary short stature is a clinical manifestation of growth hormone deficiency (GHD) affecting approximately 1 per 10,000 births. Estimated incidence ~10 per 100k globally based on congenital GHD rates. Confidence limited due to heterogeneous definition and lack of international registry data.",weak,moderate,False,,,,
C2875300,Peroneal muscular atrophy (axonal type) (hypertrophic type),1.5,,incidence,120000,0.62,True,Charcot-Marie-Tooth Disease,CMT types 1 and 2 combined. Incidence ~1-2 per 100k births (1.5 estimate).,moderate,low,False,,,,
C2919945,Cavernous Hemangioma of Brain,,400,prevalence,32000000,0.7,False,,"Cerebral cavernous malformations (CCMs) are better characterized by prevalence than incidence, as they are congenital/developmental vascular malformations often remaining asymptomatic. MRI and autopsy studies show prevalence of 0.4-0.5% of population (~400 per 100k). Most are sporadic (80%) and discovered incidentally. Annual symptomatic presentation rate much lower (~0.5 per 100k), but total prevalence is the more meaningful epidemiological metric.",strong,low,False,,Zabramski JM et al. (1994). The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 80(3):422-432,https://pubmed.ncbi.nlm.nih.gov/8113854/,literature
C2930930,Abdominal obesity metabolic syndrome,,,,,0.5,False,,Epidemiological data for Abdominal obesity metabolic syndrome requires further investigation.,moderate,moderate,False,,,,
C2931206,"Usher syndrome, type 1B",0.15,3.5,prevalence,280000,0.52,True,Usher syndrome,Usher syndrome type 1B is a rare autosomal recessive genetic disorder. Reporting prevalence (~3.5 per 100k) rather than incidence due to genetic nature of condition. Type 1B is one of several subtypes; global prevalence varies by population screening.,moderate,moderate,False,,,,
C2931263,Familial cerebral cavernous malformation,extremely rare,80,prevalence,6400000,0.5,True,Cerebral Cavernous Malformations,"Familial CCM represents ~20% of all CCM cases (autosomal dominant inheritance with mutations in KRIT1, CCM2, or PDCD10 genes). With total CCM prevalence ~400 per 100k, familial cases estimated at ~80 per 100k. Birth incidence would be <0.05 per 100k. Prevalence is more appropriate metric as these are congenital malformations with variable age of symptom onset. Higher prevalence in Hispanic populations (New Mexico founder effect).",moderate,moderate,False,,Akers A et al. (2017). Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations. Neurosurgery. 80(5):665-680,https://pubmed.ncbi.nlm.nih.gov/28327981/,literature
C2931367,"Thyroid cancer, follicular",0.7,,incidence,56000,0.75,True,Thyroid Carcinoma,"Follicular thyroid carcinoma is a specific histological subtype comprising ~10-15% of all thyroid cancers. Global thyroid cancer incidence ~5 per 100k (GLOBOCAN 2005), so follicular subtype ~0.7 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - thyroid cancer data with subtype distribution from SEER,https://gco.iarc.fr/,registry
C2931418,Bare lymphocyte syndrome 2,extremely rare,,incidence,,0.2,True,Bare Lymphocyte Syndrome,BLS type 2 is rarer variant of bare lymphocyte syndrome with <10 cases reported.,weak,unknown,False,,,,
C2931456,"Prostate cancer, familial",8.5,,incidence,680000,0.72,True,Prostate cancer,"Familial prostate cancer (FPC) represents approximately 5-10% of all prostate cancer cases, with hereditary predisposition due to germline mutations in BRCA1, BRCA2, PTEN, CHEK2, and other genes. Global prostate cancer incidence approximately 85 per 100,000 men; familial form estimated at 8-10 per 100,000 based on epidemiological studies. Characterized by earlier age of onset (mean age 55-65 vs 70+ for sporadic).",strong,moderate,True,2005,Hemminki K et al. Familial prostate cancer: epidemiological appraisal of familial risk and assessment of linkage to known susceptibility loci. Int J Cancer. 2012;131(6):1420-1429,https://pubmed.ncbi.nlm.nih.gov/22114049/,literature
C2931618,Gestational trophoblastic disease,3.2,,incidence,256000,0.55,False,,"Umbrella term including complete mole, partial mole, invasive mole, and choriocarcinoma. Global incidence approximately 1-2 per 1000 pregnancies (higher in Asia, lower in Western countries). Estimated at ~3.2 per 100k person-years based on pregnancy rates and molar pregnancy frequency.",moderate,high,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C2931689,Dystrophia myotonica 2,,,,,0.5,False,,Epidemiological data for Dystrophia myotonica 2 requires further investigation.,moderate,moderate,False,,,,
C2931822,Nasopharyngeal carcinoma,1.2,,incidence,96000,0.85,True,Head and Neck Cancer,Nasopharyngeal carcinoma global incidence from GLOBOCAN 2005: ~1.2 per 100k. Extreme geographic variation: endemic in Southern China/Southeast Asia (20-30 per 100k) but <1 per 100k in most regions due to EBV and genetic factors.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C2931845,Neurodegeneration with brain iron accumulation (NBIA),0.1,,incidence,8000,0.4,False,,Rare group of genetic neurodegenerative disorders with brain iron deposition. Estimated incidence <0.1 per 100k based on case series. Limited epidemiological data.,weak,unknown,False,,,,
C2931852,Clear-cell metastatic renal cell carcinoma,2.1,,incidence,168000,0.62,True,Renal Cell Carcinoma,"Clear-cell RCC accounts for ~70-75% of all RCC cases, and ~20-25% present with metastatic disease. Estimated from global RCC incidence of ~10 per 100k: 10 × 0.75 × 0.25 = ~1.9-2.1 per 100k. Lower confidence due to estimation of specific subtype combination.",moderate,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C2936332,Alpha-Sarcoglycanopathies,,,,,0.5,False,,Epidemiological data for Alpha-Sarcoglycanopathies requires further investigation.,moderate,moderate,False,,,,
C2936777,Nevo syndrome (disorder),extremely rare,,incidence,extremely rare,0.32,False,,Extremely rare genetic syndrome. <50 cases reported worldwide. <0.01 per 100k births.,weak,unknown,False,,,,
C2936858,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,0.14,,incidence,11200,0.82,True,Congenital Adrenal Hyperplasia,"Classic 21-hydroxylase deficiency CAH occurs in ~1 per 15,000 births globally. With crude birth rate of ~20 per 1,000 population, this translates to ~0.14 per 100k person-years.",strong,moderate,False,,Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,https://pubmed.ncbi.nlm.nih.gov/20823466/,literature
C2937421,Prostatic Hyperplasia,,2000,prevalence,160000000,0.75,False,,"Benign prostatic hyperplasia (BPH) is a chronic condition reported as prevalence. Global prevalence estimated at ~2% of total population (~2000 per 100k), though much higher in elderly males (40-50% of men over 50). Reporting population-wide prevalence estimate.",strong,moderate,False,,Parsons JK. (2010). Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 5(4):212-218,https://pubmed.ncbi.nlm.nih.gov/21114804/,literature
C2938924,Oestrogen receptor positive breast cancer,35,,incidence,2800,0.75,True,Breast Cancer,ER-positive breast cancer represents ~70% of breast cancers (~35 per 100k incidence in women).,strong,moderate,False,,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C2939419,Secondary Neoplasm,,,,,0.0,False,,Umbrella term for all metastatic cancers to any site from any primary cancer. Too heterogeneous to estimate meaningfully - encompasses metastases from hundreds of primary cancer types to dozens of organs with vastly different incidence rates and clinical significance.,none,high,False,,,,
C2939465,Deficiency of glucose-6-phosphate dehydrogenase,,,,,0.5,False,,Epidemiological data for Deficiency of glucose-6-phosphate dehydrogenase requires further investigation.,moderate,moderate,False,,,,
C2960064,Low grade dysplastic nodule,2.5,,incidence,200000,0.35,True,Hepatic dysplastic nodule,"Histopathological finding in cirrhotic livers, not a traditional disease entity. Estimated at ~20-30% of HCC cases (HCC ~12 per 100k), suggesting ~2.5 per 100k. Low confidence due to lack of population-based surveillance and unclear clinical significance.",weak,high,False,,,,
C2960065,High grade dysplastic nodule,1.8,,incidence,144000,0.32,True,Hepatic dysplastic nodule,"Pre-malignant liver lesion in cirrhotic patients, direct precursor to HCC. Less common than low-grade dysplastic nodules. Estimated at ~15% of HCC incidence (~1.8 per 100k). Very low confidence due to lack of population surveillance and detection bias.",weak,high,False,,,,
C2973725,Pulmonary arterial hypertension,2.4,,incidence,192000,0.72,False,,"All PAH including idiopathic, heritable, drug-induced, and associated forms. Incidence ~2-3 per 100k per year (2.4 estimate).",strong,low,False,,Humbert M et al. (2006). Pulmonary arterial hypertension. Am J Respir Crit Care Med. 173(9):1023-1030,https://pubmed.ncbi.nlm.nih.gov/16456139/,literature
C2981132,Shell teeth,extremely rare,,,,0.3,True,Dentin dysplasia,"Rare dental anomaly. <0.1 per 100k, sparse case reports.",weak,unknown,False,,,,
C2986703,Overgrowth Syndrome,2.0,,incidence,160000,0.28,False,,"Aggregate BOTEC estimate summing major overgrowth syndromes: Beckwith-Wiedemann (~1.0), Sotos (~0.5), Simpson-Golabi-Behmel (~0.2), Weaver (~0.1), Proteus (extremely rare), others (~0.2) = ~2 per 100k births. Heterogeneous group with varying severity.",weak,moderate,False,,,,estimate
C2987128,Digestive System Neuroendocrine Carcinoma,2.5,,incidence,200000,0.68,True,"Carcinoma, Neuroendocrine","GI and pancreatic NETs. Represents ~70% of all NETs. Total NET incidence ~3.5 per 100k, GI/pancreatic subset ~2.5 per 100k.",moderate,moderate,False,,,,
C3150928,NF1 Microdeletion Syndrome,0.25,,incidence,20000,0.58,True,Neurofibromatosis Type 1,"Specific NF1 deletion subtype representing ~5-10% of NF1 cases. NF1 incidence ~3-5 per 100k births, microdeletion subset ~0.25 per 100k.",moderate,low,False,,,,
C3150941,RUBINSTEIN-TAYBI SYNDROME 2,extremely rare,,incidence,extremely rare,0.32,True,Rubinstein-Taybi Syndrome,RTS type 2 (EP300 mutations). Rarer than RTS type 1. <50 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C3151190,RETINITIS PIGMENTOSA 48,extremely rare,,incidence,extremely rare,0.35,True,Retinitis Pigmentosa,"RP48 is an extremely rare genetic subtype caused by specific mutations. While RP overall affects ~1 in 4000 (25 per 100k prevalence), type 48 represents <1% of RP cases. Estimated <0.01 per 100k based on genetic case reports.",weak,unknown,False,,,,
C3151465,PROTEIN Z DEFICIENCY,5.0,,prevalence,400000,0.4,False,Bleeding Disorder,Protein Z deficiency prevalence estimated at 5 per 100k based on coagulation studies.,weak,unknown,False,,,,
C3152055,D-2-HYDROXYGLUTARIC ACIDURIA 1,0.05,,incidence,4000,0.4,True,D-2-hydroxyglutaric aciduria,D-2-hydroxyglutaric aciduria type 1 is a rare autosomal recessive metabolic disorder caused by mutations in D2HGDH gene. Estimated incidence approximately 0.05 per 100k based on limited case reports. No large epidemiological studies or registry data with systematic incidence estimates.,weak,unknown,False,,,,
C3160738,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",extremely rare,,incidence,extremely rare,0.28,True,Fanconi Anemia,"Fanconi anemia complementation group D2 is an extremely rare genetic subtype, with <1% of all FA cases belonging to this group. Estimated incidence <0.01 per 100k person-years based on scattered case reports in medical literature. Very limited epidemiological data available.",weak,unknown,False,,,,
C3160844,PAI-1 polymorphism,,,,,0.0,False,,"PAI-1 polymorphism is a genetic variant, not a disease. Not meaningful to estimate population incidence of genetic variants.",none,unknown,False,,,,
C3203102,Idiopathic pulmonary arterial hypertension,0.5,,incidence,40000,0.68,True,Pulmonary Arterial Hypertension,Idiopathic PAH (previously primary PAH). Incidence ~0.5-1.0 per 100k per year (0.5 estimate). Rare disease.,moderate,low,False,,Humbert M et al. (2006). Pulmonary arterial hypertension in France. Am J Respir Crit Care Med. 173(9):1023-1030,https://pubmed.ncbi.nlm.nih.gov/16456139/,literature
C3241937,Nonalcoholic Steatohepatitis,,1500.0,prevalence,120000000,0.68,True,Non-Alcoholic Fatty Liver Disease,"NASH (inflammatory NAFLD). Represents ~20-30% of NAFLD cases. NAFLD prevalence ~5,000 per 100k, NASH subset ~1,500 per 100k.",moderate,high,False,,Younossi ZM et al. (2016). Global epidemiology of NAFLD. Hepatology. 64(1):73-84,https://pubmed.ncbi.nlm.nih.gov/26707365/,literature
C3250443,MYOTONIC DYSTROPHY 1,,8.0,prevalence,640000,0.75,True,Myotonic Dystrophy,Genetic disorder measured by prevalence. DM1 prevalence approximately 8 per 100k based on population studies. Most common adult-onset muscular dystrophy. Type 1 (CTG expansion) is more common than Type 2.,strong,moderate,False,,Theadom A et al. (2014). Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 43(3-4):259-68,https://pubmed.ncbi.nlm.nih.gov/25532075/,literature
C3266262,Multiple Chronic Conditions,,25000,prevalence,2000000000,0.35,False,,"This is a prevalence-based concept (having 2+ chronic conditions simultaneously), not an incident disease. Estimated ~25% of global adults have multiple chronic conditions based on WHO 2005 data, but definition varies widely across studies.",weak,high,False,,,,
C3280216,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3",extremely rare,,incidence,extremely rare,0.3,True,Familial Juvenile Hyperuricemic Nephropathy,Extremely rare autosomal dominant tubulointerstitial kidney disease caused by specific genetic mutations. <0.01 per 100k based on case report frequency and genetic databases. Specific genetic subtype (FJHN3).,weak,unknown,False,,,,
C3463824,Myelodysplastic Syndrome,4.0,,incidence,320000,0.82,False,,"MDS global incidence ~4 per 100k overall population, but strongly age-dependent (15-50 per 100k in adults >70). Well-documented in cancer registries including SEER and European registries.",strong,moderate,False,2005,Ma X et al. (2007). Epidemiology of myelodysplastic syndromes. Am J Med. 120(7 Suppl 1):S2-10,https://pubmed.ncbi.nlm.nih.gov/17602924/,literature
C3469186,"HEMOCHROMATOSIS, TYPE 1",2.5,,incidence,200000,0.65,True,Hereditary Hemochromatosis,"HFE-related hereditary hemochromatosis (Type 1), most common form. Clinical diagnosis incidence ~2-3 per 100k despite higher genetic prevalence. Based on population screening studies.",moderate,moderate,False,2005,Adams PC et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 352:1769-78,https://pubmed.ncbi.nlm.nih.gov/15858186/,literature
C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",0.7,,incidence,56000,0.58,True,Fanconi Anemia,"Fanconi anemia complementation group A is the most common subtype, representing ~60% of all FA cases. Global incidence estimated at ~1 per 150,000 live births (~0.7 per 100k person-years). Limited epidemiological data available for this specific complementation group; estimates derived from FA registries and case series.",weak,unknown,False,,Fanconi Anemia Research Fund (FARF) and OMIM (Online Mendelian Inheritance in Man) disease registry data from case reports and genetic studies,https://www.fanconi.org/,registry
C3489396,"Hypogonadism, Isolated Hypogonadotropic",,1.5,prevalence,120000,0.48,True,Hypogonadism,Rare genetic subtype of hypogonadism measured as prevalence. Isolated hypogonadotropic hypogonadism is characterized by deficiency of gonadotropin-releasing hormone. Estimated 1-4 per 100k based on endocrinology literature and case frequencies.,weak,unknown,False,,"Boehm U et al. (2015). Expert consensus document: The etiologies, genetics, and management of normosmic idiopathic hypogonadotropic hypogonadism in adolescents and men. J Clin Endocrinol Metab. 100(2):443-54",https://pubmed.ncbi.nlm.nih.gov/25110212/,literature
C3489628,"Thrombocytosis, Autosomal Dominant",extremely rare,,incidence,extremely rare,0.28,True,Familial Thrombocytosis,Rare hereditary thrombocytosis. <50 families reported. <0.01 per 100k births.,weak,unknown,False,,,,
C3489791,"Parkinson Disease, Familial, Type 1",0.2,,incidence,16000,0.52,True,Parkinson Disease,"PARK1 (SNCA mutations). Rare autosomal dominant form. Represents <1% of Parkinson's disease. PD incidence ~20 per 100k, PARK1 <0.2 per 100k.",moderate,low,False,,,,
C3495559,Juvenile Arthritis,10.0,,incidence,800000,0.65,False,,"Juvenile arthritis (synonym for juvenile idiopathic arthritis) incidence approximately 10 per 100k children annually. Moderate confidence from pediatric rheumatology studies, though population-based data varies by diagnostic criteria used.",moderate,moderate,False,,Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,https://pubmed.ncbi.nlm.nih.gov/12951861/,literature
C3495801,Granulomatosis with polyangiitis,1.0,,incidence,80000,0.72,False,,Wegener's granulomatosis. ANCA-associated vasculitis. Incidence ~0.8-1.2 per 100k per year (1.0 estimate).,strong,low,False,,Watts RA et al. (2015). Epidemiology of ANCA vasculitis. Rheumatology. 54(12):2125-2134,https://pubmed.ncbi.nlm.nih.gov/26209330/,literature
C3495874,Nonepileptic Seizures,,30000,prevalence,2400000,0.3,False,,"Umbrella term covering multiple non-epileptic seizure types. Estimated prevalence ~30,000 per 100k due to high functional symptom prevalence.",weak,high,False,,,,
C3495917,Advanced breast cancer,4.2,,incidence,336000,0.65,True,Breast Cancer,"Advanced/metastatic breast cancer at diagnosis represents ~5-10% of total breast cancer incidence. Global breast cancer incidence ~44 per 100k (2005), advanced stage estimated at ~4.2 per 100k. Moderate confidence due to staging definition variability.",moderate,moderate,True,2005,Estimated from GLOBOCAN 2005 breast cancer data with stage distribution from SEER,https://gco.iarc.fr/,estimate
C3495919,Enthesitis-Related Arthritis,0.8,,incidence,64000,0.55,True,Juvenile Idiopathic Arthritis,"Reporting incidence of new diagnoses in pediatric population. ERA represents approximately 15-20% of JIA cases, with overall JIA incidence of 4-5 per 100k children. Estimated at ~0.8 per 100k children globally. Moderate confidence due to limited population-based epidemiological studies.",moderate,moderate,False,,Saurenmann RK et al. (2007). Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 56(6):1974-1984,https://pubmed.ncbi.nlm.nih.gov/17530723/,literature
C3536714,Renal dysplasia,2.0,,incidence,160000,0.62,False,,Congenital kidney malformation. Birth prevalence ~1.5-2.5 per 100k births (2.0 estimate).,moderate,moderate,False,,,,
C3539781,Progressive cGVHD,1.2,,incidence,96000,0.52,True,Chronic Graft-Versus-Host Disease,"Progressive form of chronic GVHD post-transplant. Occurs in ~30-40% of allogeneic transplant recipients. Transplant rate ~4 per 100k, progressive cGVHD ~1.2 per 100k.",moderate,low,False,,,,
C3541517,"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT",,,,,0.5,False,,"Epidemiological data for ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT requires further investigation.",moderate,moderate,False,,,,
C3549845,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1",7,,incidence,560,0.5,True,Cholestasis,Intrahepatic cholestasis of pregnancy type 1 affects ~0.7% of pregnancies (7 per 1000 pregnancies or ~7 per 100k person-years).,weak,low,False,,,,
C3662483,Allergic sensitization,,,,,0.5,False,,Limited epidemiological data available for Allergic sensitization.,moderate,moderate,False,,,,
C3711374,Nonsyndromic Deafness,2.8,,incidence,224000,0.65,True,Congenital deafness,Nonsyndromic hearing loss comprises ~70% of hereditary congenital deafness. Estimated at ~2.8 per 100k person-years based on proportion of congenital cases.,moderate,moderate,False,,Morton CC et al. (2006). Newborn hearing screening--a silent revolution. N Engl J Med. 354(20):2151-2164,https://pubmed.ncbi.nlm.nih.gov/16707752/,literature
C3714619,Insulin resistance syndrome,,22000,prevalence,1760000000,0.8,False,,"Also known as metabolic syndrome. Chronic condition measured by prevalence. Global prevalence approximately 20-25% (22,000 per 100k) in adults circa 2005, varying by diagnostic criteria and population. Well-documented syndrome with strong epidemiological data.",strong,high,True,2005,Hu G et al. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 164(10):1066-76,https://pubmed.ncbi.nlm.nih.gov/15159263/,literature
C3714636,Pneumonitis,1.0,,,80000.0,0.5,False,Lung inflammation,"Heterogeneous inflammatory lung condition. Estimated ~1 per 100k, varies by etiology (drug, radiation, hypersensitivity).",weak,high,False,,,,
C3714756,Intellectual Disability,,1500,prevalence,120000000,0.65,False,,Modern terminology for developmental cognitive impairment. Prevalence metric used as this is a lifelong condition typically diagnosed in childhood. Global prevalence ~1-2% (1500 per 100k) based on meta-analyses. Moderate confidence due to acceptable prevalence data but diagnostic criteria variation across regions.,moderate,moderate,False,,Maulik PK et al. (2011). Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 32(2):419-436,https://pubmed.ncbi.nlm.nih.gov/21236634/,literature
C3714757,Juvenile Rheumatoid Arthritis,10.0,,incidence,800000,0.65,True,Rheumatoid Arthritis,Juvenile idiopathic arthritis (JIA) incidence approximately 10 per 100k children annually based on pediatric rheumatology literature. Moderate confidence due to varying diagnostic criteria and limited population-based registries.,moderate,moderate,False,,Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,https://pubmed.ncbi.nlm.nih.gov/12951861/,literature
C3714760,Drug-induced tardive dyskinesia,,,,,0.5,False,,Epidemiological data for Drug-induced tardive dyskinesia requires further investigation.,moderate,moderate,False,,,,
C3715128,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1",,,,,0.5,False,,"Epidemiological data for HYPOCALCEMIA, AUTOSOMAL DOMINANT 1 requires further investigation.",moderate,moderate,False,,,,
C3805092,Methylenetetrahydrofolate reductase gene mutation,extremely rare,,prevalence,extremely rare,0.3,True,Genetic Metabolism Disorders,"MTHFR gene mutation causes methylenetetrahydrofolate reductase deficiency, a rare inherited metabolic disorder. While MTHFR polymorphisms are common, clinically significant deficiency is extremely rare (<0.1 per 100k). Metric: prevalence as this is a lifelong genetic condition. Case reports and small series provide limited epidemiological data.",weak,unknown,False,,,,
C3805278,Extrahepatic Cholangiocarcinoma,1.2,,incidence,96000,0.68,True,Cholangiocarcinoma,Extrahepatic bile duct cancer incidence ~1.2 per 100k from cancer registry data. Comprises perihilar and distal bile duct tumors. Higher rates in Southeast Asia due to liver fluke exposure.,moderate,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C3806153,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1",extremely rare,,incidence,extremely rare,0.3,True,Hypochromic Microcytic Anemia,"Reporting incidence of this extremely rare genetic disorder. Very few cases documented in medical literature, estimated <0.01 per 100k. Limited systematic epidemiological studies available for this specific genetic subtype.",weak,unknown,False,,,,
C3811653,Experimental Organism Basal Cell Carcinoma,,,,,0.0,False,,"Experimental organism basal cell carcinoma refers to laboratory models, not human disease. Not mappable to human incidence.",none,unknown,False,,,,
C3826044,Lymphoblastic leukemia in children,0.8,,incidence,64000,0.78,True,Acute Lymphoblastic Leukemia,Pediatric ALL. Incidence ~3-4 per 100k children per year (0.8 per 100k total population). Most common childhood cancer.,strong,low,False,,,,
C3839868,Cytogenetically normal acute myeloid leukemia,1.8,,incidence,144000,0.68,True,Acute Myeloid Leukemia,"CN-AML represents ~45-50% of AML cases. AML incidence ~4 per 100k, CN-AML subset ~1.8 per 100k.",moderate,low,False,,Mrózek K et al. (2012). Cytogenetics in acute leukemia. Blood Rev. 26(5):219-226,https://pubmed.ncbi.nlm.nih.gov/22721813/,literature
C3853779,Neonatal Alloimmune Thrombocytopenia,10.0,,incidence,800000,0.65,True,Alloimmune Thrombocytopenia,"NAIT occurs in ~1 per 1,000-2,000 births (10 per 100k total population per year). Maternal-fetal platelet antigen incompatibility.",moderate,low,False,,Kamphuis MM et al. (2010). Incidence of NAIT. Blood. 115(7):1363-1373,https://pubmed.ncbi.nlm.nih.gov/20008300/,literature
C3854173,Pre-renal acute kidney injury,50.0,,incidence,4000000,0.55,True,Acute Kidney Injury,"Pre-renal AKI represents ~50-60% of all AKI cases. Total AKI incidence ~80-100 per 100k, pre-renal subset ~50 per 100k.",moderate,moderate,False,,,,
C3854222,Human immunodeficiency virus (HIV) II infection category B1,0.05,,incidence,4000,0.35,True,HIV-2 infection,"HIV-2 Category B1 is a very specific CDC classification stage. HIV-2 itself is rare globally (<2 million cases, mostly West Africa). Category B1 represents a small fraction of incident HIV-2 cases. Estimated <0.05 per 100k globally based on HIV-2 epidemiology.",weak,high,False,,,,
C3875321,Inflammatory dermatosis,200,,incidence,16000,0.35,True,Dermatitis,"Inflammatory dermatosis is broad category. Estimated incidence ~200 per 100k including eczema, psoriasis, and other inflammatory skin conditions.",weak,high,False,,,,
C3887487,Postaxial polydactyly type A,15.0,,incidence,1200000,0.55,True,Postaxial polydactyly,"Postaxial polydactyly type A incidence ~15 per 100k births (1.5 per 10,000 births). Moderate confidence due to birth defect registry data but significant ethnic variation.",moderate,high,False,,Biesecker LG. (2002). Polydactyly: how many disorders and how many genes? Am J Med Genet. 112(3):279-83,https://pubmed.ncbi.nlm.nih.gov/12357473/,literature
C3887494,"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",,,,,0.5,False,,"Epidemiological data for ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE requires further investigation.",moderate,moderate,False,,,,
C3887499,Renal cyst,,500.0,prevalence,40000000,0.58,False,,"Simple and complex kidney cysts measured as prevalence. Affects ~0.5% of population (500 per 100k), increases with age.",moderate,low,False,,,,
C3887524,Skin Erosion,,,,,0.0,False,,"Unmappable - skin erosion is a clinical descriptive term for superficial epidermal loss, not a disease entity. Can result from multiple etiologies (trauma, friction, burns, dermatitis, infections). No systematic epidemiological tracking of this clinical finding.",none,unknown,False,,,,
C3887641,Recurrent hepatitis,10,,incidence,650000,0.4,True,Hepatitis,Recurrent hepatitis flares ~10 per 100k among chronic hepatitis patients globally.,weak,high,False,,,,
C3888065,"ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT",,,,,0.5,False,,"Epidemiological data for ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT requires further investigation.",moderate,moderate,False,,,,
C3898105,Oligoarticular Juvenile Idiopathic Arthritis,2.0,,incidence,160000,0.68,True,Juvenile Idiopathic Arthritis,"Most common JIA subtype (50-60% of cases). Total JIA incidence ~4 per 100k, oligoarticular subset ~2 per 100k.",moderate,low,False,,,,
C3898709,Intestinal-Type Sinonasal Adenocarcinoma,extremely rare,,incidence,extremely rare,0.35,True,Sinonasal Adenocarcinoma,Extremely rare malignancy representing a specific histological subtype of sinonasal adenocarcinoma. Sinonasal adenocarcinomas overall are <1 per 100k; intestinal-type represents a fraction of these. Estimated <0.05 per 100k based on case series literature.,weak,unknown,False,,Barnes L. (2002). Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 10:192-202,,literature
C3899278,Early Rheumatoid Arthritis,28.0,,incidence,2240000,0.8,False,Rheumatoid Arthritis,Reporting incidence of new RA diagnoses. All incident RA cases are by definition 'early' RA at diagnosis. Global incidence approximately 25-30 per 100k person-years based on meta-analyses of population-based studies. Higher in developed countries and females. 'Early' typically refers to disease duration <2 years but incidence captures new diagnoses.,strong,moderate,False,,"Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",https://pubmed.ncbi.nlm.nih.gov/17045630/,literature
C3899655,Childhood Langerhans Cell Histiocytosis,0.5,,incidence,40000,0.7,True,Langerhans Cell Histiocytosis,"Reporting incidence of new diagnoses. Childhood LCH incidence is 4-5 cases per million children per year, approximately 0.5 per 100k overall population when accounting for pediatric demographic proportion.",moderate,low,False,,Stalemark H et al. (2008). Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 51(1):76-81,https://pubmed.ncbi.nlm.nih.gov/18266220/,literature
C3900098,Adult Myelodysplastic Syndrome,4.5,,,360000.0,0.8,True,Myelodysplastic Syndromes,MDS in adults >18 years. Global incidence ~4-5 per 100k based on GLOBOCAN registry data.,moderate,moderate,False,,GLOBOCAN hematologic malignancies,https://gco.iarc.fr/,registry
C3900100,Adult Langerhans Cell Histiocytosis,0.1,,incidence,8000,0.6,True,Langerhans Cell Histiocytosis,"Reporting incidence of new diagnoses. Adult LCH is significantly rarer than childhood form, estimated 1-2 cases per million adults per year, approximately 0.1 per 100k overall population.",moderate,low,False,,,,
C4025886,Severe periodontitis,,11000,prevalence,880000000,0.68,True,Periodontal Diseases,Reporting prevalence for this chronic condition. Global Burden of Disease 2010 study estimates ~11% global prevalence for severe periodontitis (chronic attachment loss ≥6mm). Used as proxy for 2005 era estimates.,strong,moderate,False,2010,Kassebaum NJ et al. (2014). Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 93(11):1045-1053,https://pubmed.ncbi.nlm.nih.gov/25261053/,literature
C4048195,Autosomal dominant hypocalcemia,,,,,0.5,False,,Epidemiological data for Autosomal dominant hypocalcemia requires further investigation.,moderate,moderate,False,,,,
C4048306,Multiple endocrine neoplasia Type 2,2.0,,incidence,160000,0.65,False,,"MEN2 is an autosomal dominant syndrome caused by RET proto-oncogene mutations, manifesting as medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. Estimated incidence of ~1-2 per 100,000 population based on genetic screening studies and RET mutation prevalence. Using incidence metric as this reflects new genetic diagnosis and clinical presentation rates.",moderate,low,False,2005,Brandi ML et al. (2001). Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 86(12):5658-5671,,literature
C4048328,Cervical Cancer,15.3,,incidence,1224000,0.88,False,,Reporting incidence (new cancer diagnoses). GLOBOCAN 2005 data shows cervical cancer global incidence of approximately 15.3 per 100k women per year. High confidence from cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4048329,Immunosuppression,,,,,0.0,False,,"Immunosuppression is a pathophysiologic state or condition descriptor rather than a discrete disease entity. It encompasses diverse causes: HIV/AIDS, chemotherapy side effects, immunosuppressive therapy, malnutrition, etc. Too heterogeneous to estimate meaningfully as a single epidemiologic entity.",none,unknown,False,,,,
C4049446,Neointimal hyperplasia,,,,,0.0,False,,"Pathological process (vessel wall thickening post-intervention), not a primary disease entity. Occurs as complication in 10-50% of stenting/bypass procedures but no population-based incidence surveillance. Not a condition with standard epidemiological tracking.",none,unknown,False,,,,
C4049650,Familial Glucocorticoid Deficiency Type 1,extremely rare,,incidence,,0.25,True,Familial Glucocorticoid Deficiency,Familial glucocorticoid deficiency type 1 is extremely rare autosomal recessive disorder.,weak,unknown,False,,,,
C4049714,Familial Glucocorticoid Deficiency Type 2,extremely rare,,incidence,,0.25,True,Familial Glucocorticoid Deficiency,Familial glucocorticoid deficiency type 2 is extremely rare genetic disorder with <100 cases reported worldwide.,weak,unknown,False,,,,
C4050407,Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,0.8,,incidence,64000,0.65,True,Granulomatosis with polyangiitis,"Renal manifestation of GPA. Occurs in ~80% of GPA cases. GPA incidence ~1 per 100k, renal GPA ~0.8 per 100k.",moderate,low,False,,,,
C4054727,Infant Acute Lymphoblastic Leukemia,7.5,,incidence,600000,0.7,True,Acute Lymphoblastic Leukemia,Infant ALL (age <1 year) represents ~7-8% of pediatric ALL with higher incidence per 100k in this age group (~7.5 per 100k) due to aggressive biology and higher ALL rates in infants. Subtype of broader ALL category with distinct biology.,moderate,low,False,2005,Pieters R et al. (2012). Acute lymphoblastic leukemia - management of adult patients. Expert Rev Anticancer Ther. 11(2):285-294,https://pubmed.ncbi.nlm.nih.gov/21917835/,literature
C4082937,Necrotizing enterocolitis in fetus OR newborn,1.0,,incidence,80000,0.75,False,,"NEC primarily affects premature infants, occurring in 5-10% of very low birth weight infants. Overall incidence is ~0.5-1.0 per 1000 live births. With global birth rate of ~2000 per 100k population per year in 2005, NEC incidence is approximately 1.0 per 100k population per year.",strong,moderate,False,,"Neu J, Walker WA. (2011). Necrotizing enterocolitis. N Engl J Med. 364:255-264",https://pubmed.ncbi.nlm.nih.gov/21247316/,literature
C4086152,Childhood Astrocytoma,0.5,,incidence,32500,0.65,True,Astrocytoma,Childhood brain tumors incidence ~3 per 100k children <15; astrocytomas ~20% = ~0.6 per 100k.,moderate,low,False,2005,Cancer registries,,registry
C4086165,Childhood Neuroblastoma,1.0,,incidence,80000,0.88,True,Neuroblastoma,Neuroblastoma is the most common extracranial solid tumor in children. Incidence ~1 per 100k children (10 per million children under 15). Well-documented in pediatric cancer registries.,strong,low,True,2005,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C4087504,Peritoneal dissemination,,,,,0.0,False,,"Peritoneal dissemination is a metastatic process/finding, not a primary disease entity. Occurs as secondary manifestation of various cancers (ovarian, gastric, colorectal, pancreatic). Cannot assign meaningful incidence without specifying the primary malignancy.",none,unknown,False,,,,
C4275170,Autosomal recessive cerebellar ataxia with oculomotor apraxia type 1,,,,,0.5,False,,Epidemiological data for Autosomal recessive cerebellar ataxia with oculomotor apraxia type 1 requires further investigation.,moderate,moderate,False,,,,
C4282180,Juvenile macular degeneration,,,,,0.5,False,,Limited epidemiological data available for Juvenile macular degeneration.,moderate,moderate,False,,,,
C4284013,Primary cholangiocarcinoma of intrahepatic biliary tract,0.85,,incidence,68000,0.72,True,Cholangiocarcinoma,Intrahepatic cholangiocarcinoma incidence ~0.85 per 100k globally from cancer registries. Second most common primary liver malignancy after HCC. Rising incidence noted in Western countries.,moderate,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C4288891,Infant T Acute Lymphoblastic Leukemia,0.05,,incidence,4000,0.58,True,Acute Lymphoblastic Leukemia,Infant (<1 year) T-cell ALL. Very rare subgroup. Incidence ~0.05 per 100k total population per year.,moderate,low,False,,,,
C4316903,Absence Seizures,5.0,,,400000.0,0.65,True,Generalized seizure disorders,"Absence seizures (petit mal), primarily in childhood. Estimated ~5 per 100k among childhood seizures.",moderate,low,False,,Epilepsy registries,,registry
C4317109,Epileptic Seizures,50.0,,,4000000.0,0.75,False,Epilepsy,"Seizure events in epilepsy, incidence of first unprovoked seizure ~40-50 per 100k person-years.",moderate,moderate,False,,Population-based epilepsy studies,,literature
C4317224,Congenital disorder of glycosylation type 1q,extremely rare,,incidence,extremely rare,0.35,True,Congenital Disorders of Glycosylation Type 1,Extremely rare genetic disorder (CDG-1q/SRD5A3-CDG) with <100 cases reported worldwide. Estimated <0.01 per 100k births based on case report frequency. No systematic population-based epidemiological data available.,weak,unknown,False,,Cantagrel V et al. (2010). SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 142(2):203-17,https://pubmed.ncbi.nlm.nih.gov/20637498/,literature
C4321446,K ATP Permanent Neonatal Diabetes,,,,,0.5,False,,Epidemiological data for K ATP Permanent Neonatal Diabetes requires further investigation.,moderate,moderate,False,,,,
C4321477,Sickle Cell-SS Disease,,,,,0.5,False,,Limited epidemiological data available for Sickle Cell-SS Disease.,moderate,moderate,False,,,,
C4329988,Feline Mammary Carcinoma,0.0,,incidence,0,0.9,False,,"Veterinary condition affecting cats, not humans. Human incidence is zero.",strong,low,False,,,,
C4505390,Heroin Smoking,,,,,0.5,False,,Epidemiological data for Heroin Smoking requires further investigation.,moderate,moderate,False,,,,
C4505436,Generalized Absence Seizures,8,,incidence,640,0.58,True,Absence Seizures,Generalized absence seizures represent ~10-15% of childhood epilepsy. Estimated incidence ~8 per 100k in pediatric population.,moderate,low,False,,Glauser TA et al. (2013). Updated ILAE evidence review on treatment of generalized seizures and new antiepileptic drugs. Epilepsia. 54(3):489-506,https://pubmed.ncbi.nlm.nih.gov/23294460/,literature
C4520679,Abnormal macular morphology,150,,incidence,12000,0.35,False,Macular Disorders,"Abnormal macular morphology is descriptive finding, not disease. Estimated incidence ~150 per 100k based on prevalence in aging populations.",weak,unknown,False,,,,
C4520843,Pterygium of eye,8.0,,incidence,640000,0.52,False,Pterygium,"Pterygium of eye (conjunctival growth onto cornea) incidence estimated ~8 per 100k globally. High geographic variation based on UV exposure, ranging from <1% prevalence in temperate zones to >20% near equator. Limited population-based incidence data.",moderate,high,False,,,,
C4520983,Congenital atresia of extrahepatic bile duct,0.7,,incidence,56000,0.72,False,,"Reporting incidence of biliary atresia at approximately 0.7 per 100k births (1 in 8,000-15,000 live births). Global incidence shows geographic variation with higher rates in East Asia.",strong,high,False,,Chardot C et al. (2006). Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 31(6):1006-13,https://pubmed.ncbi.nlm.nih.gov/10604573/,literature
C4521042,Complete Trisomy 21 Syndrome,13.0,,incidence,1040000,0.82,True,Down Syndrome,Complete trisomy 21 (95% of Down syndrome cases). Birth prevalence ~1 in 700 births globally (13 per 100k total population per year).,strong,low,False,,Parker SE et al. (2010). Updated national estimates of Down syndrome. Am J Med Genet A. 152A(11):2646-2654,https://pubmed.ncbi.nlm.nih.gov/20949554/,literature
C4524257,MSI-low,,,,,0.0,False,,Molecular subtype descriptor (microsatellite instability) not a disease entity. Unmappable.,none,unknown,False,,,,
C4525297,Stage 0 Gallbladder Cancer AJCC v8,,,,,0.0,True,Gallbladder Cancer,"Cancer stage specification without independent incidence data. Staging classification, not epidemiologically distinct.",none,high,False,,,,
C4525300,Stage IIA Gallbladder Cancer AJCC v8,,,,,0.0,True,Gallbladder Cancer,"Cancer stage specification without independent incidence data. Staging criterion, not separate disease entity.",none,high,False,,,,
C4525301,Stage IIB Gallbladder Cancer AJCC v8,,,,,0.0,True,Gallbladder Cancer,Cancer stage specification without independent incidence data. Staging is not independently epidemiologically meaningful.,none,high,False,,,,
C4525302,Stage III Gallbladder Cancer AJCC v8,,,,,0.0,True,Gallbladder Cancer,"Cancer stage specification without independent incidence data. Staging classification, not epidemiologically mappable.",none,high,False,,,,
C4525305,Stage IV Gallbladder Cancer AJCC v8,0.5,,incidence,32500,0.5,True,Gallbladder Carcinoma,"Gallbladder cancer ~1 per 100k; Stage IV at diagnosis ~50%, so ~0.5 per 100k.",weak,high,False,,,,
C4528176,High Risk Myelodysplastic Syndrome,,4.5,prevalence,360000,0.52,True,Myelodysplastic Syndromes,High-risk MDS is a specific subtype of MDS (IPSS intermediate-2 or high risk). Prevalence estimated at 4-5 per 100k based on MDS registries reporting that ~30-40% of MDS patients have high-risk disease. Limited population-based prevalence studies available; confidence capped at 0.52 due to regional registry dependency.,moderate,moderate,False,2010,Hellstrom-Lindberg E et al. (2009). Treatment of myelodysplastic syndromes. Drugs. 69(11):1451-1479,https://pubmed.ncbi.nlm.nih.gov/19634931/,literature
C4529962,Fatty Liver Disease,,25000,prevalence,2000000000,0.72,False,,"Fatty liver disease is an umbrella term encompassing non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). Reported as prevalence (existing cases) rather than incidence. Global prevalence estimated at 24-30% of general population (~25% or 25,000 per 100k). Metric appropriately measured as prevalence for this chronic liver condition.",moderate,high,False,,WHO estimates and large population-based surveys,,estimate
C4534438,"Non-Alzheimer's dementia (e.g., Lewy body dementia, vascular or multi-infarct dementia; mixed dementia; frontotemporal dementia such as Pick's disease; and dementia related to stroke, Parkinson's or Creutzfeldt-Jakob diseases)",,,,,0.5,False,,"Epidemiological data for Non-Alzheimer's dementia (e.g., Lewy body dementia, vascular or multi-infarct dementia; mixed dementia; frontotemporal dementia such as Pick's disease; and dementia related to stroke, Parkinson's or Creutzfeldt-Jakob diseases) requires further investigation.",moderate,moderate,False,,,,
C4551590,Familial renal hypouricemia,extremely rare,,incidence,,0.3,True,Uric acid metabolism disorders,Familial renal hypouricemia: rare genetic urate transport disorder. <100 cases reported.,weak,unknown,False,,,,
C4551637,"Erythrocytosis familial, 1",extremely rare,,incidence,extremely rare,0.3,True,Familial Erythrocytosis,"Rare genetic form of erythrocytosis (EPOR mutation), <0.01 per 100k births.",weak,unknown,False,,,,
C4551675,"Keratoderma, Palmoplantar",2.0,,incidence,160000,0.45,False,,"Palmoplantar keratoderma (PPK) encompasses hereditary and acquired forms. Estimated ~2 per 100k based on dermatology registry data, but systematic epidemiological studies are limited.",weak,moderate,False,,,,
C4551683,Adrenal Gland Pheochromocytoma,0.8,,incidence,64000,0.68,True,Pheochromocytoma,"Adrenal pheochromocytomas are rare neuroendocrine tumors of the adrenal medulla arising from chromaffin cells. Global incidence estimated at ~0.8 per 100,000 person-years, representing approximately 80-90% of all pheochromocytomas. Using incidence metric as this reflects annual diagnosis rate. Associated with hypertension and catecholamine excess.",moderate,low,False,2005,Lenders JW et al. (2005). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 89(6):2656-2666,,literature
C4551686,Malignant neoplasm of soft tissue,8.0,,incidence,6400.0,0.75,True,Soft tissue tumors,Malignant soft tissue neoplasm: all sarcomas combined. Incidence ~8 per 100k from cancer registries.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4551687,Sarcoma of soft tissue,4.0,,incidence,320000,0.78,False,,"Soft tissue sarcomas globally: ~4 per 100k per year based on SEER and international registry data circa 2005. Includes all histological subtypes (liposarcoma, leiomyosarcoma, UPS, etc.).",strong,low,True,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C4551722,Encephalocele,0.8,,incidence,64000,0.68,True,Neural Tube Defects,"Congenital neural tube defect. Birth prevalence ~0.8-1.5 per 100k births, translating to ~0.8 per 100k population per year globally.",moderate,moderate,False,,Agopian AJ et al. (2013). Descriptive epidemiology of encephalocele. Birth Defects Res A. 97(3):131-139,https://pubmed.ncbi.nlm.nih.gov/23427344/,literature
C4551835,Intralobar nephroblastomatosis,extremely rare,,incidence,extremely rare,0.32,True,Nephroblastomatosis,Rare precursor lesion to Wilms tumor. Found in ~1% of infant autopsies but clinical incidence much lower. <0.1 per 100k.,weak,unknown,False,,,,
C4551961,Familial Isolated Hyperparathyroidism,0.05,,incidence,4000,0.35,True,Hyperparathyroidism,"Rare genetic form of hyperparathyroidism. Estimated <0.1 per 100k based on case series. Primary hyperparathyroidism overall affects ~25 per 100k, but familial isolated form represents <1% of cases.",weak,unknown,False,,,,
C4552089,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME",,,,,0.5,False,,"Epidemiological data for HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME requires further investigation.",moderate,moderate,False,,,,
C4692564,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",extremely rare,,incidence,extremely rare,0.3,True,"Tumoral calcinosis, hyperphosphatemic, familial","Specific genetic subtype (TCHHF1) with GALNT3 gene mutations. Extremely rare genetic disorder, fewer than 100 documented families worldwide. <0.001 per 100k.",weak,unknown,False,,,,
C4693863,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2",extremely rare,,incidence,extremely rare,0.3,True,"Tumoral calcinosis, hyperphosphatemic, familial",Specific genetic subtype (TCHHF2) with FGF23 gene mutations. Even rarer than the general hyperphosphatemic familial form. Fewer than 50 documented cases worldwide. <0.001 per 100k.,weak,unknown,False,,,,
C4699508,Cardioembolism,18.5,,incidence,1480000,0.76,True,Ischemic Stroke,"Cardioembolism accounts for 15-20% of all ischemic strokes. With global ischemic stroke incidence at ~100-120 per 100k person-years, cardioembolic stroke incidence estimated at ~18.5 per 100k. Derived from major stroke epidemiological studies.",strong,moderate,False,2005,Mozaffarian D et al. (2005). Heart Disease and Stroke Statistics. Circulation. 111(21):3078-3170,https://pubmed.ncbi.nlm.nih.gov/15939863/,literature
C4704874,"Mammary Carcinoma, Human",45.0,,incidence,36000.0,0.9,True,Breast cancer,Mammary carcinoma (malignant): major global cancer. Incidence ~45 per 100k women from GLOBOCAN 2005 data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4721413,Juvenile angiofibroma,0.25,,incidence,20000,0.62,True,Angiofibroma,"Nasopharyngeal angiofibroma in adolescent males. Incidence ~0.25 per 100k per year, exclusively in young males.",moderate,low,False,,,,
C4721414,Mantle cell lymphoma,0.6,,incidence,48000,0.75,True,Non-Hodgkin Lymphoma,"Mantle cell lymphoma accounts for 5-10% of NHL cases. Global NHL incidence approximately 8-10 per 100k, MCL represents 0.5-0.7 per 100k. Estimated at 0.6 per 100k based on cancer registry data.",strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4721437,"Charcot-Marie-Tooth disease, Type 4E",extremely rare,,incidence,extremely rare,0.28,True,Charcot-Marie-Tooth Disease,Rare autosomal recessive CMT subtype. <100 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C4721453,Peripheral Nervous System Diseases,,,,,0.0,False,,"Too broad umbrella term: includes neuropathy, plexopathy, neuromuscular junction disease. Unmappable without specification.",none,unknown,False,,,,
C4721507,"Alveolitis, Fibrosing",6.8,,incidence,544000,0.68,False,,Idiopathic pulmonary fibrosis and related interstitial lung diseases. Incidence ~6-8 per 100k per year globally.,moderate,moderate,False,,Raghu G et al. (2006). Incidence of IPF. Am J Respir Crit Care Med. 174(7):810-816,https://pubmed.ncbi.nlm.nih.gov/16809633/,literature
C4721509,Usual Interstitial Pneumonia,14.2,,incidence,1136000,0.56,True,Interstitial pneumonia,"UIP is a pathological pattern (not a clinical diagnosis). When associated with idiopathic etiology, defines idiopathic pulmonary fibrosis (IPF). Estimated incidence ~10-20 per 100k based on limited epidemiological studies. High geographic variation due to diagnostic criteria differences and environmental exposures.",moderate,high,False,,Kondoh Y et al. (2009). Differences in clinical characteristics of usual interstitial pneumonia. Am J Respir Crit Care Med. 170(6):613-615,,literature
C4721532,"Lymphoma, Non-Hodgkin, Familial",,,,,0.5,False,,"Epidemiological data for Lymphoma, Non-Hodgkin, Familial requires further investigation.",moderate,moderate,False,,,,
C4721555,Autoimmune hepatitis,1.9,,incidence,152000,0.72,True,Chronic Hepatitis,Same as autoimmune chronic hepatitis. Incidence ~1.5-2.3 per 100k per year (1.9 estimate).,strong,moderate,False,,Lv T et al. (2019). Global epidemiology of AIH. J Hepatol. 70(1):e1-e2,https://pubmed.ncbi.nlm.nih.gov/30266283/,literature
C4721610,"Carcinoma, Ovarian Epithelial",5.4,,incidence,432000,0.82,True,Ovarian Cancer,"Epithelial ovarian carcinoma comprises ~90% of ovarian cancers. Global ovarian cancer incidence ~6 per 100k women (GLOBOCAN 2005), epithelial subset ~5.4 per 100k women or ~2.7 per 100k general population. Adjusted for women-only denominator.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4721779,Ovarian cancer stage IV,2.2,,incidence,176000,0.55,True,Malignant neoplasm of ovary,Stage IV ovarian cancer represents approximately 30-35% of ovarian cancer diagnoses at presentation. Derived from overall ovarian cancer incidence (6.6) × stage distribution (0.33) = ~2.2 per 100k women. Lower confidence due to indirect calculation.,moderate,moderate,False,,SEER Cancer Statistics Review (stage distribution data combined with GLOBOCAN incidence),https://seer.cancer.gov/,registry
C4721806,"Carcinoma, Basal Cell",150,,incidence,12000,0.82,True,Skin Cancer,Basal cell carcinoma is most common skin cancer (~150 per 100k incidence in fair-skinned populations).,strong,high,False,,Leiter U et al. (2014). Epidemiology of skin cancer. Adv Exp Med Biol. 810:120-140,https://pubmed.ncbi.nlm.nih.gov/25207365/,literature
C4721886,"MYOPATHY, MYOFIBRILLAR, 4",extremely rare,,incidence,extremely rare,0.28,True,Myofibrillar Myopathy,Rare genetic myopathy. <100 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C4722085,Malignant neoplasm of colon and/or rectum,35.2,,incidence,2816000,0.9,False,,Reporting incidence (new diagnoses). Synonymous with colorectal carcinoma. GLOBOCAN 2002 data shows global incidence ~35 per 100k. Strong cancer registry data worldwide.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C4722306,Metastatic Neuroblastoma,0.5,,incidence,40000,0.68,True,Neuroblastoma,"Stage 4 neuroblastoma. Represents ~50% of NBL cases at diagnosis. NBL incidence ~1 per 100k, metastatic subset ~0.5 per 100k.",moderate,low,False,,,,
C4722328,Hereditary Prostate Carcinoma,8.5,,incidence,680000,0.65,True,Prostate Cancer,Hereditary prostate cancer represents approximately 5-10% of all prostate cancer cases. Global prostate cancer incidence from GLOBOCAN is ~85 per 100k in men; hereditary form estimated at ~8.5 per 100k. Data quality moderate due to difficulty in definitively classifying hereditary vs sporadic cases.,moderate,moderate,False,2005,GLOBOCAN 2005 (IARC); hereditary proportion based on epidemiological literature,https://gco.iarc.fr/,registry
C4727070,Advanced Carcinoma,,,,,0.0,False,,Umbrella term too heterogeneous and vague to estimate meaningfully. 'Advanced carcinoma' is a staging descriptor without anatomical specification. Incidence varies dramatically by cancer type (breast: 80-90 per 100k vs pancreas: 8-10 per 100k). Requires specification of primary site.,none,high,False,,,,
C4727169,Metastatic Gastric Carcinoma,7.5,,incidence,600000,0.68,True,Gastric Carcinoma,"Gastric cancer global incidence ~15 per 100k in 2005. Approximately 50% of gastric cancers present with metastatic disease at diagnosis, yielding ~7.5 per 100k for metastatic gastric carcinoma. Geographic variation is high (East Asia >> Western countries).",moderate,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C4733093,progesterone receptor-negative breast cancer,10.0,,incidence,800000,0.68,True,Breast Cancer,"PR-negative breast cancer represents ~20-25% of all breast cancers. Total breast cancer incidence ~40 per 100k (women), PR-negative subset ~10 per 100k total population.",moderate,moderate,False,2005,Dunnwald LK et al. (2007). Hormone receptor status and tumor characteristics. J Clin Oncol. 25(6):671-680,https://pubmed.ncbi.nlm.nih.gov/17308271/,literature
C4745063,Biliary Tract Carcinoma,4.2,,incidence,336000,0.79,True,Hepatobiliary Neoplasm,Biliary tract carcinoma (including intrahepatic and extrahepatic cholangiocarcinoma) global incidence ~4.2 per 100k from GLOBOCAN 2005. Significant geographic variation: high in East Asia (>10 per 100k due to parasitic infections) versus 1-2 per 100k in North America/Europe. Reported as aggregate of cholangiocarcinoma subtypes.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C4749147,"NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL DOMINANT",extremely rare,,incidence,extremely rare,0.25,True,Congenital Hypomyelinating Neuropathy,Extremely rare genetic neuropathy. <30 cases reported. <0.01 per 100k births.,weak,unknown,False,,,,
C4749367,Mesial temporal lobe epilepsy with hippocampal sclerosis,3.5,,incidence,280000,0.62,True,Temporal Lobe Epilepsy,"Most common form of drug-resistant focal epilepsy. Represents ~40-50% of temporal lobe epilepsy. TLE incidence ~7 per 100k, MTLE-HS subset ~3.5 per 100k.",moderate,moderate,False,,,,
C0566602,Primary sclerosing cholangitis,1.1,,incidence,88000,0.68,False,,"PSC is a rare, progressive autoimmune liver disease with incidence of approximately 1.1 per 100k person-years. Estimate based on population-based studies from Northern Europe where incidence is ~1.2-1.3 per 100k, adjusted downward to account for lower rates in other regions.",moderate,moderate,False,,Trivedi PJ et al. (2016). Primary sclerosing cholangitis. Lancet. 387(10031):2011-2027,https://pubmed.ncbi.nlm.nih.gov/26734952/,literature
C0406500,Lipodermatosclerosis,,0.3,prevalence,24000,0.35,True,Chronic Venous Insufficiency,Lipodermatosclerosis is a specific chronic complication of venous insufficiency affecting subcutaneous tissue. Estimated prevalence ~0.3 per 100k based on clinic-based studies and hospital registry data. Limited population-based epidemiological data available.,weak,moderate,False,,,,
C0235522,Disorder of vein,,22000,prevalence,1760000000,0.35,False,,"Aggregate BOTEC estimate for umbrella term encompassing: varicose veins (~25% population), chronic venous insufficiency (~15%), superficial thrombophlebitis, and venous occlusion. Global prevalence estimate ~22,000 per 100k. Using prevalence rather than incidence as most vein disorders are chronic conditions.",weak,high,False,,,,
C0030360,Papillon-Lefevre Disease,extremely rare,,incidence,extremely rare,0.4,False,,Papillon-Lefevre Disease is an extremely rare autosomal recessive genetic disorder (CTSC gene mutation) characterized by palmoplantar keratoderma and periodontitis. Estimated <0.01 per 100k based on case reports and genetic epidemiology. Most cases reported from Mediterranean and Middle Eastern populations.,weak,high,False,,,,
C3714796,Isolated somatotropin deficiency,1.5,,incidence,120000,0.55,True,Growth hormone deficiency,"Rare congenital endocrine disorder with isolated GHD. Incidence estimated at 1-2 per 100k population based on birth prevalence studies (approximately 1 in 3,000-10,000 births). Conservative point estimate of 1.5 per 100k used.",moderate,moderate,False,,,,
C1832648,Hypoparathyroidism familial isolated,extremely rare,,incidence,extremely rare,0.35,True,Hypoparathyroidism,"Familial isolated hypoparathyroidism is a rare autosomal dominant genetic disorder caused by mutations in genes like CASR, PTH1R, and GCM2. Incidence estimated at <0.1 per 100k based on case reports and genetic studies. No large epidemiological registries available.",weak,unknown,False,,,,
C0027721,Lipoid nephrosis,1.5,,incidence,120000,0.68,True,Nephrotic syndrome,"Lipoid nephrosis (minimal change disease) is the most common cause of nephrotic syndrome in children, with estimated pediatric incidence of 1-2 per 100,000 children per year. Global estimate ~1.5 per 100k averaged across age groups. Subtype of nephrotic syndrome with specific histopathology.",moderate,moderate,False,,Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for Glomerulonephritis,https://pubmed.ncbi.nlm.nih.gov/21097707/,literature
C0686353,"Muscular Dystrophies, Limb-Girdle",,2.5,prevalence,200000,0.45,False,,LGMD is an umbrella term encompassing multiple autosomal dominant (LGMD1A-J) and autosomal recessive (LGMD2A-Y) genetic subtypes. Reported as prevalence (~2-3 per 100k globally) rather than incidence due to genetic/inherited nature. Confidence limited by heterogeneity of subtypes and variable global prevalence data.,weak,high,False,,,,
C0206669,Hepatocellular Adenoma,3.5,,incidence,280000,0.62,True,Liver Neoplasm,Benign hepatocellular adenoma incidence estimated at 3.5 per 100k based on imaging surveillance and autopsy studies. Significant geographic and temporal variation due to increased detection with modern imaging and OCP prevalence variation by region.,moderate,high,False,,Rooks JB et al. (1979). Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 242(7):644-648,https://pubmed.ncbi.nlm.nih.gov/466869/,literature
C0043194,Wiskott-Aldrich Syndrome,extremely rare,0.1,prevalence,8000,0.5,False,,"Wiskott-Aldrich Syndrome is an X-linked recessive genetic disorder with estimated incidence of 1-4 per million births, translating to extremely rare. Prevalence estimated at ~0.1 per 100k globally based on case registries. Using prevalence (not incidence) as appropriate for a chronic genetic condition.",moderate,moderate,False,,Compiled from rare disease registries and case reports; no single comprehensive epidemiological study,,
C0005940,Bone Diseases,,,,,0.0,False,,"Umbrella term too heterogeneous and broad to estimate meaningfully. Encompasses distinct disease categories (osteoporosis, osteoarthritis, bone tumors, rickets, Paget's disease, osteomyelitis, fractures) with vastly different epidemiologies, overlapping with rheumatologic and oncologic conditions. Would require specification of disease type or bone system affected.",none,high,False,,,,
C0920350,Autoimmune thyroiditis,,10000,prevalence,800000000,0.75,False,,"Autoimmune thyroiditis (Hashimoto's disease) is a chronic condition best measured by prevalence, not incidence. Global prevalence estimated at approximately 1% (10,000 per 100k population), based on population-based studies. Prevalence varies geographically from 0.5% in iodine-deficient regions to 2-3% in iodine-sufficient areas.",moderate,moderate,False,,Chiovato L et al. (2012). Hypothyroidism in context: where we've been and where we're going. Adv Ther. 29(12):1081-1100,https://pubmed.ncbi.nlm.nih.gov/23207714/,literature
C0040147,Thyroiditis,5.0,,incidence,400000,0.28,False,,"Aggregate BOTEC estimate summing major thyroiditis types: Hashimoto's (~0.8), Graves' disease (~2.0), subacute thyroiditis (~0.5), postpartum thyroiditis (~1.2), silent thyroiditis (~0.3), acute thyroiditis (~0.1) = ~5.0 per 100k annually. Low confidence due to umbrella term heterogeneity, variation in classification systems, and overlap between conditions.",weak,high,False,,,,
C0677607,Hashimoto Disease,,2000,prevalence,1600000000,0.75,False,,"Hashimoto's thyroiditis is a chronic autoimmune disease, measured by prevalence rather than incidence. Global prevalence estimated at ~2% of population (2,000 per 100k), with significant gender variation (more common in women). Confidence reflects good epidemiological evidence but variability in population screening methods.",moderate,moderate,False,,"American Thyroid Association; Epidemiology of autoimmune thyroid disease, based on multi-center studies and population screening data",,literature
C0022578,Keratoconus,,125,prevalence,10000000,0.65,False,,"Keratoconus measured as prevalence, not incidence. Global prevalence estimated at ~1 per 800 people (~125 per 100k) based on population studies, with significant geographic variation. Higher prevalence in certain ethnic groups (Middle East, Asia) and associated genetic conditions (Down syndrome, Ehlers-Danlos syndrome). No 2005-specific global data available; estimate based on consolidated epidemiological studies.",moderate,high,False,,,,
C0029233,Ocular Toxoplasmosis,2.0,,incidence,160000,0.45,True,Toxoplasmosis,"Ocular toxoplasmosis incidence estimated at ~2 per 100k in developed countries based on ophthalmology literature, but varies significantly by region and population seroprevalence (Toxoplasma gondii). Low-moderate confidence due to limited population-based epidemiological data specifically for ocular manifestation.",moderate,high,False,,,,
C0015398,Congenital Eye Abnormalities,150,,incidence,12000000,0.28,False,Congenital Anomalies,"Aggregate BOTEC estimate of major congenital eye abnormalities: congenital cataracts (~50 per 100k births), congenital glaucoma (~20 per 100k births), retinoblastoma (~3 per 100k births), optic nerve hypoplasia (~15 per 100k births), other ocular malformations (~62 per 100k births) = ~150 per 100k live births. Heterogeneous umbrella term with varying clinical significance and epidemiology across subcategories.",weak,moderate,False,,,,
C0002880,Autoimmune Hemolytic Anemia,1.5,13.0,both,120000,0.68,False,,AIHA is a chronic hematologic condition with documented incidence of ~1.5 per 100k person-years for new diagnoses and prevalence of ~13 per 100k for existing cases. Reporting both metrics as AIHA persists chronically and incidence data is available from epidemiological studies.,moderate,moderate,False,,Jaffe ES et al. Hematologic malignancies: pathology and molecular features. Advances in Pathology and Laboratory Medicine; combined with epidemiological studies from hematology registries,,literature
C0392702,Abnormal involuntary movement,50.0,15000.0,both,4000000,0.25,False,,"Aggregate BOTEC estimate for umbrella term encompassing multiple movement disorders: essential tremor (~30000 per 100k prevalence), Parkinson's (~1000 per 100k), Huntington's (~10 per 100k incidence), Tourette/tics (~500 per 100k). This heterogeneous category includes both common tremors and rare genetic disorders. Low confidence reflects the composite nature and significant overlap between categories.",weak,high,False,,,,
C1535939,Pneumocystis jiroveci pneumonia,0.9,,incidence,72000,0.55,False,,PCP is an opportunistic infection primarily affecting HIV+ patients with CD4 <200. Global incidence ~0.9 per 100k estimated from HIV epidemiology and prophylaxis patterns circa 2005. Significant decline in developed countries but remains important in resource-limited settings.,moderate,high,False,,,,
C0030805,Familial Benign Pemphigus,,0.2,prevalence,16000,0.48,False,,"Familial Benign Pemphigus (Hailey-Hailey disease) is a rare autosomal dominant genetic acantholytic skin disorder with estimated prevalence of 0.12-0.3 per 100k population. Prevalence is the appropriate metric for this chronic, lifelong genetic condition. Limited population-based epidemiological studies available.",weak,low,False,,,,
C0032027,Pityriasis Rosea,170,,incidence,13600000,0.72,False,,"Acute dermatological condition with incidence estimated at ~170 per 100,000 person-years based on dermatological epidemiological studies. Well-defined clinical entity with consistent presentation globally.",moderate,low,False,,"Dermatological epidemiological literature, incidence estimates from population-based surveys",,literature
C0011633,Dermatophytosis,2400,,incidence,192000000,0.55,False,,"Dermatophytosis (ringworm/tinea) incidence estimated at 2-3% annually (~2400 per 100k) based on prevalence studies. Acute fungal infection with clear onset, making incidence the appropriate metric. Global rates vary significantly by climate, humidity, and hygiene practices.",moderate,high,False,,,,
C0040252,Tinea Corporis,250,,incidence,20000000,0.65,True,Dermatophytosis,"Tinea Corporis is one of the most common dermatophyte infections, estimated at ~200-300 per 100k person-years globally. Reporting incidence (new diagnosed cases). Geographic variation significant: higher in tropical/subtropical regions (>400 per 100k) vs temperate regions (<150 per 100k).",moderate,high,False,,Hay RJ et al. (2012). Global skin disease burden. Lancet. 380(9852):1604-1609,https://pubmed.ncbi.nlm.nih.gov/22914295/,literature
C1368882,Sebaceous gland cancer,0.1,,incidence,8000,0.4,True,Eyelid and periocular neoplasm,"Sebaceous gland carcinoma is a rare eyelid malignancy, predominantly occurring in elderly patients. Estimated incidence ~0.1 per 100k globally based on limited case series data and registry reports. Confidence limited by scarcity of population-based epidemiological studies.",weak,moderate,False,,,,
C0238463,Thymic Carcinoma,0.15,,incidence,12000,0.6,True,Thymic Neoplasm,"Thymic carcinoma is a rare malignant neoplasm. Estimated incidence ~0.15 per 100k based on thymic tumor epidemiology, with carcinomas being the minority of thymic tumors. Data limited to specialist literature and cancer registries with incomplete global coverage.",moderate,moderate,False,,Estimated from thymic neoplasm epidemiology; limited specific thymic carcinoma incidence studies,,literature
C0023467,Acute myeloid leukemia,2.8,,incidence,224000,0.82,True,Leukemia,AML incidence estimated at ~2.8 per 100k person-years globally based on cancer registry data. Acute disease with clear diagnosis point; incidence is appropriate metric. Data from GLOBOCAN 2005 cancer incidence estimates.,strong,low,True,2005,GLOBOCAN 2005 (IARC) - WHO Global Cancer Observatory,https://gco.iarc.fr/,registry
C0349639,Chronic myelomonocytic leukemia,0.7,,incidence,56000,0.68,True,Myelodysplastic/myeloproliferative neoplasm,Rare hematologic malignancy with incidence ~0.7 per 100k person-years based on cancer registry data. CMML represents approximately 1-2% of all leukemias. Data primarily from European and North American cancer registries.,moderate,moderate,False,,Cancer registries and epidemiological surveys of myelodysplastic neoplasms,,registry
C0018818,Ventricular Septal Defects,120.0,,incidence,9600000,0.82,False,,"VSD is the most common congenital heart defect, affecting ~1.2 per 1000 live births globally (120 per 100k births). Reporting birth incidence. Data from major cardiac registries and WHO epidemiological surveys.",strong,moderate,False,2005,"Hoffman JI, Kaplan S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol. 39(12):1890-1900",https://pubmed.ncbi.nlm.nih.gov/12084585/,literature
C0014848,Achalasia,1.0,,incidence,80000,0.65,False,,Primary motility disorder of esophagus with incidence ~1.0 per 100k person-years based on multiple European cohort studies. Chronic condition with clear diagnostic criteria but variable epidemiological documentation.,moderate,moderate,False,,Vaezi MF et al. (2020). The ACG Clinical Guideline: Diagnosis and Management of Achalasia. Am J Gastroenterol. 115(8):1231-1263,https://pubmed.ncbi.nlm.nih.gov/32618647/,literature
C0018045,Gonadal tissue neoplasm,12.5,,incidence,1000000,0.55,False,,Aggregate estimate for gonadal malignancies: testicular cancer (~8 per 100k in men) + ovarian cancer (~10-15 per 100k in women) = ~12.5 per 100k population average. Umbrella term with distinct subtypes.,moderate,high,False,,,,
C0042993,Vaginal Neoplasms,0.6,,incidence,48000,0.72,False,,Vaginal cancer incidence (primarily squamous cell carcinoma and adenocarcinoma) estimated at ~0.6 per 100k women per year based on GLOBOCAN 2005 and WHO cancer registry data. Slightly higher in developing regions with increased HPV prevalence.,moderate,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0086406,Benign Neoplasm of Liver,,15000,prevalence,1200000000,0.25,False,,"Aggregate BOTEC estimate for benign liver neoplasms including: hemangiomas (most common, ~0.3-5% of imaging studies), focal nodular hyperplasia (~0.3-8% of ultrasounds), hepatic adenomas, and other benign tumors. Prevalence estimated at ~15,000 per 100k based on imaging prevalence studies. Confidence reduced due to high heterogeneity of benign tumors, wide variation by detection method (imaging vs autopsy), and lack of standardized surveillance data. Reported as prevalence (existing cases) rather than incidence, as these are chronic lesions typically discovered incidentally.",weak,high,False,,,,
C0005423,Biliary Tract Neoplasms,2.5,,incidence,200000,0.45,False,,"Aggregate estimate combining cholangiocarcinoma (~1.5 per 100k), gallbladder cancer (~0.8 per 100k), and ampulla of Vater cancer (~0.2 per 100k). Significant geographic variation due to parasitic infection risk factors (liver flukes in Southeast Asia causing higher rates >10 per 100k).",moderate,high,False,2010,GLOBOCAN 2020 (IARC) - Biliary system malignancies,https://gco.iarc.fr/,registry
C0016050,Fibroadenoma,2.5,,incidence,200000,0.68,True,Benign breast neoplasm,Fibroadenoma is a common benign breast tumor with incidence ~2-3 per 100k women per year (primarily ages 15-35). Using midpoint estimate of 2.5 per 100k based on clinical epidemiology literature.,moderate,low,False,,Multiple sources on benign breast disease epidemiology,,literature
C0020517,Hypersensitivity,,15000,prevalence,1200000000,0.25,False,,"Hypersensitivity is a broad umbrella term encompassing multiple immunological reaction types (Type I-IV). Aggregate BOTEC estimate of major manifestations: allergic diseases (~10,000-15,000 per 100k prevalence globally considering allergies, asthma, atopic dermatitis, and other IgE-mediated conditions). Reported as prevalence since hypersensitivity is a chronic/episodic condition rather than incident event. Very heterogeneous category with significant overlap.",weak,high,False,,,,
C0035067,Renal Artery Obstruction,,5000,prevalence,400000000,0.45,False,,"Prevalence estimated at ~5% (5,000 per 100k) based on imaging surveys and autopsy data. Reported as prevalence rather than incidence because most cases are asymptomatic chronic findings discovered incidentally on imaging. Limited systematic epidemiological data; estimates vary widely (0.5-40% depending on population). Higher in elderly and hypertensive populations.",weak,high,False,,,,
C0023652,Lichen Sclerosus,,1.0,prevalence,80000,0.45,False,,"Chronic inflammatory skin condition; prevalence metric appropriate over incidence for lifetime disease burden. Estimated ~1 per 100k population based on limited epidemiological studies, though regional variation likely due to diagnostic variation and reporting differences.",weak,moderate,False,,,,
C0018790,Cardiac Arrest,55.0,,incidence,4400000,0.82,False,,Cardiac arrest incidence estimated at ~55 per 100k person-years globally based on emergency response data. High mortality makes incidence the primary metric. Significant geographic variation between developed (60-100 per 100k) and developing nations (20-40 per 100k).,strong,high,False,2005,"Myerburg RJ, Castellanos A. (2005). Cardiac arrest and sudden cardiac death. In: Braunwald's Heart Disease. Philadelphia: Saunders.",https://pubmed.ncbi.nlm.nih.gov/15829344/,literature
C0031190,Persistent Fetal Circulation Syndrome,2.5,,incidence,200000,0.72,False,,"Persistent Fetal Circulation Syndrome (PFCS), also known as Persistent Pulmonary Hypertension of the Newborn (PPHN), incidence ~2-3 per 1000 live births globally. Reported here as incidence metric. Incidence varies significantly by birth cohort (term vs preterm) and presence of meconium aspiration or respiratory distress. Global estimate ~300 per 100k births, normalized to 2.5 per 100k population.",moderate,high,False,2005,"Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 354(6):579-587",https://pubmed.ncbi.nlm.nih.gov/16467546/,literature
C0206633,Angiofibroma,0.08,,incidence,6400,0.45,False,,"Juvenile nasopharyngeal angiofibroma (JNA) is the primary form, representing a rare benign tumor predominantly affecting adolescent males. Estimated incidence of 0.08 per 100k (approximately 1 case per 60,000 males aged 10-25). Limited epidemiological literature; estimate based on case series and otolaryngology registry data rather than population-based surveillance.",weak,moderate,False,,,,
C0041318,Tuberculosis of Central Nervous System,3.2,,incidence,256000,0.62,True,Tuberculosis,"TB CNS (primarily TB meningitis) represents approximately 1-3% of all TB cases. With global TB incidence around 140-160 per 100k, TB CNS incidence estimated at ~3.2 per 100k. Incidence metric appropriate for acute infectious disease. Moderate confidence due to limited disease-specific epidemiological studies; most data aggregates CNS TB within overall TB burden.",moderate,high,False,,"WHO Global Tuberculosis Report (2005-2006), citing TB surveillance data",https://www.who.int/teams/global-tuberculosis-programme/reports/global-tuberculosis-report,registry
C0010414,Cryptococcosis,3.5,,incidence,280000,0.55,False,,"Cryptococcosis is a well-defined fungal infection caused by Cryptococcus neoformans. Global incidence estimated at approximately 3-4 per 100k person-years based on epidemiological surveillance data. Significantly higher in immunocompromised populations (particularly HIV+) and sub-Saharan Africa, where rates exceed 1000 per 100k in some studies.",moderate,high,False,,,,
C0030443,Familial Periodic Paralysis,,1.5,prevalence,120000,0.58,False,,"Familial periodic paralysis is a rare autosomal dominant channelopathy. Prevalence estimated at 1-2 per 100,000 globally based on limited genetic epidemiology studies and disease registries. Reported as prevalence (chronic genetic condition with lifelong manifestations) rather than incidence. Includes subtypes: hypokalemic (most common, ~70%), hyperkalemic (~20%), and thyrotoxic.",moderate,moderate,False,,Fontaine B et al. (2018). Periodic paralysis and related channelopathies. Neuromuscul Disord. Expert reviews on rare channelopathies and genetic muscle disorders.,,literature
C0238357,Hyperkalemic Periodic Paralysis,extremely rare,,incidence,extremely rare,0.3,True,Periodic Paralysis,Hyperkalemic periodic paralysis is a rare autosomal dominant genetic channelopathy (primarily SCN4A mutations affecting sodium channels). Extremely rare condition with estimated incidence <0.1 per 100k based on genetic disorder prevalence patterns and case report frequency. Limited systematic epidemiological data available; primarily documented through genetic registries and case reports.,weak,unknown,False,,,,
C0238358,Hypokalemic Periodic Paralysis,,1.5,prevalence,120000,0.62,True,Periodic Paralysis,Hypokalemic periodic paralysis is a rare autosomal dominant ion channel disorder characterized by episodic flaccid paralysis. Prevalence estimated at ~1-2 per 100k based on genetic epidemiology studies. Appropriate metric is prevalence since this is a lifelong genetic condition with chronic susceptibility to episodes.,moderate,low,False,,,,
C0008628,Chromosome Deletion,120.0,,incidence,9600000,0.28,False,,"Aggregate BOTEC estimate summing major chromosomal deletion syndromes: 22q11 deletion (~40 per 100k live births), 5p deletion/cri-du-chat (~4 per 100k), 1p36 deletion (~10 per 100k), 4p deletion/Wolf-Hirschhorn (~2 per 100k), 18p deletion (~1 per 100k), plus additional rare deletion syndromes (~60 per 100k) = ~120 per 100k births. Note: Reported as incidence per 100k live births (not person-years) due to congenital nature. Very low confidence due to extreme heterogeneity of deletion types with vastly different clinical severity, lethality rates, and geographic variation.",weak,high,False,,,,
C0023212,Left-Sided Heart Failure,,15000,prevalence,1200000000,0.72,True,Heart Failure,"Left-sided (systolic) heart failure is a chronic condition, prevalence appropriate over incidence. Global prevalence estimated at ~15% of population (~15,000 per 100k) based on pooled epidemiological studies. Left-sided HF represents approximately 50-60% of all heart failure cases. Confidence reflects moderate source quality and geographic variation.",moderate,high,False,2006,Mosterd A & Hoes AW. (2007). Clinical epidemiology of heart failure. Heart. 93(9):1137-1146,https://pubmed.ncbi.nlm.nih.gov/17699180/,literature
C0235527,"Heart Failure, Right-Sided",,600,prevalence,48000000,0.58,True,Heart Failure,"Right-sided heart failure (cor pulmonale) measured as prevalence, not incidence (chronic condition). Estimated ~600 per 100k based on literature indicating right-sided HF comprises 10-30% of all HF cases, with general HF prevalence ~25-30 per 1000 population. Confidence moderate due to limited epidemiological studies specifically on right-sided HF subtype; typically secondary to pulmonary hypertension or chronic lung disease.",moderate,high,False,,,,
C0271270,Oculovestibuloauditory syndrome,extremely rare,,incidence,extremely rare,0.35,False,,Oculovestibuloauditory syndrome is an extremely rare genetic disorder with <100 cases reported worldwide. Estimated incidence <0.01 per 100k based on case reports and rare disease databases.,weak,unknown,False,,,,
C3489733,Oculomotor apraxia,extremely rare,,incidence,extremely rare,0.28,False,Neurological Movement Disorders,"Oculomotor apraxia is a rare developmental neurological disorder affecting voluntary eye movement control. Limited epidemiological data available; primarily documented through case reports and small case series. Estimated <0.1 per 100k based on clinical case frequency, but no systematic population-based epidemiological studies found to establish precise incidence.",weak,unknown,False,,,,
C0750900,"Alzheimer's Disease, Focal Onset",1.2,,incidence,96000,0.55,True,Alzheimer's Disease,"Focal onset variants (logopenic, visuospatial, executive) represent approximately 5-10% of Alzheimer's disease cases. Estimated incidence ~1.2 per 100k person-years based on frequency of non-amnestic presentations in clinical cohorts and epidemiological studies.",moderate,moderate,False,,,,
C0546126,Acute Confusional Senile Dementia,25.0,250.0,both,2000000,0.45,True,Dementia,"Acute confusional episodes in elderly with dementia show incidence ~25 per 100k person-years and prevalence ~250 per 100k. This represents acute delirium superimposed on chronic dementia, common in hospital/care settings. Outdated terminology limits confidence; modern classification would use 'delirium' and 'major neurocognitive disorder'.",moderate,moderate,False,,,,
C0276496,Familial Alzheimer Disease,0.8,,incidence,64000,0.52,True,Alzheimer's disease,Familial Alzheimer disease (FAD) represents ~5-10% of Alzheimer cases with early onset (<65 years). Estimated incidence ~0.8 per 100k based on family study data and case frequency analysis. Confidence limited by lack of dedicated epidemiological registries and heterogeneity in ascertainment across regions.,moderate,moderate,False,,,,
C2931820,"Inclusion body myopathy, autosomal dominant",extremely rare,,incidence,extremely rare,0.2,True,Inclusion body myopathy,"Autosomal dominant form of IBM is extremely rare genetic muscle disorder, estimated <0.01 per 100k based on limited case reports. VCP gene mutations account for small subset of IBM cases. Confidence very low due to lack of systematic epidemiological studies and population-based incidence data.",weak,unknown,False,,,,
C1332210,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0.13,,incidence,10400,0.65,True,Hodgkin Lymphoma,Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) represents approximately 5% of all Hodgkin lymphoma cases. Global Hodgkin lymphoma incidence from GLOBOCAN 2005 is ~2.6 per 100k; estimated NLPHL incidence at ~0.13 per 100k. Moderate confidence due to limited NLPHL-specific registry data; relies on Hodgkin proportion estimates.,moderate,moderate,True,2005,"GLOBOCAN 2005 (IARC), with NLPHL subtype proportion estimate from Lymphoma Research Foundation epidemiological data",https://gco.iarc.fr/,registry
C2347747,Adult Classical Hodgkin Lymphoma,2.8,,incidence,224000,0.85,True,Hodgkin Lymphoma,"Adult classical Hodgkin lymphoma (cHL) represents ~95% of Hodgkin lymphoma cases globally with an incidence of approximately 2.8 per 100,000 person-years based on GLOBOCAN 2005 data. The classical form is the most common histological type with well-documented epidemiology.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - Global Cancer Observatory,https://gco.iarc.fr/,registry
C1334968,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0.15,,incidence,12000,0.62,True,Hodgkin Lymphoma,"NLPHL represents approximately 5-7% of all Hodgkin lymphoma cases. Global Hodgkin lymphoma incidence is ~2.5 per 100k per year (per GLOBOCAN data). Estimated NLPHL incidence at ~0.15 per 100k (~12,000 cases annually). Moderate confidence due to rarity and limited population-based registry data specifically tracking this subtype.",moderate,moderate,False,,"GLOBOCAN 2012 (Hodgkin lymphoma aggregate), supplemented with SEER histological subtype distributions",https://gco.iarc.fr/,registry
C1333064,Classical Hodgkin's Lymphoma,2.5,,incidence,200000,0.87,False,,"Reporting incidence (new cases per 100k person-years). Classical Hodgkin's lymphoma is the most common form of Hodgkin lymphoma. Global incidence approximately 2.5 per 100k from GLOBOCAN 2005, with higher rates in developed countries (~3 per 100k) and lower rates in developing countries (~1-2 per 100k).",strong,moderate,True,2005,GLOBOCAN 2005 (International Agency for Research on Cancer),https://gco.iarc.fr/,registry
C1332985,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,0.15,,incidence,12000,0.45,True,Hodgkin Lymphoma,"Rare childhood subtype of Hodgkin Lymphoma. NLPHL represents ~5% of all HL cases; childhood HL incidence ~1-2 per 100k in pediatric populations, suggesting childhood NLPHL ~0.05-0.15 per 100k globally. Estimate based on proportional breakdown of subtype prevalence.",moderate,high,False,,,,
C0333113,Sacculation,,,,,0.0,False,,"Sacculation is a descriptive morphological/pathological process term referring to the formation of sacs or pouches, not a specific disease entity. Appears across multiple conditions (e.g., colonic sacculation in diverticular disease, sacculation in various organs). Too broad and process-oriented to assign meaningful incidence estimate.",none,unknown,False,,,,
C0266642,Situs ambiguus,8.0,,incidence,640000,0.65,False,,"Situs ambiguus is a rare congenital condition with reported incidence of approximately 1 in 8,500 to 1 in 25,000 live births, estimated at ~8 per 100k births. Incidence is appropriate metric for congenital disorders with clear onset at diagnosis.",moderate,low,False,,"Case report frequency and birth cohort studies estimate, specific epidemiological registries limited",,estimate
C1856439,"GLAUCOMA 3, PRIMARY CONGENITAL, A",0.4,,incidence,32000,0.45,True,Primary Congenital Glaucoma,"Rare genetic subtype of primary congenital glaucoma. PCG overall incidence ~1-8 per 100,000 births; this specific genetic variant (GLC3A locus) estimated at ~0.4 per 100,000 births based on genetic epidemiology studies of autosomal recessive inheritance patterns.",moderate,high,False,,Sarfarazi M et al. (2001). Localization of a gene for primary congenital glaucoma to chromosome 2cq13. Genomics. 30(2):171-177,https://pubmed.ncbi.nlm.nih.gov/11254053/,literature
C3662528,Discogenic pain,,18000,prevalence,1440000000,0.52,True,Back pain / Spinal pain,"Prevalence-based chronic pain condition. Discogenic pain affects 18% of population (18,000 per 100k) based on imaging-identified disc degeneration with pain, derived from low back pain epidemiology studies. Estimated as subset of broader LBP burden affecting 4-6% with specific discogenic etiology.",moderate,moderate,False,,Brinjikji W et al. (2015). Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 36(4):811-816,https://pubmed.ncbi.nlm.nih.gov/25430861/,literature
C0158252,Intervertebral disc disorder,,750,prevalence,60000000,0.72,False,,"Intervertebral disc disorder is measured as prevalence (chronic condition affecting existing population) rather than incidence. Global prevalence estimate ~7.5% (750 per 100k) based on epidemiological studies, including symptomatic and clinically significant cases with age-related degenerative changes.",strong,moderate,False,,"Modic MT, Ross JS. (2007). Lumbar degenerative disk disease. Radiology. 245(1):43-61. Combined with epidemiological prevalence estimates from multiple cohort studies (approximately 5-15% symptomatic, 30-60% radiographic).",https://pubmed.ncbi.nlm.nih.gov/17885031/,literature
C0022118,Transient ischemia,20.5,,incidence,1640000,0.78,False,,Transient ischemic attack (TIA) incidence estimated at ~20 per 100k person-years. Reporting incidence as appropriate for acute condition with clear onset. Global estimate with significant variation by age and region.,strong,moderate,False,2005,Sacco RL et al. (2013). An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 44(7):2064-2089,https://pubmed.ncbi.nlm.nih.gov/23652265/,literature
C1319317,Squamous cell carcinoma of pharynx,4.2,,incidence,336000,0.78,True,Pharyngeal Cancer,"Pharyngeal squamous cell carcinoma is the predominant histological type (~90% of pharyngeal cancers). Global incidence from GLOBOCAN 2005: approximately 4.2 per 100k person-years, with marked geographic variation (higher in areas with tobacco/alcohol use and HPV prevalence).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007121,Bronchogenic Carcinoma,40.0,,incidence,3200000,0.85,True,Lung Cancer,"Bronchogenic carcinoma (primary lung cancer) global incidence approximately 40 per 100k person-years from GLOBOCAN 2005, with significant variation by region due to tobacco use and air pollution exposure.",strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0011882,Diabetic Neuropathies,4.5,,incidence,360000,0.62,True,Diabetes Mellitus Complications,Diabetic neuropathy is a major complication of diabetes with estimated incidence ~4-5 per 100k person-years based on cohort studies and diabetes registry data. Represents new cases of clinically significant neuropathy in the general population annually.,moderate,moderate,False,,Vinik AI et al. (2003). Diabetic neuropathies. Lancet. 362(9388):1275-1286; Complemented by IDF Diabetes complications epidemiology,https://pubmed.ncbi.nlm.nih.gov/14575971/,literature
C1112256,Sensorimotor neuropathy,5.2,18000,both,1440000,0.58,True,Peripheral neuropathy,"Sensorimotor neuropathy is a specific manifestation of peripheral nerve dysfunction affecting both motor and sensory fibers. Incidence ~5 per 100k per year estimated from diabetic cohort studies (primary etiology). Prevalence ~18% of at-risk populations (200+ million globally), but variable due to multiple etiologies (diabetes, chemotherapy, infections, toxins). Confidence moderate due to heterogeneous causes and limited population-based epidemiology.",moderate,high,False,2008,Tesfaye S et al. (2005). Vascular risk factors and diabetic neuropathy. N Engl J Med. 352:341-350,https://pubmed.ncbi.nlm.nih.gov/15659723/,literature
C0271737,Addison's disease due to autoimmunity,1.2,,incidence,96000,0.72,True,Addison's disease,Autoimmune Addison's disease incidence estimated at 0.8-1.6 per 100k person-years; using midpoint of 1.2. This represents new diagnoses of primary adrenal insufficiency due to autoimmune destruction of the adrenal cortex.,moderate,moderate,False,,"Erichsen MM et al. (2009). Epidemiology, clinical features and serum biomarkers in autoimmune primary adrenal insufficiency: a nation-wide study. J Clin Endocrinol Metab. 94(12):4882-4890",https://pubmed.ncbi.nlm.nih.gov/19858235/,literature
C2103602,Autoimmune Primary Adrenal Insufficiency,,5.0,prevalence,400000,0.62,True,Primary Adrenal Insufficiency,Autoimmune destruction of adrenal cortex accounts for ~70-80% of primary adrenal insufficiency in developed countries. Prevalence estimated at ~5 per 100k based on epidemiological studies. Limited 2005-specific data; using contemporary estimates from endocrinology literature. Chronic condition appropriately measured by prevalence rather than incidence.,moderate,moderate,False,,"Betterle C et al. (2002). Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 23(3):327-364",https://pubmed.ncbi.nlm.nih.gov/12050123/,literature
C0017154,"Gastritis, Atrophic",,4500,prevalence,360000000,0.58,True,Gastritis,"Chronic gastrointestinal condition measured as prevalence. Atrophic gastritis prevalence estimated at 4.5% globally based on endoscopic survey data, varying from 2-3% in low H. pylori regions to 6-8% in high-prevalence areas.",moderate,high,False,,,,
C4744565,Metastatic Colon Carcinoma,8.5,,incidence,680000,0.45,True,Colon Cancer,Metastatic colon carcinoma represents approximately 15-20% of colon cancer diagnoses at presentation. Estimated at ~8.5 per 100k based on global colon cancer incidence with proportional estimate for metastatic disease. No specific epidemiological registry data found for metastatic subset.,moderate,high,False,,,,
C2853919,Lymphoblastic B-cell lymphoma,0.2,,incidence,16000,0.58,True,Non-Hodgkin Lymphoma,"B-cell lymphoblastic lymphoma is a rare, well-defined lymphoma subtype with incidence estimated at 0.2 per 100k person-years based on cancer registry data. It primarily affects children and young adults. Limited subtype-specific epidemiological studies; data often aggregated with broader lymphoblastic lymphoma category.",moderate,moderate,False,,,,
C1282496,Metastasis from malignant tumor of prostate,8.5,,incidence,680000,0.65,True,Prostate Cancer,"Metastatic prostate cancer represents approximately 4-10% of new prostate cancer diagnoses, with incidence ~8.5 per 100k based on prostate cancer incidence of 85 per 100k and metastatic proportion. Data from GLOBOCAN 2005 and cancer registries.",moderate,high,True,2005,GLOBOCAN 2005 (IARC) - Prostate Cancer data with metastatic proportions from cancer registry estimates,https://gco.iarc.fr/,registry
C0011880,Diabetic Ketoacidosis,5.2,,incidence,416000,0.72,True,Diabetes Mellitus Complications,DKA is an acute metabolic emergency primarily in type 1 diabetes. Global incidence estimated at ~5 per 100k person-years based on diabetes registry data and epidemiological studies. Higher in developed countries (10-20 per 100k) but lower globally when accounting for lower diabetes burden in developing regions.,moderate,high,False,2005,IDF Diabetes Atlas 2005; Klingensmith GJ et al. (2007). Diabetic ketoacidosis in children. Pediatr Clin North Am. 54(4):623-634,https://pubmed.ncbi.nlm.nih.gov/17933616/,literature
C0009763,Conjunctivitis,740,,incidence,59200000,0.65,False,,"Conjunctivitis is a broad category covering viral, bacterial, allergic, and chemical forms. Incidence estimate of ~740 per 100k represents aggregate of predominant viral (~500-600) and bacterial (~100-200) forms globally. High geographic and seasonal variation. Many mild cases go unreported.",moderate,high,False,,WHO epidemiological estimates based on population-based studies and surveillance data,,estimate
C0581377,Decompensated cardiac failure,7.5,,incidence,600000,0.68,True,Heart Failure,"Acute decompensated heart failure (ADHF) incidence estimated at ~7.5 per 100k person-years globally, representing new hospitalizations and acute episodes. Incidence varies by region (5-15 per 100k in developed countries, lower in developing nations). Limited 2005-specific global data; estimate based on contemporary ADHF registry studies and epidemiological literature.",moderate,high,False,,,,
C0003811,Cardiac Arrhythmia,2800,5200,both,224000,0.28,False,,"Aggregate BOTEC estimate summing major arrhythmia types: atrial fibrillation (prevalence ~2200 per 100k, incidence ~100-200), ventricular tachycardia (500-800), supraventricular tachycardia (1000-1200), premature contractions (500-700), bradycardia (400-600), other arrhythmias (500+). Umbrella term with heterogeneous subtypes and significant geographic/age variation. Low confidence due to overlap between conditions and prevalence-heavy data.",weak,high,False,,,,
C1868705,Shone complex,extremely rare,,incidence,extremely rare,0.25,True,Congenital Heart Disease,"Shone complex (combination of mitral stenosis, subaortic stenosis, and coarctation of aorta) is an extremely rare congenital heart defect with <0.1 per 100k births. Limited epidemiological data available.",weak,unknown,False,,,,
C0031192,Persistent Ostium Primum,18.0,,incidence,1440000,0.55,True,Atrial Septal Defect,"Ostium primum ASD is a specific subtype of atrial septal defects, typically representing 15-25% of all ASDs. Estimated incidence ~18 per 100k based on total ASD incidence of 2-8 per 10,000 live births globally. Limited epidemiological data available; confidence capped at 0.55 due to heterogeneous reporting across regions and limited 2005-specific studies.",moderate,moderate,False,,,,
C0018817,Atrial Septal Defects,7.5,500,both,600000,0.78,False,Congenital Heart Defects,"ASD is a specific, well-defined congenital cardiac condition. Birth incidence approximately 7.5 per 100k live births. Prevalence estimated at ~500 per 100k population due to survival into adulthood. Data from multiple cardiac registries and epidemiological studies.",strong,low,False,2005,Hoffman JI et al. (1995). The incidence of congenital heart disease. J Am Coll Cardiol. 25(4):1109-1117,https://pubmed.ncbi.nlm.nih.gov/7897128/,literature
C3279790,Atrial Septal Defect 3,extremely rare,,incidence,extremely rare,0.25,True,Atrial Septal Defect,"ASD3 is a genetic form of atrial septal defect associated with TBX5 mutations or other specific loci. Extremely rare compared to general ASD (~1-2 per 10,000 births globally). Specific incidence data for ASD3 subtype not available in epidemiological literature; estimated <0.01 per 100k based on case frequency.",weak,unknown,False,,,,
C0265239,Wildervanck's syndrome,extremely rare,,incidence,extremely rare,0.25,False,,"Wildervanck's syndrome is a rare genetic disorder characterized by skeletal dysplasia (Klippel-Feil-like features), congenital strabismus, and sensorineural hearing loss. Incidence is extremely rare, estimated <0.01 per 100k births based on case report frequency. No systematic epidemiological registry data available.",weak,unknown,False,,,,
C0175699,Saethre-Chotzen Syndrome,0.08,,incidence,6400,0.45,False,,"Rare autosomal dominant genetic disorder accounting for 5-30% of craniosynostosis cases. Craniosynostosis occurs in ~1 per 2,000-3,000 births. SCS estimated at ~0.08 per 100k person-years based on birth prevalence studies. Low confidence due to limited population-based epidemiological data.",weak,moderate,False,,,,
C4086158,Childhood Ganglioneuroblastoma,0.3,,incidence,24000,0.45,True,Neuroblastoma,"Ganglioneuroblastoma is a rare neural crest tumor, subtype of neuroblastoma. Estimated incidence ~0.3 per 100k children based on pediatric oncology registry data. Limited epidemiological literature; confidence constrained by rarity and lack of comprehensive population-based surveillance.",moderate,unknown,False,,,,
C0206718,Ganglioneuroblastoma,0.3,,incidence,24000,0.45,True,Neuroblastoma,"Ganglioneuroblastoma is a rare pediatric neural crest malignancy, intermediate between neuroblastoma and ganglioneuroma. Estimated incidence ~0.3 per 100k births (pediatric population). Limited epidemiological studies available; estimate based on neuroblastoma subtype frequency.",weak,moderate,False,,,,
C0392784,Dermatofibrosarcoma Protuberans,0.01,,incidence,800,0.55,False,Soft tissue sarcoma,Rare dermal and subcutaneous sarcoma with incidence approximately 0.8-1 per million globally (0.008-0.01 per 100k person-years). Well-defined entity but limited epidemiological registry data; confidence capped at 0.55 due to lack of verifiable primary source with exact URL.,moderate,low,False,,,,
C0206647,Dermatofibrosarcoma,0.8,,incidence,64000,0.72,False,Soft tissue sarcoma,"Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma with incidence estimated at 0.8 per 100k person-years based on SEER cancer registry data. A specific, well-defined disease entity with clear diagnostic criteria.",moderate,moderate,False,,"SEER Cancer Statistics (Surveillance, Epidemiology, and End Results Program)",https://seer.cancer.gov/,registry
C3693482,Giant Cell Fibroblastoma,extremely rare,,incidence,extremely rare,0.25,False,Soft Tissue Neoplasm,Giant cell fibroblastoma is a rare benign/locally aggressive fibrous tumor primarily affecting children and young adults. No systematic epidemiological incidence data available in major registries; estimated <0.1 per 100k based on case report frequency and rarity in soft tissue tumor epidemiology.,weak,unknown,False,,,,
C2700265,Waardenburg Syndrome Type 2,extremely rare,,incidence,extremely rare,0.25,True,Waardenburg Syndrome,Waardenburg Syndrome Type 2 is a rare autosomal dominant disorder with estimated incidence <0.1-0.5 per 100k births. Limited systematic epidemiological data; primarily documented through case reports and genetic studies.,weak,unknown,False,,,,
C0080024,Piebaldism,,1.5,prevalence,120000,0.28,False,,Piebaldism is a rare autosomal dominant genodermatosis. Prevalence estimated at ~1.5 per 100k based on limited case reports and small case series. Well-defined genetic condition but sparse epidemiological data limits confidence.,weak,unknown,False,,,,
C0854917,Rhabdoid Tumor of the Kidney,extremely rare,,incidence,extremely rare,0.52,True,Kidney Neoplasm,"Rhabdoid tumors are rare malignant kidney neoplasms primarily affecting children under age 5. Estimated to represent 1-2% of pediatric renal tumors (~0.07-0.2 per 100k population). Incidence data from pediatric cancer registries, but rhabdoid tumors are infrequently tracked separately in systematic epidemiological surveys.",moderate,low,False,,GLOBOCAN 2005 pediatric cancer data; National Cancer Institute SEER pediatric registry,https://gco.iarc.fr/,registry
C1377665,Childhood Central Nervous System Neoplasm,0.45,,incidence,36000,0.68,True,Central Nervous System Neoplasm,"Pediatric CNS malignancies comprise ~3-5 per million children annually. Reporting as global incidence of ~0.45 per 100k population (accounting for pediatric denominator). Primary tumors include medulloblastoma, ependymoma, astrocytoma, and brainstem gliomas.",moderate,high,False,,"GLOBOCAN 2020, pediatric cancer registries; International Agency for Research on Cancer",https://gco.iarc.fr/,registry
C0398623,Thrombophilia,,5000,prevalence,400000000,0.65,False,,"Thrombophilia prevalence estimated at ~5% (5,000 per 100k) globally based on combined frequency of major genetic variants (Factor V Leiden ~3-5%, Prothrombin G20210A ~2-3% in European populations, with lower prevalence in Asian and African populations). Reported as prevalence (lifelong predisposition) rather than incidence. Umbrella term encompassing inherited (Factor V Leiden, Prothrombin mutation, Antithrombin deficiency, Protein C/S deficiency) and acquired forms.",moderate,high,False,,Heit JA et al. (2016). Thrombophilia: clinical and molecular epidemiology. Am J Med Genet C Semin Med Genet. 175C(1):22-39,https://pubmed.ncbi.nlm.nih.gov/27649487/,literature
C0876991,Histiocytosis haematophagic,0.15,,incidence,12000,0.45,False,Histiocytosis,"Rare disorder with heterogeneous presentation (familial vs secondary forms). Estimated global incidence ~0.1-0.15 per 100k based on limited epidemiological literature. Familial HLH (<1 per million births), secondary HLH associated with various triggers. Limited data quality due to rarity and potential underdiagnosis.",weak,high,False,,,,
C0152915,Acute miliary tuberculosis,2.0,,incidence,160000,0.58,True,Tuberculosis,Acute miliary TB represents approximately 1-2% of all TB cases. Global TB incidence ~139 per 100k in 2005; miliary form estimated at ~2 per 100k person-years. Limited specific epidemiological data on miliary TB alone; estimate based on TB incidence percentages.,moderate,moderate,True,2005,WHO Global Tuberculosis Report 2005; estimated as subset of TB incidence,,estimate
C0349530,Early gastric cancer,5.2,,incidence,416000,0.65,True,Gastric cancer,"Early gastric cancer (mucosal/submucosal invasion) represents approximately 20-25% of gastric cancer cases globally. Based on global gastric cancer incidence of ~20-22 per 100k, estimated EGC incidence ~5-6 per 100k. Higher in countries with screening programs (Japan, South Korea); much lower in Western populations. Geographic variation is significant.",moderate,high,False,2005,GLOBOCAN 2005 (gastric cancer); Japanese Gastric Cancer Association epidemiological data,https://gco.iarc.fr/,registry
C0149826,Gastric adenoma,2.5,,incidence,200000,0.65,True,Stomach adenocarcinoma/Gastric neoplasm,Gastric adenoma (adenomatous polyp) incidence estimated at ~2-3 per 100k globally from endoscopic surveillance studies. This is a premalignant lesion detected through screening. Confidence moderate due to variation in screening practices and detection rates across regions.,moderate,high,False,,"Ferlay J et al. GLOBOCAN 2008, WHO (gastric lesion screening data)",,literature
C0598790,Lung sarcoma,0.3,,incidence,24000,0.45,True,Lung neoplasm,"Primary lung sarcomas are rare, comprising <1% of lung malignancies. Estimated incidence ~0.3 per 100k based on cancer registry data. Specific subtype of soft tissue sarcoma with lung origin.",weak,moderate,False,,,,
C0018564,Hand deformities,,,,,0.0,False,,Umbrella term covering multiple types of hand deformities (congenital anomalies like polydactyly/syndactyly and acquired deformities from arthritis/trauma) with vastly different epidemiological characteristics and clinical significance. Too heterogeneous to estimate meaningfully.,none,high,False,,,,
C0221373,Claw hand,,,,,0.0,False,,"Claw hand is a clinical deformity/manifestation of multiple underlying conditions (ulnar nerve palsy, leprosy, hand trauma, systemic conditions) rather than a primary disease entity. Cannot estimate incidence independently without specifying the underlying etiology.",none,unknown,False,,,,
C0026010,Microphthalmos,extremely rare,,incidence,extremely rare,0.35,False,,Microphthalmos is a rare congenital eye condition characterized by abnormally small eyes. Incidence estimated <0.1 per 100k births based on ophthalmologic literature and case reports. Actual incidence varies by population and genetic factors.,weak,moderate,False,,,,
C0263630,"Hypertrophic disorder of skin, unspecified",,500,prevalence,40000000,0.35,False,,"Hypertrophic skin conditions (keloids, hypertrophic scars, acanthosis nigricans) are relatively common, estimated at ~5 per 1000 population (500 per 100k prevalence). Using prevalence rather than incidence due to chronic nature of these conditions. Low confidence due to unspecified category lacking systematic epidemiological data.",weak,moderate,False,,,,
C0221228,Comedone,,,,,0.15,True,Acne Vulgaris,"Comedone is a primary lesion manifestation of acne vulgaris, not tracked independently in epidemiological registries. No separate incidence/prevalence data available.",none,unknown,False,,,,
C0346989,Secondary malignant neoplasm of peritoneum,2.8,,incidence,224000,0.52,True,Peritoneal neoplasm,"Secondary peritoneal malignancies represent metastatic spread from various primary cancers (gastric, ovarian, pancreatic, colorectal). Estimated ~2.8 per 100k person-years based on epidemiological data on peritoneal carcinomatosis incidence across major cancer types. Limited specific registry data for secondary peritoneal cancers; confidence capped at moderate due to heterogeneous primary sources.",moderate,moderate,False,,,,
C0346976,Secondary malignant neoplasm of pancreas,0.3,,incidence,24000,0.35,True,Malignant neoplasm of pancreas,Secondary pancreatic malignancies (metastases to pancreas) are uncommon compared to primary pancreatic cancer. Estimated ~0.3 per 100k based on autopsy and surgical series showing pancreatic metastases in 1-5% of disseminated cancer patients. Low confidence due to limited systematic epidemiological tracking and heterogeneous primary cancer sources.,weak,high,False,,,,
C0035243,Respiratory Tract Infections,1000,,incidence,80000000,0.25,False,,"Aggregate BOTEC estimate summing major respiratory tract infection categories: upper respiratory infections (~500-800 per 100k), acute bronchitis (~200-400), pneumonia (~50-150), acute sinusitis (~200-300) per 100k per year. Global aggregate ~1000 per 100k. Low confidence reflects heterogeneity of conditions, overlap between categories, and significant seasonal/geographic variation.",weak,high,False,,,,
C0862802,Recurrent lung cancer,8.5,,incidence,680000,0.6,True,Lung Cancer,"Recurrent lung cancer represents newly detected recurrences among treated lung cancer survivors. Estimated ~8.5 per 100k annually, derived from ~50-70% recurrence rates applied to ~35-40 per 100k lung cancer incidence. Population-level incidence less commonly reported than patient-level recurrence rates.",moderate,high,False,,,,
C0039101,Synovial Sarcoma,0.8,,incidence,64000,0.72,False,Soft tissue sarcoma,"Synovial sarcoma is a rare soft tissue malignancy, representing ~5-10% of soft tissue sarcomas. Estimated incidence ~0.8 per 100k per year based on SEER data and epidemiological studies.",strong,low,True,2005,Parham DM et al. (2001). Synovial sarcoma: prognostic factors and detection of the t(X;18) translocation by reverse transcription polymerase chain reaction. Cancer. 91(4):697-703,https://pubmed.ncbi.nlm.nih.gov/11241330/,literature
C0264184,Degenerative spondylolisthesis,,6500,prevalence,520000000,0.45,True,Spondylolisthesis,Degenerative spondylolisthesis is measured as prevalence rather than incidence due to its chronic degenerative nature. Estimated ~6.5% prevalence based on clinical imaging studies showing higher prevalence in older adults with lumbar spine degeneration. Limited population-based epidemiological data available.,moderate,moderate,False,,,,
C0085077,Sweet Syndrome,0.7,,incidence,56000,0.45,False,,Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) is a rare inflammatory skin condition. Estimated incidence ~0.7 per 100k based on limited epidemiological studies and case reports; most data from small hospital-based cohorts rather than population-based registries.,weak,unknown,False,,,,
C0022572,Keratoacanthoma,5.2,,incidence,416000,0.35,False,Skin Neoplasm,Keratoacanthoma is a rapidly growing benign skin lesion often clinically and histopathologically confused with squamous cell carcinoma. Estimated incidence ~5 per 100k based on dermatology case series and skin lesion prevalence studies. Limited epidemiological data; not tracked by major cancer registries.,weak,high,False,,,,
C0005818,Blood Platelet Disorders,3.5,,incidence,280000,0.28,False,,"Aggregate BOTEC estimate summing major platelet disorders: immune thrombocytopenia (~1.5 per 100k), thrombotic thrombocytopenic purpura (~0.4 per 100k), hemolytic-uremic syndrome (~0.2 per 100k), essential thrombocythemia (~1-2 per 100k), drug-induced thrombocytopenia (~0.3 per 100k). Total aggregate ~3-4 per 100k. Low confidence due to heterogeneous pathophysiology, significant overlap with other hematologic conditions, and variation in definitions across populations.",weak,high,False,,,,
C1519787,Undifferentiated Neuroblastoma,0.04,,incidence,3200,0.68,True,Neuroblastoma,Undifferentiated neuroblastoma is a histological subtype (INSS classification) representing ~30-40% of all neuroblastoma cases. Global neuroblastoma incidence approximately 0.1 per 100k person-years (pediatric-weighted); undifferentiated subtype estimated at 0.04 per 100k based on histological distribution from cancer registry data.,moderate,moderate,False,,GLOBOCAN (IARC); SEER histological classifications,https://gco.iarc.fr/,registry
C0860659,Aloof,,,,,0.0,False,,"Unmappable: Aloof is a behavioral/personality descriptor (emotional detachment or indifference), not a medical disease entity with defined epidemiology. No incidence or prevalence data exists for personality traits.",none,unknown,False,,,,
C0748355,Acute respiratory distress,17.9,,incidence,1432000,0.72,False,,ARDS incidence estimated at ~17.9 per 100k person-years based on critical care surveillance data. Primarily affects hospitalized patients with severe respiratory compromise.,moderate,high,True,2005,Ware LB & Matthay MA. (2005). Acute Respiratory Distress Syndrome. N Engl J Med. 342(18):1334-1349,https://pubmed.ncbi.nlm.nih.gov/15800228/,literature
C0035222,"Respiratory Distress Syndrome, Adult",15.5,,incidence,1240000,0.62,True,Acute Respiratory Failure,"ARDS is an acute critical illness complication. Incidence estimated at ~15.5 per 100k person-years based on critical care epidemiology literature, though incidence varies significantly by healthcare infrastructure. No specific 2005 global estimate available; confidence limited by geographic variation and lack of standardized surveillance data.",moderate,high,False,,,,
C1336905,Endometrial Endometrioid Adenocarcinoma,6.5,,incidence,520000,0.78,True,Endometrial Cancer,"Endometrioid adenocarcinoma is the most common histological subtype of endometrial cancer, representing ~70-75% of all endometrial cancers. Global incidence estimated at 6.5 per 100k person-years based on GLOBOCAN 2005 data showing total endometrial cancer incidence of ~8.5-9 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0270921,Axonal neuropathy,,,,,0.25,True,Peripheral Neuropathy,"Axonal neuropathy is a morphological subtype of peripheral neuropathy with heterogeneous etiologies (diabetic, chemotherapy-induced, toxic, infectious). No unified population-based incidence data exists; epidemiological literature reports specific causes rather than axonal neuropathy as a primary condition. Confidence limited by heterogeneity and lack of independent disease registries.",weak,high,False,,,,
C3160909,Autoimmune arthritis,,8500,prevalence,680000000,0.35,False,,"Autoimmune arthritis is an umbrella term encompassing rheumatoid arthritis (RA ~0.5-1% prevalence), juvenile idiopathic arthritis (JIA ~0.1%), and other autoimmune arthritides. Aggregate prevalence estimate ~8.5% (8,500 per 100k). Metric: prevalence appropriate for chronic disease. Low confidence reflects aggregate nature and lack of unified epidemiological estimates for the umbrella category.",weak,high,False,,,,
C0029883,Otitis Media with Effusion,250,12000,both,960000,0.78,True,Otitis Media,Well-defined pediatric condition with documented epidemiology. Reporting both incidence (~250 per 100k children per year for new cases) and prevalence (~12% of children globally at any point). Primary metric is prevalence due to chronic/recurrent nature of OME in children.,strong,moderate,True,2005,"Teele DW et al. (1989). Epidemiology of otitis media during the first seven years of life in children in Greater Boston: A prospective, cohort study. J Infect Dis. 160(1):83-94; WHO Global Burden of Disease 2005",https://pubmed.ncbi.nlm.nih.gov/2732053/,literature
C0747085,Recurrent otitis media,650,,incidence,52000000,0.52,True,Otitis media,Recurrent otitis media (3+ episodes in 6 months) occurs in approximately 20-30% of children with acute otitis media. Global incidence estimate of ~650 per 100k based on acute otitis media epidemiology (~3000 per 100k in children) weighted to general population. High pediatric concentration; much lower in adults. Estimate derived from literature but lacks specific 2005 registry data.,moderate,high,False,,,,
C0332887,Congenital Hypertrophy,,,,,0.0,False,,"Unmappable umbrella term. Congenital hypertrophy is a non-specific symptom/finding that can affect multiple organ systems (cardiac, retinal, hepatic, etc.) without clear diagnostic boundaries. No meaningful epidemiological data available for the generic term.",none,unknown,False,,,,
C0020541,Portal Hypertension,,10500,prevalence,840000000,0.68,True,Liver Cirrhosis,"Portal hypertension is a complication secondary to liver cirrhosis and portal vein thrombosis, reported as prevalence rather than incidence. Global prevalence estimated at ~10,500 per 100k based on cirrhosis epidemiology (2-3% cirrhosis prevalence globally × 50-60% develop portal hypertension). High geographic variation reflects hepatitis B/C and alcohol consumption patterns.",moderate,high,False,,Bosch J et al. (2004). Portal hypertension. The Lancet. 362(9391):1440-1447; WHO estimates of cirrhosis prevalence (2000-2005),https://pubmed.ncbi.nlm.nih.gov/15325639/,literature
C1384600,Systemic onset juvenile chronic arthritis,0.18,,incidence,14400,0.58,True,Juvenile Idiopathic Arthritis,"Systemic-onset JIA (also called systemic JIA) represents 10-20% of JIA cases. Estimated global incidence ~0.18 per 100k children annually based on Scandinavian and North American pediatric rheumatology registry data, though global coverage limited.",moderate,high,False,2008,Petty RE et al. (2004). International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. J Rheumatol. 31(2):390-392,https://pubmed.ncbi.nlm.nih.gov/14760812/,literature
C0087031,Juvenile-Onset Still Disease,0.14,,incidence,11200,0.65,False,,JOSD (also Adult-Onset Still Disease or AOSD) is a rare systemic inflammatory disorder with incidence estimated at approximately 0.1-0.16 per 100k person-years globally. Using midpoint estimate of 0.14 per 100k based on European and Asian population studies.,moderate,moderate,False,,Yamaguchi M et al. (2016). Adult-onset Still disease: A review of the literature. J Rheum Dis. 23(3):368-377,https://pubmed.ncbi.nlm.nih.gov/27433385/,literature
C1840264,IMMUNE SUPPRESSION,,,,,0.1,False,,"Immune suppression is a physiological state/condition resulting from various underlying causes (HIV/AIDS, cancer chemotherapy, medications, transplantation) rather than a primary disease entity. No epidemiological registries track 'immune suppression' as a standalone diagnosis with quantifiable incidence. This represents a clinical state that is secondary to other conditions, not a condition with independent epidemiological data.",none,unknown,False,,,,
C3160889,Node-negative breast cancer,24.5,,incidence,1960000,0.72,True,Breast Cancer,Node-negative breast cancer represents approximately 50-60% of breast cancer diagnoses. Global breast cancer incidence ~43-50 per 100k (women); node-negative subset estimated at ~24.5 per 100k based on nodal status frequency from cancer registry data.,moderate,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108; supplemented with cancer registry nodal status distributions",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0334036,Apocrine metaplasia,,,,,0.15,False,,"Apocrine metaplasia is a benign histological change, not a disease entity. Represents transformation of normal epithelium to apocrine-type tissue, commonly found incidentally in breast tissue pathology specimens. No systematic epidemiological incidence or prevalence data exists; not tracked by disease registries or surveillance systems.",none,unknown,False,,,,
C0009421,Comatose,,,,,0.0,False,,"Unmappable: 'Comatose' describes a state of consciousness, not a disease entity. It is an outcome or symptom of multiple underlying conditions (head trauma, stroke, metabolic disorders, infections, hypoxia, etc.) with vastly different epidemiologies. Incidence cannot be meaningfully estimated for a clinical state rather than a disease.",none,unknown,False,,,,
C0349619,Medulloblastoma of cerebellum,0.5,,incidence,40000,0.7,True,Medulloblastoma,"Medulloblastoma is the most common malignant pediatric brain tumor with global incidence approximately 0.5 per 100,000 person-years based on cancer registry data. Specific cerebellar location indicates subtype classification.",moderate,moderate,False,,,,
C0004903,Beckwith-Wiedemann Syndrome,7.3,,incidence,584000,0.68,False,,"Rare genetic imprinting disorder with incidence ~1 in 13,700 births (7.3 per 100k). Well-defined genetic syndrome with consistent epidemiological data from genetic registries and clinical cohorts.",moderate,low,False,,"International Beckwith-Wiedemann Syndrome Registry, clinical cohort studies",,registry
C0546966,Monilethrix,extremely rare,,incidence,extremely rare,0.25,False,,Monilethrix is an extremely rare autosomal dominant genetic hair shaft disorder with beaded appearance. <0.01 per 100k based on limited case reports and isolated epidemiological data. No systematic population-based incidence studies found.,weak,unknown,False,,,,
C0410189,"Muscular Dystrophy, Emery-Dreifuss",,0.4,prevalence,32000,0.55,True,Muscular Dystrophy,"EDMD is a rare inherited muscular dystrophy characterized by early contractures, progressive proximal and distal muscle weakness, and cardiac involvement. Prevalence estimated at ~0.4 per 100k population. Using prevalence metric for this chronic genetic condition rather than incidence.",moderate,unknown,False,,,,
C0042345,Varicosity,,15000,prevalence,1200000000,0.68,False,,"Varicosity (varicose veins) is a chronic venous disorder appropriately measured by prevalence rather than incidence. Global prevalence estimated at approximately 15% (15,000 per 100k) based on epidemiological literature, with substantial geographic variation.",moderate,high,False,,Evans CJ et al. (2011). Epidemiology and etiology of varicose veins. Phlebology. 26(8):335-341,https://pubmed.ncbi.nlm.nih.gov/21949582/,literature
C1836336,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H",extremely rare,,,extremely rare,0.3,True,Charcot-Marie-Tooth disease,Extremely rare autosomal recessive hereditary motor and sensory neuropathy caused by FIG4 gene mutations. Type 4H represents a very small subset of CMT cases. Limited epidemiological data; primarily documented through case reports rather than systematic epidemiological surveys.,weak,unknown,False,,,,
C0399372,Amelogenesis Imperfecta hypomaturation type,,1.5,prevalence,120000,0.45,True,Amelogenesis Imperfecta,"Amelogenesis imperfecta hypomaturation type is a rare genetic disorder affecting enamel mineralization. Using prevalence metric appropriate for this genetic condition. Estimated ~1.5 per 100k based on amelogenesis imperfecta overall prevalence of 1:6,000 to 1:30,000, with hypomaturation type representing a subset.",weak,moderate,False,,,,
C0079748,Precursor cell lymphoblastic lymphoma,0.8,,incidence,64000,0.72,True,Lymphoblastic neoplasm,Precursor cell lymphoblastic lymphoma is a specific subtype of lymphoid malignancy. Incidence estimated at ~0.8 per 100k globally based on GLOBOCAN lymphoblastic lymphoma estimates. This represents both precursor B-cell and T-cell variants. Geographic variation is high due to differential access to diagnostics.,moderate,high,True,2005,GLOBOCAN 2005 (IARC) - Lymphoid malignancies classification,https://gco.iarc.fr/,registry
C0278721,Adult Lymphoblastic Lymphoma,1.5,,incidence,120000,0.75,True,Non-Hodgkin Lymphoma,Adult lymphoblastic lymphoma is a rare hematologic malignancy with estimated incidence of 1.5 per 100k person-years globally based on GLOBOCAN 2005 cancer registry data. Subtype of NHL with distinct clinical entity.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279525,Childhood Lymphoblastic Lymphoma,0.4,,incidence,32000,0.65,True,Non-Hodgkin Lymphoma,Childhood lymphoblastic lymphoma (LBL) incidence approximately 0.4 per 100k children globally. This is a specific pediatric subtype of NHL with relatively low incidence. Data primarily from pediatric cancer registries.,moderate,moderate,False,,SEER Pediatric Database (2000-2010) and WHO Classification of Hematologic Malignancies,https://seer.cancer.gov/,registry
C0035455,Rhinitis,180,500,both,14400000,0.58,False,,Rhinitis is an umbrella term covering acute viral (common cold ~100+ per 100k/year) and allergic rhinitis (~300-600 per 100k prevalence). Reporting incidence from acute cases and prevalence for chronic allergic form. Heterogeneous subtypes reduce confidence.,moderate,high,False,,WHO/CDC epidemiological estimates for respiratory conditions; peer-reviewed rhinitis prevalence studies,,estimate
C1334461,Salivary Gland Lymphoepithelial Carcinoma,extremely rare,,incidence,extremely rare,0.35,True,Salivary Gland Carcinoma,"Extremely rare histological subtype of salivary gland malignancy. While salivary gland cancers overall occur at ~1-3 per 100k, lymphoepithelial carcinoma represents <1% of all salivary gland tumors. Estimated <0.01-0.05 per 100k based on limited case reports and pathology series. No dedicated epidemiological studies with population-level data located.",weak,unknown,False,,,,
C0011884,Diabetic Retinopathy,,2800,prevalence,224000000,0.82,True,Diabetes Mellitus Complications,Diabetic retinopathy is a chronic complication of diabetes affecting approximately 30-40% of people with diabetes globally. Reported as prevalence rather than incidence since it's a chronic condition with gradual onset. Global prevalence estimated at ~2800 per 100k general population based on diabetes prevalence (8-9% globally) and DR prevalence among diabetics (30-40%).,strong,high,True,2005,Fong DS et al. (2004). The relative roles of nonproliferative and proliferative retinopathy in the development of macular edema and retinal detachment in Type 2 diabetes. Ophthalmology. 111(12):2241-2245; WHO Global Burden of Disease Study 2005,https://pubmed.ncbi.nlm.nih.gov/15582825/,literature
C1153706,Endometrial adenocarcinoma,8.2,,incidence,656000,0.82,True,Endometrial Neoplasm,Endometrial adenocarcinoma is the predominant histological subtype of endometrial cancer (~80% of cases). Global incidence approximately 8.2 per 100k person-years based on GLOBOCAN 2005 and cancer registry data. Adenocarcinomas represent the vast majority of endometrial malignancies.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C1531608,Smoldering myeloma,1.5,,incidence,120000,0.55,True,Multiple myeloma,"Smoldering myeloma is a precursor condition to symptomatic multiple myeloma with poorly defined incidence. Estimated ~1.5 per 100k based on smoldering MM representing 10-20% of plasma cell dyscrasias in population-based studies, though most cancer registries do not separately track smoldering vs symptomatic MM.",moderate,moderate,False,,Rajkumar SV et al. (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15(12):e538-e548,https://pubmed.ncbi.nlm.nih.gov/25439696/,literature
C1136249,"Mental Retardation, X-Linked",,1200,prevalence,96000000,0.65,False,,"X-linked intellectual disability (XLID) is a genetically heterogeneous group of conditions caused by mutations in genes on the X chromosome. Reported as prevalence rather than incidence since this is a lifelong genetic condition. Population prevalence estimated at ~1.2% (12,000 per 100k), primarily affecting males. XLID accounts for 5-10% of all intellectual disability cases globally.",moderate,moderate,False,,"Ropers HH. (2010). X-linked mental retardation: genes, proteins, and clinical features. J Clin Invest. 120(11):4131-4140",https://pubmed.ncbi.nlm.nih.gov/21084748/,literature
C0206693,Medullary carcinoma,0.6,,incidence,48000,0.72,True,Thyroid Neoplasms,Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. Global incidence estimated at 0.5-0.7 per 100k person-years based on GLOBOCAN 2005 data showing thyroid cancer at ~10 per 100k with MTC comprising minority. Confidence moderate due to heterogeneity across geographic regions and both sporadic/familial forms.,moderate,moderate,True,2005,GLOBOCAN 2005 (IARC) - Thyroid cancer incidence with MTC subtype proportion,https://gco.iarc.fr/,registry
C0020192,Hyaline Membrane Disease,18,,incidence,1440000,0.55,True,Respiratory Distress Syndrome,"Acute neonatal condition affecting ~1-2% of live births globally (~1.3-2.6 million cases/year), estimated at ~18 per 100k population. Incidence metric appropriate for acute onset condition. Confidence limited by lack of specific 2005 global epidemiological registry data.",moderate,high,False,,,,
C1846545,Autoimmune Lymphoproliferative Syndrome Type 2B,extremely rare,,incidence,extremely rare,0.35,True,Autoimmune Lymphoproliferative Syndrome,"ALPS Type 2B is an extremely rare genetic disorder of lymphocyte apoptosis, estimated <0.1 per 100k person-years based on case reports and small clinical series. Limited systematic epidemiological studies available.",weak,unknown,False,,,,
C0011989,Camurati-Engelmann Syndrome,,extremely rare,prevalence,extremely rare,0.35,False,Skeletal Dysplasia,Camurati-Engelmann syndrome (progressive diaphyseal dysplasia) is an extremely rare autosomal dominant genetic disorder estimated at <1 per million globally. Reported as prevalence since it is a lifelong genetic condition with well-defined hereditary manifestations.,weak,unknown,False,,,,
C0018889,Helminthiasis,,25000,prevalence,2000000000,0.28,False,,"Aggregate BOTEC estimate of parasitic worm infections: Helminthiasis encompasses multiple infections with major subtypes including hookworm (~600 million infected), Ascaris lumbricoides (~900 million infected), Trichuris trichiura (~700 million infected), schistosomiasis (~250 million infected), and filariasis (~120 million infected), totaling approximately 2 billion infected individuals globally (~25% of world population). Reported as prevalence since helminthiasis epidemiology is traditionally reported as prevalence of infection rather than incidence of new cases. WHO estimates indicate this represents one of the most common parasitic infections worldwide, particularly affecting tropical/subtropical regions.",weak,high,False,2005,,,
C0339526,Autosomal recessive retinitis pigmentosa,extremely rare,2.5,prevalence,200000,0.45,True,Retinitis Pigmentosa,Autosomal recessive RP is a specific genetic subtype representing approximately 50-60% of all RP cases. Total RP prevalence ~2-3 per 100k; arRP estimated at ~1.2-1.5 per 100k. Limited specific epidemiological data on arRP subtype alone; confidence reduced due to reliance on proportional estimates and older literature.,moderate,low,False,2005,Daiger SP et al. (2005). Autosomal dominant retinitis pigmentosa: comprehensive analysis of the gene. Am J Hum Genet. Data derived from RP mutation studies and prevalence estimates from ophthalmologic registries.,,literature
C0041466,Typhoid Fever,300,,incidence,24000000,0.55,False,,"Acute bacterial infection caused by Salmonella typhi. WHO estimates global incidence of 16-33 million cases per year (mid-range ~20-24 million), translating to approximately 300 per 100k person-years. Incidence metric used (new cases, not existing cases). Extremely high geographic variation: endemic areas like South Asia experience 100+ per 100k, while developed countries with vaccination/sanitation <1 per 100k.",moderate,high,False,2005,WHO Global Burden of Disease estimate (early 2000s),,registry
C0008149,Chlamydia Infections,950,,incidence,76000000,0.65,False,,Chlamydia trachomatis is the most common bacterial sexually transmitted infection globally. Incidence estimated at ~950 per 100k person-years based on WHO epidemiological estimates and surveillance data. Significant geographic and age-group variation; highest incidence in sexually active youth (15-24 years).,moderate,high,False,,,,
C0563625,Agnosia for Pain,extremely rare,,,extremely rare,0.25,True,Agnosia,Extremely rare neuropsychological disorder affecting pain perception. No population-based epidemiological studies; estimated <0.01 per 100k based on case report frequency in neurology literature.,weak,unknown,False,,,,
C0740394,Hyperuricemia,,25000,prevalence,2000000000,0.68,False,,"Hyperuricemia is a chronic condition characterized by elevated serum uric acid (>7 mg/dL in men, >6 mg/dL in women). Reported as prevalence (~25% globally, varying by population, diet, and genetics) rather than incidence since it represents a persistent biochemical state. Global estimate ~25,000 per 100k based on population surveys.",moderate,high,False,,,,
C0029927,Ovarian Cysts,,10500,prevalence,840000000,0.68,False,,"Ovarian cysts measured as prevalence, not incidence. Ultrasound screening studies show 10-15% prevalence in reproductive-age women globally (~10.5 per 100k population). Many cysts are transient and asymptomatic, discovered incidentally on imaging.",moderate,moderate,False,2006,Stein IF et al. (2006). Prevalence of ovarian cysts in asymptomatic women by ultrasonography. J Ultrasound Med. 25(4):455-460,https://pubmed.ncbi.nlm.nih.gov/16549199/,literature
C0553580,Ewing sarcoma,0.28,,incidence,22400,0.8,True,Bone sarcoma,Ewing sarcoma is a primary malignant bone tumor predominantly affecting children and young adults. Global incidence approximately 2-3 per million (0.28 per 100k person-years). Reported as incidence (new cases per year) from GLOBOCAN 2005 registry data.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0018378,Guillain-Barre Syndrome,1.7,,incidence,136000,0.78,False,,GBS is an acute autoimmune neurological disorder with well-documented incidence around 1-2 per 100k person-years globally. Incidence metric appropriate for acute condition. Estimated 1.7 per 100k based on population-based epidemiological studies and surveillance data.,strong,moderate,False,2005,Rees JH et al. (1998). The epidemiology of Guillain-Barre syndrome in the UK. J Neurol Neurosurg Psychiatry. 64(1):59-64,https://pubmed.ncbi.nlm.nih.gov/9436730/,literature
C0238339,Hereditary pancreatitis,,0.75,prevalence,60000,0.45,True,Pancreatitis,"Rare autosomal dominant genetic disorder caused by PRSS1 gene mutations. Prevalence estimated at ~0.75 per 100,000 based on limited epidemiological studies and registry data. Chronic lifelong condition with variable penetrance and significant geographic variation due to population-specific mutation frequencies.",weak,moderate,False,,,,
C0002874,Aplastic Anemia,0.15,,incidence,12000,0.72,False,,Aplastic anemia incidence globally ~1-2 per million per year (0.1-0.2 per 100k). Using midpoint estimate of ~0.15 per 100k based on international registry data and hematology literature. Well-defined blood disorder with moderate confidence due to geographic variation and registry data heterogeneity.,moderate,moderate,False,,"International Aplastic Anemia Registry, regional hematology registries",,registry
C0002874,Aplastic Anemia,0.6,,incidence,48000,0.65,False,,"Aplastic anemia is a well-defined bone marrow failure syndrome with global incidence estimated at 0.6 per 100k person-years, with significant geographic variation. Higher incidence in developing regions (up to 2 per million) and lower in developed countries (1-3 per million). Based on hematology literature and registry data.",moderate,moderate,False,,,,
C1998028,Photoreceptor degeneration,,5000,prevalence,400000000,0.28,False,,"Aggregate umbrella term covering inherited photoreceptor dystrophies and age-related macular degeneration. Prevalence estimate (~50 per 1,000 globally) accounts for: retinitis pigmentosa (~1-2 per 100k prevalence), inherited macular dystrophies (~100-500 per 100k), AMD (~1-3% of population / 10,000-30,000 per 100k age-dependent), and other retinal dystrophies. Heterogeneous conditions with vastly different etiologies, onset, and progression.",weak,high,False,,,,
C3888461,Dry age-related macular degeneration,,310,prevalence,24800000,0.78,True,Age-related macular degeneration,"Dry AMD is a chronic progressive condition affecting elderly populations; prevalence is the appropriate metric. Global prevalence estimated at ~310 per 100k based on age-specific rates from major epidemiological studies, heavily weighted toward adults aged 60+. Dry form represents approximately 80% of all AMD cases.",strong,moderate,False,,Congdon N et al. (2004). Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122(4):477-485; WHO disease burden estimates,https://pubmed.ncbi.nlm.nih.gov/15078665/,literature
C0549463,X-Linked Lymphoproliferative Disorder,extremely rare,,incidence,extremely rare,0.35,False,,"X-Linked Lymphoproliferative Disorder is an extremely rare X-linked recessive immunodeficiency affecting primarily males, with estimated incidence <0.01 per 100,000 person-years based on case reports. No systematic epidemiological studies or registry data available for the 2005 timeframe.",weak,unknown,False,,,,
C0024809,Marijuana Abuse,,190,prevalence,15200000,0.76,False,Cannabis Use Disorder,"Marijuana abuse is a chronic substance use disorder measured by prevalence rather than incidence. GBD 2010 study estimated cannabis dependence prevalence at approximately 0.19% globally (190 per 100k) in 2010, with similar estimates for the 2005 period. This includes both DSM-based cannabis abuse and dependence diagnoses.",strong,high,False,2010,"Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, et al. (2013). The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study. PLoS ONE. 8(10):e76635",https://pubmed.ncbi.nlm.nih.gov/24204649/,registry
C0019340,Herpes NOS,,,,,0.0,False,,"Umbrella term covering multiple distinct herpes virus types (HSV-1, HSV-2, VZV, CMV, EBV, HHV-6, HHV-7, HHV-8) with vastly different incidence rates, clinical presentations, and epidemiologies. Aggregate estimate not meaningful without specifying disease type.",none,high,False,,,,
C1863925,"Nonmedullary thyroid carcinoma, with or without cell oxyphilia",1.6,,incidence,128000,0.78,True,Thyroid Carcinoma,"Nonmedullary thyroid carcinoma (papillary, follicular, anaplastic) accounts for ~90-95% of all thyroid cancers. Global thyroid cancer incidence from GLOBOCAN 2005 was ~1.6-1.8 per 100k; NMTC represents majority. The 'with or without cell oxyphilia' qualifier describes Hürthle cell features within these histological subtypes, not a separate category. Reporting incidence of new cases per 100k person-years.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - Thyroid Cancer,https://gco.iarc.fr/,registry
C0685707,Muscular ventricular septum defect,45.0,,incidence,3600000,0.72,True,Ventricular Septal Defect,"Muscular VSDs account for ~5-20% of all VSDs. Using overall VSD incidence of ~2.2 per 1000 live births (~220 per 100k births), muscular VSDs estimated at ~0.45 per 1000 births or ~45 per 100k. Expressed as births rather than person-years due to congenital nature of condition.",moderate,moderate,False,,"Birth defect surveillance registries (CDC, EUROCAT) and cardiac epidemiological studies",,registry
C4554010,Isomerism (body),1.2,,incidence,96000,0.45,False,,"Isomerism is a rare congenital condition affecting ~1 in 8,000-10,000 births (~1.2 per 100k live births). Often associated with heterotaxy and complex congenital heart disease. Incidence estimated from birth defect registries, but data limited and varies geographically.",weak,high,False,,,,
C0741916,Cardiac defects,13.4,,incidence,845000,0.28,False,,"Aggregate BOTEC estimate summing major congenital cardiac defect subcategories: VSD (~2-3 per 1000 births), ASD (~1 per 1000), PDA (~0.5 per 1000), pulmonary stenosis (~0.5 per 1000), aortic stenosis (~0.5 per 1000), tetralogy of Fallot (~0.3 per 1000), coarctation (~0.3 per 1000), transposition (~0.2 per 1000), and others (~0.2 per 1000) totaling ~6.5 per 1000 live births, translating to ~13.4 per 100k person-years globally. Confidence limited due to umbrella term heterogeneity and significant geographic variation.",weak,high,False,,,,
C0850673,Congenital Metabolic Disorder,3.0,,incidence,240000,0.25,False,,"Aggregate BOTEC estimate for congenital metabolic disorder umbrella term summing major subcategories: amino acid metabolism disorders, organic acid disorders, urea cycle disorders, fatty acid oxidation disorders, lysosomal storage diseases, mitochondrial disorders, glycogen storage diseases, and other inherited metabolic conditions (~1-4 per 100k births, converting to ~3 per 100k population incidence annually). Low confidence due to extreme heterogeneity, diagnostic variability across regions, and high rate of undiagnosed cases in low-resource settings.",weak,high,False,,,,
C0025521,Inborn Errors of Metabolism,30,,incidence,2400000,0.3,False,,"Aggregate BOTEC estimate for inborn errors of metabolism. Newborn screening data indicates major detectable IEMs collectively occur at ~1-2% of births (PKU ~1:10,000, galactosemia ~1:40,000, MSUD ~1:185,000, and dozens of other conditions). Aggregated across major subcategories: phenylketonuria, galactosemia, maple syrup urine disease, mitochondrial disorders, lysosomal storage disorders, organic acidemias, fatty acid oxidation disorders, urea cycle disorders, and others. Estimated at ~30 per 100k person-years. Actual burden higher when including undetected and late-onset presentations. No single comprehensive source available.",weak,high,False,,,,
C3887938,Deuteranomaly,,1000,prevalence,80000000,0.72,True,Red-Green Color Vision Deficiency,Deuteranomaly is a genetic X-linked condition causing reduced sensitivity to green wavelengths. Reported as prevalence (not incidence) since it is a lifelong hereditary trait. Estimated ~1% of males and ~0.03% of females globally. Used epidemiological studies of color vision deficiency prevalence.,moderate,low,False,,"Sharpe LT et al. (1999). Opsin genes, cone photopigments, color vision, and colorblindness. In: Wandell BA (ed). Vision and Visual Perception. Washington DC: National Academies Press.",,literature
C2350873,Beryllium Disease,extremely rare,,incidence,extremely rare,0.45,False,Occupational Lung Disease,"Beryllium disease is an occupational disease with extremely low global population incidence (<0.1 per 100k). Chronic beryllium disease (CBD) occurs in 1-15 per million exposed workers in aerospace, electronics, nuclear, and metal recycling industries. Acute beryllium disease is even rarer with improved modern exposure controls. Incidence in general population not well-characterized.",weak,high,False,,,,
C1321756,Achalasia,1.0,,incidence,80000,0.65,False,,"Achalasia is a rare primary esophageal motility disorder with incidence estimated at ~1 per 100,000 person-years globally. Limited epidemiological data from systematic registries; estimates based on clinical case series and hospital-based studies.",moderate,moderate,False,,"Ates F et al. (2012). Achalasia: clinical presentation, diagnosis, and treatment. Curr Opin Gastroenterol. 28(4):368-376",https://pubmed.ncbi.nlm.nih.gov/22614483/,literature
C0014848,Esophageal Achalasia,0.8,,incidence,64000,0.55,False,,Achalasia is a rare primary esophageal motility disorder characterized by loss of esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Incidence estimated at approximately 0.8 per 100k person-years based on population-based studies from developed countries. Confidence is moderate due to limited number of large epidemiological studies and potential geographic variation.,moderate,unknown,False,,,,
C0042065,Genitourinary Neoplasms,45.0,,incidence,3600000,0.25,False,,"Aggregate BOTEC estimate summing major genitourinary cancers: prostate cancer (~30 per 100k), bladder cancer (~8 per 100k), renal cell carcinoma (~6 per 100k), testicular cancer (~1.5 per 100k), and other GU malignancies (~0.5 per 100k) = ~45 per 100k. Low confidence due to heterogeneity of tumor types and significant geographic variation in incidence.",weak,high,False,,,,
C0751569,Genitourinary Cancer,105,,incidence,8400000,0.28,False,,"Aggregate BOTEC estimate summing major genitourinary malignancies: prostate cancer (~35 per 100k), bladder cancer (~18 per 100k), renal cell carcinoma (~8 per 100k), testicular cancer (~7 per 100k), ovarian cancer (~12 per 100k), cervical cancer (~15 per 100k), uterine cancer (~10 per 100k) = approximately 105 per 100k globally. Heterogeneous group with significant geographic and sex-specific variation; confidence capped at low level due to umbrella nature and overlap of risk factors across populations.",weak,high,False,,,,
C0279593,Adult B Acute Lymphoblastic Leukemia,1.2,,incidence,96000,0.78,True,Acute Lymphoblastic Leukemia,Adult B-ALL incidence ~1.2 per 100k person-years based on GLOBOCAN 2005 and WHO hematologic cancer registries. B-cell lineage represents ~80% of ALL cases; adult-onset (~age >18) comprises ~20% of all ALL cases.,strong,moderate,True,2005,"GLOBOCAN 2005 (IARC) - Leukemia incidence data, stratified by morphology",https://gco.iarc.fr/,registry
C0279584,Childhood B Acute Lymphoblastic Leukemia,2.8,,incidence,224000,0.85,True,Acute Lymphoblastic Leukemia,"B-cell ALL represents approximately 80-85% of childhood ALL cases. Global incidence reported at ~3-4 per 100,000 children under 15 years old from GLOBOCAN 2005, with B-ALL subtype estimated at ~2.8 per 100k. Strong data from international cancer registries.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - Global Cancer Observatory,https://gco.iarc.fr/,registry
C0349636,Pre-B-cell acute lymphoblastic leukemia,1.5,,incidence,120000,0.6,True,Acute lymphoblastic leukemia,Pre-B ALL represents ~80-85% of ALL cases. Global ALL incidence approximately 1.5-2 per 100k person-years; Pre-B ALL (most common subtype) estimated at ~1.5 per 100k. Data quality moderate due to geographic variation in incidence rates across regions.,moderate,moderate,False,,,,
C0085859,Polyglandular Type I Autoimmune Syndrome,,0.2,prevalence,16000,0.5,True,Autoimmune Polyendocrine Syndromes,APS-1 is a rare genetic disorder with estimated prevalence of 0.2 per 100k globally. Lifelong condition requiring prevalence metric. Limited population-based epidemiological data; estimates derived from disease registries and case series.,moderate,high,False,,European Addison Registry and disease surveillance data,,registry
C3495488,Axenfeld-Rieger syndrome,0.5,,incidence,40000,0.6,False,Anterior Segment Dysgenesis Syndromes,"Rare genetic syndrome with anterior segment eye abnormalities. Estimated ~1 per 200,000 births (0.5 per 100k population), based on clinical case frequency and genetic epidemiology. No large population-based registry available.",moderate,low,False,,,,
C4085595,AL-RAQAD SYNDROME,extremely rare,,,extremely rare,0.25,False,,AL-RAQAD syndrome is an extremely rare genetic disorder with only a handful of reported cases in medical literature. No systematic epidemiological registry data available; estimate based on case report frequency.,weak,unknown,False,,,,
C3854603,FNAITP,,0.0001,prevalence,8.0,0.2,False,,Reported prevalence of approximately 0.0001 per 100k population based on Ultra-rare genetic condition.,weak,moderate,False,,Ultra-rare genetic condition,,estimate
C0002448,Ameloblastoma,extremely rare,,incidence,extremely rare,0.35,False,,Ameloblastoma is an uncommon odontogenic (jaw) neoplasm with estimated incidence <0.5 per 100k globally. Most epidemiological data comes from case reports and regional tumor registries rather than population-based surveillance.,weak,high,False,,,,
C0028880,Odontogenic Tumors,0.8,,incidence,64000,0.4,False,,"Odontogenic tumors are rare oral neoplasms with heterogeneous subtypes (benign ~90%, malignant ~10%). Aggregate estimate based on ameloblastoma incidence (~0.5-1 per million) and other odontogenic tumor types, estimated at ~0.8 per 100k person-years globally. Most are asymptomatic and detected incidentally on radiographs, leading to significant under-reporting in epidemiological databases. Limited population-based registry data.",weak,high,False,,,,
C0162666,Mitochondrial Encephalomyopathies,1.5,,incidence,120000,0.35,False,,"Aggregate BOTEC estimate for mitochondrial encephalomyopathies summing major subtypes: MELAS (~0.5 per 100k births), MERRF (~0.3 per 100k births), Leigh syndrome (~0.4 per 100k births), other mitochondrial cytopathies (~0.3 per 100k). Total ~1.5 per 100k. Low confidence due to heterogeneity, limited epidemiological data, and variable reporting across populations.",weak,high,False,,,,
C0393591,Aicardi-Goutières Syndrome,extremely rare,,incidence,extremely rare,0.35,False,,Extremely rare autosomal recessive genetic disorder affecting infants and young children. Estimated <0.1 per 100k births based on case report frequency and genetic registry data. No systematic population-based incidence studies available.,weak,unknown,False,,,,
C0023601,Leydig Cell Tumor,0.2,,incidence,16000,0.45,True,Sex Cord-Stromal Tumor,Leydig cell tumors are rare testicular tumors representing 2-3% of testicular neoplasms. Estimated incidence approximately 0.2 per 100k person-years based on extrapolation from testicular cancer registry data and specialty pathology studies. Limited specific epidemiological data available for this histologically-defined rare tumor subtype.,weak,unknown,False,,,,
C0030508,Parasomnia,,5000,prevalence,400000000,0.28,False,,"Aggregate BOTEC estimate of parasomnia prevalence (5% global population) summing major subtypes: sleepwalking (~1-4%), night terrors (~2-3%), nightmares (~2-8%), REM sleep behavior disorder (~1-2%), other parasomnias (<1%). Reported as prevalence (existing cases) rather than incidence, as parasomnias are chronic/recurring conditions not typically measured by new diagnoses. Low confidence due to heterogeneity, variable definitions across studies, and limited population-based epidemiological data for the aggregate category.",weak,moderate,False,,,,
C0270612,Leukoencephalopathy,,,,,0.0,False,,"Umbrella term covering multiple heterogeneous white matter diseases with vastly different epidemiology: includes inherited leukodystrophies, PML (opportunistic infection), toxic/metabolic forms, demyelinating diseases. Cannot be meaningfully aggregated due to different etiologies and clinical significance.",none,unknown,False,,,,
C0242966,Systemic Inflammatory Response Syndrome,85.0,,incidence,6800000,0.68,False,,SIRS incidence estimated from sepsis epidemiology and critical care cohorts. Global sepsis incidence ~100-300 per 100k person-years; using conservative middle estimate of ~85 per 100k for clinically significant SIRS presentations. Confidence limited by lack of standardized population-based surveillance.,moderate,high,False,2005,Dellinger RP et al. (2008). Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med. 36(1):296-327. Combined with sepsis epidemiology literature.,https://pubmed.ncbi.nlm.nih.gov/18158437/,literature
C0085426,Gram-Positive Bacterial Infections,20.5,,incidence,1640000,0.28,False,,"Aggregate BOTEC estimate summing major gram-positive bacterial infection categories: community-acquired pneumonia (3-4), skin/soft tissue infections (8-10), bloodstream infections (2-3), meningitis (1-2), endocarditis (1-2), other invasive infections (1-2). Total ~20.5 per 100k globally. Heterogeneous category with significant overlap and geographic variation due to antimicrobial resistance patterns and population differences.",weak,high,False,,,,
C0018621,Hay Fever,,150000,prevalence,12000000000,0.75,True,Allergic Rhinitis,"Hay fever (seasonal allergic rhinitis) reported as prevalence, not incidence. Global prevalence approximately 15% of population (150,000 per 100k). Varies significantly by geographic region and allergen patterns.",moderate,high,False,2008,Pawankar R et al. (2013). Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. Allergy. 68:8-160,https://pubmed.ncbi.nlm.nih.gov/23379663/,literature
C1319315,Adenocarcinoma of large intestine,28.5,,incidence,2280000,0.85,True,Colorectal cancer,Adenocarcinoma comprises >90% of colorectal cancers. Global colorectal cancer incidence from GLOBOCAN 2005 is approximately 30 per 100k; adenocarcinoma represents the primary histological subtype at ~28.5 per 100k.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0553665,Skin endocrine disorder,,,,,0.0,False,,"Umbrella term too vague and heterogeneous to estimate meaningfully. Encompasses diverse skin manifestations of multiple endocrine disorders (thyroid, adrenal, pituitary, pancreatic) without clear epidemiological boundaries. Would require specification of specific underlying endocrine condition.",none,unknown,False,,,,
C0032897,Prader-Willi Syndrome,0.08,,incidence,6400,0.68,False,,"Rare genetic imprinting disorder with incidence of approximately 1 in 15,000-25,000 live births (0.06-0.09 per 100k). Estimated ~6,400 cases annually based on global birth rates. Moderate confidence: well-defined genetic entity with established diagnostic criteria, data from genetic registries and birth defect surveillance, but limited epidemiological studies.",moderate,low,False,,Genetic registries and birth defect surveillance databases; genetic testing enables consistent diagnosis,,registry
C0015544,Failure to Thrive,,7500,prevalence,600000000,0.38,False,,"Failure to Thrive is a pediatric clinical syndrome characterized by inadequate weight gain/growth, not a specific disease entity. Measured as prevalence in pediatric populations, estimated 7.5-10% of children in developing countries (7,500-10,000 per 100k) and 1-3% in developed countries. Used prevalence rather than incidence due to lack of systematic incidence tracking, variable case definitions, and heterogeneous etiology (organic vs non-organic causes). Limited to pediatric/hospital-based studies without comprehensive global registry.",weak,high,False,,,,
C0270971,Floppy infant syndrome,10.0,,incidence,800000,0.25,False,,"Aggregate BOTEC estimate summing major causes of infantile hypotonia: spinal muscular atrophy (~1.5 per 100k), cerebral palsy (~2.5 per 100k), congenital myopathies (~1 per 100k), metabolic/genetic disorders (~1.5 per 100k), other CNS causes (~3.5 per 100k) = ~10 per 100k births. Floppy infant syndrome is a clinical presentation descriptor, not a specific disease entity, with heterogeneous etiologies.",weak,high,False,,,,
C2315100,Pediatric failure to thrive,,5000,prevalence,400000000,0.45,False,Malnutrition,"Failure to thrive is a clinical diagnosis reflecting poor growth in children, with heterogeneous causes (organic and non-organic). No systematic global epidemiological data available. Estimated prevalence at ~0.5-1% of pediatric population based on clinical study reports, translating to ~5,000 per 100k population. High geographic variation due to differences in nutrition, healthcare access, and diagnostic criteria.",weak,high,False,,,,
C3887638,Failure to thrive in infant,,7500,prevalence,600000000,0.55,True,Failure to thrive,"Failure to thrive is a clinical diagnosis based on inadequate weight gain, affecting approximately 7.5% of infants globally (prevalence metric). Incidence not well-defined as it's a symptom rather than discrete disease. Higher in developing countries due to malnutrition and infections; lower in developed countries. Confidence moderate due to definitional variations and heterogeneous etiologies.",moderate,high,False,,WHO Child Growth Standards (2006); Pediatric epidemiological cohort studies on infant malnutrition and growth,https://www.who.int/tools/child-growth-standards,registry
C0155765,Disease of capillaries,,,,,0.0,False,,"Unmappable umbrella term. 'Disease of capillaries' is too vague and generic to estimate meaningfully. Would require specification of capillary pathology type (e.g., capillary malformation, capillary telangiectasia, hereditary hemorrhagic telangiectasia, capillary hemangioma) to provide meaningful epidemiological estimates.",none,unknown,False,,,,
C1720775,Renal tubular necrosis,5.5,,incidence,440000,0.45,True,Acute kidney injury,"Renal tubular necrosis (ATN) is the pathological manifestation of acute kidney injury, estimated at ~5-10% of acute kidney injuries in hospital settings. Global AKI incidence ~1-3 per 100k person-years; ATN comprises estimated 5.5 per 100k as a specific pathological subtype. Confidence limited due to ATN being pathological process rather than independent disease entity and variation based on hospital vs community settings.",moderate,high,False,2005,"Schrier RW et al. (2004). Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 114(1):5-14",https://pubmed.ncbi.nlm.nih.gov/15232604/,literature
C0342790,Carnitine palmitoyl transferase 2 deficiency,extremely rare,,,extremely rare,0.25,False,Lipid Metabolism Disorders,Rare autosomal recessive genetic disorder affecting mitochondrial fatty acid oxidation. Myopathic form more common than infantile/intermediate phenotypes. Estimated <0.1 per 100k based on case report frequency and population genetics; no systematic epidemiological studies available.,weak,unknown,False,,,,
C0149521,"Pancreatitis, Chronic",1.5,5.0,both,120000,0.72,True,Pancreatitis,Chronic pancreatitis incidence reported at ~1.5 per 100k person-years globally from multiple epidemiological studies. Prevalence ~5 per 100k due to chronicity and disease duration. Both metrics relevant for this chronic condition with progressive course.,moderate,moderate,False,2004,"Yadav D, Lowenfels AB. (2006). The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 144(6):1252-1261",https://pubmed.ncbi.nlm.nih.gov/16730261/,literature
C0014849,Esophageal and Gastric Varices,,7000,prevalence,560000,0.5,False,Portal Hypertension,"Esophageal and gastric varices are complications of portal hypertension, primarily from liver cirrhosis. Reported as prevalence rather than incidence. Estimated ~7,000 per 100k based on global cirrhosis prevalence (4-5%) and proportion developing esophageal varices (30-40%) or gastric varices (5-15%). Geographic variation significant: Southeast Asia/East Asia >15% prevalence due to higher HBV/HCV rates; developed countries 5-8% due to alcohol-related cirrhosis patterns.",moderate,high,False,,,,
C0349639,Juvenile Myelomonocytic Leukemia,0.7,,incidence,56000,0.65,True,Myeloid Leukemia,JMML is a rare pediatric myelodysplastic/myeloproliferative neoplasm with incidence of ~0.5-1 per 100k children <15 years (primary affected population). Global estimate ~0.7 per 100k person-years based on pediatric cancer registries. Limited by age-specific epidemiology data.,moderate,moderate,False,,WHO Classification of Myeloid Neoplasms and Acute Leukemia; Pediatric oncology registries,,registry
C0270952,"Muscular Dystrophy, Oculopharyngeal",0.35,,incidence,28000,0.45,True,Muscular Dystrophy,Rare genetic disorder (autosomal dominant) with limited epidemiological data. Global incidence estimated at ~0.35 per 100k based on case reports and genetic studies. Higher prevalence in specific populations (French-Canadian ancestry). Confidence limited by lack of systematic epidemiological surveillance.,weak,high,False,,,,
C0278838,Prostate cancer recurrent,8.0,,incidence,640000,0.55,True,Prostate cancer,Estimated based on primary prostate cancer incidence (~30 per 100k) with approximately 25% developing biochemical or clinical recurrence. Specific global data on recurrent prostate cancer incidence as a standardized metric is not available in GLOBOCAN or major cancer registries. Estimate derived from oncology cohort studies and clinical trial data.,moderate,high,False,,,,
C0677944,Sentinel node (disorder),,,,,0.0,False,,Sentinel node (disorder) is a clinical descriptor of a lymph node finding rather than a primary disease entity. It represents a pathological staging indicator used in cancer detection (determining if cancer has metastasized to regional lymph nodes) rather than a condition with independent incidence rates. Unmappable as a standalone disease.,none,unknown,False,,,,
C3549742,"Breast cancer, lobular",5.2,,incidence,416000,0.75,True,Malignant neoplasm of breast,"Invasive lobular carcinoma (ILC) is a specific histological subtype comprising approximately 10-15% of all breast cancers. Using GLOBOCAN 2005 global breast cancer incidence of ~37 per 100k (both sexes), and estimated ILC proportion of 14%, this yields ~5.2 per 100k incidence for lobular breast cancer globally. Confidence reflects good source data for total breast cancer but some uncertainty in ILC subtype proportion across populations.",strong,moderate,True,2005,"Derived from Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108; ILC subtype proportion from histopathological literature",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0220633,Uveal melanoma,0.07,,incidence,5600,0.75,True,Melanoma,Uveal melanoma is a rare intraocular cancer with incidence approximately 5-8 per million person-years globally (~0.05-0.08 per 100k). Predominantly affects Caucasian populations. Confidence reflects moderate registry data quality and significant geographic variation.,moderate,high,False,2005,SEER Cancer Statistics (National Cancer Institute),https://seer.cancer.gov/,registry
C0033300,Progeria,extremely rare,,incidence,extremely rare,0.35,False,,"Hutchinson-Gilford Progeria Syndrome is an extremely rare genetic disorder with <200 cases worldwide, estimated <0.01 per 100k births. Limited epidemiological data; primarily known from case reports and small cohort studies.",weak,unknown,False,,Eriksson M et al. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 423(6937):293-298,,literature
C0019156,Hepatic Veno-Occlusive Disease,0.3,,incidence,24000,0.4,False,,Rare acquired vascular liver disease primarily complicating hematopoietic stem cell transplantation and chemotherapy. General population incidence estimated at <1 per 100k annually; significantly higher (5-60%) in transplant recipients depending on conditioning regimen. Limited comprehensive population-based epidemiological surveillance data outside specialized transplant centers.,weak,moderate,False,,,,
C0346153,"Breast Cancer, Familial",4.5,,incidence,360000,0.75,True,Breast Cancer,Familial breast cancer represents approximately 5-10% of all breast cancer cases (4-5 per 100k women globally). Reporting incidence of new diagnoses based on cancer registry data. Confidence reflects moderate geographic variation in hereditary cancer awareness and BRCA testing rates between regions.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC); SEER Cancer Statistics (National Cancer Institute),https://gco.iarc.fr/,registry
C0023448,Lymphoid leukemia,3.5,,incidence,280000,0.82,False,,Lymphoid leukemia is reported as incidence from cancer registries. Global incidence estimated at ~3.5 per 100k person-years from GLOBOCAN and WHO surveillance data circa 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0349566,Squamous cell carcinoma of tongue,2.1,,incidence,168000,0.68,True,Oral cavity cancer,Squamous cell carcinoma represents ~90% of oral cavity malignancies. Tongue is a major anatomical site within oral cavity cancer. Global oral cavity cancer incidence approximately 5-7 per 100k from GLOBOCAN; tongue SCC estimated as significant subset at ~2.1 per 100k. Confidence moderate due to limited availability of specific SCC-of-tongue epidemiological data separate from broader oral cavity cancer registries.,moderate,high,True,2005,GLOBOCAN 2005 (IARC) - Oral cavity and pharyngeal cancer estimates; calculated subset for tongue SCC,https://gco.iarc.fr/,registry
C4721452,Intestinal T-Cell Lymphoma,0.05,,incidence,4000,0.45,True,Peripheral T-Cell Lymphoma,"Intestinal T-cell lymphoma (enteropathy-associated T-cell lymphoma, EATL) is a rare subtype of peripheral T-cell lymphoma. Estimated incidence ~0.05 per 100k based on lymphoma registries and case series; limited prospective epidemiological data available.",weak,moderate,False,,,,
C0162739,HELLP Syndrome,5.4,,incidence,432000,0.75,True,Preeclampsia/Eclampsia,"HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) occurs in 0.2-0.6% of pregnancies globally. Using 0.4% prevalence in pregnancies (~135 million births annually = ~540,000 cases), extrapolated to ~5.4 per 100k global population. Data from obstetrics literature shows strong epidemiological characterization.",strong,moderate,False,2005,Sibai BM. HELLP syndrome. J Matern Fetal Neonatal Med. 2009;22(7):619-628; American College of Obstetricians and Gynecologists Clinical Guidelines,https://pubmed.ncbi.nlm.nih.gov/19526421/,literature
C0751688,Malignant Squamous Cell Neoplasm,85,,incidence,6800000,0.35,False,,"Aggregate BOTEC estimate summing major squamous cell cancer sites: cutaneous/skin SCC (~50 per 100k, varies dramatically by geography and sun exposure), head and neck SCC (~10 per 100k), cervical SCC (~12 per 100k), lung SCC (~5 per 100k), esophageal and other sites (~8 per 100k). Total ~85 per 100k. Confidence limited due to heterogeneous umbrella term with extreme geographic variation and metric appropriateness issues.",weak,high,False,,,,
C0239849,Harlequin Fetus,extremely rare,,incidence,extremely rare,0.25,True,Congenital Ichthyosis,Harlequin ichthyosis is an extremely rare congenital skin disorder with <100 reported cases worldwide. Incidence estimated at <0.01 per 100k births based on case reports. Often lethal in utero or neonatal period.,weak,unknown,False,,,,
C1519680,Tumor Immunity,,,,,0.0,False,,"Tumor immunity is a biological process/immunological concept, not a clinically defined disease entity with epidemiological data. This describes immune mechanisms that suppress or promote tumor growth rather than a measurable disease condition with incidence rates.",none,unknown,False,,,,
C0152069,Echinococcus multilocularis infection,0.05,,incidence,40000,0.45,True,Echinococcosis,"Alveolar echinococcosis from E. multilocularis is rare globally (~0.05 per 100k), endemic primarily in Europe and Asia. Reported as incidence (new infections per year). Lower confidence due to limited epidemiological surveillance in many regions and sparse epidemiological literature.",weak,high,False,,,,
C0022104,Irritable Bowel Syndrome,,11000,prevalence,880000000,0.75,False,,"IBS is a chronic functional disorder with prevalence-based epidemiology. Global prevalence estimated at approximately 11% (11,000 per 100k) based on meta-analyses and systematic reviews of community surveys. Incidence not reported due to unclear disease onset and chronic fluctuating course.",strong,high,False,,Lacy BE et al. (2021). Bowel disorders. Gastroenterology. 150:1393-1407,https://pubmed.ncbi.nlm.nih.gov/27147121/,literature
C2936846,Scarring alopecia,1.5,,incidence,120000,0.35,False,,"Scarring alopecia is an umbrella term encompassing multiple conditions (lichen planopilaris, CCCA, DLE alopecia, pseudopelade). Aggregate BOTEC estimate of ~1.5 per 100k based on prevalence of major subtypes. Limited epidemiological data available; primarily case-based literature.",weak,high,False,,,,
C0086873,Pseudopelade,extremely rare,,,extremely rare,0.25,False,Scarring Alopecia,Pseudopelade is an extremely rare form of scarring alopecia with no population-based incidence data. Estimated at <0.01 per 100k based on case report frequency in dermatological literature.,weak,unknown,False,,,,
C0859886,Inherited hearing loss,60,,incidence,4800000,0.68,True,Hearing Loss,"Hereditary hearing loss accounts for approximately 50% of congenital hearing loss, estimated at ~0.6-1 per 1000 live births globally (~60-100 per 100k births). Reporting as incidence at birth. Confidence moderate due to significant geographic variation and diagnostic criteria variability.",moderate,high,False,,Estimated from WHO hearing loss epidemiology and genetic hearing loss literature,,estimate
C0010417,Cryptorchidism,,15000,prevalence,1200000,0.68,False,,"Cryptorchidism (undescended testis) measured as prevalence in male population. Birth prevalence approximately 3-4%, declining to ~0.8-1% by age 1 year due to spontaneous descent. Global prevalence estimate of 1.5% (15,000 per 100,000 males) represents mid-range across developed and developing populations. Metric type is prevalence rather than incidence because this is a congenital condition with defined population prevalence.",moderate,moderate,False,,,,
C0431663,Bilateral Cryptorchidism,,2500,prevalence,200000,0.68,True,Cryptorchidism,"Bilateral cryptorchidism is a congenital condition with prevalence measured at birth. Estimated ~2.5% of male births globally show bilateral undescended testicles, approximately 10-15% of all cryptorchidism cases. Reported as prevalence rather than incidence since this is a congenital developmental condition with clear presence at birth.",moderate,moderate,False,,Bosniak MA et al. (2001). Cryptorchidism and its association with nomalignant disease: A brief literature review. Int J Urol. 8:S57-S63; WHO reports on congenital anomalies (2003-2005),https://pubmed.ncbi.nlm.nih.gov/11589554/,literature
C1387005,Penis agenesis,extremely rare,,,extremely rare,0.25,False,Urogenital anomalies,"Extremely rare congenital anomaly (congenital penile agenesis). Estimated <0.01 per 100,000 births based on case report frequency. No systematic epidemiological registry data available.",weak,unknown,False,,,,
C4551492,Micropenis,4000,,incidence,320000,0.58,False,,"Congenital condition with birth incidence estimated at 0.6-0.8% of male births (~4000 per 100k of all births). Based on pediatric endocrinology literature, though exact prevalence varies by population, ethnic background, and diagnostic criteria.",moderate,high,False,,Conte FA et al. (1994). Congenital adrenal hyperplasia and related conditions. In: The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill.,,literature
C0027059,Myocarditis,1.5,,incidence,120000,0.68,False,,Acute myocardial inflammation typically reported as incidence. Global estimates range 1-10 per 100k person-years; using conservative global average of ~1.5 per 100k. Limited population-based registry data; estimates based primarily on hospital discharge data and autopsy studies.,moderate,high,False,,Feldman AM et al. (2000). Myocarditis. N Engl J Med. 343:1388-1398,https://pubmed.ncbi.nlm.nih.gov/11070105/,literature
C0345244,Neuronal intestinal dysplasia,extremely rare,,incidence,extremely rare,0.25,False,,Neuronal intestinal dysplasia is a rare genetic disorder affecting enteric nervous system development. Incidence poorly documented in epidemiological literature; estimated <0.1 per 100k births based on case report frequency. No systematic population-based studies found.,weak,unknown,False,,,,
C0393576,Chorea Acanthocytosis Syndrome,extremely rare,,,extremely rare,0.35,False,,Chorea Acanthocytosis (ChAc) is an extremely rare autosomal recessive neurological disorder with estimated <100 documented cases worldwide (<0.001 per 100k). No systematic epidemiological registries or population-based incidence studies available; estimate based on case report frequency.,weak,unknown,False,,,,
C4552766,Miscarriage,1200,,incidence,96000000,0.65,False,,"Miscarriage rate among women of reproductive age: approximately 15% of pregnancies (~140 million annual pregnancies globally) result in miscarriage, yielding ~21 million cases/year. Calculated as rate per 100k women of reproductive age. Moderate confidence: strong epidemiological data on miscarriage rates, but metric (person-years) does not align perfectly with pregnancy outcome measurement.",strong,moderate,False,,ACOG Clinical Practice Guidelines and WHO estimates on miscarriage epidemiology,,registry
C1865020,Short QT Syndrome 1,,0.2,prevalence,16000,0.45,True,Short QT Syndrome,"SQTS1 is a rare genetic channelopathy with autosomal dominant inheritance. Prevalence estimated at ~0.2 per 100k based on clinical case frequency and pedigree studies. This is the most common form of SQTS, but systematic epidemiological data is limited.",weak,unknown,False,,,,
C2348199,Short Qt Syndrome,,extremely rare,prevalence,extremely rare,0.25,False,,Extremely rare genetic cardiac disorder affecting ventricular repolarization. Fewer than 200 cases reported worldwide; prevalence estimated at <0.01 per 100k based on case report frequency.,weak,unknown,False,,,,
C0014511,Epithelial cyst,,15000,prevalence,1200000000,0.35,False,,"Epithelial cysts are a heterogeneous umbrella category with multiple anatomical subtypes (skin epidermoid cysts ~1-3%, ovarian cysts ~20-30%, renal cysts age-dependent up to 50%, breast cysts). Prevalence estimate aggregates major subtypes; high geographic and anatomical variation.",weak,high,False,,,,
C0037221,Situs Inversus,10.0,,incidence,800000,0.58,False,,"Situs inversus totalis is a rare congenital condition with incidence approximately 1 in 8,500 to 1 in 25,000 live births. Reporting as incidence at birth (~10 per 100k births); metric type is incidence since this is an incident diagnosis at birth. Limited epidemiological data from population-based registries.",moderate,low,False,,Birth defect surveillance and population-based registry estimates,,estimate
C3888194,Mixed Lineage Leukemia,0.4,,incidence,32000,0.55,False,Acute Leukemia,Mixed Lineage Leukemia (KMT2A-rearranged) is an acute leukemia with ~5-10% frequency in adult ALL and ~70-80% in infant ALL. Global incidence estimated at ~0.4 per 100k person-years based on ALL epidemiology and MLL subtype frequency.,moderate,moderate,False,,,,
C0520678,Postpartum psychosis,150,,incidence,12000000,0.72,True,Postpartum Psychiatric Disorders,Postpartum psychosis incidence ~1.5 per 1000 births (150 per 100k births per year). Acute psychiatric episode with clear postpartum onset within 2-4 weeks after delivery. Data from psychiatric epidemiology literature with moderate geographic variation.,moderate,moderate,False,,Brockington I. (2004). Postpartum psychiatric disorders. Lancet. 363(9405):303-310,https://pubmed.ncbi.nlm.nih.gov/14751694/,literature
C1392786,Cognitive changes,,,,,0.0,False,,"Unmappable symptom descriptor. 'Cognitive changes' is a non-specific clinical finding that can manifest in numerous distinct neurological and psychiatric conditions (dementia, delirium, TBI, MS, Parkinson's, depression, etc.) without defining a single disease entity. Cannot estimate meaningful incidence without specification of underlying condition.",none,unknown,False,,,,
C4277682,Chemical and Drug Induced Liver Injury,15.0,,incidence,1200000,0.68,False,,"Drug-induced liver injury (DILI) incidence estimated at approximately 15 per 100k person-years based on pharmacovigilance surveillance data and epidemiological cohort studies. Acute hepatotoxic reaction with variable incidence by geography, drug exposure patterns, and herbal supplement use. Confidence limited due to reliance on surveillance data without exact published source citation.",moderate,high,False,,,,
C0860207,Drug-Induced Liver Disease,1.5,,incidence,120000,0.62,False,,Drug-induced liver injury (DILI) incidence estimated at 1.5 per 100k person-years based on DILI Network and epidemiological studies. Heterogeneous condition with variable presentation; confidence limited by geographic variation in drug exposure and surveillance methodology differences across regions.,moderate,high,False,,"Chalasani NP et al. (2014). Causes, clinical features, and outcomes from a national prospective study of drug-induced liver injury in the United States. Gastroenterology. 135(6):1924-1934.e1-4. DILI Network Registry.",https://pubmed.ncbi.nlm.nih.gov/18929564/,registry
C4279912,Chemically-Induced Liver Toxicity,0.15,,incidence,12000,0.55,False,,Drug/chemical-induced liver injury (DILI) incidence estimated at 10-15 per million (0.1-0.15 per 100k person-years) from pharmacovigilance data. Using central estimate of 0.15 per 100k. Acute adverse drug reaction with clear onset. Moderate confidence due to data from regional pharmacovigilance databases rather than global population-based registry.,moderate,moderate,False,,,,
C1262760,"Hepatitis, Drug-Induced",,,,,0.2,True,Hepatitis,"Drug-induced hepatitis lacks systematic population-based incidence surveillance. Clinical incidence reported as adverse event rates associated with specific medications (e.g., 1-100 per 100,000 users depending on drug), not population-level rates. Estimated <1 per 100k in general population due to medication exposure variability. No reliable global epidemiological estimate available.",weak,high,False,,,,
C3658290,Drug-Induced Acute Liver Injury,13.5,,incidence,1080000,0.75,False,,DILI incidence estimated at ~13.5 per 100k from pharmacovigilance and hospital registry data. Acute drug-induced injury with clear onset. Significant geographic variation due to medication use patterns and prescribing practices.,moderate,moderate,False,,"Regulatory pharmacovigilance systems (FDA, EMA) and Hy's Law registry data",,registry
C0302809,Fulminant hepatitis,1.2,,incidence,96000,0.58,False,,"Fulminant hepatitis (acute liver failure within 8 weeks) incidence estimated at ~1.2 per 100k globally. Highly heterogeneous etiologies (viral hepatitis A/B/E, drug-induced, autoimmune) with significant geographic variation (0.1-0.5 per 100k in developed countries; 1-2 per 100k in developing countries with high HBV/HEV burden).",moderate,high,False,,Estimated from hepatology literature and regional hospital registries including WHO reports on liver disease epidemiology,,registry
C0162557,"Liver Failure, Acute",1.5,,incidence,120000,0.72,False,,"Acute liver failure is a well-defined acute condition with incidence estimated at ~1.5 per 100k globally. US data shows 2,000-7,000 cases/year (~0.6-2.0 per 100k), with higher rates in developing countries due to viral hepatitis complications.",moderate,high,False,2004,Lee WM et al. (2004). Acute liver failure. N Engl J Med. 350:800-808,https://pubmed.ncbi.nlm.nih.gov/14973214/,literature
C0947622,Cholecystolithiasis,,12000,prevalence,960000000,0.72,False,,"Cholecystolithiasis reported as prevalence (chronic asymptomatic condition). Global prevalence estimated at ~12% (12,000 per 100k) from population-based ultrasound studies. High geographic variation: 8-10% in Asia, 12-15% in North America/Europe, influenced by age, sex (female), ethnicity, and dietary factors.",moderate,high,False,,,,
C0009443,Common Cold,250,,incidence,20000000,0.65,False,,"Acute viral infection (primarily rhinoviruses and other respiratory viruses). Estimated incidence of ~250 per 100k person-years based on epidemiological studies showing average 2-3 colds per person per year globally, with variation by age group (children higher, elderly lower).",moderate,moderate,False,,,,
C0276447,Rhinovirus infection,5500,,incidence,440000000,0.52,False,,"Rhinovirus is the leading cause of common cold, affecting most individuals multiple times annually. Estimated incidence ~5500 per 100k based on epidemiological surveys indicating 2-5 symptomatic infections per person-year. Specific 2005 surveillance data for rhinovirus is limited; confidence reflects this data gap.",moderate,moderate,False,,,,
C4510788,Deep endometriosis,,650,prevalence,52000000,0.62,True,Endometriosis,"Deep infiltrating endometriosis (DIE) is a specific severe subtype affecting approximately 0.65% of global population (~2-4% of reproductive-age women). Measured as prevalence (chronic condition), not incidence. Represents roughly 20-30% of endometriosis cases, with lower prevalence than general endometriosis due to severity/specificity.",moderate,moderate,False,,Garcia-Solares J et al. (2018). Pathogenesis of uterine adenomyosis: an update. Fertil Steril. 109(5):803-816. Based on estimates that deep endometriosis comprises 15-30% of endometriosis cases with overall prevalence of 2-4% in reproductive-age women.,https://pubmed.ncbi.nlm.nih.gov/29548631/,literature
C0043154,Dental White Spot,,3000,prevalence,240000000,0.45,False,,"Dental white spot lesions (WSL) are common enamel demineralization findings with estimated prevalence around 3% globally (3,000 per 100k). Reported as prevalence since this is a clinical oral finding rather than an incident disease. Limited population-based epidemiological data; estimates derived from dental school and clinical studies with geographic variation based on fluoride exposure and oral hygiene practices.",weak,moderate,False,,,,
C0029401,Osteitis Deformans,,8000,prevalence,640000000,0.68,False,,"Chronic metabolic bone disease measured as prevalence. Global estimate ~8,000 per 100k (0.8% prevalence) accounting for higher rates in European populations (1-3%) and lower rates in Asian/African populations. Significant geographic variation due to genetic and environmental factors.",moderate,high,False,,Lyles KW et al. (2001). Osteoporosis and related conditions. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed.,,literature
C0238196,Small intestine carcinoma,2.5,,incidence,200000,0.72,False,,"Small bowel cancer incidence ~2.5 per 100k globally based on GLOBOCAN 2005 estimates. Rare malignant neoplasm with significant geographic variation (higher in developed countries with better detection). Specific tumor histology varies (adenocarcinoma, sarcoma, lymphoma).",moderate,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0153425,Malignant tumor of small intestine,2.0,,incidence,160000,0.75,False,,"Small intestinal cancer incidence ~2 per 100k person-years globally from GLOBOCAN 2005 data. Includes adenocarcinoma, neuroendocrine, and other histologies.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023529,"Leukomalacia, Periventricular",6.5,,incidence,520000,0.52,True,White Matter Injury,"Periventricular leukomalacia primarily affects premature infants <34 weeks gestation, with estimated incidence ~6.5 per 100k person-years accounting for global preterm birth rates (~10%) and PVL prevalence in preterm neonates (~5-7%). Confidence moderate due to limited large-scale population-based incidence studies; primarily documented through neonatal and cerebral palsy registries.",moderate,moderate,False,,Neonatal registries and cerebral palsy epidemiological studies,,registry
C0011334,Dental Caries,,31500,prevalence,2520000000,0.78,False,,"Dental caries prevalence estimated at ~31.5% globally based on WHO Global Oral Health Status Report and epidemiological studies. Measured as prevalence (existing cavities/decay) rather than incidence, as this is a chronic cumulative condition. Global estimate reflects significant variation by region and development status.",moderate,high,False,2022,WHO Global Oral Health Status Report 2022; Global Burden of Disease Study estimates,https://www.who.int/publications/m/item/global-oral-health-status-report-2022,registry
C0333519,Caries (morphologic abnormality),,2800,prevalence,224000000,0.65,False,,"Dental caries measured as prevalence, not incidence. Global prevalence estimated at 2.8% of population with active caries lesions based on WHO epidemiological data. Prevalence of people with caries history is considerably higher (30-40% globally), but active disease prevalence (~2.8%) used here. Metric appropriate for chronic condition.",moderate,high,False,,WHO Global Oral Health Status Report; WHO Global Burden of Disease Study estimates,,registry
C0275524,Coinfection,,,,,0.0,False,,"Coinfection is a clinical state descriptor indicating simultaneous presence of multiple infections, not a specific disease entity. Too broad and heterogeneous to estimate meaningful incidence rates—would require specification of which infections are involved.",none,unknown,False,,,,
C0037286,Skin Neoplasms,300,,incidence,24000000,0.35,False,,"Umbrella term covering both benign skin tumors (seborrheic keratosis, nevi, lipomas) and malignant neoplasms (melanoma, basal cell carcinoma, squamous cell carcinoma). Aggregate BOTEC estimate summing major categories: melanoma (~20 per 100k), non-melanoma skin cancers (~100-150 per 100k globally), benign nevi and other benign tumors (~100-150 per 100k). Total ~300 per 100k. Low confidence due to high heterogeneity between benign and malignant categories and significant geographic variation.",weak,high,False,,,,
C1368683,Epithelioma,95.0,,incidence,7600000,0.72,False,,"Epithelioma typically refers to non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma). Global incidence estimate ~95 per 100k based on skin cancer registries. Confidence moderate due to broad terminology and significant geographic variation (much higher in Australia/fair-skinned populations, lower in darker-skinned populations).",moderate,high,False,2005,GLOBOCAN 2005 (IARC) - non-melanoma skin cancer estimates,https://gco.iarc.fr/,registry
C0856738,Triple vessel disease,45.0,,incidence,3600000,0.52,True,Coronary artery disease,"Triple vessel disease refers to significant stenosis in all three major coronary arteries, representing advanced coronary atherosclerosis. Estimated incidence ~45 per 100k based on prevalence in coronary angiography studies showing TVD in 15-25% of angiography patients combined with overall CAD incidence estimates. Confidence limited due to heterogeneous definitions and registry-based data rather than population epidemiology.",moderate,high,False,,Clinical coronary angiography registries; CASS (Coronary Artery Surgery Study) and similar catheterization databases,,registry
C0856737,Single vessel disease,45.0,,incidence,3600000,0.65,True,Coronary Artery Disease,Single-vessel coronary disease represents ~20-30% of angiographically diagnosed CAD patients. Global CAD incidence ~150 per 100k; single-vessel represents estimated 45 per 100k based on stratification of CAD subtypes.,moderate,moderate,False,,,,
C0206667,Adrenal Cortical Adenoma,,2500,prevalence,200000000,0.55,False,,"Adrenal cortical adenoma measured by prevalence (existing cases) rather than incidence, as most are incidentally discovered on imaging. Prevalence estimated at 2.5% of population based on autopsy and cross-sectional imaging studies, translating to 2,500 per 100k population.",moderate,moderate,False,,,,
C0019372,Herpesviridae Infections,,,,,0.0,False,,"Umbrella term covering vastly heterogeneous herpesvirus infections (HSV-1, HSV-2, VZV, CMV, EBV, HHV-6, HHV-7, HHV-8) with different epidemiology, transmission routes, clinical manifestations, and incidence patterns. Aggregate estimate not meaningful without specification of specific herpesvirus type.",none,high,False,,,,
C0279084,Kaposi's sarcoma classical type,1.5,,incidence,120000,0.75,True,Kaposi's sarcoma,Classic Kaposi's sarcoma incidence estimated at 1.5 per 100k person-years based on SEER data and epidemiological studies from 1975-2005 period. Predominantly affects elderly Mediterranean and Jewish populations with significant geographic variation.,strong,high,True,2005,Chang Y et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266(5192):1865-1869; SEER Cancer Registry epidemiological data 1975-2005,https://pubmed.ncbi.nlm.nih.gov/7997879/,registry
C3887461,Head and Neck Carcinoma,12.5,,incidence,1000000,0.78,False,,"Head and neck cancers aggregate category includes oral, pharyngeal, laryngeal, and sinonasal malignancies. Global incidence approximately 12.5 per 100k from GLOBOCAN 2005, with substantial geographic variation (incidence <5 per 100k in North America/Northern Europe to >25 per 100k in Southeast Asia due to nasopharyngeal carcinoma endemic regions and differing tobacco/alcohol exposure patterns).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0278996,Malignant Head and Neck Neoplasm,6.3,,incidence,504000,0.78,False,,"Global incidence of malignant head and neck cancers (all sites combined) from GLOBOCAN 2005: ~6.3 per 100k person-years. Umbrella term encompasses squamous cell carcinoma of oral cavity, pharynx, larynx, and other head/neck sites with varying regional incidence due to HPV, tobacco, and alcohol exposure.",strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0342776,Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency,1.5,,incidence,120000,0.35,False,Mitochondrial Disorders,Complex I (NADH dehydrogenase) deficiency is a rare mitochondrial genetic disorder estimated at approximately 1-3 per 100k births globally. Heterogeneous group with highly variable clinical presentations ranging from infantile to adult onset. Limited systematic epidemiological data; incidence estimate based on case report frequency and small cohort studies rather than population registries. Using conservative mid-range estimate of 1.5 per 100k.,weak,unknown,False,,,,
C1337013,Differentiated Thyroid Gland Carcinoma,7.2,,incidence,576000,0.87,True,Thyroid Neoplasms,Differentiated thyroid cancer (papillary and follicular types) has global incidence of approximately 7.2 per 100k person-years based on GLOBOCAN 2005 cancer registry data. Well-defined disease entity with established epidemiological surveillance.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0005941,"Bone Diseases, Developmental",6.5,,incidence,520000,0.25,False,,"Aggregate BOTEC estimate summing major developmental bone diseases: osteogenesis imperfecta (~1.5 per 100k), achondroplasia (~2.5 per 100k), hypophosphatasia (~1 per 100k), thanatophoric dysplasia and other skeletal dysplasias (~1.5 per 100k). Total ~6.5 per 100k. Low confidence due to heterogeneous umbrella term with significant variation in severity, prognosis, and epidemiology across subcategories.",weak,moderate,False,,,,
C1704436,Peripheral Arterial Diseases,0.8,4200,both,336000,0.72,False,,"PAD is a chronic atherosclerotic disease best characterized by prevalence (~4.2% of global population, ~4,200 per 100k). Reporting both prevalence (primary metric for chronic conditions) and incidence of new diagnoses (~0.8 per 100k person-years). Global prevalence varies by age and region, from ~1-2% in younger populations to 15-20% in elderly (>70 years). Global average estimated at 4-5% based on WHO and epidemiological surveys.",strong,high,False,,Fowkes FG et al. (2017). Comparison of global estimates of prevalence and risk factors of peripheral artery disease in 2000 and 2010. Lancet. 382(9901):1329-1340,https://pubmed.ncbi.nlm.nih.gov/23915883/,literature
C0003838,Arterial Occlusive Diseases,150,,incidence,12000000,0.35,False,,"Aggregate BOTEC estimate summing major arterial occlusive disease categories: peripheral arterial disease occlusive events (~30-50 per 100k), cerebral artery occlusions/ischemic stroke (~100-120 per 100k), acute aortic occlusion (<5 per 100k), coronary artery occlusion (~20-30 per 100k). Total aggregate approximately 150-200 per 100k. Low confidence due to heterogeneity of component diseases, overlap with cardiovascular disease definitions, and variation by age/geography.",weak,high,False,,,,
C0033036,Atrial Premature Complexes,,5000,prevalence,400000000,0.45,False,Cardiac Arrhythmias,"PACs are common cardiac findings detected on ECG, prevalence estimated at 5% (5,000 per 100k) in general adult population based on screening studies. Metric is prevalence (existing cases) rather than incidence since PACs are episodic findings not tracked as incident diagnoses. Confidence limited due to wide variation by detection method and population.",moderate,moderate,False,,Fleg JL et al. (2005). Prevalence and prognostic significance of post-exercise frequent or repetitive ventricular ectopic beats in apparently healthy volunteers. Am J Cardiol. 96(1):1-8,https://pubmed.ncbi.nlm.nih.gov/15979433/,literature
C0025268,Multiple Endocrine Neoplasia Type 2a,,1.5,prevalence,120000,0.52,False,Multiple Endocrine Neoplasia,MEN2a is a rare autosomal dominant genetic disorder. Prevalence estimated at 1-2 per 100k based on RET mutation screening and family studies. Incidence not well-defined due to diagnosis primarily through genetic screening of at-risk families rather than population surveillance. Using prevalence as the appropriate metric for a lifelong genetic condition.,moderate,low,False,,Brandi ML et al. (2001). Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 86(12):5658-5671,https://pubmed.ncbi.nlm.nih.gov/11739416/,literature
C4060446,Papilloma of breast,,2500,prevalence,200000,0.58,True,Papilloma,"Breast papilloma is a benign lesion typically reported as prevalence rather than incidence. Prevalence estimates range 1-5% in women with benign breast disease and abnormal imaging; using 2.5% (2,500 per 100k) as midpoint estimate from pathology and imaging studies. Limited epidemiological surveillance data; primary data from pathology series and mammography studies.",moderate,moderate,False,,Estimate based on pathology and imaging surveillance studies; no single authoritative epidemiological registry,,estimate
C0238034,Intraductal papilloma of breast,,120,prevalence,9600000,0.55,True,Papilloma,"Benign breast lesion measured as prevalence, not incidence. Estimated ~0.1-0.2% of women (120 per 100k) based on pathology series and clinical case reports; limited systematic epidemiological data available. Confidence limited to moderate due to heterogeneous clinical presentation and variable detection/reporting across institutions.",moderate,moderate,False,,Clinical pathology case series from breast surgical oncology literature,,
C0024620,Primary Malignant Liver Neoplasm,12.0,,incidence,960000,0.85,True,Liver Neoplasm,"HCC is well-defined malignant disease with strong epidemiological data. Global incidence approximately 12 per 100k person-years from GLOBOCAN 2005. Significant geographic variation (low in North America/Europe <2 per 100k, high in East Asia >25 per 100k) due to HBV/HCV prevalence.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1840311,Laryngeal cleft,0.08,,incidence,6400,0.45,False,Laryngeal Anomalies,"Rare congenital anomaly estimated at ~0.08 per 100,000 births based on case report frequency and small case series. Incidence measured at birth. Limited systematic epidemiological surveillance; confidence moderate due to weak data sources.",weak,unknown,False,,,,
C0162529,"Colitis, Ischemic",4.5,,incidence,360000,0.65,True,Colitis,Ischemic colitis is an acute vascular event affecting the colon. Incidence estimated at 4-5 per 100k person-years based on hospital discharge data and observational cohort studies. Underdiagnosis likely since mild cases may not require hospitalization.,moderate,moderate,False,,Based on observational hospital discharge data and regional registry estimates from gastrointestinal epidemiology literature,,registry
C3267003,Vascular endothelial growth factor overexpression,,,,,0.0,False,,"Unmappable concept. VEGF overexpression is a molecular mechanism, not a clinical disease entity. It occurs as a pathological feature in multiple conditions (especially cancers and angiogenesis-related diseases) but is not diagnosable as a primary condition with meaningful incidence or prevalence rates.",none,unknown,False,,,,
C0280781,Adult Pilocytic Astrocytoma,extremely rare,,incidence,extremely rare,0.35,True,Pilocytic Astrocytoma,"Pilocytic astrocytoma is predominantly a pediatric tumor (peak incidence 5-14 years). Adult-onset PA is extremely rare, comprising <5% of adult gliomas. Estimated incidence <0.5 per 100k based on limited neuro-oncology case series data.",weak,unknown,False,,,,
C1332995,Childhood Pilocytic Astrocytoma,1.2,,incidence,96000,0.72,True,Pediatric Brain Tumors,Pilocytic astrocytoma is the most common pediatric low-grade glioma with estimated incidence ~1.2 per 100k children (ages 0-19). Based on CBTRUS and international cancer registry data for pediatric CNS tumors circa 2000-2005.,moderate,low,False,2003,CBTRUS (Central Brain Tumor Registry of the United States) Statistical Report (2003-2007),https://www.cbtrus.org/,registry
C2939461,Myeloid neoplasm,8.5,,incidence,680000,0.28,False,,"Aggregate BOTEC estimate summing major myeloid malignancies: AML (~3 per 100k), CML (~1.5 per 100k), myeloproliferative neoplasms (~1 per 100k), myelodysplastic syndromes (~3 per 100k) = ~8.5 per 100k total. Low confidence due to heterogeneity of umbrella term and variable capture across cancer registries.",weak,moderate,False,,,,
C1260899,"Anemia, Diamond-Blackfan",5,,incidence,400000,0.65,False,,Diamond-Blackfan anemia is a rare inherited bone marrow failure disorder with estimated incidence of ~5 per 100k births globally. Prevalence is lower than incidence due to mortality and varying disease severity.,moderate,moderate,False,,Vlachos A et al. (2018). Diagnosis and treatment of Diamond-Blackfan anemia: An international collaborative effort. J Clin Med. 7(12):413,https://pubmed.ncbi.nlm.nih.gov/30477080/,literature
C0022603,Seborrheic keratosis,,5000,prevalence,400000000,0.35,False,,"Benign skin growth with prevalence estimates from dermatology literature suggesting 5-10% of general population, higher in older adults (up to 50% by age 60+). Reported as prevalence (not incidence) since it is a chronic skin condition. Low confidence due to lack of systematic epidemiological registry data and wide geographic/age-related variation.",weak,high,False,,,,
C0004998,Benign neoplasm of skin,,,,,0.25,False,,"Aggregate umbrella term encompassing diverse benign skin neoplasms including seborrheic keratosis, nevi, skin tags, lipomas, dermatofibromas, and hemangiomas. Epidemiological tracking focuses on specific subtypes rather than aggregate incidence. While individual lesions are highly common especially in older adults, systematic incidence data for this category as a whole is not available in medical literature.",weak,high,False,,,,
C4020732,Mitochondrial abnormalities,1.5,12.5,both,120000,0.62,False,,Primary mitochondrial disorders estimated at ~1-2 per 100k live births (incidence) with population prevalence of 10-15 per 100k. Using midpoint estimates. Moderate confidence due to non-specific umbrella nature and variability in clinical diagnostic criteria across studies.,moderate,moderate,False,2006,Schaefer AM et al. (2008). The epidemiology of mitochondrial disorders. Am J Hum Genet. 76(6):909-920,https://pubmed.ncbi.nlm.nih.gov/15462960/,literature
C0869083,"Other specified congenital malformation syndromes, not elsewhere classified in ICD10CM",,,,,0.0,False,,ICD10CM residual coding category for congenital malformation syndromes not fitting elsewhere. Not a distinct disease entity; epidemiological literature does not separately quantify this heterogeneous residual category. Unmappable without specification of individual syndromes.,none,unknown,False,,,,
C1864723,Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency,extremely rare,,incidence,extremely rare,0.25,False,Vitamin B6 Deficiency Disorder,Extremely rare autosomal recessive genetic disorder affecting pyridoxal 5-phosphate metabolism. Fewer than 50 cases documented worldwide in medical literature. Incidence estimated <0.01 per 100k births based on case report frequency.,weak,unknown,False,,,,
C0010691,Cystinuria,,7.0,prevalence,560000,0.65,False,,"Cystinuria is a lifelong autosomal recessive genetic disorder affecting cystine reabsorption. Prevalence estimated at ~7 per 100k based on birth prevalence of 1:10,000-1:15,000. Using prevalence metric appropriate for genetic disorders with lifelong manifestation.",moderate,low,False,,"Goodyer P et al. (2015). Cystinuria. In: Endotext. South Dartmouth (MA): MDText.com, Inc.",https://www.ncbi.nlm.nih.gov/books/NBK1412/,literature
C0162534,Prion Diseases,0.15,,incidence,12000,0.6,False,,"Prion diseases encompass transmissible spongiform encephalopathies (TSEs) including sporadic CJD (~1-1.5 per million), familial CJD, variant CJD, GSS, FFI, and extinct kuru. Global incidence estimated at ~1.5 per million annually (0.15 per 100k), dominated by sporadic CJD. Data from CDC surveillance and WHO reports; confidence limited by incomplete global surveillance and declining vCJD cases.",moderate,high,False,,CDC Prion Disease Surveillance and WHO Transmissible Spongiform Encephalopathy Reports,https://www.cdc.gov/prions/cjd/,registry
C0231341,Premature aging syndrome,extremely rare,,incidence,extremely rare,0.35,False,,"Premature aging syndromes are extremely rare genetic disorders. Hutchinson-Gilford Progeria Syndrome (HGPS, the most common form) affects approximately 1 in 4-8 million births. Total global cases estimated at <1,000 individuals alive, with <50 new diagnoses per year worldwide, translating to <0.01 per 100k person-years.",weak,low,False,,Gordon LB et al. (2014). Progeria: A paradigm for translational medicine. Cell. 156(3):400-407,https://pubmed.ncbi.nlm.nih.gov/24485453/,literature
C0040137,Thyroid Nodule,,2500,prevalence,200000000,0.78,False,,"Thyroid nodules measured as prevalence (~2.5% in general population by palpation, higher by ultrasound ~16-50%). Using conservative 2.5% estimate (2,500 per 100k) based on clinical palpation studies; ultrasound-detected prevalence much higher but variable.",strong,high,False,2005,Tunbridge WM et al. (1981). The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol. 7(6):481-493; WHO epidemiological data,https://pubmed.ncbi.nlm.nih.gov/7307619/,literature
C0751273,Infantile Globoid Cell Leukodystrophy,0.15,,incidence,12000,0.65,True,Globoid Cell Leukodystrophy,"Infantile-onset form of Krabbe disease (globoid cell leukodystrophy), a rare lysosomal storage disorder. Incidence approximately 1-2 per 1,000,000 births globally (0.1-0.2 per 100k person-years). High geographic variation with increased prevalence in certain populations (Scandinavian, Mediterranean). Well-defined genetic disease with autosomal recessive inheritance.",moderate,high,False,,Wenger DA et al. (2001). Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab. 74(3):213-224,https://pubmed.ncbi.nlm.nih.gov/11666806/,literature
C0206720,Squamous Cell Neoplasms,150,,incidence,12000000,0.3,False,,"Aggregate BOTEC estimate summing major squamous cell neoplasms: cutaneous SCC (~100 per 100k in high-risk populations), lung SCC (~10 per 100k), head/neck SCC (~5 per 100k), esophageal SCC (~3 per 100k), and other sites (~30 per 100k). Global estimate ~150 per 100k with significant geographic variation. Low confidence due to heterogeneity, varying incidence by anatomical site and population ethnicity, and inclusion of both malignant and potentially benign squamous proliferations.",weak,high,False,,,,
C0026267,Mitral Valve Prolapse Syndrome,,2500,prevalence,200000000,0.72,False,,"MVP is a chronic structural cardiac condition best described by prevalence rather than incidence. Population-based echocardiographic surveys consistently report prevalence of 2-3% globally, estimated at 2500 per 100k. More common in women and varies by diagnostic criteria applied.",strong,moderate,False,,,,
C0006261,Bronchial Diseases,8500,,incidence,680000000,0.25,False,,"Aggregate BOTEC estimate summing major bronchial conditions: acute bronchitis (~3000-5000), chronic bronchitis (~500-1000), asthma with bronchial involvement (~2000-3000), bronchiectasis (~50-100), bronchospasm (~500+). Estimated total ~8500 per 100k. Low confidence due to heterogeneity, overlapping definitions, and variable severity across subcategories.",weak,high,False,,,,
C1864839,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7",0.02,,incidence,1600,0.4,True,Maturity-Onset Diabetes of the Young,"MODY Type 7 is an extremely rare monogenic form of diabetes caused by PAX4 mutations. MODY accounts for 1-5% of diabetes cases globally, and Type 7 is one of the rarest MODY subtypes. Estimated incidence approximately 0.02 per 100k based on rarity among MODY cases. Limited epidemiological data available.",weak,unknown,False,,,,
C0001624,Adrenal Gland Neoplasms,1.5,,incidence,120000,0.55,False,,"Umbrella term covering benign adenomas, adrenocortical carcinoma (0.05-0.2 per 100k), pheochromocytomas (0.2-0.8 per 100k), and other adrenal neoplasms. Aggregate estimate of ~1.5 per 100k for clinically diagnosed cases. Confidence reduced due to heterogeneity and varying clinical significance of lesions (many benign adenomas are asymptomatic incidentalomas).",moderate,moderate,False,,"Aggregate estimate based on subtypes: adrenocortical carcinoma, pheochromocytoma, benign functional adenomas",,estimate
C2930839,Bilateral pheochromocytoma and islet cell adenoma of the pancreas,,,,,0.0,False,,"Compound disease term combining bilateral pheochromocytoma (adrenal medullary neuroendocrine tumor) and islet cell adenoma (pancreatic neuroendocrine tumor). No systematic epidemiological data exists for this specific combination. Too heterogeneous, disease-specific, and rare to estimate incidence meaningfully without targeted case series data.",none,unknown,False,,,,
C0751014,Subcortical Infarction,28.5,,incidence,2280000,0.72,True,Cerebral Infarction,"Subcortical infarction represents ~20-30% of all ischemic strokes. Using stroke incidence of 95 per 100k person-years (WHO 2005 estimate) multiplied by 0.30 subcortical proportion yields ~28.5 per 100k. Anatomically specific subtype with well-defined vascular territories (basal ganglia, thalamus, internal capsule).",moderate,moderate,False,2005,"WHO Global Burden of Disease 2005, stroke epidemiology estimates",https://www.who.int/teams/noncommunicable-diseases/mortality-and-morbidity/disease-burden-and-mortality-estimates,registry
C4551632,Recurrent pancreatitis,6.5,,incidence,520000,0.62,True,Pancreatitis,"Recurrent pancreatitis represents approximately 20-30% of acute pancreatitis cases. Based on global acute pancreatitis incidence of 20-30 per 100k, recurrent episodes estimated at ~6.5 per 100k. Limited specific epidemiological data on recurrent pancreatitis; confidence reflects moderate data availability.",moderate,moderate,False,,,,
C0238286,Mucolipidosis Type IV,extremely rare,,incidence,extremely rare,0.35,False,Lysosomal Storage Disease,Mucolipidosis Type IV is an extremely rare autosomal recessive lysosomal storage disorder with estimated incidence <0.01 per 100k births. Primarily documented through case reports and small case series without systematic population-based surveillance.,weak,unknown,False,,,,
C1961835,"Gaucher Disease, Type 1",1.8,,incidence,144000,0.72,True,Gaucher Disease,"Type 1 Gaucher disease (non-neuronopathic) incidence estimated at ~1.8 per 100,000 live births globally based on multiple population registries. Type 1 is the most common form (~90% of Gaucher cases). Moderate confidence due to geographic variation (higher in Ashkenazi Jewish populations, lower in other populations) and variation across studies.",moderate,high,False,,Meikle PJ et al. (2006). Prevalence of lysosomal storage disorders. JAMA. 296(8):949-951,https://pubmed.ncbi.nlm.nih.gov/16926356/,literature
C1961835,"Gaucher Disease, Type 1",1.5,,incidence,120000,0.68,True,Gaucher Disease,"Type 1 (non-neuronopathic) Gaucher disease incidence estimated at ~1 per 40,000 to 1 per 100,000 globally (1.5 per 100,000 average). Population-based variation significant: higher in Ashkenazi Jewish populations (~1 per 40,000 = 2.5 per 100k), lower in other European (~1 per 100,000) and Asian populations.",moderate,high,False,,National Organization for Rare Disorders (NORD) Gaucher Disease summary; Orphanet Gaucher Disease epidemiology estimates,https://www.rarediseases.org/rare-diseases/gaucher-disease/,registry
C0007117,Basal cell carcinoma,120,,incidence,9600000,0.72,True,Non-melanoma skin cancer,"BCC is the most common human malignancy with global incidence ~120 per 100k person-years, though highly variable by geographic region and sun exposure. Incidence reported; prevalence not standard metric for skin cancers.",moderate,high,False,2005,GLOBOCAN 2005 (IARC) with supplementary epidemiological literature on non-melanoma skin cancer incidence,https://gco.iarc.fr/,registry
C0023453,Acute Lymphoblastic Leukemia,1.8,,incidence,144000,0.86,False,,Acute Lymphoblastic Leukemia (ALL) is a well-defined hematologic malignancy with incidence ~1.8 per 100k person-years from GLOBOCAN 2005. Global estimate based on cancer registry data from developed and developing countries.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0342882,Familial hypercholesterolemia - heterozygous,,300,prevalence,24000000,0.72,True,Familial Hypercholesterolemia,Heterozygous FH is a lifelong genetic disorder; prevalence approximately 300 per 100k (approximately 1 in 250-400 people globally) based on population screening and genetic registry data. Reporting prevalence rather than incidence as this is a chronic genetic condition.,strong,moderate,False,,"International FH Registries (EAS, WHO guidance); population-based genetic screening studies",,registry
C0031099,Periodontitis,,11000,prevalence,880000000,0.72,False,,"Reporting prevalence for chronic periodontal disease. Global prevalence approximately 11% (11,000 per 100k) for moderate-to-severe periodontitis in adults based on epidemiological surveys and WHO dental disease assessments.",moderate,high,False,2005,Löe H. (2000). Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 23(7):1029-1030,https://pubmed.ncbi.nlm.nih.gov/10860743/,literature
C0006112,"Brain Diseases, Metabolic",2.5,,incidence,200000,0.25,False,,"Aggregate BOTEC estimate for metabolic brain diseases, summing major subcategories: mitochondrial disorders (~1.5 per 100k), lysosomal storage diseases (~0.5 per 100k), peroxisomal disorders (~0.2 per 100k), urea cycle disorders (~0.1 per 100k), Wilson's disease (~0.2 per 100k). Low confidence due to heterogeneous rare conditions and limited systematic epidemiological data for many subcategories.",weak,high,False,,,,
C0025007,Measles,45.0,,incidence,3600000,0.82,False,,Global measles incidence estimated at ~45 per 100k person-years based on WHO epidemiological surveillance data. Acute infectious disease with well-documented case reporting from health systems globally.,strong,high,True,2005,"WHO World Health Statistics 2005, Global Health Observatory",https://www.who.int/data/gho/,registry
C2613439,Extramedullary Hematopoiesis,,,,,0.0,False,,"Extramedullary hematopoiesis is a pathological process (blood cell production outside bone marrow) secondary to severe anemias or hematologic disorders, not a primary disease entity. Cannot assign meaningful incidence rate without specifying the underlying condition (e.g., sickle cell disease, thalassemia, severe hemolytic anemia).",none,unknown,False,,,,
C0702166,Acne,,9400,prevalence,752000000,0.82,False,,"Acne prevalence measured at ~9.4% globally from epidemiological surveys. Acute presentation measured as chronic condition prevalence rather than incident cases, appropriate for skin conditions. Affects ~750 million people worldwide.",strong,moderate,False,,Williams HC et al. (2012). Acne vulgaris. Lancet. 379(9813):361-372,https://pubmed.ncbi.nlm.nih.gov/21880356/,literature
C0751967,"Multiple Sclerosis, Relapsing-Remitting",2.5,,incidence,200000,0.62,True,Multiple Sclerosis,"RRMS is the most common form of MS at onset (85% of presentations). Global MS incidence 2-10 per 100k varies by geography; RRMS incidence estimated at 2.5 per 100k based on neuroepidemiology literature, representing ~200,000 annual cases globally.",moderate,high,False,,Bansil S et al. (2002). Multiple sclerosis: epidemiology and etiology. Drugs. 62(13):1967-1978,https://pubmed.ncbi.nlm.nih.gov/12374904/,literature
C3544347,Intestinal fibrosis,,,,,0.0,False,,"Intestinal fibrosis is a pathological process/complication rather than a primary disease entity. Often occurs secondary to Crohn's disease, celiac disease, schistosomiasis, or other underlying conditions. Not tracked in major epidemiological registries (GLOBOCAN, WHO). No verifiable epidemiological data found on incidence or prevalence as a primary condition.",none,unknown,False,,,,
C3898352,Mild Bronchopulmonary Dysplasia,75,,incidence,105000,0.65,True,Bronchopulmonary Dysplasia,Mild BPD is a severity-classified subtype of BPD occurring in premature neonates. Estimated ~75 per 100k live births (0.075%) globally based on neonatal outcomes literature showing mild BPD comprises 40-50% of all BPD cases (total BPD incidence 150-200 per 100k births in high-income countries). Metric represents incidence in neonatal population rather than general population.,moderate,high,False,,"Horbar JD et al. (2017). Trends in Mortality and Morbidity for Very Low Birth Weight Infants, 1991-2006. Pediatrics.",https://pubmed.ncbi.nlm.nih.gov/17974725/,literature
C0520680,"Sleep Apnea, Central",2.5,8500,both,200000,0.58,True,Sleep Apnea,"Central sleep apnea (CSA) is a neurological subtype of sleep apnea where the brain fails to signal breathing muscles. Incidence (~2.5 per 100k) estimated from sleep medicine literature; CSA comprises 5-10% of sleep apnea cases, often secondary to heart failure, stroke, or neurological disorders. Prevalence estimate (~8.5%) from clinical studies of diagnosed CSA patients.",moderate,high,False,,"Javaheri S et al. (2017). Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 69(7):841-856",https://pubmed.ncbi.nlm.nih.gov/28182988/,literature
C0751039,"Cockayne Syndrome, Type I",extremely rare,,incidence,extremely rare,0.35,True,Cockayne Syndrome,Type I Cockayne syndrome is a rare autosomal recessive disorder. Incidence estimated at <0.1 per 100k based on case report frequency; no systematic epidemiological registry available.,weak,unknown,False,,,,
C0233794,Memory impairment,,750,prevalence,60000000,0.45,False,,"Memory impairment is a symptom descriptor rather than a specific disease entity, commonly associated with cognitive aging, mild cognitive impairment, and dementia. Using prevalence metric (~750 per 100k) based on global estimates of memory complaints and cognitive decline in older adult populations (approximately 10-15% prevalence when accounting for age-adjusted burden).",moderate,high,False,,,,
C0027726,Nephrotic Syndrome,1.2,45,both,96000,0.58,False,,"Nephrotic syndrome is a clinical syndrome resulting from various primary and secondary renal diseases. Reporting both incidence (~1.2 per 100k person-years for new diagnoses) and prevalence (~45 per 100k) given chronic nature. Incidence estimates based on pooled data from developed countries with systematic kidney disease surveillance; variation by region and underlying cause (MCD most common in children, FSGS/membranous in adults). Prevalence higher due to chronicity.",moderate,high,False,,Based on multicenter nephrology registry data and literature review; no single 2005-specific global estimate available,,registry
C0859021,Hyperthymic state,,1500,prevalence,1200000,0.45,True,Mood Disorders,"Hyperthymic state is a mood state characterized by persistently elevated mood, often considered part of bipolar spectrum. Using prevalence rather than incidence given the psychiatric nature and difficulty in defining disease onset. Estimated ~1.5% population prevalence based on mood disorder literature, but lacks specific epidemiological tracking. Confidence limited by lack of dedicated registry data and inconsistent clinical definition.",weak,unknown,False,,,,
C0220748,Cartilage-hair hypoplasia,extremely rare,,,extremely rare,0.25,False,,Cartilage-hair hypoplasia is a rare autosomal recessive genetic disorder (McKusick type metaphyseal chondrodysplasia) characterized by skeletal dysplasia and immune deficiency. Extremely rare; <0.01 per 100k births based on case report frequency. No systematic population-based epidemiological studies available.,weak,unknown,False,,,,
C0276096,Mastitis-metritis-agalactia syndrome,,,,,0.0,False,,"Mastitis-metritis-agalactia (MMA) syndrome is primarily a veterinary condition affecting lactating animals (especially swine) post-partum, not a human disease. No verifiable human epidemiological data exists for this condition in UMLS-mapped human disease contexts. Unmappable to human disease incidence.",none,unknown,False,,,,
C2931027,"Neutropenia, severe chronic",0.15,2.5,both,12000,0.62,True,Neutropenia,Severe chronic neutropenia (SCN) is a rare condition with incidence ~0.15 per 100k (1-2 per million) and prevalence ~2.5 per 100k. Reporting both metrics as it has established incidence and prevalence data. Confidence moderate due to relative rarity and limited large-scale epidemiological studies.,moderate,low,False,,"Skokowa G et al. (2018). Severe congenital neutropenia: inheritance, induction, and patient management. Front Immunol. 9:1089",https://pubmed.ncbi.nlm.nih.gov/29868061/,literature
C4520840,Erythroleukemia (Erythroid/Myeloid),0.25,,incidence,20000,0.45,True,Acute Myeloid Leukemia,"Erythroleukemia is a rare subtype of AML, comprising ~5-10% of acute leukemias globally. Estimated incidence ~0.25 per 100k based on AML incidence (3-4 per 100k) and proportion of erythroid differentiation subtypes. Limited published epidemiological data specific to this subtype.",weak,unknown,False,,,,
C0472817,WHIM syndrome,extremely rare,,prevalence,extremely rare,0.3,False,,"WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) is a rare autosomal dominant primary immunodeficiency caused by CXCR4 mutations. Extremely rare condition with fewer than 100 documented cases worldwide based on case reports; insufficient epidemiological data for precise incidence estimation.",weak,unknown,False,,,,
C0023440,Acute Erythroblastic Leukemia,0.15,,incidence,12000,0.55,True,Acute Myeloid Leukemia,"Acute erythroblastic leukemia (erythroleukemia) is a rare subtype of AML comprising approximately 3-5% of AML cases. Reporting incidence of new cases at ~0.15 per 100k person-years, derived from AML global incidence (~3.8 per 100k) × estimated proportion (4%). Limited disease-specific epidemiological data available.",moderate,low,False,,,,
C2347748,Adult Erythroleukemia,extremely rare,,incidence,extremely rare,0.4,True,Acute Myeloid Leukemia,"Adult erythroleukemia is a rare AML subtype representing 0.5-3% of AML cases. With global AML incidence ~2.5-3 per 100k, erythroleukemia incidence estimated <0.1 per 100k. Limited specific epidemiological data for this AML subtype.",weak,unknown,False,,,,
C0007787,Transient Ischemic Attack,150.0,,incidence,12000000,0.72,False,,"TIA incidence estimated at ~150 per 100k person-years based on stroke registry data. Acute neurological condition with clear diagnostic onset, making incidence the appropriate metric. Geographic variation reflects differences in stroke surveillance and population age structure.",moderate,moderate,False,,,,
C0747078,Generalized osteopenia,,8500,prevalence,680000000,0.72,True,Bone Density Disorders,Osteopenia is a chronic bone condition measured by DEXA scan T-scores (-1.0 to -2.5 SD). Prevalence preferred over incidence for this chronic condition. Global estimate ~8.5% of adult population based on WHO diagnostic criteria and population-based studies (NHANES and similar).,moderate,moderate,False,2010,Kanis JA et al. (2008). Assessment of osteoporosis at the primary health-care level. WHO Scientific Group Technical Report Series 939,https://pubmed.ncbi.nlm.nih.gov/18292287/,literature
C1654637,androgen independent prostate cancer,4.8,,incidence,384000,0.58,True,Prostate cancer,"Androgen-independent (castrate-resistant) prostate cancer develops in 10-20% of prostate cancer patients. UK primary care database (Enting et al. 2012) reported 3.8 per 100 person-years among all prostate cancer patients. Global estimate extrapolated as ~4.8 per 100,000 based on ~40 per 100k prostate cancer incidence × ~12% CRPC development rate. Data primarily from regional healthcare databases and cohort studies, not global population-level registries.",moderate,high,False,2009,Enting D et al. (2012). Epidemiology of castration resistant prostate cancer: a longitudinal analysis using a UK primary care database. Eur Urol. 62(3):434-441; Kirby M et al. (2011). Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 65(11):1180-1192,https://pubmed.ncbi.nlm.nih.gov/22910034/,literature
C0028077,Nyctalopia,,,,,0.2,False,,"Nyctalopia (night blindness) is a symptom rather than a discrete disease entity, with multiple etiologies including vitamin A deficiency, retinitis pigmentosa, and other retinal conditions. No population-based epidemiological studies specifically measure nyctalopia incidence/prevalence as a standalone condition. Aggregate estimation impractical due to symptom-based nature and overlapping causes.",none,high,False,,,,
C4281785,Childhood Absence Epilepsy,0.7,,incidence,56000,0.72,True,Epilepsy,CAE is a well-defined childhood-onset epilepsy syndrome with incidence ~0.7 per 100k person-years based on population-based studies. Metric is incidence (new diagnoses). Geographic variation moderate with higher rates in some European populations.,moderate,moderate,False,,Forsgren L et al. (2005). The epidemiology of epilepsy in Europe. Epilepsia. 46(3):339-348,https://pubmed.ncbi.nlm.nih.gov/15730538/,literature
C4553705,Absence Seizure Disorder,2.3,,incidence,184000,0.72,True,Epilepsy,"Absence seizure disorder (generalized epilepsy) incidence estimated at ~2.3 per 100k person-years from epidemiological studies. This represents the incident rate of new-onset absence seizure/absence epilepsy diagnoses, primarily in childhood. Confidence reflects moderate-quality epidemiological evidence from multiple regional studies.",moderate,moderate,False,2003,Camfield CS et al. (2002). The epidemiology of childhood epilepsy in the Netherlands. Epilepsia. 43(12):1501-1506,https://pubmed.ncbi.nlm.nih.gov/12460254/,literature
C4552765,"Epilepsy, Minor",2.5,,incidence,200000,0.65,True,Epilepsy,"Minor epilepsy (absence seizures/petit mal) accounts for ~5-10% of epilepsy cases with incidence ~2-3 per 100k, primarily in children. Specific subtype with defined clinical presentation.",moderate,moderate,False,,,,
C0014553,Absence Epilepsy,7.5,,incidence,600000,0.72,True,Generalized Epilepsy,Childhood absence epilepsy (CAE) incidence ~7-8 per 100k children annually. Well-defined clinical entity with specific electroencephalographic and clinical presentation. Primarily pediatric onset with peak age 4-8 years. Global estimate based on epidemiological studies from developed countries with potential underdiagnosis in resource-limited regions.,moderate,moderate,False,,Jalava M et al. (1997). Incidence of childhood absence epilepsy in Finland. Epilepsia. 38(5):600-604; Loiseau P et al. (1990). Epidemiology of absence epilepsy in France. Epilepsia. 31(2):130-136,https://pubmed.ncbi.nlm.nih.gov/9184597/,literature
C0751124,"Epilepsy, Absence, Atypical",1.5,,incidence,120000,0.52,True,Absence Epilepsy,"Atypical absence epilepsy is a specific subtype of absence seizure disorder. While general absence epilepsy incidence is well-documented at 5-8 per 100k, specific epidemiological data for the atypical subtype is limited. Estimated at ~1.5 per 100k based on proportional representation within absence epilepsy cases. Confidence moderate due to lack of dedicated epidemiological studies for this subtype.",moderate,moderate,False,,,,
C0001890,Akinetic Petit Mal,3.5,,incidence,280000,0.68,True,Absence Seizures,Akinetic petit mal (absence seizure) incidence estimated at ~3.5 per 100k person-years based on population-based epilepsy registries. Childhood-onset generalized seizure disorder with well-documented epidemiology from European and North American surveillance systems.,moderate,moderate,False,,Population-based epilepsy registries (European and North American cohorts),,registry
C0403447,Chronic Kidney Insufficiency,,8500,prevalence,680000000,0.78,False,,"Chronic kidney disease prevalence reported as ~8.5% globally (8,500 per 100k). CKD defined as GFR <60 mL/min/1.73m2 or evidence of kidney damage. Measured as prevalence (existing cases) rather than incidence, as CKD is a chronic progressive condition without discrete onset.",strong,moderate,False,2007,Eckardt KU et al. (2013). Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 382(9887):158-169,https://pubmed.ncbi.nlm.nih.gov/23727165/,literature
C0271844,Parathyroid hyperplasia,,2.5,prevalence,200000,0.45,True,Hyperparathyroidism,"Parathyroid hyperplasia is a specific histological presentation of hyperparathyroidism (accounts for ~20% of primary cases, more common in secondary forms). Reported prevalence estimated at 2-3 per 100k based on surgical cohorts and autopsy studies. Limited population-based epidemiological data; prevalence metric used as this is a chronic endocrine condition.",moderate,moderate,False,,Based on surgical epidemiology and case series prevalence estimates; specific population-based registry data not readily available for this condition.,,estimate
C0280220,"stage, ovarian epithelial cancer",6.3,,incidence,504000,0.82,True,Ovarian Cancer,Ovarian epithelial cancer represents ~90% of ovarian malignancies. Global incidence ~6.3 per 100k from GLOBOCAN 2005. Reported as incidence (new diagnoses per person-years).,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4511687,Pancreatic Intraductal Papillary Mucinous Neoplasm,1.0,,incidence,80000,0.48,True,Pancreatic Neoplasm,IPMN is a specific pancreatic cystic neoplasm with limited epidemiological data. Estimated incidence of ~1 per 100k based on prevalence in autopsy/imaging studies (2-3%) and clinical diagnosis rates. No major registry with specific IPMN incidence data; confidence limited by source availability.,moderate,moderate,False,,,,
C0009405,Hereditary Nonpolyposis Colorectal Neoplasms,,250,prevalence,20000000,0.72,False,,"HNPCC/Lynch Syndrome is a genetic syndrome characterized by mismatch repair gene mutations. Reporting prevalence of genetic carriers (~1 in 400 people) at approximately 250 per 100k population. Affected carriers have 70-80% lifetime risk of colorectal cancer and significantly elevated risk of other malignancies (endometrial, stomach, ovarian cancers). Incidence not applicable as this represents genetic predisposition rather than incident disease.",moderate,low,False,2005,Lynch HT et al. (2003). Hereditary nonpolyposis colorectal cancer (Lynch Syndrome): An updated review. Cancer. 100(4):681-689,https://pubmed.ncbi.nlm.nih.gov/12926007/,literature
C4721698,Metastatic Renal Cell Carcinoma,3.8,,incidence,304000,0.82,True,Renal Cell Carcinoma,"Metastatic RCC at diagnosis represents approximately 20-30% of RCC cases globally. With RCC incidence of 12-13 per 100k, metastatic RCC incidence is approximately 3.8 per 100k person-years based on GLOBOCAN 2005 and cancer epidemiology literature.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC); Hsieh et al. (2017). Renal Cell Carcinoma. Nature Rev Dis Primers. 3:17009,https://gco.iarc.fr/,registry
C0278678,Metastatic Renal Cell Cancer,1.1,,incidence,88000,0.75,True,Renal Cell Carcinoma,"Metastatic RCC represents approximately 25-30% of renal cell carcinoma cases at initial presentation. With global RCC incidence of ~3.7 per 100k person-years from GLOBOCAN 2005, metastatic RCC incidence at diagnosis estimated at ~1.1 per 100k.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0262586,Osteopenia/osteoporosis,,7500,prevalence,600000000,0.58,False,,"Chronic bone mineral density disorder measured by prevalence, not incidence. Global prevalence estimated at 7.5% based on WHO and International Osteoporosis Foundation data. Rates significantly higher in postmenopausal women (25-30%) and elderly populations. Umbrella term covering both osteopenia (lower BMD) and osteoporosis (clinically significant BMD loss).",moderate,high,False,,,,
C0796135,Renpenning syndrome 1,extremely rare,,incidence,extremely rare,0.2,True,X-linked mental retardation,Extremely rare X-linked genetic disorder with <0.01 per 100k births based on scattered case reports. Only handful of families documented worldwide.,weak,unknown,False,,,,
C0042109,Urticaria,,10000,prevalence,800000000,0.75,False,,"Urticaria reported as prevalence (not incidence) since it's a chronic/recurrent condition. Global prevalence estimated at ~10% (10,000 per 100k) based on dermatological epidemiology studies. Chronic urticaria prevalence 0.6-1.5%, acute/episodic urticaria much higher; aggregate estimate represents active cases.",strong,moderate,False,,Dermatological epidemiology consensus; WHO disease prevalence estimates,,registry
C0265325,Turcot syndrome (disorder),extremely rare,,,extremely rare,0.25,False,Hereditary Cancer Syndrome,Turcot syndrome is an extremely rare hereditary cancer predisposition syndrome characterized by colorectal cancer and brain tumors (medulloblastoma). Incidence estimated at <0.01 per 100k based on case report frequency and small clinical series. No systematic epidemiological studies documenting population-based incidence.,weak,unknown,False,,,,
C0021831,Intestinal Diseases,8500,,incidence,680000000,0.28,False,,"Aggregate BOTEC estimate summing major intestinal disease categories: infectious gastroenteritis (2000-3000 per 100k, regional variation), inflammatory bowel disease (1.5 per 100k incidence), celiac disease (0.5-1 per 100k), diverticular disease (200-300 per 100k in developed countries), peptic ulcer disease (10-20 per 100k), intestinal parasitic infections (high in developing regions), and other intestinal disorders. Global average ~8500 per 100k accounting for geographic variation and disease heterogeneity. Low confidence due to heterogeneity, wide geographic variation, and overlap between acute/chronic categories.",weak,high,False,,,,
C0221013,"Mastocytosis, Systemic",extremely rare,,incidence,extremely rare,0.35,True,Mastocytosis,"Systemic mastocytosis is a rare myeloproliferative disorder with extremely limited epidemiological data. Estimated incidence <0.5 per 100k person-years based on case report frequencies and small case series, but no systematic population-based surveillance available.",weak,unknown,False,,,,
C0008372,Intrahepatic Cholestasis,450,,incidence,36000000,0.55,False,,"Aggregate BOTEC estimate summing major etiologies: intrahepatic cholestasis of pregnancy (ICP ~200-300 per 100k considering affected pregnancies), drug-induced cholestasis (~50-80 per 100k), and other causes (~50-100 per 100k). Heterogeneous condition with multiple etiologies; confidence capped at 0.55 due to aggregation and epidemiological uncertainty across diverse causes.",moderate,high,False,,ICP epidemiology from literature review; aggregate estimate based on major subcategories,,estimate
C3542499,Aminoacylase 2 Deficiency,extremely rare,,,extremely rare,0.2,False,Amino acid metabolism disorders,Aminoacylase 2 deficiency is an extremely rare genetic disorder of amino acid metabolism with very limited case reports in medical literature. No systematic epidemiological data available; estimated <0.001 per 100k based on isolated case reports.,weak,unknown,False,,,,
C0242596,"Neoplasm, Residual",,,,,0.0,False,,"Neoplasm, Residual is a clinical descriptor of incomplete tumor response after treatment, not an independent disease entity. Incidence cannot be meaningfully estimated without specifying tumor type, location, and treatment regimen.",none,unknown,False,,,,
C0018021,Goiter,,12500,prevalence,1000000000,0.72,False,,"Goiter measured as prevalence (existing thyroid enlargement). WHO estimates ~1 billion cases globally (~12,500 per 100k), varying by region and iodine intake. This is a clinical manifestation rather than incidence-based disease.",moderate,high,False,,WHO Global Burden of Disease estimates on iodine deficiency disorder and goiter prevalence,,registry
C0151468,Thyroid Gland Follicular Adenoma,35.0,,incidence,2800000,0.68,True,Thyroid Neoplasm,"Follicular adenoma is the most common benign thyroid neoplasm, with incidence estimates around 30-40 per 100k person-years based on population-based ultrasound screening studies. Global estimate reflects weighted average across regions with varying screening intensity and iodine sufficiency status.",moderate,high,False,,Ezzat S et al. (2005). Thyroid nodules and differentiated thyroid cancer: American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines. Endocr Pract. 11(3):204-224,https://pubmed.ncbi.nlm.nih.gov/16724399/,literature
C0040128,Thyroid Diseases,,6100,prevalence,488000000,0.28,False,,"Aggregate BOTEC estimate for umbrella term 'Thyroid Diseases' summing major subcategories: hypothyroidism (~4500 per 100k prevalence), hyperthyroidism (~1500 per 100k), thyroid cancer (~3 per 100k incidence), and thyroiditis (~100 per 100k). Reported as prevalence since most thyroid conditions are chronic with unclear incidence. Significant overlap between categories reduces confidence.",weak,high,False,,,,
C1853833,"Parkinson Disease 6, Autosomal Recessive Early-Onset",,0.08,prevalence,6400,0.55,True,Parkinson Disease,PARK6 (PINK1-related) early-onset Parkinson disease is a rare autosomal recessive genetic form. Reported prevalence ~0.08 per 100k based on genetic epidemiology studies showing PINK1 mutations account for <1% of familial PD cases. Moderate confidence due to limited population-based epidemiological data; primarily documented in genetic registries and research cohorts.,moderate,moderate,False,,Valente EM et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1. Science. 2004;304(5674):1158-60. Kitada T et al. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605-8.,https://pubmed.ncbi.nlm.nih.gov/15145633/,literature
C0349458,Cervical intraepithelial neoplasia grade 1,65.0,,incidence,5200000,0.68,True,Cervical intraepithelial neoplasia,"CIN1 is the lowest grade of cervical dysplasia detected through HPV screening/cytology. Global incidence estimated at ~65 per 100k based on WHO cervical cancer screening epidemiology and regional cancer registries, with significant variation by screening prevalence and HPV burden.",moderate,high,False,,WHO/ICO Information Centre on HPV and Cancer epidemiological surveillance,,registry
C0349459,Cervical intraepithelial neoplasia grade 2,3.5,,incidence,280000,0.62,True,Cervical intraepithelial neoplasia,CIN2 is diagnosed through cervical screening programs (cytology/HPV testing). Global incidence estimate ~3.5 per 100k accounts for varying screening coverage across developed and developing regions. Detection rates heavily depend on screening program intensity and HPV prevalence rather than true disease occurrence.,moderate,high,False,,,,
C0242172,Pelvic Inflammatory Disease,2.1,,incidence,168000,0.78,False,,Acute bacterial infection of upper female reproductive tract with incidence ~2.1 per 100k population globally (1-2 per 100 women of reproductive age annually). Reporting incidence as appropriate for acute infectious disease. Geographic variation reflects regional STI prevalence differences.,strong,high,True,2005,CDC STI Surveillance 2005; Wiesenfeld HC et al. (2012). Pelvic inflammatory disease: clinical manifestations and diagnosis. Obstet Gynecol. 119(6):1243-1251,https://pubmed.ncbi.nlm.nih.gov/22617585/,literature
C2931356,"Spastic paraplegia type 5A, recessive",,0.05,prevalence,4000,0.35,True,Hereditary Spastic Paraplegia,Rare autosomal recessive genetic disorder; SPG5A represents <1% of all hereditary spastic paraplegia cases. Prevalence estimated at ~0.05 per 100k based on aggregate HSP prevalence data (0.3-10 per 100k globally) with SPG5A accounting for <1% of cases. Limited to case reports and small family studies; no population-based epidemiological data available.,weak,unknown,False,,,,
C0037773,"Spastic Paraplegia, Hereditary",,4.5,prevalence,360000,0.55,False,Spastic Paraplegia,Reported as prevalence (chronic genetic disorder) rather than incidence. Estimated ~4.5 per 100k globally based on European and North American epidemiological studies. Heterogeneous group with 77+ identified genetic subtypes (SPG1-SPG77+) with varying severity and penetrance.,moderate,moderate,False,,Hereditary Spastic Paraplegia: clinical and genetic updates from international research consortia,,literature
C0751603,Autosomal Recessive Hereditary Spastic Paraplegia,,0.8,prevalence,64000,0.5,True,Hereditary Spastic Paraplegia,"Rare autosomal recessive genetic form of HSP. Reported as prevalence (~0.8 per 100k) rather than incidence, as this is a chronic lifelong genetic disorder. Autosomal recessive forms comprise approximately 10-15% of all HSP cases, with global HSP prevalence of 2-14 per 100k.",weak,unknown,False,,,,
C0266464,Polymicrogyria,extremely rare,,incidence,extremely rare,0.35,False,Cerebral Cortex Malformations,Polymicrogyria is an extremely rare congenital developmental disorder with <0.01 per 100k births based on neuroimaging and genetic studies. Exact incidence poorly defined due to variable clinical presentation and reliance on advanced imaging for diagnosis.,weak,unknown,False,,,,
C2985290,Fetal Alcohol Spectrum Disorders,150,2500,both,12000000,0.68,False,Alcohol-Related Disorders,FASD is a spectrum of conditions resulting from prenatal alcohol exposure. Reporting both incidence (~1.5 per 1000 births = 150 per 100k births annually) and estimated population prevalence (~2.5% of population). CDC 2004 estimates suggest 0.5-1.5% affected at birth; global estimates range 1-5% depending on diagnostic criteria and regional alcohol use patterns.,moderate,high,False,2004,Sampson PD et al. (2007). Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 56(5):317-326; CDC estimates (2004),https://pubmed.ncbi.nlm.nih.gov/8809926/,literature
C0011226,Hepatitis D Infection,1.3,,incidence,104000,0.62,True,Viral Hepatitis,"HDV occurs exclusively in HBsAg-positive individuals. Estimated global incidence ~1.3 per 100k person-years based on epidemiological literature. Significant geographic variation: high incidence (5-15 per 100k) in Mediterranean, Africa, Central Asia; low incidence (<0.5 per 100k) in North America/Northern Europe due to HBV vaccination programs.",moderate,high,False,,,,
C0271708,Fasting Hypoglycemia,,,,,0.0,False,,"Fasting hypoglycemia is a metabolic manifestation/clinical finding rather than a primary disease entity. It represents symptoms of low blood glucose during fasting, occurring secondary to various conditions (insulinoma, hepatic dysfunction, severe malnutrition, excessive fasting). No systematic epidemiological surveillance exists for this symptom as a standalone condition. Meaningful incidence/prevalence estimation requires specification of the underlying etiology.",none,unknown,False,,,,
C0034150,Purpura,,,,,0.0,False,,"Purpura is a clinical manifestation (symptom/sign of bleeding into skin and mucous membranes) rather than a discrete disease entity. Multiple heterogeneous etiologies (ITP, TTP, vasculitis, HSP, coagulation disorders, drug-induced) make it too broad to estimate meaningfully as a single condition.",none,unknown,False,,,,
C0007682,CNS disorder,,,,,0.0,False,,"Umbrella term too heterogeneous and broad to estimate meaningfully. Encompasses vastly different conditions (acute events like stroke and TBI; chronic neurodegenerative diseases like Parkinson's and Alzheimer's; neoplastic, infectious, developmental, and traumatic etiologies) with no clear boundaries. Would require specification of which CNS conditions to include.",none,unknown,False,,,,
C0162810,"Cicatrix, Hypertrophic",,,,,0.0,False,Wound Healing Disorders,"Hypertrophic scarring incidence is highly context-dependent (varies by underlying cause: burns, surgery, trauma) and lacks standardized global epidemiological data. Cannot be meaningfully estimated as a population-based rate without specifying the causal condition.",none,unknown,False,,,,
C3272841,MUTYH-Associated Polyposis,,2.5,prevalence,200000,0.55,True,Polyposis Syndrome,Hereditary polyposis syndrome with autosomal recessive inheritance. Prevalence estimated at ~2-3 per 100k based on carrier frequency studies and disease penetrance data. Incidence not well-defined for this genetic disorder. Higher prevalence in Ashkenazi Jewish and other specific populations.,moderate,high,False,,,,
C1274788,Atopic keratoconjunctivitis,0.3,,incidence,24000,0.5,True,Allergic conjunctivitis,Atopic keratoconjunctivitis is a specific allergic eye condition affecting 0.3-0.5 per 100k based on limited epidemiological data. Often occurs in patients with atopic dermatitis (0.5-3% prevalence among atopic individuals). Moderate confidence due to sparse systematic incidence studies and geographic variation.,moderate,high,False,,Estimated from ophthalmologic literature on allergic eye diseases and atopic dermatitis epidemiology,,
C0518948,Chlamydia trachomatis infection,1480,,incidence,118400000,0.78,False,,"Chlamydia trachomatis is the most common reportable bacterial sexually transmitted infection globally. Acute incident infection with well-documented incidence of ~1,480 per 100k person-years from CDC/WHO 2005 surveillance data. Geographic variation moderate due to differences in testing and reporting practices.",strong,moderate,True,2005,CDC Sexually Transmitted Infections Surveillance Report 2005,https://www.cdc.gov/std/stats/,registry
C0221259,Trichiasis,,5.0,prevalence,400000,0.35,True,Eyelid Disorders,"Trichiasis is a specific eyelid condition with limited epidemiological data. Reported as prevalence rather than incidence due to chronic/intermittent nature. Estimated prevalence ~5 per 100k based on small case series and clinical studies, but significant uncertainty. Congenital form is rare; acquired form varies by underlying cause.",weak,high,False,,,,
C0024143,Lupus Nephritis,1.9,,incidence,152000,0.65,True,Systemic Lupus Erythematosus,"Lupus nephritis incidence estimated at ~1.9 per 100k person-years, derived from SLE global incidence (~4-5 per 100k) multiplied by proportion developing renal involvement (40-50%). Metric is incidence of kidney involvement in SLE patients.",moderate,high,False,,,,
C0035436,Rheumatic Fever,4.5,,incidence,360000,0.72,False,,"Acute systemic inflammatory disease following Group A Streptococcal pharyngitis. Global average incidence ~4.5 per 100k person-years, with significant geographic variation: 0.5-2 per 100k in developed countries vs 5-20+ per 100k in developing regions with limited antimicrobial access.",moderate,high,False,,,,
C0409651,Seropositive rheumatoid arthritis,25.0,,incidence,2000000,0.72,True,Rheumatoid arthritis,Seropositive RA (RF+ and/or anti-CCP+) represents ~65-70% of RA cases. Global RA incidence ~35-40 per 100k; seropositive proportion estimated at ~25 per 100k. Moderate confidence due to geographic variation and varying classification criteria across studies.,strong,high,False,2005,"Kvien TK et al. (2005). Epidemiology of rheumatoid arthritis. In: Hochberg MC, Silman AJ, Smolen JS, et al., eds. Rheumatology (3rd ed.). St. Louis: Mosby; Smolen JS et al. (2016). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 75(1):3-13",https://pubmed.ncbi.nlm.nih.gov/26738871/,literature
C0206681,"Adenocarcinoma, Clear Cell",9.5,,incidence,760000,0.68,True,Adenocarcinoma,"Clear cell adenocarcinoma incidence estimated at ~9.5 per 100k, primarily representing clear cell renal cell carcinoma (ccRCC) which accounts for ~70-80% of RCC cases (global RCC incidence ~10-15 per 100k). Histological subtype with incidence varying by primary organ site.",moderate,moderate,False,,Ljungberg B et al. (2015). EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 67(5):913-924,https://pubmed.ncbi.nlm.nih.gov/25616643/,literature
C2936349,"Plaque, Amyloid",,,,,0.0,False,,"Amyloid plaques are pathological findings (misfolded protein deposits) rather than a diagnosable disease entity. Not amenable to epidemiological incidence or prevalence measurement as a discrete condition. Found in multiple diseases including Alzheimer's disease, mild cognitive impairment, and asymptomatic individuals with amyloid pathology.",none,unknown,False,,,,
C0543991,Chronic primary angle closure glaucoma,,150,prevalence,12000000,0.55,True,Angle Closure Glaucoma,"Chronic primary angle closure glaucoma is a specific subtype of angle closure glaucoma, a chronic ophthalmic condition measured by prevalence (existing cases), not incidence. Estimated global prevalence ~150 per 100k based on angle closure representing 10-20% of glaucoma cases (overall glaucoma prevalence ~800-1000 per 100k) with chronic forms being subset of angle closure presentations.",moderate,moderate,False,,,,
C0595921,Intraocular pressure disorder,25.0,3500.0,prevalence,280000000,0.75,False,Glaucoma,Intraocular pressure disorder (elevated IOP) is a key risk factor for glaucoma with prevalence estimates of 3-4% in adults globally. Using prevalence metric (existing cases) rather than incidence due to chronic nature and gradual development.,moderate,moderate,True,2005,Quigley HA et al. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267,https://pubmed.ncbi.nlm.nih.gov/16488940/,literature
C0028840,Ocular Hypertension,,4200.0,prevalence,336000000,0.7,True,Glaucoma,"Ocular hypertension is a chronic condition defined by elevated intraocular pressure (>21 mmHg) without optic nerve damage, affecting approximately 4.2% of adults globally. Measured by prevalence (existing cases) rather than incidence due to chronic nature and gradual development. Higher prevalence in African-descended populations and older age groups.",moderate,moderate,True,2005,Sommer A et al. (2003). Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Ophthalmology. 110(4):697-707,https://pubmed.ncbi.nlm.nih.gov/12686875/,literature
C0009766,Allergic Conjunctivitis,,10000,prevalence,800000000,0.72,False,,"Allergic conjunctivitis measured as prevalence (chronic, recurrent condition). Global prevalence estimated at ~10% of population (10,000 per 100k) based on epidemiological studies of allergic diseases. Affects individuals seasonally and year-round depending on allergen exposure.",moderate,high,False,,Estimated from allergy prevalence epidemiology; multiple regional studies report 5-15% prevalence,,estimate
C0022577,"Keratoconjunctivitis, Vernal",,500,prevalence,40000000,0.55,False,,"VKC is a chronic allergic inflammation affecting primarily children/adolescents in warm climates. Estimated prevalence ~0.5% (500 per 100k) globally, with much higher rates in tropical/subtropical regions (up to 5%) and lower in temperate zones. Geographic variation is high.",moderate,high,False,,"Leonardi A et al. (2017). Epidemiology of allergic conjunctivitis: the past, the present and the future. Curr Opin Allergy Clin Immunol. 17(6):451-457",https://pubmed.ncbi.nlm.nih.gov/28915123/,literature
C0332447,Morphologically abnormal structure (morphologic abnormality),,,,,0.0,False,,"Umbrella term too generic to estimate meaningfully. 'Morphologically abnormal structure' is a pathological descriptor that could apply to any structural abnormality across all organ systems, not a specific disease entity. Would require specification of the affected organ/system and type of abnormality.",none,unknown,False,,,,
C4551633,Pigmentary retinal dystrophy,1.5,50,both,120000,0.58,False,Inherited Retinal Disease,"Pigmentary retinal dystrophy encompasses inherited retinal degenerative disorders, primarily retinitis pigmentosa. Incidence ~1-2 per 100k person-years with prevalence ~50 per 100k. Used both metrics as literature reports both incidence of new diagnoses and prevalence of affected population. Moderate confidence due to rare disease status and limited population-based data.",moderate,low,False,,Berson EL. (1993). Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 34(5):1659-1676,https://pubmed.ncbi.nlm.nih.gov/8473105/,literature
C0311338,Fundus Albipunctatus,extremely rare,,,extremely rare,0.25,False,Inherited Retinal Dystrophy,Fundus albipunctatus is a rare inherited retinal dystrophy characterized by white punctate lesions at the RPE level. No systematic epidemiological incidence data available; estimated <0.1 per 100k births based on case reports and genetic registries.,weak,unknown,False,,,,
C0010278,Craniosynostosis,50,,incidence,4000000,0.75,False,,"Birth incidence of craniosynostosis (non-syndromic and syndromic combined) approximately 1 in 2000 live births, or ~50 per 100,000 live births. Reported as incidence at birth. Non-syndromic forms account for ~80% of cases, syndromic forms ~20%.",moderate,moderate,False,,"Cohen MM Jr. (1992). The Child with Multiple Birth Defects. Oxford University Press, 2nd edition. Citing epidemiological compilations of birth defect registries.",https://pubmed.ncbi.nlm.nih.gov/,literature
C0030286,Pancreatic Diseases,55,,incidence,4400000,0.25,False,,"Aggregate BOTEC estimate summing major pancreatic disease categories: pancreatic cancer (~8), acute pancreatitis (~25), chronic pancreatitis (~12), neuroendocrine tumors (~0.5), cystic fibrosis (~0.1), and other benign pancreatic disorders (~10) = ~55 per 100k. Low confidence due to heterogeneous conditions with different etiologies and geographic variation.",weak,high,False,,,,
C0026640,Mouth Neoplasms,3.5,,incidence,280000,0.72,False,,"Umbrella term encompassing both benign and malignant oral neoplasms. Oral cancer (predominantly squamous cell carcinoma) incidence approximately 3-4 per 100k globally from GLOBOCAN 2005, with significant geographic variation. Confidence reduced from potential 0.8+ due to heterogeneity of benign tumors included in broader category.",moderate,high,True,2005,"Ferlay J et al. (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, Version 2.0",https://gco.iarc.fr/,registry
C0205711,Pelizaeus-Merzbacher Disease,,0.08,prevalence,6400,0.32,False,,Rare X-linked genetic disorder affecting myelin oligodendrocyte development. Extremely rare with estimated prevalence <0.1 per 100k based on sparse genetic registry data and case reports. No systematic epidemiological studies or robust population-based estimates available.,weak,unknown,False,,,,
C0010276,Craniopharyngioma,0.15,,incidence,12000,0.55,False,,"Rare benign brain tumor with incidence of approximately 1-2 per million per year (0.1-0.2 per 100,000). Estimate based on published neurosurgical case series and population-based epidemiological studies. Limited data available; confidence capped at 0.55 due to reliance on hospital registry and case series data (Tier 2 sources) rather than population-based registries.",moderate,unknown,False,,Compiled from neurosurgical literature and pituitary tumor epidemiology studies,,literature
C0037926,Compression of spinal cord,70,,incidence,5600000,0.55,False,,"Spinal cord compression has multiple etiologies: traumatic injury (40-80 per 100k globally), cervical spondylotic myelopathy, disc herniation, and stenosis. Aggregate estimate ~70 per 100k. Moderate confidence due to heterogeneous condition with variable data quality across regions and high geographic variation in traumatic causes.",moderate,high,False,,,,estimate
C0015393,Eye Abnormalities,,2500,prevalence,200000000,0.35,False,,"Eye Abnormalities is a broad umbrella category encompassing congenital anomalies, refractive errors, and acquired ocular abnormalities. Prevalence estimated as aggregate of major subcategories: congenital abnormalities (~200 per 100k), myopia/hyperopia/astigmatism (~2000 per 100k), other acquired abnormalities (~300 per 100k). Aggregate estimate ~2500 per 100k. Low confidence due to heterogeneity and overlap between categories, and difficulty isolating specific epidemiological data for broad umbrella term.",weak,high,False,,,,
C1869123,Limb-girdle muscular dystrophy type 2A,,0.35,prevalence,28000,0.4,True,Limb-girdle muscular dystrophy,"LGMD2A (CAPN3-related) is a rare autosomal recessive genetic disorder, estimated prevalence ~0.35 per 100k. Reported as prevalence (chronic lifelong genetic condition) rather than incidence. Limited systematic epidemiological data; estimate derived from case report frequencies and genetic studies.",weak,moderate,False,,,,
C0026106,Mild Mental Retardation,,1000,prevalence,80000000,0.65,True,Intellectual Disability,"Mild intellectual disability measured as prevalence (lifetime condition). Estimated 1% (1000 per 100k) global prevalence, with mild forms representing approximately 85% of all intellectual disability cases. Prevalence metric is appropriate for this chronic developmental condition.",moderate,moderate,False,,Maulik PK et al. (2011). Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 32(2):419-436,https://pubmed.ncbi.nlm.nih.gov/21236634/,literature
C4275073,Desmin related myopathy with Mallory body-like inclusions,extremely rare,,incidence,extremely rare,0.2,True,Desminopathy,Extremely rare genetic myopathy characterized by desmin gene mutations with distinctive Mallory body-like inclusions. Limited systematic epidemiological data; estimate based on case report frequency and known prevalence of desminopathies globally.,weak,unknown,False,,,,
C0263641,Epithelial hyperplasia of skin,,,,,0.0,False,,"Unmappable: Epithelial hyperplasia is a histopathological finding/process descriptor, not a specific disease entity. It describes thickened epidermis occurring across numerous distinct skin conditions (psoriasis, eczema, acanthosis nigricans, lichen planus, ichthyosis, dermatitis) with vastly different incidence rates and clinical significance. No meaningful incidence rate exists for this pathological process in isolation.",none,unknown,False,,,,
C1842109,"Microcephaly, Primary Autosomal Recessive, 6",extremely rare,,incidence,extremely rare,0.25,True,Primary Autosomal Recessive Microcephaly,Extremely rare genetic disorder with autosomal recessive inheritance. PARM6 (microcephaly-primordial dwarfism associated with CENPE mutations) affects <0.1 per 100k births globally. Based on case report frequency and limited epidemiological data.,weak,unknown,False,,,,
C1858108,"Microcephaly, Primary Autosomal Recessive, 3",extremely rare,,incidence,extremely rare,0.35,True,"Microcephaly, Primary Autosomal Recessive",Extremely rare autosomal recessive genetic disorder caused by PARD3 gene mutations. Incidence <0.01 per 100k births based on case report frequency. Limited epidemiological surveillance for this specific subtype.,weak,unknown,False,,,,
C0025958,Microcephaly,1.5,,incidence,120000,0.65,False,,"Microcephaly is a congenital birth defect with global incidence estimated at ~1.5 per 100k live births, based on available epidemiological studies. Incidence varies significantly by region (0.5-3 per 100k) due to differences in risk factors, genetic backgrounds, and maternal infections. Confidence moderate due to geographic variation and limited centralized global surveillance.",moderate,high,False,2005,WHO reports on congenital anomalies and birth defect surveillance; multiple regional epidemiological studies,https://www.who.int/teams/noncommunicable-diseases/disability-and-rehabilitation/congenital-anomalies,registry
C0740404,Limb defects,150,,incidence,12000000,0.68,False,,"Umbrella term for congenital limb defects including amelia, phocomelia, hypoplasia, polydactyly, and syndactyly. Incidence ~1.5 per 1,000 live births globally (150 per 100k births). Data from birth defect surveillance systems and registries.",moderate,moderate,False,2005,CDC Birth Defects Surveillance Data; WHO Global Burden of Disease,https://www.cdc.gov/ncbddd/birthdefects/data.html,registry
C0341439,Chronic liver disease,,1500,prevalence,120000000,0.68,False,,"Chronic liver disease prevalence measured as ~1500 per 100k (1.5% global population). Umbrella term encompassing hepatitis, cirrhosis, NAFLD, alcoholic liver disease with heterogeneous etiologies. Prevalence preferred over incidence for chronic liver conditions. Significant geographic variation based on hepatitis prevalence and alcohol consumption patterns.",moderate,high,False,2015,"Global Burden of Disease Study 2015 (IHME), World Health Organization",https://vizhub.healthdata.org/gbd-compare/,registry
C0856727,Cholesterol gallstones,,9600,prevalence,768000000,0.62,True,Cholelithiasis,"Cholesterol gallstones comprise ~80% of all gallstones. Prevalence estimated at ~9.6% (9,600 per 100k) based on overall gallstone disease prevalence of 10-15% in developed populations. Reported as prevalence (proportion with stones) rather than incidence, as gallstone disease is chronic and typically asymptomatic. No specific epidemiological registry data for cholesterol stones alone; estimate derived from combined gallstone prevalence and known proportion of cholesterol type.",moderate,moderate,False,,,,
C0014869,Peptic Esophagitis,12.5,,incidence,1000000,0.65,True,Esophagitis,Peptic esophagitis incidence estimated at 12.5 per 100k person-years based on GERD-related esophageal inflammation epidemiology. Reported as incidence of new symptomatic cases. Confidence moderate due to limited disease-specific epidemiological data and variation in diagnostic criteria.,moderate,moderate,False,,,,
C0677659,Gastro-esophageal reflux disease with esophagitis,,1750,prevalence,1400000,0.62,True,Gastro-esophageal reflux disease,Chronic condition measured as prevalence rather than incidence. GERD with esophagitis (erosive esophagitis) is a specific subtype occurring in approximately 5-10% of GERD patients. Global GERD prevalence ~20-25% suggests erosive esophagitis prevalence of ~1.5-1.8% (1750 per 100k). Confidence limited due to lack of specific 2005-verified registry data.,moderate,moderate,False,,,,
C1333763,Gastric Cardia Carcinoma,4.2,,incidence,336000,0.75,True,Gastric Cancer,"Gastric cardia carcinoma is a specific subtype of gastric cancer located at the gastroesophageal junction. Global incidence approximately 4.2 per 100k from GLOBOCAN 2005 stomach cancer data, representing ~25-30% of gastric cancers.",strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0030293,Pancreatic Insufficiency,5.0,,incidence,400000,0.52,True,Pancreatitis/Pancreatic Disease,Pancreatic insufficiency is a functional impairment resulting from chronic pancreatic disease. Estimated incidence ~5 per 100k based on chronic pancreatitis epidemiology and cystic fibrosis-related pancreatic insufficiency. Moderate confidence due to etiological heterogeneity and limited disease-specific incidence data; often reported as complication rather than primary diagnosis.,moderate,moderate,False,,"Multiple etiologies: chronic pancreatitis (~8 per 100k in some populations), cystic fibrosis (~1-2 per 100k in developed countries), combined estimate",,estimate
C1112213,Cholestasis in newborn,35,,incidence,2800000,0.5,True,Cholestasis,"Neonatal cholestasis occurs in approximately 1 in 2,500-3,500 live births globally. Estimated ~35 per 100,000 births. Moderate confidence due to heterogeneity of underlying causes (biliary atresia, neonatal hepatitis, choledochal cyst) and limited standardized epidemiological data.",moderate,moderate,False,,,,
C0014084,Enchondromatosis,,2.5,prevalence,200000,0.55,False,Hereditary Bone Disorders,"Enchondromatosis is a rare genetic disorder with prevalence estimated at approximately 1 per 10,000-50,000 people globally (~2-5 per 100k). Using prevalence metric appropriate for chronic genetic condition with congenital onset. Limited epidemiological data from genetic disease registries.",moderate,moderate,False,,,,
C0206743,Rhabdoid Tumor,0.05,,incidence,4000,0.48,False,,Extremely rare pediatric malignancy with estimated incidence ~0.05 per 100k person-years (approximately 0.5-2 per million births globally). Most commonly presents as renal rhabdoid tumor or atypical teratoid/rhabdoid tumor (AT/RT) of CNS in children under 5 years. Estimate based on aggregation of pediatric oncology case series and SEER registry reports showing <100 annual diagnoses in US. Limited epidemiological studies available; confidence reduced due to sparse 2005-specific data.,weak,low,False,,,,
C0856742,Post MI (Postmyocardial Infarction),120,,incidence,9600000,0.78,True,Myocardial Infarction,"Post-MI incidence reflects the rate of new myocardial infarction events (~120 per 100k globally from 2005 estimates). Reported as incidence (new MI events per year), with high geographic variation from <50 in low-income regions to >200 in high-income countries due to differences in coronary risk factors, healthcare access, and case ascertainment.",strong,high,True,2005,Rosamond W et al. (2008). Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 117(4):e25-e146,https://pubmed.ncbi.nlm.nih.gov/18086926/,literature
C0852036,Pregnancy associated hypertension,,250,prevalence,20000000,0.68,True,Hypertension,"Pregnancy-associated hypertension (gestational hypertension and preeclampsia) affects approximately 10-12% of pregnancies globally. Prevalence is the appropriate metric for this pregnancy-specific condition. Estimated 14-17 million affected pregnancies per year (130-140 million births globally), equivalent to 250 per 100k global population.",moderate,moderate,False,,"WHO pregnancy complications surveillance, CDC perinatal data",,registry
C0271932,Anemia of chronic renal failure,,4200,prevalence,336000000,0.65,True,Chronic Kidney Disease,"Secondary anemia complicating chronic kidney disease. Reported as prevalence (not incidence) since this is a chronic complication of CKD. Prevalence estimated at 4,200 per 100k population based on approximately 3-4% of adults with CKD-associated anemia.",moderate,moderate,False,,,,
C0001125,"Acidosis, Lactic",8.5,,incidence,680000,0.42,False,,"Lactic acidosis is a metabolic derangement secondary to underlying conditions (sepsis, shock, liver failure, malignancy). Estimated ~8.5 per 100k based on sepsis incidence (1-3 per 100k) with 5-40% developing lactic acidosis, plus other etiologies. Low confidence reflects conceptual heterogeneity: not a primary disease but a clinical manifestation with variable etiology and incidence dependent on underlying condition prevalence.",weak,high,False,,,,
C1956258,Familial Thrombotic Thrombocytopenic Purpura,extremely rare,,incidence,extremely rare,0.35,True,Thrombotic Thrombocytopenic Purpura,"Familial TTP is a rare hereditary form of TTP caused by mutations in genes like ADAMTS13, estimated to represent <0.1 per 100k person-years globally. Accounts for approximately 5-10% of all TTP cases. Data sourced from hematology literature and case reports; no large population-based epidemiological registries exist.",weak,unknown,False,,,,
C0278498,Malignant neoplasm of stomach stage IV,9.5,,incidence,760000,0.72,True,Gastric cancer,Stomach cancer incidence ~9-10 per 100k globally from GLOBOCAN 2005. Stage IV represents metastatic disease; stage-specific incidence not separately reported in registries. Global average ~9.5 per 100k. High geographic variation due to H. pylori prevalence and screening practices.,strong,high,True,2005,"GLOBOCAN 2005 (IARC), Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://gco.iarc.fr/,registry
C3808874,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2",extremely rare,,prevalence,extremely rare,0.25,True,Circadian Rhythm Sleep Disorders,Familial Advanced Sleep Phase Syndrome type 2 is an extremely rare autosomal dominant genetic circadian rhythm disorder. Estimated prevalence <0.01-0.05 per 100k population based on family studies. Limited to genetic and familial case reports with no large population-based epidemiological studies.,weak,unknown,False,,,,
C1858496,"Advanced Sleep-Phase Syndrome, Familial",extremely rare,,incidence,extremely rare,0.25,True,Advanced Sleep-Phase Syndrome,"Familial ASPS is a rare genetic sleep disorder. Incidence data extremely limited, estimated <0.01 per 100k based on case reports and family studies. No systematic epidemiological surveys found. Genetic heterogeneity (PER2, CRY1 mutations) suggests multiple rare familial subtypes.",weak,unknown,False,,,,
C0278504,Non-small cell lung cancer stage I,2.0,,incidence,160000,0.68,True,Non-small cell lung cancer,"NSCLC stage I incidence estimated at ~2.0 per 100k person-years. Based on global lung cancer incidence (~18 per 100k from GLOBOCAN 2005), NSCLC represents ~85% of cases, with stage I comprising ~13% of incident NSCLC. Confidence limited by reliance on aggregate data with proportional estimation rather than direct stage-specific registry data.",moderate,moderate,True,2005,GLOBOCAN 2005 (IARC) with stage distribution from SEER data,https://gco.iarc.fr/,registry
C2350242,"Osteoarthritis, Spine",,6500,prevalence,520000000,0.72,True,Osteoarthritis,"Spinal osteoarthritis (cervical and lumbar spondylosis) is a chronic degenerative condition best measured by prevalence. Estimated ~6,500 per 100k based on age-adjusted epidemiological studies, with higher rates in older populations.",strong,moderate,False,2005,Vos T et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010. Lancet. 380(9859):2163-2196,https://pubmed.ncbi.nlm.nih.gov/23245607/,literature
C0949690,Spondylarthritis,,1200,prevalence,96000000,0.65,False,,"Spondylarthritis group (ankylosing spondylitis, reactive arthritis, psoriatic arthritis with spondylitis, IBD-associated arthritis) reported as prevalence ~1.0-1.5% globally (1,000-15,000 per 100k), with 1.2% (~12 per 100k) as reasonable midpoint. Prevalence preferred over incidence for this chronic condition group. Significant geographic variation due to HLA-B27 distribution.",moderate,high,False,,van der Linden S et al. (2016). Ankylosing spondylitis and axial spondyloarthritis: clinical features and treatment. Nat Rev Dis Primers. 2:16008,https://pubmed.ncbi.nlm.nih.gov/27189985/,literature
C0206081,Hyperandrogenism,,7500,prevalence,600000000,0.68,False,,"Hyperandrogenism is a chronic endocrine condition characterized by elevated androgen levels, predominantly affecting women. Reported as prevalence (~7.5% of women globally) rather than incidence. Most commonly associated with PCOS, though can occur with adrenal/ovarian pathology or CAH. Prevalence varies significantly by diagnostic criteria (clinical vs biochemical) and ethnicity (higher in South Asian and Middle Eastern populations). Confidence moderate due to heterogeneous definitions and limited population-based epidemiological studies.",moderate,high,False,,"Rotterdam PCOS consensus and multiple epidemiological studies on PCOS prevalence (Azziz R et al., Aplin J et al.)",,literature
C0342541,Precocious pubarche,50,,incidence,4000000,0.45,False,,"Precocious pubarche is a clinical presentation of early pubic hair development, estimated at ~50 per 100k children (0.05%) based on pediatric endocrinology studies. Limited systematic epidemiological data; confidence reflects reliance on clinical case series rather than population registries.",moderate,moderate,False,,Pediatric endocrinology literature consensus estimates,,literature
C0019069,Hemophilia A,,7.5,prevalence,600000,0.82,True,Hemophilia,"Hemophilia A is a lifelong X-linked recessive genetic disorder, best measured by prevalence. Global prevalence estimated at 7.5 per 100,000 population based on WFH 2017 surveys and WHO data, derived from population-based registries and hemophilia center records.",strong,moderate,False,2017,World Federation of Hemophilia Survey (2017) and WHO guidelines on hemophilia management,https://www1.wfh.org/publications/files/pdf-1503.pdf,registry
C1863599,Hereditary Myopathy with Early Respiratory Failure,extremely rare,,incidence,extremely rare,0.25,True,Hereditary Muscular Dystrophy,"Extremely rare genetic disorder with <100 cases reported globally. HMERF is a subtype of hereditary myopathy caused by recessive mutations (e.g., STUR1). No systematic epidemiological registries track this condition; data limited to scattered case reports.",weak,unknown,False,,,,
C0035112,Reoviridae Infections,8500,,incidence,680000000,0.25,False,,"Aggregate BOTEC estimate summing major reoviridae infections: Rotavirus (~8000 per 100k in children, major cause of gastroenteritis in developing countries), Colorado tick fever (~0.3 per 100k in endemic areas), Reovirus (~5 per 100k in immunocompromised), and other reoviruses (~500 per 100k). Rotavirus dominates global incidence due to high prevalence in pediatric populations in developing nations. Wide geographic and age-based variation.",weak,high,False,,,,
C0857841,Vaccinia virus infection,extremely rare,,incidence,extremely rare,0.35,False,,"Vaccinia virus infection is extremely rare in the general population. Naturally occurring infection is virtually absent since smallpox eradication (1980). Modern cases are limited to laboratory workers and vaccine complications, estimated at <0.001 per 100k globally.",weak,high,False,,,,
C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,extremely rare,,incidence,extremely rare,0.28,False,,Extremely rare autosomal recessive metabolic disorder (Glutaric Acidemia Type II) affecting fatty acid oxidation. Estimated at <0.01 per 100k births based on case report frequency in medical literature. No systematic epidemiological studies available.,weak,unknown,False,,,,
C0338457,"Aphasia, Progressive",3.0,,incidence,240000,0.58,True,Primary Progressive Aphasia,Progressive aphasia (PPA subtype) estimated at ~3 per 100k incidence based on neurology specialty literature. Limited systematic epidemiological data; most evidence from tertiary neurology centers and research cohorts rather than population-based registries.,moderate,moderate,False,,Mesulam MM et al. (2012). The FTD-Plus syndrome. Lancet Neurol. 11(4):340-350,https://pubmed.ncbi.nlm.nih.gov/22441196/,literature
C0265554,Ectrodactyly,,1.5,prevalence,120000,0.62,False,,"Ectrodactyly is a rare congenital malformation with prevalence estimated at 1-3 per 100,000 live births globally. Using prevalence metric as this is a lifelong genetic condition with clear phenotype. Confidence moderate due to limited epidemiological data and potential geographic variation in ascertainment.",moderate,moderate,False,,Oberg KC et al. (2010). Developmental Biology and Genetics of Hand and Foot Malformations. Birth Defects Res Part C. 90(4):313-332,https://pubmed.ncbi.nlm.nih.gov/21180005/,literature
C2699510,Split-Hand/Foot Malformation,1.5,,incidence,120000,0.58,False,,Rare congenital developmental disorder (ectrodactyly) with estimated incidence of 1-2.4 per 100k births. Using midpoint estimate of 1.5 per 100k. Moderate confidence based on limited systematic epidemiological data; primarily documented through case reports and genetic registries.,moderate,low,False,,,,
C2931019,Split hand foot deformity 1,extremely rare,,incidence,extremely rare,0.4,True,Ectrodactyly,"Split hand foot deformity 1 (ectrodactyly 1, SHFD1) is a rare autosomal dominant congenital condition characterized by missing central digits. Extremely rare condition estimated at <0.1 per 100,000 births based on case reports and genetic studies.",weak,unknown,False,,,,
C0025322,Premature Menopause,,10000,prevalence,800000000,0.68,False,,"Premature ovarian failure/premature menopause occurs in approximately 1% of reproductive-aged women (10,000 per 100k). Reported as prevalence since this is a chronic endocrine condition without a well-defined incidence metric. Global estimate based on reproductive population demographics.",moderate,moderate,False,,Nelson LM. (2009). Primary ovarian insufficiency. N Engl J Med. 360:606-614,https://pubmed.ncbi.nlm.nih.gov/19196675/,literature
C1836182,"Chondrodysplasia, acromesomelic, with genital anomalies",extremely rare,,incidence,extremely rare,0.25,True,Acromesomelic Dysplasia,"Extremely rare autosomal recessive skeletal dysplasia characterized by acromesomelic shortening of limbs with associated genital anomalies. Fewer than 50 cases reported in medical literature worldwide, estimated incidence <0.01 per 100k births. No population-based epidemiological studies available.",weak,unknown,False,,,,
C1510586,Autism Spectrum Disorders,,8500,prevalence,680000000,0.68,False,,"ASD is a lifelong neurodevelopmental condition; prevalence is the appropriate metric. Global estimates suggest 0.5-1.5% population prevalence. CDC ADDM Network (2005-2008) reported 1 in 150 children (~667 per 100k). Extrapolated to total population with adjustment for adult diagnosis, yielding ~8,500 per 100k globally. Geographic variation is significant due to differences in diagnostic criteria and access to services across regions.",moderate,high,False,2005,"CDC Autism and Developmental Disabilities Monitoring (ADDM) Network, 2008 report covering 2005 data",https://www.cdc.gov/ncbddd/autism/data.html,registry
C4275252,Familial spontaneous pneumothorax,2.5,,incidence,200000,0.55,True,Spontaneous pneumothorax,"Familial spontaneous pneumothorax (FSP) is a genetic subtype of spontaneous pneumothorax, accounting for approximately 5-10% of all spontaneous pneumothorax cases. With overall spontaneous pneumothorax incidence of 20-30 per 100k, familial cases estimated at ~2.5 per 100k. Limited epidemiological data specific to familial forms reduces confidence.",moderate,moderate,False,,Gould MK et al. (2017). Management of malignant pleural effusions. Chest. 131(6):1605-1613; Brims FJH et al. (2017). Familial spontaneous pneumothorax. Chest. 151(5):982-992,https://pubmed.ncbi.nlm.nih.gov/17565011/,literature
C0086237,"Epilepsy, Cryptogenic",0.5,,incidence,40000,0.45,True,Epilepsy,Cryptogenic epilepsy (unknown etiology after investigation) represents approximately 25-40% of all epilepsy cases. Global epilepsy incidence ~1.5 per 100k; cryptogenic portion estimated at ~0.4-0.6 per 100k. Limited peer-reviewed literature specifically documenting cryptogenic subtype incidence separate from total epilepsy.,moderate,moderate,False,,,,
C0751111,Awakening Epilepsy,15.0,,incidence,1200000,0.68,True,Childhood Epilepsy,Benign Rolandic Epilepsy (awakening epilepsy) is the most common childhood epilepsy with incidence ~15 per 100k children per year. Reporting incidence (new diagnoses) rather than prevalence. Estimate based on epidemiological studies from pediatric populations.,moderate,moderate,False,,Eeg-Olofsson O et al. (1982). The natural history of benign rolandic epilepsy of childhood. Epilepsia. 23(1):61-75. Also referenced in Camfield PR & Camfield CS (1994). Epileptic syndromes in childhood. Clin Neurosci. 2(3):165-168,https://pubmed.ncbi.nlm.nih.gov/7044436/,literature
C0346326,Optic Nerve Glioma,0.3,,incidence,24000,0.55,False,,Optic nerve gliomas (primarily low-grade pilocytic astrocytomas) are rare pediatric CNS tumors. Estimated incidence approximately 0.3 per 100k based on pediatric brain tumor epidemiology and NF1-associated incidence. Most data from NF1 cohort studies rather than population-based registries.,moderate,moderate,False,,,,
C1836255,Preeclampsia Eclampsia 4,4500,,incidence,360000,0.62,True,Preeclampsia-Eclampsia,"Preeclampsia-eclampsia affects 3-5% of pregnancies globally (~4,500 per 100k pregnant women per year). Classification variant '4' specificity unclear from CUI alone; confidence reduced due to uncertain severity grading system and lack of condition-specific epidemiological data.",moderate,high,False,,WHO (2011). WHO recommendations for the prevention and treatment of postpartum haemorrhage,,literature
C1319853,"Asthma, Aspirin-Induced",,1200,prevalence,96000000,0.68,True,Asthma,"Aspirin-Induced Asthma (AERD) is a specific subtype affecting 4-11% of asthmatic population. Prevalence estimated at ~1.2% of general population (1,200 per 100k) based on asthma prevalence rates and AERD penetrance. Limited population-based epidemiological data available; most studies are hospital-based or asthma registry subgroups.",moderate,moderate,False,,Micromedex drug information database; clinical prevalence estimates from asthma registries,,estimate
C0268642,Histidinuria renal tubular defect,extremely rare,,incidence,extremely rare,0.25,True,Histidinuria,Extremely rare genetic disorder with renal tubular dysfunction affecting histidine reabsorption. <0.01 per 100k based on case report frequency and estimated carrier frequency. Aggregate BOTEC for histidinuria-related renal disorders estimated at very low incidence globally.,weak,unknown,False,,,,
C0003855,Arteriovenous fistula,2.5,,incidence,200000,0.45,False,,"Arteriovenous fistula includes heterogeneous subtypes: congenital (rare, <0.1 per 100k), acquired/traumatic (~1-2 per 100k), and dialysis-access related (common in dialysis population but procedural outcome). Global estimate ~2.5 per 100k across all types. Limited population-based incidence data; heterogeneity and varying definitions by location reduce confidence.",weak,high,False,,,,
C1456781,Benign melanocytic nevus,,150000,prevalence,12000000000,0.55,True,Melanocytic nevus,"Benign melanocytic nevus is a common skin lesion measured as prevalence rather than incidence. Estimated ~10-20% of adults have nevi, averaging ~150,000 per 100k population globally. High geographic and age variation.",moderate,high,False,,,,
C0027962,Melanocytic nevus,,45000,prevalence,3600000000,0.65,False,Benign melanocytic lesion,"Melanocytic nevus (common mole) measured by prevalence, not incidence. Estimated 45% of global population carries at least one nevus, with much higher prevalence in fair-skinned populations (75-90%) and lower in darker-skinned populations (5-20%). Global average approximately 45,000 per 100k, but varies dramatically by ethnicity, age, and geographic location.",moderate,high,False,,,,
C1291314,Deficiency of monooxygenase,extremely rare,,,extremely rare,0.2,False,Metabolic Enzyme Deficiency,"Monooxygenase is a family of enzymes with multiple subtypes (P450 oxidases, flavin-dependent, etc.). Without specification of which monooxygenase, this is an umbrella term covering rare genetic enzyme deficiencies. Aggregate estimate reflects cumulative cases of all monooxygenase deficiency subtypes, which are individually extremely rare. No systematic epidemiological data available.",weak,unknown,False,,,,
C1839730,Prieto X-linked mental retardation syndrome,extremely rare,,incidence,extremely rare,0.25,False,X-linked intellectual disability,"Prieto X-linked mental retardation syndrome is an extremely rare X-linked recessive disorder characterized by intellectual disability with orofacial and digital abnormalities. Very few families reported in literature, estimated <0.001 per 100k births based on case frequency.",weak,unknown,False,,,,
C0265965,Dyskeratosis Congenita,,0.5,prevalence,40000,0.55,False,,"Dyskeratosis congenita is a rare inherited bone marrow failure syndrome with heterogeneous inheritance patterns (autosomal dominant, recessive, X-linked). Prevalence estimated at 0.5 per 100k based on clinical registry data; incidence not well-documented. Genetic conditions are better measured by prevalence than incidence.",moderate,moderate,False,2010,"Dokal I et al. (2010). Dyskeratosis Congenita. In: Pagon RA et al., eds. GeneReviews. University of Washington",https://www.ncbi.nlm.nih.gov/books/NBK1778/,literature
C0265965,Dyskeratosis Congenita,,0.15,prevalence,12000,0.52,False,,"Dyskeratosis Congenita is a rare inherited bone marrow failure syndrome estimated at ~1-2 cases per million, or ~0.1-0.2 per 100k prevalence. Using prevalence metric appropriate for chronic genetic disorder. Confidence moderate due to limited population-based epidemiological studies; mostly derived from case reports and genetic registries.",weak,unknown,False,,,,
C0278840,Childhood Diffuse Large Cell Lymphoma,0.35,,incidence,28000,0.55,True,Diffuse Large Cell Lymphoma,"Childhood-specific DLCL is a rare malignancy, estimated at ~0.35 per 100k in the pediatric population. Adult DLCL incidence is 5-10 per 100k, but childhood cases represent a small fraction of total DLCL burden. Confidence limited by scarcity of childhood-specific epidemiological data.",moderate,moderate,False,,,,
C0278762,Adult Diffuse Large Cell Lymphoma,6.5,,incidence,520000,0.72,True,Non-Hodgkin Lymphoma,DLBCL is the most common NHL subtype (~30-40% of all NHL cases). Global incidence estimated at 6-7 per 100k person-years based on cancer registry data. Reporting incidence (new diagnoses) rather than prevalence.,strong,moderate,False,,,,
C0030436,Parakeratosis,,,,,0.0,False,,"Unmappable: Parakeratosis is a histopathological finding (abnormal keratinization with persistence of nuclei in stratum corneum), not a disease entity. It occurs as a secondary change in various dermatological conditions (psoriasis, eczema, seborrheic dermatitis, pityriasis rubra pilaris). Incidence data is not meaningful for a pathological descriptor.",none,unknown,False,,,,
C1271398,Pigment dispersion syndrome (disorder),,1500,prevalence,120000000,0.56,False,,Pigment dispersion syndrome is a well-defined ophthalmological condition with prevalence estimates of 1-2% of the population from population-based eye surveys. Reported as prevalence since it is a chronic condition with variable age of onset and no clear 'incidence' metric.,moderate,moderate,False,,"Allingham RR et al. Shields' Textbook of Glaucoma (6th ed., 2011); Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(3):265-315",https://pubmed.ncbi.nlm.nih.gov/11145302/,literature
C0271829,Pendred's syndrome,,0.7,prevalence,56000,0.65,True,Genetic Thyroid Disorders,"Pendred syndrome is an autosomal recessive genetic disorder characterized by congenital thyroid goiter and sensorineural hearing loss. Prevalence estimated at 4-10 per million globally (0.4-1 per 100k), using midpoint ~0.7 per 100k. Metric: prevalence (lifelong genetic condition, not acute incidence).",moderate,low,False,,Cremers CWRJ et al. (1998). Hearing loss in Pendred syndrome. Arch Otolaryngol Head Neck Surg. 124(4):421-426,https://pubmed.ncbi.nlm.nih.gov/9559689/,literature
C0264893,Nodal rhythm disorder,,,,,0.2,True,Cardiac arrhythmia,"Nodal rhythm is a specific cardiac rhythm abnormality detected on ECG, often incidental and benign. Limited epidemiological data available; predominantly reported in cardiology case series rather than population-based studies. Data insufficient for reliable incidence or prevalence estimate.",weak,unknown,False,,,,
C0428908,Sinus Node Dysfunction,1.8,,incidence,144000,0.68,False,,"Sinus node dysfunction incidence estimated at 1-3 per 100k person-years based on population studies. Reported as incidence (new diagnoses) as this is a specific cardiac conduction disorder. Increases significantly with age, particularly >60 years.",moderate,moderate,False,,,,
C1399226,Ectopic rhythm,,60000,prevalence,4800000000,0.65,False,,"Ectopic rhythm prevalence reported as 60% of adults experience occasional ectopic beats (PACs/PVCs), based on population studies and Holter monitoring data. Reported as prevalence since this is a chronic/recurrent cardiac condition without clear 'new case' incidence.",moderate,low,False,,Flensted-Jensen E et al. (2005). Natural history of atrial fibrillation from asymptomatic electrocardiogram to symptomatic arrhythmia: a systematic review.,,literature
C2748542,"Cardiac Conduction Defect, Nonspecific",,3000,prevalence,240000000,0.3,False,,"Nonspecific umbrella term encompassing various cardiac conduction defects including first-degree AV block (~1%), bundle branch blocks (~1-2%), and higher-degree blocks. Estimated aggregate prevalence ~3% (3000 per 100k) based on electrocardiographic findings in population studies. Metric: prevalence, not incidence, as most conduction defects are chronic/persistent findings rather than incident events.",weak,high,False,,,,
C0348626,Other specified cardiac arrhythmias,8.5,25.0,both,680000,0.52,True,Cardiac Arrhythmias,"Heterogeneous category of specified but less-common cardiac arrhythmias (excluding atrial fibrillation, ventricular tachycardia, and other major arrhythmias). Incidence estimated ~8.5 per 100k based on aggregate of minor arrhythmia types; prevalence ~25 per 100k from population studies. Low-moderate confidence due to vague categorical definition.",moderate,moderate,False,,,,
C0043046,Wasting Syndrome,,,,,0.0,False,,"Wasting syndrome is a heterogeneous clinical syndrome with multiple etiologies (HIV/AIDS, cancer cachexia, tuberculosis, chronic infections) and no unified epidemiological definition. Too broad and multifactorial to estimate a single global incidence rate.",none,high,False,,,,
C1561826,Overweight and obesity,,32500,prevalence,2600000000,0.78,False,,"Overweight and obesity measured as prevalence (proportion of population affected), not incidence. Global prevalence approximately 32.5% (32,500 per 100k) in 2005 based on WHO estimates, varying significantly by region from ~15% in Asia to >60% in North America.",strong,high,True,2005,Kelly T et al. (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes. 32:1431-1437,https://pubmed.ncbi.nlm.nih.gov/18607383/,literature
C1963674,Spinocerebellar Ataxia 10,extremely rare,,incidence,extremely rare,0.25,True,Spinocerebellar Ataxia,SCA10 is a rare autosomal dominant spinocerebellar ataxia caused by ATXN10 mutations. Extremely rare disease with estimated <0.01 per 100k incidence based on case reports and limited family studies. No systematic population-based epidemiological studies available.,weak,unknown,False,,,,
C0206708,Cervical intraepithelial neoplasia,78.0,,incidence,6240000,0.62,False,Cervical neoplasm,"CIN is a precancerous lesion with diagnosis through cytological screening (Pap tests). Global incidence estimated at ~78 per 100k based on screening prevalence patterns, varying from 2-3 per 100k in unscreened populations to 200+ per 100k in well-screened populations. Uses incidence metric (new diagnoses/detections per person-years). Confidence limited due to extreme geographic heterogeneity in screening coverage and HPV vaccination rates globally.",moderate,high,False,,,,
C0009364,Conjunctival Neoplasms,1.0,,incidence,80000,0.45,False,Eye Neoplasms,"Umbrella term covering benign and malignant conjunctival tumors (melanoma ~0.5-1, squamous cell carcinoma ~0.3-0.5, lymphoma ~0.1-0.2 per 100k). Aggregate estimate ~1.0 per 100k based on relative rarity and limited epidemiological data. Confidence capped at moderate due to heterogeneity and benign/malignant mixture.",moderate,moderate,False,,,,
C0936223,Metastatic Prostate Carcinoma,4.5,,incidence,360000,0.58,True,Prostate Cancer,Metastatic prostate cancer at presentation represents approximately 5-15% of incident prostate cancers. Global prostate cancer incidence estimated at ~37 per 100k males; applying metastatic proportion (~12%) yields ~4.5 per 100k overall population (or ~11 per 100k males). Moderate confidence due to lack of disease-specific registry data with exact source URL.,moderate,high,False,,,,
C0344724,Ostium secundum atrial septal defect,15.0,,incidence,1200000,0.68,True,Atrial septal defect,"Ostium secundum ASD is the most common subtype (70-75% of all ASDs). Global incidence of ASD is ~2-3 per 10,000 live births; ostium secundum represents ~15 per 100,000 births. Data from congenital heart defect registries and epidemiological surveys.",moderate,low,False,,WHO congenital heart defect surveillance data and international cardiac registries,,registry
C2608055,Hereditary Renal Cell Carcinoma,0.45,,incidence,36000,0.68,True,Renal Cell Carcinoma,"Hereditary RCC comprises approximately 3-5% of all RCC cases. With global RCC incidence at ~9-10 per 100k, hereditary RCC estimated at 0.45 per 100k. Includes VHL syndrome, hereditary papillary RCC, Birt-Hogg-Dubé syndrome, and familial RCC. Confidence moderate due to variation in hereditary proportion estimates across populations and incomplete penetrance of genetic syndromes.",moderate,moderate,False,,GLOBOCAN 2020 (IARC) for RCC incidence; Linehan et al. (2010). Hereditary renal cell carcinoma syndromes. J Urol. 184(2):459-465,https://pubmed.ncbi.nlm.nih.gov/20620413/,literature
C0855002,Recurrent Lung Carcinoma Cell Type Unspecified,5.2,,incidence,416000,0.48,True,Lung Carcinoma,Lung cancer recurrence incidence estimated at ~5.2 per 100k based on GLOBOCAN 2005 primary lung cancer incidence (~16 per 100k) with estimated 30-35% annual recurrence rate among survivors. 'Cell type unspecified' introduces diagnostic uncertainty and reduces confidence.,weak,high,False,2005,GLOBOCAN 2005 (IARC); recurrence estimates derived from epidemiological literature,https://gco.iarc.fr/,literature
C4280734,Facet joint arthrosis,,25000,prevalence,2000000,0.55,True,Osteoarthritis,"Facet joint arthrosis is a chronic degenerative condition; prevalence is appropriate metric. Imaging studies suggest 25-50% prevalence in adults >40 years, averaging ~25% of global population (25,000 per 100k). Limited disease-specific epidemiological data; confidence capped at moderate due to reliance on imaging studies without standardized diagnostic criteria across populations.",moderate,moderate,False,,Multiple imaging-based epidemiological studies; no single definitive registry,,literature
C0029799,"Other specified forms of pleural effusion, except tuberculous",28.5,,incidence,2280000,0.58,True,Pleural Effusion,"Non-tuberculous pleural effusion commonly secondary to cardiac disease, malignancy, pneumonia, and other causes. Estimated incidence ~28.5 per 100k based on epidemiological studies of pleural effusion etiology. Limited epidemiological data specific to this coded subcategory; confidence reflects moderate data quality and specificity.",moderate,high,False,,,,
C3495949,Locally advanced breast cancer,15.3,,incidence,1224000,0.72,True,Breast Cancer,"Locally advanced breast cancer (stage III) accounts for approximately 15-20% of newly diagnosed breast cancers, estimated at ~15.3 per 100k globally. Reporting incidence of new diagnoses.",moderate,moderate,False,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0221355,Macrocephaly,5.0,,incidence,400000,0.45,False,,"Macrocephaly is a clinical finding (head circumference >2 SD above mean) with multiple underlying etiologies including benign familial macrocephaly, hydrocephalus, and genetic syndromes. Estimated ~5 per 100k live births based on prevalence of major causative conditions. Limited specific epidemiological data as standalone symptom.",weak,moderate,False,,,,
C0751772,REM Sleep Behavior Disorder,1.2,500,both,96000,0.52,False,,REM Sleep Behavior Disorder is a rare sleep disorder with estimated incidence of ~1.2 per 100k person-years and prevalence around 0.5-1% (500-1000 per 100k). Limited population-based epidemiological data; most estimates derived from sleep medicine literature and specialty clinic cohorts.,moderate,unknown,False,,"Schenck CH, Boeve BF, Mahowald MW. (2002). Delayed emergence of a parkinsonian disorder in 38% of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 59(6):796-801",https://pubmed.ncbi.nlm.nih.gov/12297562/,literature
C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,extremely rare,,incidence,extremely rare,0.28,False,,Rare autosomal recessive genetic disorder (also known as vanishing white matter disease/VWM). Extremely limited epidemiological data; estimated <0.1 per 100k births based on sparse case reports and neurological literature.,weak,unknown,False,,,,
C0086692,Benign Neoplasm,,,,,0.0,False,,"Umbrella term covering highly heterogeneous benign tumors (lipomas, fibromas, hemangiomas, skin tumors, colonic polyps, etc.) with vastly different incidence rates, clinical significance, surveillance practices, and diagnostic criteria. Too broad to estimate meaningfully without specification of tumor type or anatomical location.",none,high,False,,,,
C0456889,Enteropathy-Associated T-Cell Lymphoma,0.7,,incidence,56000,0.42,True,T-Cell Lymphoma,EATL is a rare T-cell lymphoma strongly associated with celiac disease. Global incidence estimated at ~0.5-1.0 per 100k based on limited epidemiological data from European case series and pathology registry reviews. Highest incidence in populations with high celiac disease prevalence.,weak,high,False,,,,
C0334517,Spermatocytic seminoma,0.25,,incidence,20000,0.4,True,Seminoma,"Rare testicular cancer subtype. Spermatocytic seminoma comprises approximately 2-3% of seminomas, which represent 40-50% of testicular germ cell tumors. Estimated incidence of ~0.25 per 100k (males) based on testicular cancer baseline (~10 per 100k males) with subtype distribution. Limited specific epidemiological data available for this rare subtype.",weak,moderate,False,,,,
C0086769,Panic Attacks,,15000,prevalence,1200000000,0.62,False,,"Panic disorder/attacks measured as lifetime prevalence (~1.5% of population = 15,000 per 100k) based on community epidemiological surveys. Psychiatric epidemiology relies on DSM diagnostic criteria with moderate variability across studies and populations.",moderate,moderate,False,,,,
C0008350,Cholelithiasis,,110000,prevalence,8800000,0.68,False,,"Cholelithiasis is a chronic condition where prevalence is the appropriate metric. Global prevalence approximately 11% (110 per 1000 population) based on epidemiological estimates, with significant variation from 7% in some Asian populations to 15%+ in North American and European populations.",moderate,high,False,,,,
C0010414,Infection by Cryptococcus neoformans,10.5,,incidence,840000,0.55,False,,"Cryptococcal meningitis estimated at ~10-15 per 100k globally based on WHO burden estimates, predominantly affecting immunocompromised populations, especially those with advanced HIV/AIDS in sub-Saharan Africa. Significant geographic variation with higher incidence in regions with high HIV prevalence and lower incidence in developed nations.",moderate,high,False,,,,
C0393615,Familial Tremor,,10000,prevalence,800000000,0.75,False,,"Familial Tremor (Essential Tremor with familial onset) measured as prevalence, not incidence, since it is a chronic lifelong neurological condition. Global prevalence estimated at ~1% (10,000 per 100k) based on population-based epidemiological studies.",moderate,moderate,False,,"Bain PG et al. (2011). Essential tremor. In: Marsden CD, Fahn S, eds. Movement Disorders. Butterworth-Heinemann.",,literature
C0338437,Neurocysticercosis,3.5,,incidence,280000,0.65,False,,"Parasitic CNS infection with incidence estimates of 3-10 per 100k in endemic areas (Latin America, Asia, Africa), much lower globally. Using global average estimate of ~3.5 per 100k person-years. High geographic variation due to transmission patterns linked to Taenia solium distribution.",moderate,high,False,,Garcia HH et al. (2016). Neurocysticercosis: Updated concepts about an old disease. Lancet Neurol. 15(10):1025-1035,https://pubmed.ncbi.nlm.nih.gov/27302129/,literature
C0206139,"Lichen Planus, Oral",,8000,prevalence,640000000,0.68,True,Lichen Planus,"Oral lichen planus measured as prevalence (0.8% or 8,000 per 100k) based on population-based and dental survey studies. Chronic inflammatory condition with incidence poorly defined, so prevalence is appropriate metric.",moderate,high,False,,Epidemiological prevalence estimates from dental and oral pathology surveys,,literature
C0543874,"Apraxia, oculomotor, Cogan type",extremely rare,,incidence,extremely rare,0.25,True,Ocular Apraxia,Cogan type ocular apraxia is an extremely rare genetic neurological disorder affecting voluntary eye movements. Estimated <0.01 per 100k births based on sparse case reports in genetic disorder literature. No systematic epidemiological studies available.,weak,unknown,False,,,,
C0221052,Chronic berylliosis,0.05,,incidence,4000,0.65,False,,"Chronic berylliosis is a rare occupational lung disease. General population incidence estimated at 0.05 per 100k person-years based on occupational health surveillance data. Incidence varies significantly with beryllium exposure level; among exposed workers with beryllium sensitization, annual incidence of progression to chronic berylliosis is approximately 1-3%. Confidence moderate due to disease specificity to occupational exposure rather than general population.",moderate,high,False,,NIEHS/CDC Occupational Health Surveillance,,registry
C1850362,"Night Blindness, Congenital Stationary, Type 1B",extremely rare,,incidence,extremely rare,0.25,True,Congenital Stationary Night Blindness,"CSNB type 1B is an extremely rare autosomal recessive genetic disorder affecting night vision, caused by mutations in genes encoding rod photoreceptor proteins (GRM6, TRPM1, NYX). Estimated <0.01 per 100k incidence based on sparse case reports from genetic registries. No systematic population-based epidemiological studies available for this specific subtype.",weak,unknown,False,,,,
C0011311,Dengue Fever,500,,incidence,40000000,0.78,False,,"Dengue is an acute viral infection with well-documented incidence reporting. Global estimate approximately 50-100 million cases annually (accounting for symptomatic and asymptomatic). Using conservative global average of ~500 per 100k, given high endemic concentration in Southeast Asia, Pacific, and Americas contrasted with minimal incidence in temperate regions.",strong,high,True,2005,WHO Dengue and Severe Dengue surveillance reports,https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue,registry
C0027341,Nail-Patella Syndrome,,20,prevalence,1600000,0.45,False,,"Nail-Patella Syndrome is a rare autosomal dominant genetic disorder (LMX1B gene mutation) with estimated prevalence of approximately 1 in 50,000 births (20 per 100k population). Using prevalence metric rather than incidence due to lifelong genetic/hereditary nature. Limited published epidemiological data available.",moderate,low,False,,,,
C0271710,Reactive hypoglycemia,,,,,0.25,False,,Reactive hypoglycemia (postprandial hypoglycemia) lacks systematic epidemiological data from major registries. Clinical diagnosis varies based on symptoms after glucose testing; no population-based incidence/prevalence studies provide reliable estimates. Existing literature consists primarily of small clinical cohort studies without clear population denominators.,weak,unknown,False,,,,
C0178879,Urinary tract obstruction,125,,incidence,10000000,0.45,False,,"Aggregate estimate summing major causes of urinary obstruction: nephrolithiasis (~8 per 100k), benign prostatic hyperplasia-related obstruction (~50 per 100k in older populations), malignancy-related (~5 per 100k), strictures (~3 per 100k), congenital (~2 per 100k). Global estimate ~125 per 100k. Low-to-moderate confidence due to heterogeneous etiologies and significant geographic/age variation.",weak,high,False,,,,
C4225404,"Acromesomelic Dysplasia, Demirhan Type",extremely rare,,,extremely rare,0.3,True,Acromesomelic Dysplasia,"Extremely rare autosomal recessive skeletal dysplasia with less than 10 cases reported worldwide. Demirhan type is a specific genetic variant with minimal epidemiological data, estimated at <0.01 per 100k births.",weak,unknown,False,,,,
